0001564590-20-038439.txt : 20200826 0001564590-20-038439.hdr.sgml : 20200826 20200807195229 ACCESSION NUMBER: 0001564590-20-038439 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 64 CONFORMED PERIOD OF REPORT: 20200630 FILED AS OF DATE: 20200807 DATE AS OF CHANGE: 20200807 FILER: COMPANY DATA: COMPANY CONFORMED NAME: LM FUNDING AMERICA, INC. CENTRAL INDEX KEY: 0001640384 STANDARD INDUSTRIAL CLASSIFICATION: FINANCE SERVICES [6199] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-37605 FILM NUMBER: 201086260 BUSINESS ADDRESS: STREET 1: 302 KNIGHTS RUN AVENUE STREET 2: SUITE 1000 CITY: TAMPA STATE: FL ZIP: 33602 BUSINESS PHONE: 813-222-8996 MAIL ADDRESS: STREET 1: 302 KNIGHTS RUN AVENUE STREET 2: SUITE 1000 CITY: TAMPA STATE: FL ZIP: 33602 10-Q 1 lmfa-10q_20200630.htm 10-Q - JUNE 2020 lmfa-10q_20200630.htm

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

FORM 10-Q

 

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2020

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from                  to                 

Commission file number 001-37605

 

LM FUNDING AMERICA, INC.

(Exact name of Registrant as specified in its charter)

 

 

Delaware

47-3844457

(State or other jurisdiction of

incorporation or organization)

(I.R.S. employer

identification no.)

 

 

1200 West Platt Street

Suite 100

Tampa, FL

33606

(Address of principal executive offices)

(Zip code)

Registrant’s telephone number, including area code: 813-222-8996

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class:

Trading symbol

Name of each exchange on which registered

Common Stock par value $0.001 per share

LMFA

The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports) and (2) has been subject to such filing requirements for the past 90 days.    Yes      No  

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).    Yes      No  

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and "emerging growth company" in Rule 12b-2 of the Exchange Act.:

 

Large accelerated filer

Accelerated filer

 

 

 

 

Non-accelerated filer

Smaller reporting company

 

 

 

 

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    Yes      No  

The registrant had 5.1 million shares of Common Stock, par value $0.001 per share, outstanding as of August 6, 2020.

 

 

 

 


LM FUNDING AMERICA, INC.

TABLE OF CONTENTS

 

 

 

Page

 

 

 

PART I.

FINANCIAL INFORMATION

3

 

 

 

Item 1.

Financial Statements

3

 

 

 

 

LM Funding America, Inc. and Subsidiaries Condensed Consolidated Balance Sheets
June 30, 2020 (unaudited) and December 31, 2019

3

 

 

 

 

LM Funding America, Inc. and Subsidiaries Condensed Consolidated Statements of Operations
Three and Six Months Ended June 30, 2020 and 2019 (unaudited)

4

 

 

 

 

LM Funding America, Inc. and Subsidiaries Condensed Consolidated Statements of Cash Flows
Six Months Ended June 30, 2020 and 2019 (unaudited)

5

 

 

 

 

LM Funding America, Inc. and Subsidiaries Condensed Consolidated Statements of Equity
for the Three and Six Months Ended June 30, 2020 and 2019 (unaudited)

6

 

Notes to Unaudited Condensed Consolidated Financial Statements

7

 

 

 

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

25

 

 

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

32

 

 

 

Item 4.

Controls and Procedures

33

 

 

 

PART II.

OTHER INFORMATION

34

 

 

 

Item 1.

Legal Proceedings

34

 

 

 

Item 1A.

Risk Factors

34

 

 

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

34

 

 

 

Item 3.

Defaults Upon Senior Securities

35

 

 

 

Item 4.

Mine Safety Disclosures

35

 

 

 

Item 5.

Other Information

35

 

 

 

Item 6.

Exhibits

36

 

 

SIGNATURES

37

 

2


PART I. FINANCIAL INFORMATION

ITEM 1. Financial Statements

LM Funding America, Inc. and Subsidiaries Condensed Consolidated Balance Sheets

 

 

 

June 30, 2020

 

 

December 31,

2019

 

 

 

(Unaudited)

 

 

 

 

 

ASSETS

 

 

 

 

 

 

 

 

Cash

 

$

6,238,678

 

 

$

822,909

 

Finance receivables:

 

 

 

 

 

 

 

 

Original product - net (Note 3)

 

 

212,121

 

 

 

273,711

 

Special product - New Neighbor Guaranty program, net of allowance for credit losses of (Note 4)

 

 

97,196

 

 

 

129,272

 

Prepaid expenses and other assets

 

 

97,008

 

 

 

145,267

 

Due from related party (Note 5)

 

 

-

 

 

 

125,045

 

Discontinued operations - current assets (Note 10)

 

 

-

 

 

 

276,953

 

Current assets

 

 

6,645,003

 

 

 

1,773,157

 

Fixed assets, net (Note 1)

 

 

6,274

 

 

 

8,288

 

Real estate assets owned  (Note 1)

 

 

13,426

 

 

 

21,084

 

Operating lease - right of use assets (Note 8)

 

 

209,031

 

 

 

260,260

 

Other investments - related party (Note 1)

 

 

-

 

 

 

1,500,000

 

Goodwill (Note 2)

 

 

-

 

 

 

4,039,586

 

Other Assets

 

 

10,220

 

 

 

11,021

 

Discontinued operations - long-term assets, net (Note 10)

 

 

-

 

 

 

27,245

 

Long-term assets

 

 

238,951

 

 

 

5,867,484

 

Total assets

 

$

6,883,954

 

 

$

7,640,641

 

 

 

 

 

 

 

 

 

 

LIABILITIES AND STOCKHOLDERS' EQUITY

 

 

 

 

 

 

 

 

Note payable (Note 6)

 

 

-

 

 

 

69,540

 

Related party convertible note payable

 

 

-

 

 

 

3,461,782

 

Accounts payable and accrued expenses

 

 

131,940

 

 

 

210,870

 

Due to related party (Note 5)

 

 

171,501

 

 

 

-

 

Current portion of lease liability (Note 8)

 

 

98,846

 

 

 

94,235

 

Discontinued operations - current liabilities (Note 10)

 

 

-

 

 

 

280,057

 

Total current liabilities

 

 

402,287

 

 

 

4,116,484

 

 

 

 

 

 

 

 

 

 

Lease liability - long-term (Note 8)

 

 

121,295

 

 

 

171,648

 

Note payable - long-term (Note 6)

 

 

185,785

 

 

 

-

 

Discontinued operations - long-term liabilities (Note 10)

 

 

-

 

 

 

517,584

 

Long-term liabilities

 

 

307,080

 

 

 

689,232

 

Total liabilities

 

 

709,367

 

 

 

4,805,716

 

Stockholders’ equity:

 

 

 

 

 

 

 

 

Common stock, par value $.001; 30,000,000 shares authorized; 5,068,799  and 3,134,261 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively

 

 

5,069

 

 

 

3,134

 

Additional paid-in capital

 

 

21,653,342

 

 

 

17,326,553

 

Accumulated deficit

 

 

(15,483,824

)

 

 

(14,494,762

)

Total stockholders’ equity

 

 

6,174,587

 

 

 

2,834,925

 

Total liabilities and stockholders’ equity

 

$

6,883,954

 

 

$

7,640,641

 

 

The accompanying notes are an integral part of these condensed unaudited consolidated financial statements.

 


3


LM Funding America, Inc. and Subsidiaries Condensed Consolidated Statements of Operations (unaudited)

 

 

 

For the Three Months

Ended June 30,

 

 

For the Six Months

Ended June 30,

 

 

 

2020

 

 

2019

 

 

2020

 

 

2019

 

Revenues:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Interest on delinquent association fees

 

$

170,174

 

 

$

463,738

 

 

$

389,688

 

 

$

878,013

 

Administrative and late fees

 

 

35,423

 

 

 

43,314

 

 

 

58,468

 

 

 

82,807

 

Recoveries in excess of cost - special product

 

 

62,362

 

 

 

4,502

 

 

 

84,990

 

 

 

26,272

 

Underwriting and other revenues

 

 

41,235

 

 

 

74,791

 

 

 

69,164

 

 

 

115,515

 

Rental revenue

 

 

33,344

 

 

 

72,285

 

 

 

81,424

 

 

 

219,954

 

Total revenues

 

 

342,538

 

 

 

658,630

 

 

 

683,734

 

 

 

1,322,561

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Expenses:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Staff costs and payroll

 

 

312,493

 

 

 

342,186

 

 

 

628,552

 

 

 

605,331

 

Professional fees

 

 

479,581

 

 

 

524,764

 

 

 

986,576

 

 

 

954,073

 

Settlement costs with associations

 

 

-

 

 

 

38,286

 

 

 

11,920

 

 

 

40,178

 

Selling, general and administrative

 

 

74,728

 

 

 

83,656

 

 

 

154,951

 

 

 

183,403

 

Recovery of cost from related party receivable

 

 

(100,000

)

 

 

-

 

 

 

(200,000

)

 

 

-

 

Provision for credit losses

 

 

-

 

 

 

(7,375

)

 

 

-

 

 

 

(7,375

)

Real estate management and disposal

 

 

14,108

 

 

 

100,306

 

 

 

99,450

 

 

 

297,434

 

Depreciation and amortization

 

 

7,954

 

 

 

19,526

 

 

 

13,766

 

 

 

37,391

 

Collection costs

 

 

(20,934

)

 

 

9,786

 

 

 

(29,255

)

 

 

(13,301

)

Other operating expenses

 

 

6,844

 

 

 

16,191

 

 

 

10,638

 

 

 

15,256

 

Total operating expenses

 

 

774,774

 

 

 

1,127,326

 

 

 

1,676,598

 

 

 

2,112,390

 

Operating loss from continuing operations

 

 

(432,236

)

 

 

(468,696

)

 

 

(992,864

)

 

 

(789,829

)

Interest expense

 

 

5,732

 

 

 

52,731

 

 

 

12,626

 

 

 

53,763

 

Loss from continuing operations before income taxes

 

 

(437,968

)

 

 

(521,427

)

 

 

(1,005,490

)

 

 

(843,592

)

Income tax benefit

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Net loss from continuing operations

 

 

(437,968

)

 

 

(521,427

)

 

 

(1,005,490

)

 

 

(843,592

)

Gain on disposal of discontinued operations

 

 

-

 

 

 

-

 

 

 

16,428

 

 

 

-

 

Gain (loss) from operations of discontinued operations

 

 

-

 

 

 

70,924

 

 

 

-

 

 

 

(63,929

)

Net gain/(loss) from discontinued operations

 

 

 

 

 

 

70,924

 

 

 

16,428

 

 

 

(63,929

)

Net loss

 

$

(437,968

)

 

$

(450,503

)

 

$

(989,062

)

 

$

(907,521

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Earnings/(loss) per share:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic loss per common share - continuing operations

 

$

(0.11

)

 

$

(0.17

)

 

$

(0.28

)

 

$

(0.27

)

Basic earnings/(loss) per common share - discontinued operations

 

$

-

 

 

$

0.02

 

 

$

0.00

 

 

$

(0.02

)

Basic loss per common share - net loss

 

$

(0.11

)

 

$

(0.14

)

 

$

(0.28

)

 

$

(0.29

)

Diluted loss per common share - continuing operations

 

$

(0.11

)

 

$

(0.17

)

 

$

(0.28

)

 

$

(0.27

)

Diluted earnings/(loss) per common share - discontinued operations

 

$

-

 

 

$

0.02

 

 

$

0.00

 

 

$

(0.02

)

Diluted loss per common share - net loss

 

$

(0.11

)

 

$

(0.14

)

 

$

(0.28

)

 

$

(0.29

)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted average number of common shares outstanding:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Basic

 

 

3,915,123

 

 

 

3,134,261

 

 

 

3,575,098

 

 

 

3,133,106

 

Diluted

 

 

3,915,123

 

 

 

3,134,261

 

 

 

3,575,098

 

 

 

3,133,106

 

The accompanying notes are an integral part of these condensed unaudited consolidated financial statements.

 

4


LM Funding America, Inc. and Subsidiaries Condensed Consolidated Statements of Cash Flows

(unaudited)

 

 

 

For the Six Months Ended June 30,

 

 

 

2020

 

 

2019

 

CASH FLOWS FROM OPERATING ACTIVITIES:

 

 

 

 

 

 

 

 

Net loss

 

$

(989,062

)

 

$

(907,521

)

 

 

 

 

 

 

 

 

 

Adjustments to reconcile net loss to cash used in operating activities

 

 

 

 

 

 

 

 

Depreciation and amortization

 

 

11,727

 

 

 

32,550

 

Right to use asset depreciation

 

 

51,229

 

 

 

4,852

 

Stock compensation

 

 

132,244

 

 

 

6,931

 

Recovery of uncollectible related party receivables

 

 

(200,000

)

 

 

-

 

Gain on disposal of business unit

 

 

(16,426

)

 

 

-

 

 

 

 

 

 

 

 

 

 

Change in assets and liabilities

 

 

 

 

 

 

 

 

Prepaid expenses and other assets

 

 

49,059

 

 

 

52,389

 

Accounts payable and accrued expenses

 

 

21,858

 

 

 

89,329

 

Repayments from related party

 

 

496,546

 

 

 

32,395

 

Other liabilities

 

 

-

 

 

 

48,578

 

Lease liability payments

 

 

(45,742

)

 

 

(4,426

)

Deferred taxes

 

 

-

 

 

 

(14,200

)

Net cash used in operating activities

 

 

(488,567

)

 

 

(659,123

)

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM INVESTING ACTIVITIES:

 

 

 

 

 

 

 

 

Net collections of finance receivables - original product

 

 

61,590

 

 

 

95,242

 

Net collections of finance receivables - special product

 

 

32,076

 

 

 

79,874

 

(Payments)/proceeds for real estate assets owned

 

 

(2,055

)

 

 

64,101

 

Net cash payment for IIU disposal

 

 

(246,914

)

 

 

-

 

Investment in note receivable - related party

 

 

1,500,000

 

 

 

-

 

Net cash received from business acquisition

 

 

-

 

 

 

51,327

 

Net cash provided by investing activities

 

 

1,344,697

 

 

 

290,544

 

 

 

 

 

 

 

 

 

 

CASH FLOWS FROM FINANCING ACTIVITIES:

 

 

 

 

 

 

 

 

Borrowings

 

 

185,785

 

 

 

-

 

Principal repayments

 

 

(69,540

)

 

 

(80,761

)

Exercise of warrants

 

 

2,946,480

 

 

 

22,320

 

Proceeds from stock subscription

 

 

1,250,000

 

 

 

-

 

 

 

 

 

 

 

 

 

 

Net cash provided by (used in) financing activities

 

 

4,312,725

 

 

 

(58,441

)

 

 

 

 

 

 

 

 

 

NET INCREASE (DECREASE) IN CASH

 

 

5,168,855

 

 

 

(427,020

)

 

 

 

 

 

 

 

 

 

CASH - BEGINNING OF YEAR

 

 

1,069,823

 

 

 

3,520,753

 

CASH - END OF YEAR

 

$

6,238,678

 

 

$

3,093,733

 

 

 

 

 

 

 

 

 

 

SUPPLEMENTAL DISCLOSURES OF CASHFLOW INFORMATION

 

 

 

 

 

 

 

 

Cash paid for interest

 

$

12,626

 

 

$

16,743

 

Income taxes

 

$

-

 

 

$

-

 

SUPPLEMENTAL DISCLOSURES OF NON-CASHFLOW INFORMATION

 

 

 

 

 

 

 

 

ROU asset obligation recognized

 

$

-

 

 

$

26,685

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

5


LM Funding America, Inc. and Subsidiaries Consolidated Statements of Changes in Stockholders’ Equity (unaudited)

For the Three and Six Months Ended June 30, 2020 and 2019

 

 

 

Common Stock

 

 

Additional paid-

 

 

Accumulated

 

 

 

 

 

 

 

Shares

 

 

Amount

 

 

in capital

 

 

Deficit

 

 

Total Equity

 

Balance - December 31, 2018

 

 

3,124,961

 

 

$

3,125

 

 

$

17,295,408

 

 

$

(11,489,884

)

 

$

5,808,649

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Warrants exercised for cash

 

 

9,300

 

 

 

9

 

 

 

22,311

 

 

 

-

 

 

 

22,320

 

Stock compensation expense

 

 

-

 

 

 

-

 

 

 

3,500

 

 

 

-

 

 

 

3,500

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(457,018

)

 

 

(457,018

)

Balance - March 31, 2019

 

 

3,134,261

 

 

$

3,134

 

 

$

17,321,219

 

 

$

(11,946,902

)

 

$

5,377,451

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock compensation expense

 

 

-

 

 

 

-

 

 

 

3,431

 

 

 

-

 

 

 

3,431

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(450,503

)

 

 

(450,503

)

Balance - June 30, 2019

 

 

3,134,261

 

 

$

3,134

 

 

$

17,324,650

 

 

$

(12,397,405

)

 

$

4,930,379

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Balance - December 31, 2019

 

 

3,134,261

 

 

$

3,134

 

 

$

17,326,553

 

 

$

(14,494,762

)

 

$

2,834,925

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock compensation expense

 

 

186,000

 

 

 

186

 

 

 

128,661

 

 

 

-

 

 

 

128,847

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(551,094

)

 

 

(551,094

)

Balance - March 31, 2020

 

 

3,320,261

 

 

$

3,320

 

 

$

17,455,214

 

 

$

(15,045,856

)

 

$

2,412,678

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Stock compensation expense

 

 

-

 

 

 

-

 

 

 

3,397

 

 

 

-

 

 

 

3,397

 

Warrants exercised for cash

 

 

1,227,700

 

 

 

1,228

 

 

 

2,945,252

 

 

 

 

 

 

 

2,946,480

 

Common stock issued for cash

 

 

520,838

 

 

 

521

 

 

 

1,249,479

 

 

 

 

 

 

 

1,250,000

 

Net loss

 

 

-

 

 

 

-

 

 

 

-

 

 

 

(437,968

)

 

 

(437,968

)

Balance - June 30, 2020

 

 

5,068,799

 

 

$

5,069

 

 

$

21,653,342

 

 

$

(15,483,824

)

 

$

6,174,587

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

6


LM FUNDING AMERICA, INC. AND SUBSIDIARIES

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

 

 

Note 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

LM Funding America, Inc. (“LMFA” or the “Company”) was formed as a Delaware corporation on April 20, 2015. LMFA was formed for the purpose of completing a public offering and related transactions in order to carry on the business of LM Funding, LLC and its subsidiaries (the “Predecessor”). LMFA is the sole member of LM Funding, LLC and operates and controls all of its businesses and affairs.

LM Funding, LLC a Florida limited liability company organized in January 2008 under the terms of an Operating Agreement effective January 8, 2008 as amended, had two members: BRR Holding, LLC and CGR 63, LLC. The members contributed their equity interest to LMFA prior to the closing of its initial public offering.

The Company acquired IIU, Inc. on January 16, 2019 (“IIU”), which provided global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies were fully underwritten with no claim risk remaining with IIU. IIU was disposed of on January 8, 2020.

We are a specialty finance company that provides funding to nonprofit community associations primarily located in the state of Florida. We offer incorporated nonprofit community associations, which we refer to as “Associations,” a variety of financial products customized to each Association’s financial needs. Our original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. Historically, we provided funding against such delinquent accounts, which we refer to as “Accounts,” in exchange for a portion of the proceeds collected by the Associations from the account debtors on the Accounts. In addition to our original product offering, we have started purchasing Accounts on varying terms tailored to suit each Association’s financial needs, including under our New Neighbor Guaranty™ program.

 

Specialty Finance Company

We purchase an Association’s right to receive a portion of the Association’s collected proceeds from owners that are not paying their assessments. After taking assignment of an Association’s right to receive a portion of the Association’s proceeds from the collection of delinquent assessments, we engage law firms to perform collection work on a deferred billing basis wherein the law firms receive payment upon collection from the account debtors or a predetermined contracted amount if payment from account debtors is less than legal fees and costs owed. Under this business model, we typically fund an amount equal to or less than the statutory minimum an Association could recover on a delinquent account for each Account, which we refer to as the “Super Lien Amount”. Upon collection of an Account, the law firm working on the Account, on behalf of the Association, generally distributes to us the funded amount, interest, and administrative late fees, with the law firm retaining legal fees and costs collected, and the Association retaining the balance of the collection. In connection with this line of business, we have developed proprietary software for servicing Accounts, which we believe enables law firms to service Accounts efficiently and profitably.

Under our New Neighbor Guaranty program, an Association will generally assign substantially all of its outstanding indebtedness and accruals on its delinquent units to us in exchange for payment by us of monthly dues on each delinquent unit. This simultaneously eliminates a substantial portion of the Association’s balance sheet bad debts and assists the Association to meet its budget by receiving guaranteed monthly payments on its delinquent units and relieving the Association from paying legal fees and costs to collect its bad debts. We believe that the combined features of the program enhance the value of the underlying real estate in an Association and the value of an Association’s delinquent receivables. We intend to leverage our proprietary software platform, as well as our industry experience and knowledge gained from our original line of business, to expand the New Neighbor Guaranty program in certain situations and to potentially develop other new products in the future.

Because we acquire and collect on the delinquent receivables of Associations, the Account debtors are third parties about whom we have little or no information. Therefore, we cannot predict when any given Account will be paid off or how much it will yield. In assessing the risk of purchasing Accounts, we review the property values of the underlying units, the governing documents of the relevant Association, and the total number of delinquent receivables held by the Association.

Specialty Finance Products

Original Product

Our original product relies upon Florida statutory provisions that effectively protect the principal amount invested by us in each Account. In particular, Section 718.116(1), Florida Statutes, makes purchasers and sellers of a unit in an Association jointly and

7


severally liable for all past due assessments, interest, late fees, legal fees, and costs payable to the Association. As discussed above, the Florida Statutes grants to Associations a so-called “super lien”, which is a category of lien that is given a statutorily higher priority than all other types of liens other than property tax liens. The amount of the Association’s priority over a first mortgage holder that takes title to a property through foreclosure (or deed in lieu), referred to as the Super Lien Amount, is limited to twelve months’ past due assessments or, if less, one percent (1.0%) of the original mortgage amount. Under our contracts with Associations for our original product, we pay Associations an amount up to the Super Lien Amount for the right to receive all collected interest and late fees on Accounts purchased from the Associations.

The Statutes specify that the rate of interest an association (or its assignor) may charge on delinquent assessments is equal to the rate set forth in the association’s declaration or bylaws. In Florida if a rate is not specified, the statutory rate is equal to 18% but may not exceed the maximum rate allowed by law. Similarly, the Statutes in Florida also stipulate that administrative late fees cannot be charged on delinquent assessments unless so provided by the association’s declaration or bylaws and may not exceed the greater of $25 or 5% of each delinquent assessment.

In other states in which we have offered our original product, which are currently only in Washington, Colorado and Illinois, we rely on statutes that we believe are similar to the above-described Florida statutes in relevant respects. A total of approximately 22 U.S. states, Puerto Rico and the District of Columbia have super lien statutes that give Association assessments super lien status under some circumstances, and of these states, we believe that all of these jurisdictions other than Alaska have a regulatory and business environment that would enable us to offer our original product to Associations in those states on materially the same basis.

New Neighbor Guaranty

In 2012, we developed a new product, the New Neighbor Guaranty, wherein an Association assigns substantially all of its outstanding indebtedness and accruals on its delinquent units to us in exchange for payments in an amount equal to the regular ongoing monthly or quarterly assessments for delinquent units when those amounts would be due to the Association. We assume both the payment and collection obligations for these assigned Accounts under this product. This simultaneously eliminates an Association’s balance sheet bad debts and assists the Association to meet its budget by receiving guaranteed assessment payments on its delinquent units and relieving the Association from paying legal fees and costs to collect its bad debts. We believe that the combined features of the product enhance the value of the underlying real estate in an Association and the value of an Association’s delinquent receivables.

Before we implement the New Neighbor Guaranty program for an Association typically asks us to conduct a review of its accounts receivable. After we have conducted the review, we inform the Association which Accounts we are willing to purchase and the terms of such purchase. Once we implement the New Neighbor Guaranty program, we begin making scheduled payments to the Association on the Accounts as if the Association had non-delinquent residents occupying the units underlying the Accounts. Our New Neighbor Guaranty contracts typically allow us to retain all collection proceeds on each Account other than special assessments and accelerated assessment balances. Thus, the Association foregoes the potential benefit of a larger future collection in exchange for the certainty of a steady stream of immediate payments on the Account.

Recent Developments

IIU Acquisition and Disposal

On November 2, 2018, the Company invested cash by purchasing a Senior Convertible Promissory Note in the original principal amount of $1,500,000 (the “IIU Note”) from IIU, a synergistic Virginia based travel insurance brokerage company controlled by Craven House North America, LLC (“Craven”) N.A., (whose ownership excluding unexercised warrants was approximately 20% of the Company’s outstanding stock at the time of the acquisition).  The maturity date of the IIU Note was 360 dates after the date of issuance (subject to acceleration upon an event of default).  The IIU Note carried a 3.0% interest rate, with accrued but unpaid interest being payable on the IIU Note’s maturity date.  

On January 16, 2019, the Company entered into a Stock Purchase Agreement with Craven (the “IIU SPA”) to purchase all of the outstanding capital stock of IIU as a possible synergistic effort to diversify revenue sources that were believed to be accretive to earnings.  IIU provided global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies were fully underwritten with no claim risk remaining with IIU.

The Company purchased 100% of the issued and outstanding capital stock of IIU from Craven for $5,089,357 subject to adjustment as set forth in the IIU SPA.  IIU was required to have a minimum net working capital of $15,000 and at least $152,000 in cash. The Company paid the purchase price under the IIU SPA at closing as follows:

 

The Company cancelled all principal and accrued interest of the IIU Note, which consisted of aggregate principal indebtedness and accrued interest of $1,507,375 as of January 16, 2019.

 

The Company issued to Craven a $3,581,982 Senior Convertible Promissory Note (the “Craven Convertible Note”) for the balance of the purchase price.  At the option of Craven, the Craven Convertible Note could be paid in restricted shares of our common stock or cash.  The Craven Convertible Note bore simple interest at 3% per annum.  The Craven Convertible Note

8


 

was due and payable 360 days from the closing date of the IIU SPA. If repaid by the Company in restricted common stock, the outstanding principal and interest of the Craven Convertible Note would be paid by the Company by issuing to Craven a number of restricted common shares equal to the adjusted principal and accrued interest owing to Craven under the Craven Convertible Note divided by $2.41. On the date of issuance of the Craven Convertible Note, the closing share price of the Company was $1.42.

 

Pursuant to the terms of the IIU SPA, the purchase price was subsequently reduced by $120,200, to $4,969,200.

On December 20, 2019, the Company loaned $1.5 million to Craven (“Craven Secured Promissory Note”) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly. The Company subsequently extended the due date of the Craven Secured Promissory Note to August 1, 2021.   The Craven Secured Promissory Note was secured by, among other things, a pledge of Craven’s 640,000 shares of common stock of the Company and the assignment of the assets of Craven in favor of the Company. On June 29, 2020, the Company received from Craven $1,503,719 as payment in full of all principal and accrued interest due from the Craven Secured Promissory Note.

On January 8, 2020, the Company entered into a Stock Purchase Agreement (“SPA”) with Craven pursuant to which the Company sold back to Craven all of the issued and outstanding shares of IIU for $3,562,569.  The purchase price was paid by Craven through the cancellation of the $3,461,782Craven Convertible Note plus forgiveness of $100,787 of accrued interest. The Company originally paid $4,969,200 for the purchase of IIU in January 2019, which included a negative $720,386 net fair value of assets and $5,689,586 of goodwill. As a result, goodwill was impaired by $1.65 million. The sale of IIU resulted in a gain of $16,428.  

Specialty Health Insurance

Our former subsidiary IIU Inc. (“IIU”) through its wholly owned company Wallach and Company (“Wallach”) offered health insurance, travel insurance and other travel services to:

 

United States citizens and residents traveling abroad

 

Non United States citizens or residents who travel to the United States

These services were typically sold through a policy offered by Wallach and fully underwritten by a third party insurance company.  The policies offered included:

 

HealthCare Abroad - Short term medical insurance, medical evacuation and international assistance for Americans traveling overseas. There is an age limit of 84 years old.

 

HealthCare Global – up to 6 months coverage for Americans traveling abroad and foreign nationals traveling outside their home countries to destinations other than the United States.  There is an age limit of 70 years old.

 

HealthCare America – up to 90 days coverage for foreign nationals visiting the United States. There is an age limit of 70 years old.

 

HealthCare International – International medical insurance & assistance for persons living outside their home country.  There is an age limit of 70 years old.

 

HealthCare War – up to 6 months coverage for Americans traveling abroad and foreign nationals traveling outside their home countries to identified war risk areas.  There is an age limit of 70 years old.

 

As such, IIU is considered a discontinued operation. We did not report any activity from operations from IIU for the six months ended June 30, 2020.

 

Entry into and Termination of Hanfor Share Exchange Agreement

On March 23, 2020, the Company entered into a Share Exchange Agreement, dated March 23, 2020 (the “Share Exchange Agreement”), with Hanfor (Cayman) Limited, a Cayman Islands exempted company (“Hanfor”), and BZ Industrial Limited, a British Virgin Islands business company and the sole stockholder of Hanfor (“Hanfor Owner”).  The Share Exchange Agreement contemplated a business combination transaction in which Hanfor Owner would transfer and assign to the Company all of the share capital of Hanfor in exchange for a number of shares of the Company’s common stock that would result in Hanfor Owner owning 86.5% of the outstanding common stock of the Company.

Under the agreement, Hanfor Owner was required to deliver to the Company audited financial statements for Hanfor for the 2019 and 2018 fiscal years, and such audited financial statements were required to be delivered by May 31, 2020 (subject to extension to June 30, 2020 under specified circumstances).  In connection with the execution of the Share Exchange Agreement, the Company and Hanfor Owner entered into a Stock Purchase Agreement, dated March 23, 2020, pursuant to which Hanfor Owner purchased from the Company an aggregate of 520,838 shares of the Company’s common stock at a price of $2.40 per share. Hanfor Owner paid $250,000 cash on March 23, 2020 and the Company received an additional $1,000,000 in April 2020 at which time the Company issued the 520,838 shares.

On July 14, 2020, the Company notified Hanfor and Hanfor Owner that the Company had elected to terminate the Share Exchange Agreement due to Hanfor’s inability to provide audited financial statements by June 30, 2020.  Although the Company believes that it

9


properly terminated the Share Exchange Agreement, on July 21, 2020, counsel to Hanfor Owner informed the Company that Hanfor Owner believes that the Company’s termination of the Share Exchange Agreement was not effected in accordance with the terms of the Share Exchange Agreement.  The Company and Hanfor Owner are engaged in discussions to resolve this disagreement, but there is no assurance that this disagreement will be promptly resolved or resolved on terms favorable to the Company, and there is no assurance that Hanfor Owner will not seek to take legal action.

Nasdaq Listing

On March 27, 2020, the Company received a notification letter from the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has not regained compliance with Nasdaq Continued Listing Rule 5550(a)(2), which requires the Company’s listed securities to maintain a minimum bid price of $1.00 per share (the "Minimum Bid Price Rule"). The notification stated that the Company’s securities would be delisted from the Nasdaq Capital Market on April 7, 2020 unless the Company timely requested a hearing before a Nasdaq Hearing Panel.  The Company has timely requested a hearing.  However, on April 16, 2020, Nasdaq suspended any enforcement actions relating to bid price issues through June 30, 2020. On July 1, 2020, the Company received a letter from Nasdaq stating that the Company had regained compliance with the Minimum Bid Price Rule because the closing price for the Company’s common stock was $1.00 per share or greater for ten (10) consecutive business days.

Additionally, on January 3, 2020, the Company received a deficiency letter from Nasdaq, indicating that it was in violation of Listing Rules 5620(a) and 5810(c)(2)(G) by virtue of passing the applicable deadline for holding of its annual general meeting of shareholders for the financial year ended December 31, 2018.  The Company resolved this issue by having its annual general meeting of shareholders on May 11, 2020.

Reverse Stock Split Approval

On May 11, 2020, our shareholders voted in favor of the approval of an amendment to our Certificate of Incorporation, in the event it is deemed advisable by our Board of Directors, to effect an additional reverse stock split of the Company’s issued and outstanding common stock at a ratio within the range of one-for-two (1:2) and one-for-ten (1:10), as determined by the Board of Directors.  However, a reverse stock split has not yet been effected pursuant to such approval.

 

Principles of Consolidation

The condensed consolidated financial statements include the accounts of LMFA and its wholly-owned subsidiaries: LM Funding, LLC; LMF October 2010 Fund, LLC; REO Management Holdings, LLC (including all 100% owned subsidiary limited liability companies); LM Funding of Colorado, LLC; LM Funding of Washington, LLC; LM Funding of Illinois, LLC; and LMF SPE #2, LLC and various single purpose limited liability corporations owned by REO Management Holdings, LLC which own various properties. It also includes IIU and its wholly-owned subsidiary: Wallach & Company for the time that the Company owned IIU. All significant intercompany balances have been eliminated in consolidation.

 

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and note disclosures normally included in the annual consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. The interim condensed consolidated financial statements as of June 30, 2020 and for the three and six months ended June 30, 2020 and June 30, 2019, respectively are unaudited. In the opinion of management, the interim condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary to provide a fair statement of the results for the interim periods. The accompanying condensed consolidated balance sheet as of December 31, 2019, is derived from the audited consolidated financial statements presented in the Company’s Annual Report on Form 10-K for fiscal the year ended December 31, 2019.

 

Use of Estimates

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the evaluation of any probable losses on amounts funded under the Company’s New Neighbor Guaranty program as disclosed below, the evaluation of probable losses on balances due from a related party, the realization of deferred tax assets, the evaluation of contingent losses related to litigation and fair value estimates of real estate assets owned.

10


We are not presently aware of any events or circumstances arising from the COVID-19 pandemic that would require us to update our estimates or judgments or revise the carrying value of our assets or liabilities. Our estimates may change, however, as new events occur and additional information is obtained, and any such changes will be recognized in the condensed consolidated financial statements.

 

Revenue Recognition

Accounting Standards Codification (“ASC”) 606 of the Financial Accounting Standards Board (“FASB”) states an entity needs to conclude at the inception of the contract that collectability of the consideration to which it will be entitled in exchange for the goods and services that will be transferred to the customer is probable. That is, in some circumstances, an entity may not need to assess its ability to collect all of the consideration in the contract. The Company provides funding to community associations by purchasing their rights under delinquent accounts from unpaid assessments due from property owners (the “accounts”). Collections on the accounts may vary greatly in both the timing and amount ultimately recovered compared with the total revenues earned on the accounts because of a variety of economic and social factors affecting the real estate environment in general. The Company’s contracts with its customers have very specific performance obligations.  The Company has determined that the known amount of cash to be realized or realizable on its revenue generating activities cannot be reasonably estimated.  The Company determined rental income from leasing arrangements is specifically excluded from the standard.  The Company analyzed its remaining revenue streams and concluded there were no changes in revenue recognition with the adoption of the new standard.

 

Under ASC 606, the Company applies the cash basis method to its original product and the cost recovery method to its special product as follows:

Finance Receivables—Original Product: Under the Company’s original product, delinquent assessments are funded only up to the Super Lien Amount as discussed above. Recoverability of funded amounts is generally assured because of the protection of the Super Lien Amount. As such, payments by unit owners on the Company’s original product are recorded to income when received in accordance with the provisions of the Florida Statute (718.116(3)) and the provisions of the purchase agreements entered into between the Company and community associations. Those provisions require that all payments be applied in the following order: first to interest, then to late fees, then to costs of collection, then to legal fees expended by the Company and then to assessments owed. In accordance with the cash basis method of recognizing revenue and the provisions of the statute, the Company records revenues for interest and late fees when cash is received. In the event the Company determines the ultimate collectability of amounts funded under its original product are in doubt, payments are applied to first reduce the funded or principal amount.

Finance Receivables—Special Product (New Neighbor Guaranty program): During 2012, the Company began offering associations an alternative product under the New Neighbor Guaranty program where the Company will fund amounts in excess of the Super Lien Amount. Under this special product, the Company purchases substantially all of the delinquent assessments owed to the association, in addition to all accrued interest and late fees, in exchange for payment by the Company of (i) a negotiated amount or (ii) on a going forward basis, all monthly assessments due for a period up to 48 months. Under these arrangements, the Company considers the collection of amounts funded is not assured and under the cost recovery method, cash collected is applied to first reduce the carrying value of the funded or principal amount with any remaining proceeds applied next to interest, late fees, legal fees, collection costs and any amounts due to the community association. Any excess proceeds still remaining are recognized as revenues. If the future proceeds collected are lower than the Company’s funded or principal amount, then a loss is recognized.

Net Commission Revenue: The Company acted as an agent in providing health travel insurance policies. As a result, the Company revenue was recorded at net. The Company has determined that the known amount of cash to be realized or realizable on its revenue generating activities can be reasonably estimated and as such, classifies its receivables as accrual and recognizes revenues in the accompanying statements of income on the accrual basis.  If a policy is not effective as of the end of a period, then the associated revenue and underwriting costs are deferred until the effective date.

Cash

The Company maintains cash balances at several financial institutions that are insured under the Federal Deposit Insurance Corporation’s (“FDIC”) Transition Account Guarantee Program. Balances with the financial institutions may exceed federally insured limits.

Finance Receivables

Finance receivables are recorded at the amount funded or cost (by unit). The Company evaluates its finance receivables at each period end for losses that are considered probable and can be reasonably estimated in accordance with ASC 450-20. As discussed above, recoverability of funded amounts under the Company’s original product is generally assured because of the protection of the Super

11


Lien Amount. However, the Company did have an accrual at June 30, 2020 and December 31, 2019 for an allowance for credit losses for this program of $112,027 and $112,027.

Under the New Neighbor Guaranty program (special product), the Company funds amounts in excess of the Super Lien Amount. When evaluating the carrying value of its finance receivables, the Company looks at the likelihood of future cash flows based on historical payoffs, the fair value of the underlying real estate, the general condition of the community association in which the unit exists, and the general economic real estate environment in the local area. The Company estimated an allowance for credit losses for this program of $6,564 as of June 30, 2020 and $20,016 at December 31, 2019 under ASC 450-20 related to its New Neighbor Guaranty program.

The Company will charge any receivable against the allowance for credit losses when management believes the collectability of the receivable is confirmed. The Company considers writing off a receivable when (i) a first mortgage holder who names the association in a foreclosure suit takes title and satisfies an estoppel letter for amounts owed which are less than amounts the Company funded to the association; (ii) a tax deed is issued with insufficient excess proceeds to pay amounts the Company funded to the association; (iii) an association settles an account for less than amounts the Company funded to the association or (iv) the association terminates its relationship with the Company’s designated legal counsel. Upon the occurrence of any of these events, the Company evaluates the potential recovery via a deficiency judgment against the prior owner and the ability to collect upon the deficiency judgment within the statute of limitations period or whether the deficiency judgment can be sold. If the Company determines that collection through a deficiency judgment or sale of a deficiency judgment is not feasible, the Company writes off the unrecoverable receivable amount. Any losses greater than the recorded allowance will be recognized as expenses. Under the Company’s revenue recognition policies, all finance receivables (original product and special product) are classified as nonaccrual.

During the six months ended June 30, 2020 and 2019, write offs charged against the allowance for credit losses were $13,452 and $20,743, respectively. Any losses greater than the recorded allowance will be recognized as expenses. Under the Company’s revenue recognition policies, all finance receivables (original product and special product) are classified as nonaccrual.

Real Estate Assets Owned

In the event collection of a delinquent assessment results in a unit being sold in a foreclosure auction, the Company has the right to bid (on behalf of the community association) for the delinquent unit as attorney in fact, applying any amounts owed for the delinquent assessment to the foreclosure price as well as any additional funds that the Company, in its sole discretion, decides to pay. If a delinquent unit becomes owned by the community association by acquiring title through an association lien foreclosure auction, by accepting a deed-in-lieu of foreclosure, or by any other way, the Company in its sole discretion may direct the community association to quitclaim title of the unit to the Company.

Properties quitclaimed to the Company are in most cases acquired subject to a first mortgage or other liens, and are recognized in the accompanying consolidated balance sheets solely at costs incurred by the Company in excess of original funding. At times, the Company will acquire properties through foreclosure actions free and clear of any mortgages or liens. In these cases, the Company records the estimated fair value of the properties in accordance with ASC 820-10, Fair Value Measurements. Any real estate held for sale is adjusted to fair value less the cost to dispose in the event the carrying value of a unit or property exceeds its estimated net realizable value.

The Company capitalizes costs incurred to acquire real estate owned properties and any costs incurred to get the units in a condition to be rented.  These costs include, but are not limited to, renovation/rehabilitation costs, legal costs, and delinquent taxes.  These costs are depreciated over the estimated minimum time period the Company expects to maintain possession of the units.  Costs incurred for unencumbered units are depreciated over 20 years and costs for units subject to a first mortgage are depreciated over 3 years.  As of June 30, 2020 and December 31, 2019, capitalized real estate costs, net of accumulated depreciation, were $13,426 and $21,084, respectively.  

During the three and six month period ended June 30, 2020 and 2019, depreciation expense was $4,110 and $9,713 for 2020 and $5,526 and $11,969 for 2019, respectively.

If the Company elects to take a quitclaim title to a unit or property held for sale, the Company is responsible to pay all future assessments on a current basis, until a change of ownership occurs. The community association must allow the Company to lease or sell the unit to satisfy obligations for delinquent assessments of the original debt. All proceeds collected from any sale of the unit shall be first applied to all amounts due the Company plus any additional funds paid by the Company to purchase the unit, if applicable. Rental revenues and sales proceeds related to real estate assets held for sale are recognized when earned and realizable. Expenditures for current assessments owed to associations, repairs and maintenance, utilities, etc. are expensed when incurred.

If the community association elects (prior to the Company obtaining title through its own election) to maintain ownership and not quitclaim title to the Company, the community association must pay the Company all interest, late fees, collection costs, and legal fees

12


expended, plus the original funding on the unit, which have accrued according to the purchase agreement entered into by the community association and the Company. In this event, the unit will be reassigned to the community association.

Fixed Assets

The Company capitalizes all acquisitions of fixed assets in excess of $500. Fixed assets are stated at cost. Depreciation is provided on the straight-line method over the estimated useful lives of the assets. Fixed assets are comprised of furniture, computer and office equipment with an assigned useful life of 3 to 5 years. Fixed assets also include capitalized software costs. Capitalized software costs include costs to develop software to be used solely to meet the Company’s internal needs, consist of employee salaries and benefits and fees paid to outside consultants during the application development stage, and are amortized over their estimated useful life of 5 years. As of June 30, 2020 and December 31, 2019, capitalized software costs, net of accumulated amortization, was nil. Amortization expense for capitalized software costs for the three and six month period ended June 30, 2020 and 2019 was $nil and $nil for 2020 and $5,815 and $11,630 for 2019, respectively. 

Right to Use Assets

The Company capitalizes all leased assets pursuant to ASU 2016-02, "Leases (Topic 842)," which requires lessees to recognize right-of-use assets and lease liability, initially measured at present value of the lease payments, on its balance sheet for leases with terms longer than 12 months and classified as either financing or operating leases.  As of June 30, 2020 and December 31, 2019, right to use assets, net of accumulated amortization, was $209,031 and $260,260, respectively. Amortization expense for right to use assets for the three and six month period ended June 30, 2020 and 2019 was $26,136 and $51,229 for 2020 and was $2,426 and $4,852 for 2019, respectively while the payments totaled $45,742 for the six months ended June 30, 2020. 

Other Investments – Note Receivable - Related Party

On December 20, 2019, the Company loaned $1.5 million to Craven (“Craven Secured Promissory Note”) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly. The Company subsequently extended the due date of the Craven Secured Promissory Note to August 1, 2021 and allowed for the deferral of monthly interest payments.   The Craven Secured Promissory Note was secured by, among other things, Stock Pledge of Craven’s 640,000 Common Shares of the Company and the Assignment of the assets of Craven in favor of the Company. On June 29, 2020, the Company received from Craven $1,503,719 as payment in full of all principal and accrued interest due from the Craven Secured Promissory Note.

Goodwill

Goodwill represents the excess purchase price of acquired businesses over the fair value of the net assets acquired. Goodwill is not amortized, but instead is tested for impairment annually or whenever events or changes in circumstances indicate that the carrying amount may not be fully recoverable.

During the year ended December 31, 2019, the Company recorded goodwill of approximately $5.7 million which represented amounts for the purchase of IIU. For purposes of the 2019 annual test, we will elect to perform a goodwill impairment analysis to assess whether it was more likely than not that the fair value of these reporting units exceeded their respective carrying values. In performing these assessments, management will rely on a number of factors including, but not limited to, macroeconomic conditions, industry and market considerations, cost factors that would have a negative effect on earnings and cash flows, overall financial performance compared with forecasted projections in prior periods, and other relevant reporting unit events, the impact of which are all significant judgments and estimates.  This assessment was performed as of December 31, 2019 and showed a $1.65 million impairment due to the sale of IIU on January 8, 2020. The balance of goodwill as of June 30, 2020 and December 31, 2019 was approximately $0 million and $4.0 million, respectively. 

Stock Issued

In connection with the execution of the Share Exchange Agreement, the Company and Hanfor Owner entered into a Stock Purchase Agreement, dated March 23, 2020, pursuant to which Hanfor Owner purchased from Company an aggregate of 520,838 shares of the Company’s common stock at a price of $2.40 per share for a total of $1,250,000 cash.       

Debt Issue Costs

The Company capitalizes all debt issue costs and amortizes them on a method that approximates the effective interest method over the remaining term of the note payable. The Company did not have any unamortized debt issue costs at June 30, 2020 and at December 31, 2019. Any costs will be presented in the accompanying condensed consolidated balance sheets as other assets until the loan proceeds are received which at that time will be reclassified as a direct deduction from the carrying amount of that debt liability in accordance with Accounting Standards Update (“ASU”) 2015-03 (see below). The Company adopted this new standard in the first quarter of fiscal 2016. The adoption of this standard did not have a material impact on the Company's consolidated financial position

13


and had no impact on its consolidated income or cash flows. In addition, the amortization of debt issuance costs is to be reported as interest expense under ASU 2015-03 (ASC 835-30-45-3).    

Settlement Costs with Associations

Community associations working with the Company will at times incur costs in connection with litigation initiated by the Company against property owners and or mortgage holders. These costs include settlement agreements whereby the community association agrees to pay some monetary compensation to the opposing party or judgments against the community associations for fees of opposing legal counsel or other damages awarded by the courts. The Company indemnifies the community association for these costs pursuant to the provisions of the agreement between the Company and the community association. Costs incurred by the Company for these indemnification obligations for the three and six months ended June 30, 2020 and 2019 were approximately $zero  and $12,000 for 2020 and $38,000  and $40,000 for 2019, respectively. The Company does not limit its indemnification based on amounts ultimately collected from property owners.  

Income Taxes

Income taxes are provided for the tax effects of transactions reported in the consolidated financial statements and consist of taxes currently due plus deferred taxes resulting primarily from the tax effects of temporary differences between financial and income tax reporting. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.

 

Under ASC 740-10-30-5, Income Taxes, deferred tax assets should be reduced by a valuation allowance if, based on the weight of available evidence, it is more-likely-than-not (i.e., a likelihood of more than 50%) that some portion or all of the deferred tax assets will not be realized. The Company considers all positive and negative evidence available in determining the potential realization of deferred tax assets including, primarily, the recent history of taxable earnings or losses. Based on operating losses reported by the Company during 2018, 2017 and 2016, the Company concluded there was not sufficient positive evidence to overcome this recent operating history. As a result, the Company believes that a valuation allowance was necessary based on the more-likely-than-not threshold noted above. During the year ended December 31, 2019, the Company decreased the valuation allowance to $3,634,857 to reflect a change in deferred tax assets.

Loss Per Share

Basic loss per share is calculated as net loss to common stockholders divided by the weighted average number of common shares outstanding during the period.  

The Company issued 2,500,000 shares at various times during the month of November 2018 and has weighted average these new shares in calculating loss per share.

On October 15, 2018, the Company effected a common share consolidation (“Reverse Stock Split”) by means of a one-for-ten (1:10) reverse split of its outstanding common stock, par value $0.001 per share which resulted in a decrease in outstanding common stock to 625,318 shares.  The Reverse Stock Split became effective on October 16, 2018 and the Company’s common stock began trading on The Nasdaq Global Market on a split-adjusted basis on October 16, 2018.

The Company has restated all share amounts to reflect the Reverse Stock Split.

Diluted loss per share for the period equals basic loss per share as the effect of any convertible notes, stock based compensation awards or stock warrants would be anti-dilutive.  

The anti-dilutive stock based compensation awards and convertible notes consisted of:

 

 

 

As of June 30,

 

 

2020

 

2019

Stock Options

 

19,300

 

19,300

Stock Warrants

 

2,731,587

 

3,959,287

Convertible Note

 

-

 

-

 

As part of its initial public offering, on October 23, 2015 the Company issued 1,200,000 warrants that allowed for the right to purchase 1,200,000 shares of common stock at an average exercise price of $12.50 per share. Due to the Reverse Stock Split on October 16, 2018, each warrant may only purchase one-tenth of one share of common stock at $12.50. These warrants have weighted average price of $12.50 per share and a weighted average remaining life of .44 years and .94 years as of June 30, 2020 and December 31, 2019, respectively. These warrants expire in the year 2020.  The aggregate intrinsic value of the outstanding common stock warrants as of June 30, 2020 and December 31, 2019 was $0 and $0, respectively.

14


 

On October 31, 2018, the Company issued warrants as part of its secondary offering that allowed for the right to purchase 2,500,000 shares of common stock at an exercise price of $2.40 per share. These warrants expire in the year 2023.  During the six months ended June 30, 2020, warrants for 1,277,700 shares were exercised for $2,946,480.

 

As part of its underwriting agreement dated, October 31, 2018, the Company issued additional warrants, effective May 1, 2019, to its underwriter as part of its secondary offering that allowed for the right to purchase 125,000 shares of common stock at an exercise price of $2.64 per share on or after May 1, 2019. These warrants expire on May 2, 2022.

 

On April 2, 2018, the Company issued warrants that allowed for the right to purchase 40,000 shares of common stock at an exercise price of $6.605 per share. If the Company, at any time this warrant is outstanding, combines its outstanding shares of Common Stock into a smaller number of shares or enters into a corporate action or transaction to change the number of outstanding share of common stock, then the exercise price is adjusted along with the number of shares that can be purchased under this agreement. Due to the subsequent issuance of stock and warrants on October 31, 2018, these warrants now have the right to purchase 143,587 shares at an exercise price of $1.84 per share. These warrants expire in the year 2023.  

 

A senior secured convertible note to Craven House Capital North America LLC (Related Party), bearing interest at 3.0% was issued on January 16, 2019 and matures on either January 14, 2020 or convertible into 1,436,424 shares of the Company's common shares. On January 8, 2020, the Company entered into a Stock Purchase Agreement (“SPA”) with Craven pursuant to which the Company sold to Craven all of the issued and outstanding shares of IIU, Inc., a Virginia based travel insurance brokerage company and wholly owned subsidiary of LMFA (“IIU”), for $3,562,569.  The purchase price was paid by Craven through the cancellation of the $3,461,782 Craven Convertible Note issued by LMFA to Craven dated January 16, 2019 plus forgiveness of $100,787 of accrued interest. LMFA originally paid $4,969,200 for the purchase of IIU in January 2019, which included a negative $720,386 net fair value of assets and $5,689,586 of goodwill. The sale of IIU resulted in a gain of $16,428.  

Stock-Based Compensation

The Company records all equity-based incentive grants to employees and non-employee members of the Company’s Board of Directors in operating expenses in the Company’s Consolidated Statements of Operations based on their fair values determined on the date of grant. Stock-based compensation expense, reduced for estimated forfeitures, is recognized on a straight-line basis over the requisite service period of the award, which is generally the vesting term of the outstanding equity awards.

Contingencies

The Company accrues for contingent obligations, including estimated legal costs, when the obligation is probable and the amount is reasonably estimable. As facts concerning contingencies become known, the Company reassesses its position and makes appropriate adjustments to the consolidated financial statements. Estimates that are particularly sensitive to future changes include those related to tax, legal and other regulatory matters.     

Fair Value of Financial Instruments

FASB ASC 825-10, Financial Instruments, requires disclosure of fair value information about financial instruments, whether or not recognized in the balance sheet. The Company engages a third-party valuation firm to assist in estimating the fair value of its finance receivables.

Risks and Uncertainties

Funding amounts are secured by a priority lien position provided under Florida law (see discussion above regarding Florida Statute 718.116). However, in the event the first mortgage holder takes title to the property, the amount payable by the mortgagee to satisfy the priority lien is capped under this same statute and would generally only be sufficient to reimburse the Company for funding amounts noted above for delinquent assessments. Amounts paid by the mortgagee would not generally reimburse the Company for interest, administrative late fees and collection costs. Even though the Company does not recognize these charges as revenues until collected, its business model and long-term viability is dependent on its ability to collect these charges.  

In the event a delinquent unit owner files for bankruptcy protection, the Company may at its option be reimbursed by the association for the amounts funded (i.e., purchase price) and all collection rights are re-assigned to the association.

Non-cash Financing and Investing Activities

During the six months ended June 30, 2020 and 2019, the Company acquired unencumbered title to certain properties as a result of foreclosure proceedings.  Properties were recorded at fair value less cost to dispose of approximately $0 and $0, respectively.  The fair value of these properties was first applied to recover the Company’s initial investment with any remaining proceeds applied to interest, late fees, and other amounts owed by the property owner.

15


During the six months ended June 30, 2020, the Company disposed of IIU which included assets and liabilities listed in Note 10.  

Recent Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses, which establishes a new approach for credit impairment based on an expected loss model rather than an incurred loss model. The standard requires the consideration of all available relevant information when estimating expected credit losses, including past events, current conditions and forecasts and their implications for expected credit losses.  The guidance is effective January 1, 2020 with a one-year early adoption permitted.  We adopted this new standard on January 1, 2020 and determined that this did not impact our consolidated financial statements.

Recent accounting guidance not discussed above is not applicable, did not have, or is not expected to have a material impact to the Company.

 

Reclassifications

 

Certain prior period amounts have been reclassified to conform to the current period presentation.

Subsequent Events

The Company has evaluated subsequent events through the date which the condensed consolidated financial statements were issued. 

 

Note 2. Goodwill and Acquisition

On November 2, 2018, the Company invested cash by purchasing stock under a Securities Purchase Agreement (the “IIU SPA”) from IIU, a synergistic Virginia based travel insurance brokerage company controlled by Craven House N.A. (whose ownership excluding unexercised warrants is approximately 20% of the Company’s outstanding stock as of the date of acquisition), pursuant to which IIU issued to the Company a Senior Convertible Promissory Note (“IIU Note”) in the original principal amount of $1,500,000 in exchange for a purchase price of $1,500,000.  The maturity date of the Note is 360 dates after the date of issuance (subject to acceleration upon an event of default).  The Note carries a 3.0% interest rate, with accrued but unpaid interest being payable on the Note’s maturity date.  

The IIU Note allows the Company the right on or after the maturity date to convert any unpaid principal and accrued and unpaid interest of the IIU Note into shares of IIU based on a conversion amount which is the fair value of the common shares of IIU at the time. The conversion price will be reset if IIU issues or sells common shares, convertibles securities or options at a price per share that is less than the conversion price in effect immediately prior to such issue or sale or deemed issuance or sale of such dilutive issuance.

On January 16, 2019, the Company entered into a Stock Purchase Agreement with Craven House North America, LLC (“Craven”) to purchase all of the outstanding shares of IIU as a possible synergistic effort to diversify revenue sources that were believed to be accretive to earnings. IIU provided global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies are fully underwritten with no claim risk remaining with IIU.

The Board of Directors of LMFA approved the purchase of IIU. LMFA purchased 100% of the outstanding stock of IIU for $5,089,357.  LMFA paid the Purchase Price at closing as follows:

 

 

Cancellation by LMFA of all principal and accrued interest of IIU’s Promissory Note dated November 3, 2018 and issued to LMFA for principal indebtedness and accrued interest of $1,507,375.

 

LMFA issued to Craven a $3,581,982 Senior Convertible Promissory Note (“Craven Convertible Note”) for the balance of the Purchase Price.  At the option of Craven, the Convertible Note may be paid in restricted common shares of LMFA or cash.  The Craven Convertible Note shall bear simple interest at 3% per annum.  The Craven Convertible Note shall be due and payable 360 days from the Closing Date. If repaid by LMFA in restricted common stock, the outstanding principal and interest of the Craven Convertible Note shall be paid by LMFA by issuing to Seller a number of restricted common shares equal to the adjusted principal and accrued interest owing on the Craven Convertible Note divided by $2.41. On the date of issuance of the Craven Convertible Note, the closing share price of the Company was $1.42. The note principal was subsequently reduced by $120,200 arising from lower than expected Closing Cash and Net Working Capital. Craven had verbally agreed to extend repayment of this Craven Convertible Note 12 months from April 15, 2019.

 

Net cash received in the business acquisition was $51,327.As such, the $1.5 million note receivable was cancelled as of January 16, 2019.

16


 

The following table summarizes the approximate consideration paid and the amounts of the identified assets acquired and liabilities assumed at the acquisition date:

 

 

January 16, 2019

 

 

Total adjusted purchase price

$

4,969,200

 

 

Recognized preliminary amounts of identifiable assets acquired and (liabilities assumed), at fair value:

 

 

 

 

Cash

 

51,300

 

 

Prepaid and other current assets

 

5,200

 

 

Profit on purchased policies

 

14,600

 

 

Property, plant and equipment

 

17,100

 

 

Accounts payable

 

(5,100

)

 

Accrued expenses and other liabilities

 

(62,686

)

 

Income taxes

 

(28,500

)

 

Deferred revenue

 

(9,300

)

 

Debt

 

(703,000

)

 

Preliminary estimate of the fair value of assets and liabilities assumed

 

(720,386

)

 

 

 

 

 

 

Goodwill

$

5,689,586

 

 

 

We performed an assessment effective as of December 31, 2019 in light of the Company’s sale of IIU on January 8, 2020 which resulted in a $1.65 million goodwill impairment.  On January 8, 2020, the Company entered into a SPA with Craven pursuant to which the Company sold to Craven all of the issued and outstanding shares of IIU for $3,562,569.  The purchase price was paid by Craven through the cancellation of the $3,461,782 Convertible Promissory Note issued by LMFA to Craven dated January 16, 2019 plus forgiveness of $100,787 of accrued interest. See Note 10 Discontinued Operations.

 

Note 3. Finance Receivables – Original Product

The Company’s original funding product provides financing to community associations only up to the secured or “Super Lien Amount” as discussed in Note 1.  Finance receivables for the original product as of June 30, 2020 and December 31, 2019 based on the year of funding are approximately as follows:

 

 

 

June 30, 2020

 

 

December 31,

2019 (Audited)

 

Funded during the current year

 

$

14,000

 

 

$

40,000

 

1-2 years outstanding

 

 

16,000

 

 

 

15,000

 

2-3 years outstanding

 

 

9,000

 

 

 

20,000

 

3-4 years outstanding

 

 

18,000

 

 

 

11,000

 

Greater than 4 years outstanding

 

 

267,000

 

 

 

300,000

 

 

 

 

324,000

 

 

 

386,000

 

Reserve for credit losses

 

 

(112,000

)

 

 

(112,000

)

 

 

$

212,000

 

 

$

274,000

 

Number of active units with delinquent assessments

 

 

511

 

 

 

598

 

Amount of outstanding interest and late fees on active units

 

$

8,727,000

 

 

$

9,167,000

 

 

Note 4. Finance Receivables – Special Product (New Neighbor Guaranty program)

The Company typically funds amounts equal to or less than the “Super Lien Amount”.  During 2012 the Company began offering Associations an alternative product under the New Neighbor Guaranty program where the Company funds amounts in excess of the “Super Lien Amount”.  

Under this special product, the Company purchases substantially all of the outstanding past due assessments due from delinquent property owners, in addition to all interest, late fees and other charges in exchange for the Company’s commitment to pay monthly assessments on a going forward basis up to 48 months.  

17


As of June 30, 2020, maximum future contingent payments under these arrangements was approximately $45,000.  

Delinquent assessments and accrued charges under these arrangements as of June 30, 2020 and December 31, 2019, are as follows: 

 

 

 

June 30, 2020

 

 

December 31,

2019 (Audited)

 

Finance receivables, net

 

$

97,000

 

 

$

129,000

 

Delinquent assessments

 

 

209,000

 

 

 

374,000

 

Accrued interest and late fees

 

 

91,000

 

 

 

235,000

 

Number of active units with delinquent assessments

 

 

24

 

 

 

31

 

 

Allowance for credit losses are recorded for losses that are considered “probable” and can be “reasonably estimated” in accordance with ASC 450-20.  Recoverability of the Company’s Original Product is generally assured because of the protection of the Super Lien under Florida statute and as such no allowance is recorded.    

Credit losses on the NNG product were estimated by the Company based on analyzing the investment in each unit and comparing that balance to the average payout for completed units for the past 12 months. The allowance for losses based on these analyses, had a remaining balance of $7,000 and $20,000 as of June 30, 2020 and December 31, 2019, respectively.

 

Note 5. Due to Related Party

Legal services for the Company associated with the collection of delinquent assessments from property owners are performed by a law firm, Business Law Group (“BLG”), which was owned solely by Bruce M. Rodgers, the Chief Executive Officer of LMFA until and through the date of the initial public offering. Following the offering, Mr. Rodgers transferred his interest in BLG to other attorneys at the firm through a redemption of his interest in the firm, and BLG is now under control of those lawyers. The law firm has historically performed collection work primarily on a deferred billing basis wherein the law firm receives payment for services rendered upon collection from the property owners or at amounts ultimately subject to negotiations with the Company.

During 2016, the Company experienced a decline in collection events that affected revenues both to the Company and BLG.  That resulted in an increase in the related party receivable and reflects the decision by the Company to advance funds to BLG based on the amount of their unpaid legal fees due from property owners.  Effective January 1, 2017, the Company entered into a new services agreement with BLG which partially alters the traditional deferred billing arrangement noted above.  

 

Under the new agreement, the Company pays BLG a fixed monthly fee of $82,000 for services rendered.  The Company will continue to pay BLG a minimum per unit fee of $700 in any case where there is a collection event and BLG receives no payment from the property owner.  This provision has been expanded to also include any unit where the Company has taken title to the unit or where the association has terminated its contract with either BLG or the Company.    

Amounts expensed by the Company to BLG for the three and six months ended June 30, 2020 and 2019, respectively were approximately $250,000 and $509,000 for 2020 and $291,000 and $536,000 for 2019, respectively.  As of June 30, 2020 and December 31, 2019, receivables from property owners for charges ultimately payable to BLG approximate $1,375,000 and $1,883,000, respectively.

Under the related party agreement with BLG in effect during 2020 and 2019, the Company pays all costs (lien filing fees, process and serve costs) incurred in connection with the collection of amounts due from property owners.  Any recovery of these collection costs is accounted for as a reduction in expense incurred.  The Company incurred expenses related to these types of costs for the three and six months ended June 30, 2020 and 2019 were $31,000 and $67,000 for 2020 and $62,000 and $109,000 for 2019, respectively. Recoveries during the three and six months ended June 30, 2020 and 2019, related to those costs were approximately $51,000 and $96,000 for 2020 and $52,000 and $122,000 for 2019, respectively.  

The Company also shares office space and related common expenses with BLG.  All shared expenses, including rent, are charged to the legal firm based on an estimate of actual usage.  Any expenses of BLG paid by the Company that have not been reimbursed or settled against other amounts are reflected as due from related parties in the accompanying consolidated balance sheet. BLG was charged approximately $30,000 for the office sub-lease.

Amounts (payable) receivable from BLG as of June 30, 2020 and December 31, 2019 were approximately ($171,500) and $152,800, respectively. In the first six months of June 30, 2020, the Company subsequently recouped $200,000 of previously write-off amounts to BLG.

On December 20, 2019, the Company loaned $1.5 million to Craven in the form of a secured promissory note (the “Craven Secured

18


Promissory Note”) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly.

The Company subsequently extended the due date of the Craven Secured Promissory Note and the monthly interest payments to August 1, 2021. The Craven Secured Promissory Note is secured by, among other things, stock pledge of Craven’s 640,000 common stock of the Company and the assignment of the assets of Craven in favor of the Company.  This loan and the accrued interest was repaid on June 29, 2020.

Note 6. Debt and Other Financing Arrangements

 

 

 

 

June 30, 2020

 

 

December 31,

2019 (Audited)

 

Financing agreement with FlatIron capital that is unsecured.  Down payment of $19,170 was required upfront and equal installment payments of $11,590 to be made over a 11 month period. The note matures June 1, 2020. Annualized interest is 6.8%

 

$

-

 

 

$

69,540

 

 

 

 

 

 

 

 

 

 

Promissory note issued by a financial institution, bearing interest at 1.0%, interest and no principal payments.   The note matures April 30, 2022. Annualized interest is 1.0%. This is a U.S. Small Business Administration’s Paycheck Protection Program (the “PPP Loan”)

 

$

185,785

 

 

$

-

 

 

 

 

 

 

 

 

 

 

Senior secured convertible note to Craven House Capital North America LLC (Related Party), bearing interest at 3.0%.  Note was issued on January 16, 2019 and either matured on January 14, 2020 or became convertible into 1,436,424 shares of the Company's common shares. The value of the beneficial conversion feature as of January 16, 2019 was zero*.

 

 

-

 

 

 

3,461,782

 

 

 

 

 

 

 

 

 

 

Promissory note issued by a financial institution, bearing interest at 9.09%, interest and principal payments due monthly of $323.  Note is secured by an automobile and was issued on July 26, 2019 with original borrowings of $12,892.  The note matures on August 26, 2023.

 

 

-

 

 

 

11,802

 

 

 

 

 

 

 

 

 

 

Promissory note issued by a financial institution, bearing interest at 5.85%, interest and principal payments due monthly of $10,932. Note was issued on May 31, 2018 with original borrowings of $608,000 and subsequent borrowings of $141,000 and repayments of $51,000.  The note matures on May 30, 2025 and can be prepaid at any time without penalty. This note is secured by the Company’s inventory, chattel paper, accounts, equipment and general intangible intangibles and deposit accounts.

 

 

-

 

 

 

606,454

 

 

 

 

 

 

 

 

 

 

 

 

$

185,785

 

 

$

4,149,578

 

 

 

 


19


As of June 30, 2020, minimum annual principal payments are as follows:

Years Ending

 

 

 

 

December 31,

 

 

 

 

2020

 

 

-

 

2021

 

 

-

 

2022

 

 

185,785

 

2023

 

 

-

 

2024

 

 

-

 

After 2024

 

 

-

 

 

 

$

185,785

 

 

On April 30, 2020, the company obtained a $185,785 Paycheck Protection Program loan. These business loans were established by the 2020 US Federal government Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) to help certain businesses, self-employed workers, sole proprietors, certain nonprofit organizations, and tribal businesses continue paying their workers.

 

The Paycheck Protection Program allows entities to apply for low interest private loans to pay for their payroll and certain other costs. The loan proceeds will be used to cover payroll costs, rent, interest, and utilities. The loan may be partially or fully forgiven if the Company keeps its employee counts and employee wages stable. The program was implemented by the U.S. Small Business Administration. The interest rate is 1.0% and has a maturity date of 2 years. We anticipate applying for loan and interest forgiveness in the third quarter of 2020.

 

 

Note 7. Going Concern

 The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are issued.

In accordance with Financial Accounting Standards Board, or the FASB, Accounting Standards Update No. 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40), our management evaluates whether there are conditions or events, considered in aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued.

The Company has experienced significant operating losses over the past 4 years (2016 through June 30, 2020) with cumulative losses of approximately $15,046,000 and negative cashflows from operations. These losses resulted in the usage of all cash proceeds from the Company’s initial public offering in 2015. For the year ended December 31, 2019, the Company disclosed the substantial doubt about the Company’s ability to continue as a going concern

The Company received a total of approximately $5.7 million during the three months ended June 30, 2020 due to a number of factors including:

 

Holders of our warrants exercised such warrants for 1.2 million shares in June 2020 which resulted in the Company receiving approximately $2.9 million.

 

The Company was repaid approximately $1.5 million on a related party receivable.

 

The Company received $1.25 million for the issuance of 520,838 common shares.

 

As such, we have $6.2 million of cash which will be enough to satisfy our estimated liquidity needs for the 12 months from the issuance of these financial statements. These factors mitigated the substantial doubt about the Company’s ability to continue as a going concern as defined by ASU 2014-15.

  

Note 8. Commitments and Contingencies

Leases

The Company leases certain office space, construction and office equipment, vehicles and temporary housing generally under non-cancelable operating leases. Leases with an initial term of one year or less are not recorded on the balance sheet, and the Company generally recognizes lease expense for these leases on a straight-line basis over the lease term. As of June 30, 2020, the Company’s operating leases have remaining lease terms ranging from less than one year to 3 years, some of which include options to renew the leases. The exercise of lease renewal options is generally at the Company’s sole discretion. The Company’s leases do not contain any material residual value guarantees or material restrictive covenants.

The Company determines if an arrangement is a lease at inception. Operating lease ROU assets and current and long-term operating lease liabilities are separately stated on the Consolidated Balance Sheet as of June 30, 2020. ROU assets represent the Company’s

20


right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. The present value of future lease payments are discounted using either the implicit rate in the lease, if known, or the Company’s incremental borrowing rate for the specific lease as of the lease commencement date. The rate was determined as a fair value of the lease over a 37 month period using a 6.5% interest rate for the present value calculation. The ROU asset is also adjusted for any prepayments made or incentives received. The lease terms include options to extend or terminate the lease only to the extent it is reasonably certain any of those options will be exercised. Lease expense is recognized on a straight-line basis over the lease term. The Company accounts for lease components (e.g., fixed payments) separate from the non-lease components (e.g., common-area maintenance costs). The Company does not have any material financing leases.

The Company leased its office under an operating lease beginning March 1, 2014 and ending July 31, 2019. The Company’s new office lease began July 15, 2019 and ends July 31, 2022. It also had a month to month lease for its IIU operations in 2019. A related party has a sub-lease for approximately $4,900 per month plus operating expenses.

 

The Company shares this space and the related costs associated with this operating lease with a related party (see Note 5) that also performs legal services associated with the collection of delinquent assessments.  Net rent expense recognized for the three and six months ended June 30, 2020 and 2019 were approximately $20,000 and $50,000 for 2020 and $38,000 and $97,000 for 2019, respectively.

 

The following table presents components of lease expense excluding discontinued operations for the three and six months ended June 30, 2020 and 2019:

 

 

Three Months

Ended

June 30,

2020

 

Six Months

Ended

June 30,

2020

Three Months

Ended

June 30,

2019

Six Months

Ended

June 30,

2019

Operating lease expense

$

20,377

$

50,109

38,457

97,301

 

$

20,377

$

50,109

38,457

97,301

 

The following table presents supplemental balance sheet information related to operating leases as of June 30, 2020 and December 31, 2019:

 

 

 

Balance Sheet Line Item

As of June 30, 2020

 

As of December 31, 2019

 

 

 

Assets

 

 

 

 

 

 

 

 

 

 

ROU assets

 

Right of use asset, net

$

209,031

 

$

260,260

 

 

 

Total lease assets

 

 

$

209,031

 

$

260,260

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

Current lease liabilities

 

Lease liability

$

98,846

 

$

94,235

 

 

 

Long-term lease liabilities

 

Lease liability

 

121,295

 

 

171,648

 

 

 

Total lease liabilities

 

 

$

220,141

 

$

265,883

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average remaining lease term (in years)

 

 

 

2.13

 

 

2.60

 

 

 

Weighted-average discount rate

 

 

 

6.55

%

 

6.55

%

 

 

21


 

The following table presents supplemental cash flow information and non-cash activity related to operating leases for the six months ended June 30, 2020 and 2019:

 

 

 

 

Six Months Ended June 30, 2020

 

Six Months Ended June 30, 2019

 

 

 

Operating cash flow information

 

 

 

 

 

 

 

 

 

 

Cash paid for amounts included in the measurement of lease liabilities

 

 

$

(45,742

)

$

(4,426

)

 

 

Supplemental Disclosure of non-cashflow information

 

 

 

 

 

 

 

 

 

 

ROU assets and operating lease obligation recognized

 

 

$

-

 

$

26,685

 

 

 

 

The following table presents maturities of operating lease liabilities on an undiscounted basis as of June 30, 2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Leases

 

 

 

 

 

2020 (excluding the six months ended June 30, 2020)

 

 

$

48,493

 

 

 

 

 

2021

 

 

 

103,646

 

 

 

 

 

2022

 

 

 

68,002

 

 

 

 

 

 

 

 

$

220,141

 

 

 

 

 

 

Legal Proceedings

Other than the lawsuits described below, we are not currently a party to material litigation proceedings. However, we frequently become party to litigation in the ordinary course of business, including either the prosecution or defense of claims arising from contracts by and between us and client Associations. Regardless of the outcome, litigation can have an adverse impact on us because of prosecution, defense, and settlement costs, diversion of management resources and other factors.

 

The Company accrues for contingent obligations, including estimated legal costs, when the obligation is probable and the amount is reasonably estimable. As facts concerning contingencies become known, the Company reassesses its position and makes appropriate adjustments to the consolidated financial statements. Estimates that are particularly sensitive to future changes include those related to tax, legal, and other regulatory matters.

 

Note 9. Stockholders’ Equity

Stock Options

The 2015 Omnibus Incentive Plan provides for the issuance of stock options, stock appreciation rights, performance shares,

performance units, restricted stock, restricted stock units, shares of our common stock, dividend equivalent units, incentive cash

awards or other awards based on our common stock. Awards may be granted alone or in addition to, in tandem with, or (subject to the

2015 Omnibus Incentive Plan’s prohibitions on repricing) in substitution for any other award (or any other award granted under

another plan of ours or of any of our affiliates).

 

22


The following is a summary of the stock option plan activity during the six months ended June 30, 2020 and 2019:

 

 

 

2020

 

 

2019

 

 

 

Number of

 

 

Weighted Average

 

 

Number of

 

 

Weighted Average

 

 

 

Options

 

 

Exercise Price

 

 

Options

 

 

Exercise Price

 

Options Outstanding at Beginning of the year

 

 

19,300

 

 

$

60.51

 

 

 

19,300

 

 

$

60.51

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Adjustment

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Forfeited

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding at June 30,

 

 

19,300

 

 

$

60.51

 

 

 

19,300

 

 

$

60.51

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Exercisable at June 30,

 

 

11,800

 

 

$

84.49

 

 

 

7,634

 

 

$

113.81

 

 

Compensation expense recognized from the vesting of stock options was approximately $6,800 and $7,800 for the three months ended June 30, 2020 and 2019. The remaining unrecognized compensation cost associated with unvested stock options as of June 30, 2020 is approximately $11,400.

 

The aggregate intrinsic value of the outstanding common stock options as of June 30, 2020 and December 31, 2019 was $0 and $0 respectively.

 

Warrants

 

The following is a summary of the warrant activity during the six months ended June 30, 2020 and 2019:

 

 

 

2020

 

 

2019

 

 

 

Number of

 

 

Weighted Average

 

 

Number of

 

 

Weighted Average

 

 

 

Warrants

 

 

Exercise Price

 

 

Warrants

 

 

Exercise Price

 

Warrants Outstanding at Beginning of the year

 

 

3,959,287

 

 

$

5.36

 

 

 

3,843,587

 

 

$

5.44

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

-

 

 

 

-

 

 

 

125,000

 

 

 

2.64

 

Exercised

 

 

1,227,700

 

 

 

2.40

 

 

 

9,300

 

 

 

2.40

 

Forfeited

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Warrants Outstanding at June 30,

 

 

2,731,587

 

 

$

6.83

 

 

 

3,959,287

 

 

$

5.36

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

During June 2020, the Company received approximately $2,946,480 upon the exercise by warrant holders of warrants for 1,227,700 shares.

 

Common Share Issuance

On March 23, 2020, the Company entered into a Share Exchange Agreement, dated March 23, 2020 (the “Share Exchange Agreement”), with Hanfor (Cayman) Limited, a Cayman Islands exempted company (“Hanfor”), and BZ Industrial Limited, a British Virgin Islands business company and the sole stockholder of Hanfor (“Hanfor Owner”).  In connection with the execution of the Share Exchange Agreement, the Company and Hanfor Owner entered into a Stock Purchase Agreement, dated March 23, 2020, pursuant to which Hanfor Owner purchased from Company an aggregate of 520,833 shares of the Company’s common stock at a price of $2.40 per share. Hanfor Owner paid $250,000 cash on March 23, 2020 and the Company received the remaining $1.0 million in April 2020 2020 at which time the Company issued the 520,838 shares.

 

23


On March 23, 2020, the Company issued 186,000 shares to Maxim Holdings LLC for services and recognized $125,450 as stock compensation expense for the six months ended June 30, 2020.

 

Note 10. Discontinued Operations

On January 8, 2020, the Company entered into a Stock Purchase Agreement (“SPA”) with Craven pursuant to which the Company sold to Craven all of the issued and outstanding shares of IIU for $3,562,569.  The purchase price was paid by Craven through the cancellation of the $3,461,782 Craven Convertible Note plus forgiveness of $100,787 of accrued interest. The Company originally paid $4,969,586 of goodwill. As a result, goodwill was impaired by $1.65 million. The sale of IIU resulted in a gain of $16,428.  

 

The impact of this transaction is reflected as a discontinued operation in the consolidated financial statements. Pursuant to ASU 2014-08, the major classes of assets and liabilities of IIU were as follows:

 

 

As of December 31, 2019

Major classes of assets

 

Cash

$   246,914

Related party receivable

27,738

Prepaid expenses

2,301

Total major classes of current assets – discontinued assets

276,953

Fixed assets, net

27,245

Total major classes of assets – discontinued assets

$   304,198

 

 

Accounts payable and accrued expenses

$   144,006

Note payable – short term

100,672

Other liabilities

21,153

Income taxes payable

14,226

Total major classes of current liabilities – discontinued liabilities

280,057

 

 

Debt

517,584

Total major classes of liabilities - discontinued liabilities

$   797,641

 

 

 

The operating results for IIU, Inc. have been presented in the accompanying consolidated financial statements of operations for the three and six months ended June 30, 2020 and 2019 as discontinued operations are summarized below:

 

 

Three Months Ended June 30, 2020

Three Months Ended June 30, 2019

 

Six Months Ended June 30, 2020

 

Six Months Ended June 30, 2019

Revenue

$              -

$      181,391

$              -

$       280,159

Total operating costs and expenses

-

100,511

-

327,377

Gain (Loss) from discontinued operations

-

80,880

-

(47,218)

Other expense, net

-

9,956

-

16,711

Gain on disposal of discontinued operations

-

-

16,428

-

Net gain (loss) from discontinued operations

$               -

$  70,924

$     16,428

$  (63,929)

 

 

 

 

 

Net cash provided by operating activities

$                -

$ 169,009

$                -

113,829

Net cash (used in) provided by investing activities

  -

-

(246,914)

51,327

Net cash used in financing activities

-

(18,452)

 

(37,886)

 

 

 

 

24


Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

This Quarterly Report on Form 10-Q contains certain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. All statements other than statements of historical facts included in this Quarterly Report on Form 10-Q, including, without limitation, statements regarding our future financial position, business strategy, budgets, projected revenues, projected costs, and plans and objectives of management for future operations, are forward-looking statements. Forward-looking statements generally can be identified by the use of forward-looking terminology such as “may,” “will,” “expects,” “intends,” “plans,” “projects,” “estimates,” “anticipates,” “believes,” or the negative thereof or any variation thereon or similar terminology or expressions.

We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are not guarantees and are subject to known and unknown risks, uncertainties, and assumptions about us that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance, or achievements expressed or implied by such forward-looking statements. Important factors which could materially affect our results and our future performance include, without limitation:

 

our ability to purchase defaulted consumer receivables at appropriate prices,

 

competition to acquire such receivables,

 

our dependence upon third party law firms to service our accounts,

 

our ability to obtain funds to purchase receivables,

 

our ability to manage growth or declines in the business,

 

changes in government regulations that affect our ability to collect sufficient amounts on our defaulted consumer receivables,

 

the impact of class action suits and other litigation on our business or operations,

 

our ability to keep our software systems updated to operate our business,

 

our ability to employ and retain qualified employees,

 

our ability to establish and maintain internal accounting controls,

 

changes in the credit or capital markets,

 

changes in interest rates,

 

deterioration in economic conditions,

 

negative press regarding the debt collection industry which may have a negative impact on a debtor’s willingness to pay the debt we acquire,

 

the spread of the novel coronavirus (COVID-19), its impact on the economy generally and, more specifically, the specialty finance or specialty health insurance industries,

 

negative press regarding the debt collection industry which may have a negative impact on a debtor’s willingness to pay the debt we acquire, and

 

other factors set forth under “Item 1A. Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended December 31, 2019 and Item 1A of this Quarterly Report on Form 10-Q.

Except as required by law, we assume no duty to update or revise any forward-looking statements.

Overview

We are a specialty finance company that provides funding to nonprofit community associations primarily located in the state of Florida. We offer incorporated nonprofit community associations, which we refer to as “Associations,” a variety of financial products customized to each Association’s financial needs. Our original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. Historically, we provided funding against such delinquent accounts, which we refer to as “Accounts,” in exchange for a portion of the proceeds collected by the Associations from the account debtors on the Accounts. In addition to our original product offering, we have started purchasing Accounts on varying terms tailored to suit each Association’s financial needs, including under our New Neighbor Guaranty™ program.

25


 

Specialty Finance Company

We purchase an Association’s right to receive a portion of the Association’s collected proceeds from owners that are not paying their assessments. After taking assignment of an Association’s right to receive a portion of the Association’s proceeds from the collection of delinquent assessments, we engage law firms to perform collection work on a deferred billing basis wherein the law firms receive payment upon collection from the account debtors or a predetermined contracted amount if payment from account debtors is less than legal fees and costs owed. Under this business model, we typically fund an amount equal to or less than the statutory minimum an Association could recover on a delinquent account for each Account, which we refer to as the “Super Lien Amount”. Upon collection of an Account, the law firm working on the Account, on behalf of the Association, generally distributes to us the funded amount, interest, and administrative late fees, with the law firm retaining legal fees and costs collected, and the Association retaining the balance of the collection. In connection with this line of business, we have developed proprietary software for servicing Accounts, which we believe enables law firms to service Accounts efficiently and profitably.

Under our New Neighbor Guaranty program, an Association will generally assign substantially all of its outstanding indebtedness and accruals on its delinquent units to us in exchange for payment by us of monthly dues on each delinquent unit. This simultaneously eliminates a substantial portion of the Association’s balance sheet bad debts and assists the Association to meet its budget by receiving guaranteed monthly payments on its delinquent units and relieving the Association from paying legal fees and costs to collect its bad debts. We believe that the combined features of the program enhance the value of the underlying real estate in an Association and the value of an Association’s delinquent receivables. We intend to leverage our proprietary software platform, as well as our industry experience and knowledge gained from our original line of business, to expand the New Neighbor Guaranty program in certain situations and to potentially develop other new products in the future.

Because we acquire and collect on the delinquent receivables of Associations, the Account debtors are third parties about whom we have little or no information. Therefore, we cannot predict when any given Account will be paid off or how much it will yield. In assessing the risk of purchasing Accounts, we review the property values of the underlying units, the governing documents of the relevant Association, and the total number of delinquent receivables held by the Association.

Specialty Finance Products

Original Product

Our original product relies upon Florida statutory provisions that effectively protect the principal amount invested by us in each Account. In particular, Section 718.116(1), Florida Statutes, makes purchasers and sellers of a unit in an Association jointly and severally liable for all past due assessments, interest, late fees, legal fees, and costs payable to the Association. As discussed above, the Florida Statutes grants to Associations a so-called “super lien”, which is a category of lien that is given a statutorily higher priority than all other types of liens other than property tax liens. The amount of the Association’s priority over a first mortgage holder that takes title to a property through foreclosure (or deed in lieu), referred to as the Super Lien Amount, is limited to twelve months’ past due assessments or, if less, one percent (1.0%) of the original mortgage amount. Under our contracts with Associations for our original product, we pay Associations an amount up to the Super Lien Amount for the right to receive all collected interest and late fees on Accounts purchased from the Associations.

The Statutes specify that the rate of interest an association (or its assignor) may charge on delinquent assessments is equal to the rate set forth in the association’s declaration or bylaws. In Florida if a rate is not specified, the statutory rate is equal to 18% but may not exceed the maximum rate allowed by law. Similarly, the Statutes in Florida also stipulate that administrative late fees cannot be charged on delinquent assessments unless so provided by the association’s declaration or bylaws and may not exceed the greater of $25 or 5% of each delinquent assessment.

In other states in which we have offered our original product, which are currently only in Washington, Colorado and Illinois, we rely on statutes that we believe are similar to the above-described Florida statutes in relevant respects. A total of approximately 22 U.S. states, Puerto Rico and the District of Columbia have super lien statutes that give Association assessments super lien status under some circumstances, and of these states, we believe that all of these jurisdictions other than Alaska have a regulatory and business environment that would enable us to offer our original product to Associations in those states on materially the same basis.

New Neighbor Guaranty

In 2012, we developed a new product, the New Neighbor Guaranty, wherein an Association assigns substantially all of its outstanding indebtedness and accruals on its delinquent units to us in exchange for payments in an amount equal to the regular ongoing monthly or quarterly assessments for delinquent units when those amounts would be due to the Association. We assume both the payment and collection obligations for these assigned Accounts under this product. This simultaneously eliminates an Association’s balance sheet bad debts and assists the Association to meet its budget by receiving guaranteed assessment payments on its delinquent units and relieving the Association from paying legal fees and costs to collect its bad debts. We believe that the combined features of the product enhance the value of the underlying real estate in an Association and the value of an Association’s delinquent receivables.

26


Before we implement the New Neighbor Guaranty program for an Association typically asks us to conduct a review of its accounts receivable. After we have conducted the review, we inform the Association which Accounts we are willing to purchase and the terms of such purchase. Once we implement the New Neighbor Guaranty program, we begin making scheduled payments to the Association on the Accounts as if the Association had non-delinquent residents occupying the units underlying the Accounts. Our New Neighbor Guaranty contracts typically allow us to retain all collection proceeds on each Account other than special assessments and accelerated assessment balances. Thus, the Association foregoes the potential benefit of a larger future collection in exchange for the certainty of a steady stream of immediate payments on the Account.

Recent Developments

IIU Acquisition and Disposal

On November 2, 2018, the Company invested cash by purchasing a Senior Convertible Promissory Note in the original principal amount of $1,500,000 (the “IIU Note”) from IIU, a synergistic Virginia based travel insurance brokerage company controlled by Craven House North America, LLC (“Craven”) N.A., (whose ownership excluding unexercised warrants was approximately 20% of the Company’s outstanding stock at the time of the acquisition).  The maturity date of the IIU Note was 360 dates after the date of issuance (subject to acceleration upon an event of default).  The IIU Note carried a 3.0% interest rate, with accrued but unpaid interest being payable on the IIU Note’s maturity date.  

On January 16, 2019, the Company entered into a Stock Purchase Agreement with Craven (the “IIU SPA”) to purchase all of the outstanding capital stock of IIU as a possible synergistic effort to diversify revenue sources that were believed to be accretive to earnings.  IIU provided global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies were fully underwritten with no claim risk remaining with IIU.

The Company purchased 100% of the issued and outstanding capital stock of IIU from Craven for $5,089,357 subject to adjustment as set forth in the IIU SPA.  IIU was required to have a minimum net working capital of $15,000 and at least $152,000 in cash. The Company paid the purchase price under the IIU SPA at closing as follows:

 

The Company cancelled all principal and accrued interest of the IIU Note, which consisted of aggregate principal indebtedness and accrued interest of $1,507,375 as of January 16, 2019.

 

The Company issued to Craven a $3,581,982 Senior Convertible Promissory Note (the “Craven Convertible Note”) for the balance of the purchase price.  At the option of Craven, the Craven Convertible Note could be paid in restricted shares of our common stock or cash.  The Craven Convertible Note bore simple interest at 3% per annum.  The Craven Convertible Note was due and payable 360 days from the closing date of the IIU SPA. If repaid by the Company in restricted common stock, the outstanding principal and interest of the Craven Convertible Note would be paid by the Company by issuing to Craven a number of restricted common shares equal to the adjusted principal and accrued interest owing to Craven under the Craven Convertible Note divided by $2.41. On the date of issuance of the Craven Convertible Note, the closing share price of the Company was $1.42.

 

Pursuant to the terms of the IIU SPA, the purchase price was subsequently reduced by $120,200, to $4,969,200.

On December 20, 2019, the Company loaned $1.5 million to Craven (“Craven Secured Promissory Note”) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly. The Company subsequently extended the due date of the Craven Secured Promissory Note to August 1, 2021.   The Craven Secured Promissory Note was secured by, among other things, a pledge of Craven’s 640,000 shares of common stock of the Company and the assignment of the assets of Craven in favor of the Company. On June 29, 2020, the Company received from Craven $1,503,719 as payment in full of all principal and accrued interest due from the Craven Secured Promissory Note.

On January 8, 2020, the Company entered into a Stock Purchase Agreement (“SPA”) with Craven pursuant to which the Company sold back to Craven all of the issued and outstanding shares of IIU for $3,562,569.  The purchase price was paid by Craven through the cancellation of the $3,461,782Craven Convertible Note plus forgiveness of $100,787 of accrued interest. The Company originally paid $4,969,200 for the purchase of IIU in January 2019, which included a negative $720,386 net fair value of assets and $5,689,586 of goodwill. As a result, goodwill was impaired by $1.65 million. The sale of IIU resulted in a gain of $16,428.  

As such, IIU is considered a discontinued operation. We did not report any activity from operations from IIU for the six months ended June 30, 2020.

Specialty Health Insurance

Our former subsidiary IIU through its wholly owned company Wallach and Company (“Wallach”) offered health insurance, travel insurance and other travel services to:

 

United States citizens and residents traveling abroad; and

 

Non United States citizens or residents who travel to the United States

27


These services were typically sold through a policy offered by Wallach and fully underwritten by a third party insurance company.  The policies offered include: HealthCare Abroad, HealthCare Global, HealthCare America, HealthCare International, HealthCare War.

 

Entry into and Termination of Hanfor Share Exchange Agreement

On March 23, 2020, the Company entered into a Share Exchange Agreement, dated March 23, 2020 (the “Share Exchange Agreement”), with Hanfor (Cayman) Limited, a Cayman Islands exempted company (“Hanfor”), and BZ Industrial Limited, a British Virgin Islands business company and the sole stockholder of Hanfor (“Hanfor Owner”).  The Share Exchange Agreement contemplated a business combination transaction in which Hanfor Owner would transfer and assign to the Company all of the share capital of Hanfor in exchange for a number of shares of the Company’s common stock that would result in Hanfor Owner owning 86.5% of the outstanding common stock of the Company.

Under the agreement, Hanfor Owner was required to deliver to the Company audited financial statements for Hanfor for the 2019 and 2018 fiscal years, and such audited financial statements were required to be delivered by May 31, 2020 (subject to extension to June 30, 2020 under specified circumstances).  In connection with the execution of the Share Exchange Agreement, the Company and Hanfor Owner entered into a Stock Purchase Agreement, dated March 23, 2020, pursuant to which Hanfor Owner purchased from the Company an aggregate of 520,838 shares of the Company’s common stock at a price of $2.40 per share. Hanfor Owner paid $250,000 cash on March 23, 2020 and the Company received an additional $1,000,000 in April 2020 at which time the Company issued the 520,838 shares.

On July 14, 2020, the Company notified Hanfor and Hanfor Owner that the Company had elected to terminate the Share Exchange Agreement due to Hanfor’s inability to provide audited financial statements by June 30, 2020.  Although the Company believes that it properly terminated the Share Exchange Agreement, on July 21, 2020, counsel to Hanfor Owner informed the Company that Hanfor Owner believes that the Company’s termination of the Share Exchange Agreement was not effected in accordance with the terms of the Share Exchange Agreement.  The Company and Hanfor Owner are engaged in discussions to resolve this disagreement, but there is no assurance that this disagreement will be promptly resolved or resolved on terms favorable to the Company, and there is no assurance that Hanfor Owner will not seek to take legal action.

Nasdaq Listing

On March 27, 2020, the Company received a notification letter from the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has not regained compliance with Nasdaq Continued Listing Rule 5550(a)(2), which requires the Company’s listed securities to maintain a minimum bid price of $1.00 per share (the "Minimum Bid Price Rule"). The notification stated that the Company’s securities would be delisted from the Nasdaq Capital Market on April 7, 2020 unless the Company timely requested a hearing before a Nasdaq Hearing Panel.  The Company has timely requested a hearing.  However, on April 16, 2020, Nasdaq suspended any enforcement actions relating to bid price issues through June 30, 2020. On July 1, 2020, the Company received a letter from Nasdaq stating that the Company had regained compliance with the Minimum Bid Price Rule because the closing price for the Company’s common stock was $1.00 per share or greater for ten (10) consecutive business days.

Additionally, on January 3, 2020, the Company received a deficiency letter from Nasdaq, indicating that it was in violation of Listing Rules 5620(a) and 5810(c)(2)(G) by virtue of passing the applicable deadline for holding of its annual general meeting of shareholders for the financial year ended December 31, 2018.  The Company resolved this issue by having its annual general meeting of shareholders on May 11, 2020.

Reverse Stock Split Approval

On May 11, 2020, our shareholders voted in favor of the approval of an amendment to our Certificate of Incorporation, in the event it is deemed advisable by our Board of Directors, to effect an additional reverse stock split of the Company’s issued and outstanding common stock at a ratio within the range of one-for-two (1:2) and one-for-ten (1:10), as determined by the Board of Directors.  However, a reverse stock split has not yet been effected pursuant to such approval.

COVID-19 Update

Although COVID-19 is currently not material to our results of operations, there is uncertainty relating to the potential future impact on our business.  While our employees currently have the ability and are encouraged to work remotely, such measures have and may continue to have an impact on employee attendance or productivity, which, along with the possibility of employees’ illness, may adversely affect our operations. In addition to encouraging employees to work remotely, the Company has increased sanitation of its offices, provided hand gel and masks to its employees and has closed the offices during identified periods of high contagion.

The extent to which COVID-19 impacts our operations, or our ability to obtain financing should we require it, will depend on future developments which are uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions taken by governments and private businesses to contain COVID-19 to treat its impact, among others.  If the disruptions posed by COVID-19 continue for an extended period of time, financial markets may not be available to the Company

28


for raising capital in order to fund future growth. Should the Company not be able to obtain financing when required, in the amounts necessary or under terms which are economically feasible, we may be required to reduce planned future growth and/or the scope of our operations.

On April 30, 2020, the company obtained a $185,785 Paycheck Protection Program loan (“PPP Loan”). These business loans were established by the 2020 US Federal government Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) to help certain businesses, self-employed workers, sole proprietors, certain nonprofit organizations, and tribal businesses continue paying their workers.

The Paycheck Protection Program allows entities to apply for low interest private loans to pay for their payroll and certain other costs. The loan proceeds will be used to cover payroll costs, rent, interest, and utilities. The loan may be partially or fully forgiven if the Company keeps its employee counts and employee wages stable. The program was implemented by the U.S. Small Business Administration. The interest rate is 1.0% and has a maturity date of 2 years. We anticipate applying for loan and interest forgiveness in the third quarter of 2020.

Corporate History and Reorganization

The Company was originally organized in January 2008 as a Florida limited liability company under the name LM Funding, LLC. Historically, all of our business was conducted through LM Funding, LLC and its subsidiaries (the “Predecessor”). Immediately prior to our initial public offering in October 2015, the members of the LM Funding, LLC contributed all of their membership interests to LM Funding America, Inc., a Delaware corporation incorporated on April 20, 2015 (“LMFA”), in exchange for an aggregate of 2,100,000 shares of the common stock of LMFA (the “Corporate Reorganization”). Immediately after such contribution and exchange, the former members of LM Funding, LLC became the holders of 100% of the issued and outstanding common stock of LMFA, thereby making LM Funding, LLC a wholly-owned subsidiary of LMFA. As used in this discussion and analysis, unless the context requires otherwise, references to “LMF,” “LM Funding,” “we,” “us,” “our,” “the Company,” “our company,” and similar references refer to (i) following the date of the Corporate Reorganization, LM Funding America, Inc., a Delaware corporation, and its consolidated subsidiaries, and (ii) prior to the date of the Corporate Reorganization, LM Funding, LLC, a Florida limited liability company, and its consolidated subsidiaries.

Results of Operations – Three Months

The Three Months Ended June 30, 2020 compared with the Three Months Ended June 30, 2019

Revenues

During the Three Months ended June 30, 2020, total revenues decreased by $316 thousand, or 48.0%, to $343 thousand from $659 thousand in the Three Months ended June 30, 2019.

Interest on delinquent association fees for the Three Months ended June 30, 2020 decreased $294 thousand or 63.3% as the number of payoffs decreased to 86 payoff occurrences as compared to 119 payoff occurrences for the three months ended June 30, 2019.   We believe these payoffs were impacted in part by the negative impact COVID-19 has had on the general economy. “Payoffs” consist of recovery of the entire legally collectible portion, or a settlement thereof, of our principal investment, accrued interest, and late fees owed to us from the proceeds of the Accounts collected by the Associations in accordance with our contracts with Associations. The decrease in payoff occurrences was also due to a decrease in revenue per unit. The average revenue per unit per the Statement of Operations, excluding rental revenue and net commission revenue decreased to $3,573 for the Three Months ended June 30, 2020 compared with $4,927 for the Three Months ended June 30, 2019.

We saw a decrease in rental revenue in the Three Months ended June 30, 2020 of $39 thousand to $33 thousand from $72 thousand for the Three Months ended June 30, 2019. This was due to a reduced number of rental units in 2020 as compared to 2019.

Operating Expenses

During the Three Months ended June 30, 2020, operating expenses decreased $353 thousand, or 31.3%, to $775 thousand from $1,127 thousand for the Three Months ended June 30, 2019. The decrease in operating expenses can be attributed to various factors, including in part a reduction in real estate management expenses of $86 thousand, decreased staffing costs of $30 thousand, professional fees of $45 thousand and a $100 thousand recovery of bad debt allowance for a related party.

Professional fees, excluding fees from the BLG service agreement, for the Three Months ended June 30, 2020 were approximately $229,000 compared with approximately $257,000 for the Three Months ended June 30, 2019.  In the ordinary course of our business, we are involved in numerous legal proceedings and expenses associated with acquisitions and corporate initiatives. We regularly initiate collection lawsuits, using our network of third party law firms, against debtors. In addition, debtors occasionally initiate litigation against us. The settlement costs of these lawsuits decreased by approximately $38,000 to nil compared with a charge of approximately $38,000 for the Three Months ended June 30, 2019.

29


Legal fees for BLG for the Three Months ended June 30, 2020 were $250 thousand compared to $291 thousand for the Three Months ended June 30, 2019. See Note 5. Due From Related Party for further discussion regarding the service agreements with BLG.  

Interest Expense

During the Three Months ended June 30, 2020, the Company incurred $6 thousand of interest expense as compared to $53 thousand of interest expense for the Three Months ended June 30, 2019.  

Net Loss from Continuing Operations

During the Three Months ended June 30, 2020, the net income from continuing operations was $438 thousand as compared to a net loss of $521 thousand for the Three Months ended June 30, 2019.  

Income from Discontinued Operations

During the Three Months ended June 30, 2020, the income from discontinued operations was $0 as compared to net income of $71 thousand for the Three Months ended June 30, 2019.  

Net Loss

During the Three Months ended June 30, 2020, the net loss was $438 thousand as compared to net loss of $451 thousand for the Three Months ended June 30, 2019.  The change in the loss was primarily due to reduced revenue offset in part by a recovery of costs from related party receivables and a reduction in other operating expenses.

Results of Operations – Six Months

The Six Months Ended June 30, 2020 compared with the Six Months Ended June 30, 2019

Revenues

During the Six Months ended June 30, 2020, total revenues decreased by $639 thousand, or 48.3%, to $684 thousand from $1,323 thousand in the Six Months ended June 30, 2019.

Interest on delinquent association fees for the Six Months ended June 30, 2020 decreased $488 thousand or 55.6% as the number of payoffs decreased to 164 payoff occurrences as compared to 254 payoff occurrences for the Six months ended June 30, 2019.  We believe these payoffs were impacted in part by the negative impact COVID-19 has had on the general economy. “Payoffs” consist of recovery of the entire legally collectible portion, or a settlement thereof, of our principal investment, accrued interest, and late fees owed to us from the proceeds of the Accounts collected by the Associations in accordance with our contracts with Associations. The decrease in payoff occurrences was also due to a decrease in revenue per unit. The average revenue per unit per the Statement of Operations, excluding rental revenue and net commission revenue decreased to $3,673 for the Six Months ended June 30, 2020 compared with $4,341 for the Six Months ended June 30, 2019.

We saw a decrease in rental revenue in the Six Months ended June 30, 2020 of $139 thousand to $81 thousand from $220 thousand for the Six Months ended June 30, 2019. This was due to a reduced number of rental units in 2020 as compared to 2019.

Operating Expenses

During the Six Months ended June 30, 2020, operating expenses decreased $436 thousand, or 20.6%, to $1,677 thousand from $2,112 thousand for the Six Months ended June 30, 2019. The decrease in operating expenses can be attributed to various factors, including in part a reduction in real estate management expenses of $198 thousand and a $200 thousand recovery of bad debt allowance for a related party offset in part by increased staffing costs of $23 thousand and professional fees of $33 thousand.

Professional fees, excluding fees from the BLG service agreement, for the Six Months ended June 30, 2020 were approximately $477,000 compared with approximately $614,000 for the Six Months ended June 30, 2019.  In the ordinary course of our business, we are involved in numerous legal proceedings and expenses associated with acquisitions and corporate initiatives. We regularly initiate collection lawsuits, using our network of third party law firms, against debtors. In addition, debtors occasionally initiate litigation against us. The settlement costs of these lawsuits decreased by approximately $28,000 to approximately $12,000 compared with approximately $40,000 for the Six Months ended June 30, 2019. We also issued approximately $125,000 of our stock for investment banking services.

Legal fees for BLG for the Six Months ended June 30, 2020 were $510 thousand compared to $537 thousand for the Six Months ended June 30, 2019. See Note 5. Due From Related Party for further discussion regarding the service agreements with BLG.  

30


Interest Expense

During the Six Months ended June 30, 2020, the Company incurred $13 thousand of interest expense, net as compared to $54 thousand of interest expense for the Six Months ended June 30, 2019.  

Net Loss from Continuing Operations

During the Six Months ended June 30, 2020, the net loss from continuing operations was $1,005 thousand as compared to a net loss of $844 thousand for the Six Months ended June 30, 2019.  

Gain on Disposal of Discontinued Operations

During the Six Months ended June 30, 2020, the Company disposed of IIU which generated a net gain of $16 thousand.

Loss from Discontinued Operations

During the Six Months ended June 30, 2020, the loss from discontinued operations was $0 as compared to net loss of $64 thousand for the Six Months ended June 30, 2019.  

Net Loss

During the Six Months ended June 30, 2020, the net loss was $989 thousand as compared to net loss of $908 thousand for the Six Months ended June 30, 2019.  The change in the loss was primarily due to reduced revenue offset in part by a recovery of costs from related party receivables.

Liquidity and Capital Resources

General

As of June 30, 2020, we had cash and cash equivalents of $6,239 thousand compared with $1,070 thousand which includes $247 thousand held by our discontinued operations at December 31, 2019.

Cash from Operations

Net cash used in operations was $489 thousand during the Six Months ended June 30, 2020 compared with $659 thousand during the Six Months ended June 30, 2019. This change in cash used by operating activities was primarily driven by the recovery of related party receivables, $132 thousand of stock compensation and the disposal of IIU.

Cash from Investing Activities

For the Six Months ended June 30, 2020 net cash generated by investing activities was $1,345 thousand as compared to net cash provided by investing activities of $291 thousand for the Six Months ended June 30, 2019.  The increase was due to the receipt of a $1.5 million note receivable from related party offset in part by a decrease from the disposal of IIU and the reduced sale of real estate. Net collections from our finance receivables for the Six Months ended June 30, 2020 was $94 thousand compared to $175 thousand for the Six Months ended June 30, 2019.

Cash from Financing Activities

Net cash provided by financing activities was $4,313 thousand for the Six Months ended June 30, 2020 compared with net cash used in financing activities of $58 thousand during the Six Months ended June 30, 2019. At June 30, 2020, the principal indebtedness of the Company was $186 thousand (excluding lease liability of $220 thousand) compared with $4.1 million at December 31, 2019 and $4.3 million at June 30, 2019. For the Six Months ended June 30, 2020 the Company repaid $70 thousand of principal repayments compared to $81 thousand principal repayments for the Six Months ended June 30, 2019. During the Six Months ended June 30, 2019 the Company received $22 thousand from the exercise of warrants. During the Six Months ended June 30, 2020 the Company received $1,250 thousand from a stock subscription agreement and $2,946 thousand from the exercise of warrants.

Shareholders’ Equity

On March 23, 2020, the Company entered into a Share Exchange Agreement, dated March 23, 2020 (the “Share Exchange Agreement”), with Hanfor (Cayman) Limited, a Cayman Islands exempted company (“Hanfor”), and BZ Industrial Limited, a British Virgin Islands business company and the sole stockholder of Hanfor (“Hanfor Owner”).  In connection with the execution of the Share Exchange Agreement, the Company and Hanfor Owner entered into a Stock Purchase Agreement, dated March 23, 2020, pursuant to which Hanfor Owner purchased from Company an aggregate of 520,838 shares of the Company’s common stock at a price of $2.40 per share. Hanfor Owner paid $250,000 cash on March 23, 2020 and the Company received the remaining $1.0 million in April 2020  at which time the Company issued the 520,838 shares.

Holders of our warrants exercised such warrants for 1,227,700 shares for total consideration of $2,946,480.

Debt of the Company consisted of the following at June 30, 2020 and December 31, 2019:

31


  

 

 

June 30, 2020

 

 

December 31,

2019 (Audited)

 

Financing agreement with FlatIron capital that is unsecured.  Down payment of $19,170 was required upfront and equal installment payments of $11,590 to be made over a 11 month period. The note matures June 1, 2020. Annualized interest is 6.8%

 

$

-

 

 

$

69,540

 

 

 

 

 

 

 

 

 

 

Promissory note issued by a financial institution, bearing interest at 1.0%, interest and no principal payments.   The note matures April 30, 2022. Annualized interest is 1.0%. This is a U.S. Small Business Administration’s Paycheck Protection Program (the “PPP Loan”)

 

$

185,785

 

 

$

-

 

 

 

 

 

 

 

 

 

 

Senior secured convertible note to Craven House Capital North America LLC (Related Party), bearing interest at 3.0%.  Note was issued on January 16, 2019 and either matured on January 14, 2020 or became convertible into 1,436,424 shares of the Company's common shares. The value of the beneficial conversion feature as of January 16, 2019 was zero*.

 

 

-

 

 

 

3,461,782

 

 

 

 

 

 

 

 

 

 

Promissory note issued by a financial institution, bearing interest at 9.09%, interest and principal payments due monthly of $323.  Note is secured by an automobile and was issued on July 26, 2019 with original borrowings of $12,892.  The note matures on August 26, 2023.

 

 

-

 

 

 

11,802

 

 

 

 

 

 

 

 

 

 

Promissory note issued by a financial institution, bearing interest at 5.85%, interest and principal payments due monthly of $10,932. Note was issued on May 31, 2018 with original borrowings of $608,000 and subsequent borrowings of $141,000 and repayments of $51,000.  The note matures on May 30, 2025 and can be prepaid at any time without penalty. This note is secured by the Company’s inventory, chattel paper, accounts, equipment and general intangible intangibles and deposit accounts.

 

 

-

 

 

 

606,454

 

 

 

 

 

 

 

 

 

 

 

 

$

185,785

 

 

$

4,149,578

 

As of June 30, 2020, minimum required annual principal payments are as follows:

 

Years Ending

 

 

 

 

December 31,

 

 

 

 

2020

 

 

-

 

2021

 

 

-

 

2022

 

 

185,785

 

2023

 

 

-

 

2024

 

 

-

 

After 2024

 

 

-

 

 

 

$

185,785

 

Off-Balance Sheet Arrangements

We do not have any off-balance sheet arrangements.

 

Item 3.

Quantitative and Qualitative Disclosures About Market Risk

As a smaller reporting company, we are not required to make disclosures under this item.

 

32


Item 4.

Controls and Procedures

(a) Evaluation of disclosure controls and procedures.

Our management, with the participation of our Chief Executive Officer and Chief Financial Officer, evaluated the effectiveness of our disclosure controls and procedures pursuant to Rule 13a-15 under the Securities Exchange Act of 1934, as amended, as of the end of the period covered by this Quarterly Report on Form 10-Q. In designing and evaluating the disclosure controls and procedures, management recognizes that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives. In addition, the design of disclosure controls and procedures must reflect the fact that there are resource constraints and that management is required to apply its judgment in evaluating the benefits of possible controls and procedures relative to their costs.

Management, with the participation of our Chief Executive Officer and Chief Financial Officer, performed an evaluation of the effectiveness of our disclosure controls and procedures as of June 30, 2020. Based on that evaluation, our management, including our Chief Executive Officer and Chief Financial Officer, concluded that our disclosure controls and procedures were not effective as of June 30, 2020 for the reasons discussed below. In addition, management identified the following material weaknesses in its assessment of the effectiveness of disclosure controls and procedures as of June 30, 2020:

The Company did not effectively segregate certain accounting duties due to the small size of its accounting staff.

A material weakness is a deficiency, or a combination of control deficiencies, in internal control over financial reporting such that there is a reasonable possibility that a material misstatement of our annual or interim consolidated financial statements will not be prevented or detected on a timely basis. Notwithstanding the determination that our internal control over financial reporting was not effective, as of June 30, 2020, and that there was a material weakness as identified in this Quarterly Report, we believe that our consolidated financial statements contained in this Quarterly Report fairly present our financial position, results of operations and cash flows for the years covered hereby in all material respects.

We expect to be dependent upon our Chief Financial Officer who is knowledgeable and experienced in the application of U.S. Generally Accepted Accounting Principles to maintain our disclosure controls and procedures and the preparation of our financial statements for the foreseeable future. We plan on increasing the size of our accounting staff at the appropriate time for our business and its size to ameliorate our concern that we do not effectively segregate certain accounting duties, which we believe would resolve the material weakness in disclosure controls and procedures, but there can be no assurances as to the timing of any such action or that we will be able to do so. 

(b) Changes in internal control over financial reporting.

 

There were no changes in our internal control over financial reporting that occurred during the quarter ended June 30, 2020 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. We have not to date experienced any material impact to our internal controls over financial reporting despite the fact that most of our employees are working remotely due to the COVID-19 pandemic. We are continually monitoring and assessing the COVID-19 situation on our internal controls to minimize the impact on their design and operating effectiveness.

 

33


PART II. OTHER INFORMATION

 

Item 1.

Legal Proceedings

We are not currently a party to material litigation proceedings. However, we frequently become party to litigation in the ordinary course of business, including either the prosecution or defense of claims arising from contracts by and between us and client Associations. Regardless of the outcome, litigation can have an adverse impact on us because of prosecution, defense, and settlement costs, diversion of management resources and other factors.

 

The Company accrues for contingent obligations, including estimated legal costs, when the obligation is probable and the amount is reasonably estimable. As facts concerning contingencies become known, the Company reassesses its position and makes appropriate adjustments to the consolidated financial statements. Estimates that are particularly sensitive to future changes include those related to tax, legal, and other regulatory matters.

 

Item 1A.

Risk Factors

There have been no material changes from the risk factors previously disclosed in the section entitled “Risk Factors” in our Annual Report on Form 10-K for the year ended December 31, 2019, except for the addition of the risk factor set forth below:

Our business, results of operations, and financial condition may be impacted by the recent coronavirus (COVID-19) outbreak.

The global spread of COVID-19 has created significant volatility and uncertainty. The COVID-19 pandemic has caused a global economic slowdown that may last for a potentially extended duration, and it is possible that it could cause a global recession.  Deteriorating economic and political conditions caused by COVID-19, such as increased unemployment, decreases in capital spending, declines in customer confidence, or economic slowdowns or recessions, could cause a decrease in demand for our products and services.

While our employees currently have the ability and are encouraged to work remotely, such measures have had, and may continue to have, an impact on employee attendance or productivity, which, along with the possibility of employees’ illness, may adversely affect our operations. Although COVID-19 is currently not material to our results of operations, there is uncertainty relating to the potential future impact on our business. The extent to which COVID-19 impacts our operations, or our ability to obtain financing should we require it, will depend on future developments which are uncertain and cannot be predicted, including new information which may emerge concerning the severity of COVID-19 and the actions taken by governments and private businesses to contain COVID-19 to treat its impact, among others. If the disruptions posed by COVID-19 continue for an extended period of time, financial markets may not be available to the Company for raising capital in order to fund future growth. Should the Company not be able to obtain financing when required, in the amounts necessary or under terms which are economically feasible, we may be required to reduce planned future growth and/or the scope of our operations. In addition, actions we have taken or may take, or decisions we have made or may make, as a consequence of COVID-19, may result in legal claims or litigation against us.

 

A potential legal dispute between Hanfor Owner and the Company could have material adverse effect on our business, financial condition, and results of operations.

On March 23, 2020, the Company entered into the Share Exchange Agreement with Hanfor and Hanfor Owner.  The Share Exchange Agreement contemplated a business combination transaction in which Hanfor Owner would transfer and assign to the Company all of the share capital of Hanfor in exchange for a number of shares of the Company’s common stock that would result in Hanfor Owner owning 86.5% of the outstanding common stock of the Company.  Under the agreement, Hanfor Owner was required to deliver to the Company audited financial statements for Hanfor for the 2019 and 2018 fiscal years, and such audited financial statements were required to be delivered by May 31, 2020 (subject to extension to June 30, 2020 under specified circumstances).  On July 14, 2020, the Company notified Hanfor and Hanfor Owner that the Company had terminated the Share Exchange Agreement due to Hanfor’s inability to provide audited financial statements by June 30, 2020.  Although the Company believes that it properly terminated the Share Exchange Agreement, on July 21, 2020, counsel to Hanfor Owner informed the Company that Hanfor Owner believes that the Company’s termination of the Share Exchange Agreement was not effected in accordance with the terms of the Share Exchange Agreement.  The Company and Hanfor Owner are engaged in discussions to resolve this disagreement, but there is no assurance that this disagreement will be promptly resolved or resolved on terms favorable to the Company.  If the Company and Hanfor Owner cannot resolve this disagreement, any resulting formal legal dispute could have a material adverse effect on the Company’s business, financial conditions, and results of operation.

 

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

(a) Sales of Unregistered Securities.

None.

34


(b) Use of Proceeds.

None.

(c) Repurchase of Securities.

None.

Item 3.

Defaults Upon Senior Securities

None.

Item 4.

Mine Safety Disclosures

None.

Item 5.

Other Information

None

 

35


Item 6.

Exhibits

The following documents are filed as a part of this report or are incorporated herein by reference.

 

 

EXHIBIT

NUMBER

DESCRIPTION

 

 

  31.1

Rule 13a – 14(a) Certification of the Principal Executive Officer

 

 

  31.2

Rule 13a – 14(a) Certification of the Principal Financial Officer

 

 

  32.1

Written Statement of the Principal Executive Officer and Principal Financial Officer, Pursuant to 18 U.S.C. § 1350

 

 

101.INS

XBRL Instance Document.

 

 

101.SCH

XBRL Taxonomy Extension Schema.

 

 

101.CAL

XBRL Taxonomy Extension Calculation Linkbase.

 

 

101.DEF

XBRL Taxonomy Extension Definition Linkbase.

 

 

101.LAB

XBRL Taxonomy Extension Label Linkbase.

 

 

101.PRE

XBRL Taxonomy Extension Presentation Linkbase.

 

 

 

 


36


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized:

 

 

 

LM FUNDING AMERICA, INC.

 

 

 

 

Date: August 7, 2020

 

By:

/s/ Bruce M. Rodgers

 

 

 

Bruce M. Rodgers

 

 

 

Chief Executive Officer and Chairman of the Board

 

 

 

(Principal Executive Officer)

 

 

 

 

Date: August 7, 2020

 

By:

/s/ Richard Russell

 

 

 

Richard Russell

 

 

 

Chief Financial Officer

 

 

 

(Principal Accounting Officer)

 

 

37

EX-31.1 2 lmfa-ex311_8.htm EX-31.1 lmfa-ex311_8.htm

Exhibit 31.1

 

Certification of Chief Executive Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Bruce Rodgers, certify that:

1. I have reviewed this quarterly report on Form 10-Q of LM Funding America, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

/s/ Bruce Rodgers

August 7, 2020

 

Bruce Rodgers

 

 

Chief Executive Officer

 

 

(Principal Executive Officer)

 

A signed original of this document has been provided to LM Funding America, Inc. and will be retained by LM Funding America, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

EX-31.2 3 lmfa-ex312_6.htm EX-31.2 lmfa-ex312_6.htm

Exhibit 31.2

 

Certification of Chief Financial Officer

Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

I, Richard Russell, certify that:

1. I have reviewed this quarterly report on Form 10-Q of LM Funding America, Inc.;

2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3. Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4. The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

a) Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

b) Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

c) Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

d) Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5. The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

a) All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

b) Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

 

 

/s/ Richard Russell

August 7, 2020

 

Richard Russell

 

 

Chief Financial Officer

 

 

(Principal Financial and Accounting Officer)

 

A signed original of this document has been provided to LM Funding America, Inc. and will be retained by LM Funding America, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

EX-32.1 4 lmfa-ex321_7.htm EX-32.1 lmfa-ex321_7.htm

Exhibit 32.1

 

Written Statement of the Chief Executive Officer

Pursuant to 18 U.S.C. Section 1350

Solely for the purposes of complying with 18 U.S.C. ss.1350, I, the undersigned Chief Executive Officer of LM Funding America, Inc. (the “Company”), hereby certify, based on my knowledge, that the Quarterly Report on Form 10-Q of the Company for the quarterly period ended June 30, 2020 as filed with the Securities and Exchange Commission on August 7, 2020 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

 

 

 

/s/ Bruce Rodgers

 

 

 

 

Bruce Rodgers

 

 

 

 

Chief Executive Officer

 

 

 

 

(Principal Executive Officer)

August 7, 2020

A signed original of this document has been provided to LM Funding America, Inc. and will be retained by LM Funding America, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.


 


 

 

Written Statement of the Chief Financial Officer

Pursuant to 18 U.S.C. Section 1350

Solely for the purposes of complying with 18 U.S.C. ss.1350, I, the undersigned Chief Financial Officer of LM Funding America, Inc. (the “Company”), hereby certify, based on my knowledge, that the Quarterly Report on Form 10-Q of the Company for the quarterly period ended June 30, 2020 as filed with the Securities and Exchange Commission on August 7, 2020 (the “Report”), fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and that information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

 

 

 

 

 

 

/s/ Richard Russell

 

 

 

 

Richard Russell

 

 

 

 

Chief Financial Officer

 

 

 

 

(Principal Financial and Accounting Officer)

August 7, 2020

A signed original of this document has been provided to LM Funding America, Inc. and will be retained by LM Funding America, Inc. and furnished to the Securities and Exchange Commission or its staff upon request.

 

 

EX-101.INS 5 lmfa-20200630.xml XBRL INSTANCE DOCUMENT xbrli:shares iso4217:USD iso4217:USD xbrli:shares lmfa:Ownership xbrli:pure iso4217:USD lmfa:Assessment lmfa:Unit iso4217:USD lmfa:Unit 0001640384 2020-01-01 2020-06-30 0001640384 2020-08-06 0001640384 2020-06-30 0001640384 2019-12-31 0001640384 2020-04-01 2020-06-30 0001640384 2019-04-01 2019-06-30 0001640384 2019-01-01 2019-06-30 0001640384 us-gaap:ServiceMember 2020-04-01 2020-06-30 0001640384 us-gaap:ServiceMember 2019-04-01 2019-06-30 0001640384 us-gaap:ServiceMember 2020-01-01 2020-06-30 0001640384 us-gaap:ServiceMember 2019-01-01 2019-06-30 0001640384 lmfa:OriginalProductMember 2020-01-01 2020-06-30 0001640384 lmfa:OriginalProductMember 2019-01-01 2019-06-30 0001640384 lmfa:SpecialProductMember 2020-01-01 2020-06-30 0001640384 lmfa:SpecialProductMember 2019-01-01 2019-06-30 0001640384 2018-12-31 0001640384 2019-06-30 0001640384 us-gaap:CommonStockMember 2018-12-31 0001640384 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0001640384 us-gaap:RetainedEarningsMember 2018-12-31 0001640384 us-gaap:CommonStockMember 2019-01-01 2019-03-31 0001640384 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-03-31 0001640384 2019-01-01 2019-03-31 0001640384 us-gaap:RetainedEarningsMember 2019-01-01 2019-03-31 0001640384 us-gaap:CommonStockMember 2019-03-31 0001640384 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0001640384 us-gaap:RetainedEarningsMember 2019-03-31 0001640384 2019-03-31 0001640384 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0001640384 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0001640384 us-gaap:CommonStockMember 2019-06-30 0001640384 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0001640384 us-gaap:RetainedEarningsMember 2019-06-30 0001640384 us-gaap:CommonStockMember 2019-12-31 0001640384 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001640384 us-gaap:RetainedEarningsMember 2019-12-31 0001640384 us-gaap:CommonStockMember 2020-01-01 2020-03-31 0001640384 us-gaap:AdditionalPaidInCapitalMember 2020-01-01 2020-03-31 0001640384 2020-01-01 2020-03-31 0001640384 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001640384 us-gaap:CommonStockMember 2020-03-31 0001640384 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001640384 us-gaap:RetainedEarningsMember 2020-03-31 0001640384 2020-03-31 0001640384 us-gaap:AdditionalPaidInCapitalMember 2020-04-01 2020-06-30 0001640384 us-gaap:CommonStockMember 2020-04-01 2020-06-30 0001640384 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001640384 us-gaap:CommonStockMember 2020-06-30 0001640384 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001640384 us-gaap:RetainedEarningsMember 2020-06-30 0001640384 lmfa:OriginalProductMember 2020-01-01 2020-06-30 0001640384 lmfa:SpecialProductMember 2020-01-01 2020-06-30 0001640384 lmfa:IIUIncMember lmfa:StockPurchaseAgreementMember 2020-01-01 2020-06-30 0001640384 srt:SubsidiariesMember 2020-01-01 2020-06-30 0001640384 lmfa:SecuritiesPurchaseAgreementMember lmfa:SeniorConvertiblePromissoryNotesMember 2018-11-02 0001640384 lmfa:SecuritiesPurchaseAgreementMember lmfa:SeniorConvertiblePromissoryNotesMember 2018-11-01 2018-11-02 0001640384 lmfa:StockPurchaseAgreementMember lmfa:IIUIncMember 2020-06-30 0001640384 lmfa:StockPurchaseAgreementMember lmfa:IIUIncMember 2020-01-01 2020-06-30 0001640384 srt:MinimumMember lmfa:IIUIncMember 2020-01-01 2020-06-30 0001640384 srt:MinimumMember lmfa:IIUIncMember 2020-06-30 0001640384 lmfa:IIUIncMember lmfa:ConvertiblePromissoryNoteMember 2019-01-15 2019-01-16 0001640384 lmfa:IIUIncMember lmfa:ConvertiblePromissoryNoteMember 2019-01-16 0001640384 lmfa:IIUIncMember lmfa:ConvertiblePromissoryNoteMember 2020-06-30 0001640384 lmfa:SecuritiesPurchaseAgreementMember lmfa:IIUIncMember 2020-01-01 2020-06-30 0001640384 lmfa:SeniorConvertiblePromissoryNotesMember lmfa:CravenHouseCapitalNorthAmericaLLCMember 2019-12-20 0001640384 lmfa:SeniorConvertiblePromissoryNotesMember lmfa:CravenHouseCapitalNorthAmericaLLCMember 2019-12-19 2019-12-20 0001640384 lmfa:SeniorConvertiblePromissoryNotesMember lmfa:CravenHouseCapitalNorthAmericaLLCMember 2020-01-01 2020-06-30 0001640384 lmfa:SeniorConvertiblePromissoryNotesMember lmfa:CravenHouseCapitalNorthAmericaLLCMember 2020-06-29 0001640384 lmfa:CravenHouseCapitalNorthAmericaLLCMember lmfa:StockPurchaseAgreementMember 2020-01-08 0001640384 lmfa:SeniorConvertiblePromissoryNotesMember lmfa:CravenHouseCapitalNorthAmericaLLCMember lmfa:StockPurchaseAgreementMember 2019-01-15 2019-01-16 0001640384 lmfa:IIUIncMember 2019-01-01 2019-01-31 0001640384 lmfa:IIUIncMember 2019-01-31 0001640384 lmfa:IIUIncMember 2020-01-07 2020-01-08 0001640384 srt:SubsidiariesMember lmfa:HealthCareAbroadMember 2020-01-01 2020-06-30 0001640384 srt:SubsidiariesMember lmfa:HealthCAreGlobalMember srt:MaximumMember 2020-01-01 2020-06-30 0001640384 srt:SubsidiariesMember lmfa:HealthCAreGlobalMember 2020-01-01 2020-06-30 0001640384 srt:SubsidiariesMember lmfa:HealthCareAmericaMember srt:MaximumMember 2020-01-01 2020-06-30 0001640384 srt:SubsidiariesMember lmfa:HealthCareAmericaMember 2020-01-01 2020-06-30 0001640384 srt:SubsidiariesMember lmfa:HealthCareInternationalMember 2020-01-01 2020-06-30 0001640384 srt:SubsidiariesMember lmfa:HealthCareWarMember srt:MaximumMember 2020-01-01 2020-06-30 0001640384 srt:SubsidiariesMember lmfa:HealthCareWarMember 2020-01-01 2020-06-30 0001640384 lmfa:SecuritiesPurchaseAgreementMember lmfa:HanforCaymanLimitedMember 2020-03-23 0001640384 lmfa:SecuritiesPurchaseAgreementMember lmfa:HanforCaymanLimitedMember 2020-06-30 0001640384 lmfa:SecuritiesPurchaseAgreementMember lmfa:HanforCaymanLimitedMember 2020-03-23 2020-03-23 0001640384 2020-03-27 2020-03-27 0001640384 srt:MaximumMember 2020-01-01 2020-06-30 0001640384 2020-05-11 2020-05-11 0001640384 srt:MaximumMember lmfa:REOManagementHoldingsLlcMember lmfa:SubsidiaryLimitedLiabilityMember 2020-01-01 2020-06-30 0001640384 srt:SubsidiariesMember lmfa:SpecialProductMember 2020-01-01 2020-06-30 0001640384 srt:SubsidiariesMember lmfa:OriginalProductMember 2020-06-30 0001640384 srt:SubsidiariesMember lmfa:OriginalProductMember 2019-12-31 0001640384 srt:SubsidiariesMember lmfa:SpecialProductMember 2020-06-30 0001640384 srt:SubsidiariesMember lmfa:SpecialProductMember 2019-12-31 0001640384 srt:MinimumMember 2020-01-01 2020-06-30 0001640384 us-gaap:FirstMortgageMember srt:MinimumMember 2020-01-01 2020-06-30 0001640384 srt:SubsidiariesMember 2020-06-30 0001640384 srt:SubsidiariesMember srt:MinimumMember us-gaap:FurnitureAndFixturesMember 2020-01-01 2020-06-30 0001640384 srt:SubsidiariesMember us-gaap:FurnitureAndFixturesMember srt:MaximumMember 2020-01-01 2020-06-30 0001640384 srt:SubsidiariesMember srt:MinimumMember us-gaap:ComputerEquipmentMember 2020-01-01 2020-06-30 0001640384 srt:SubsidiariesMember us-gaap:ComputerEquipmentMember srt:MaximumMember 2020-01-01 2020-06-30 0001640384 srt:SubsidiariesMember srt:MinimumMember us-gaap:OfficeEquipmentMember 2020-01-01 2020-06-30 0001640384 srt:SubsidiariesMember us-gaap:OfficeEquipmentMember srt:MaximumMember 2020-01-01 2020-06-30 0001640384 srt:SubsidiariesMember us-gaap:ComputerSoftwareIntangibleAssetMember 2020-01-01 2020-06-30 0001640384 srt:SubsidiariesMember 2019-12-31 0001640384 srt:SubsidiariesMember 2020-04-01 2020-06-30 0001640384 srt:SubsidiariesMember 2019-04-01 2019-06-30 0001640384 srt:SubsidiariesMember 2019-01-01 2019-06-30 0001640384 us-gaap:AccountingStandardsUpdate201602Member 2020-06-30 0001640384 us-gaap:AccountingStandardsUpdate201602Member 2019-12-31 0001640384 us-gaap:AccountingStandardsUpdate201602Member 2020-04-01 2020-06-30 0001640384 us-gaap:AccountingStandardsUpdate201602Member 2019-04-01 2019-06-30 0001640384 us-gaap:AccountingStandardsUpdate201602Member 2020-01-01 2020-06-30 0001640384 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 2019-06-30 0001640384 lmfa:PromissoryNotesMember lmfa:CravenHouseCapitalNorthAmericaIncMember 2019-12-20 0001640384 lmfa:PromissoryNotesMember lmfa:CravenHouseCapitalNorthAmericaIncMember 2019-12-19 2019-12-20 0001640384 lmfa:IIUIncMember 2019-12-31 0001640384 lmfa:IIUIncMember 2020-01-01 2020-06-30 0001640384 lmfa:IIUIncMember 2019-01-01 2019-12-31 0001640384 lmfa:ShareExchangeAgreementMember lmfa:HanforCaymanLimitedMember 2020-03-23 2020-03-23 0001640384 lmfa:ShareExchangeAgreementMember lmfa:HanforCaymanLimitedMember 2020-03-23 0001640384 2018-11-30 0001640384 2018-10-15 2018-10-15 0001640384 2018-10-15 0001640384 us-gaap:EmployeeStockOptionMember 2020-01-01 2020-06-30 0001640384 us-gaap:EmployeeStockOptionMember 2019-01-01 2019-06-30 0001640384 us-gaap:WarrantMember 2020-01-01 2020-06-30 0001640384 us-gaap:WarrantMember 2019-01-01 2019-06-30 0001640384 us-gaap:WarrantMember us-gaap:IPOMember 2015-10-23 0001640384 us-gaap:WarrantMember 2018-10-15 2018-10-16 0001640384 us-gaap:WarrantMember 2018-10-16 0001640384 us-gaap:WarrantMember 2020-06-30 0001640384 us-gaap:WarrantMember 2020-01-01 2020-06-30 0001640384 us-gaap:WarrantMember 2019-01-01 2019-12-31 0001640384 us-gaap:WarrantMember 2019-12-31 0001640384 lmfa:SecondaryOfferingMember us-gaap:WarrantMember 2018-10-31 0001640384 lmfa:SecondaryOfferingMember us-gaap:WarrantMember 2020-01-01 2020-06-30 0001640384 lmfa:SecondaryOfferingMember us-gaap:WarrantMember 2018-10-31 2018-10-31 0001640384 lmfa:SecondaryOfferingMember lmfa:AdditionalWarrantMember 2018-10-31 0001640384 lmfa:SecondaryOfferingMember lmfa:AdditionalWarrantMember 2018-10-31 2018-10-31 0001640384 us-gaap:WarrantMember 2018-04-02 0001640384 us-gaap:WarrantMember 2018-10-31 0001640384 us-gaap:WarrantMember 2019-01-01 2019-09-30 0001640384 us-gaap:ConvertibleNotesPayableMember lmfa:StockPurchaseAgreementMember 2019-01-15 2019-01-16 0001640384 us-gaap:ConvertibleNotesPayableMember lmfa:StockPurchaseAgreementMember 2019-01-16 0001640384 lmfa:CravenHouseCapitalNorthAmericaLLCMember lmfa:SeniorConvertiblePromissoryNotesMember lmfa:StockPurchaseAgreementMember 2020-01-07 2020-01-08 0001640384 lmfa:StockPurchaseAgreementMember lmfa:IIUIncMember 2019-01-15 2019-01-16 0001640384 lmfa:StockPurchaseAgreementMember lmfa:IIUIncMember 2019-01-16 0001640384 lmfa:SecuritiesPurchaseAgreementMember lmfa:IIUIncMember 2019-01-16 0001640384 lmfa:SecuritiesPurchaseAgreementMember lmfa:IIUIncMember 2019-01-15 2019-01-16 0001640384 lmfa:PromissoryNoteMember lmfa:IIUIncMember 2019-01-15 2019-01-16 0001640384 lmfa:ConvertiblePromissoryNoteMember lmfa:IIUIncMember 2019-01-16 0001640384 lmfa:ConvertiblePromissoryNoteMember lmfa:IIUIncMember 2019-01-15 2019-01-16 0001640384 lmfa:SeniorConvertiblePromissoryNotesMember 2019-01-16 0001640384 lmfa:ConvertiblePromissoryNoteMember lmfa:IIUIncMember 2019-04-15 2019-04-15 0001640384 lmfa:IIUIncAndWallachAndCompanyMember 2019-01-15 2019-01-16 0001640384 lmfa:IIUIncAndWallachAndCompanyMember 2019-01-16 0001640384 2020-01-09 2020-01-10 0001640384 lmfa:OriginalProductMember lmfa:CurrentYearMember 2020-06-30 0001640384 lmfa:OriginalProductMember lmfa:CurrentYearMember 2019-12-31 0001640384 lmfa:OriginalProductMember lmfa:FundForNextOneToTwoYearsMember 2020-06-30 0001640384 lmfa:OriginalProductMember lmfa:FundForNextOneToTwoYearsMember 2019-12-31 0001640384 lmfa:OriginalProductMember lmfa:FundForNextTwoToThreeYearsMember 2020-06-30 0001640384 lmfa:OriginalProductMember lmfa:FundForNextTwoToThreeYearsMember 2019-12-31 0001640384 lmfa:OriginalProductMember lmfa:FundForNextThreeToFourYearsMember 2020-06-30 0001640384 lmfa:OriginalProductMember lmfa:FundForNextThreeToFourYearsMember 2019-12-31 0001640384 lmfa:OriginalProductMember lmfa:FundForGreaterThanFourYearsMember 2020-06-30 0001640384 lmfa:OriginalProductMember lmfa:FundForGreaterThanFourYearsMember 2019-12-31 0001640384 lmfa:OriginalProductMember 2020-06-30 0001640384 lmfa:OriginalProductMember 2019-12-31 0001640384 lmfa:OriginalProductMember 2019-01-01 2019-12-31 0001640384 lmfa:SpecialProductMember 2020-06-30 0001640384 lmfa:SpecialProductMember 2019-12-31 0001640384 lmfa:SpecialProductMember 2019-01-01 2019-12-31 0001640384 lmfa:NewNeighborGuarantyMember 2020-06-30 0001640384 lmfa:NewNeighborGuarantyMember 2019-12-31 0001640384 lmfa:BusinessLawGroupMember 2017-01-02 2017-01-02 0001640384 lmfa:BusinessLawGroupMember 2020-04-01 2020-06-30 0001640384 lmfa:BusinessLawGroupMember 2020-01-01 2020-06-30 0001640384 lmfa:BusinessLawGroupMember 2019-04-01 2019-06-30 0001640384 lmfa:BusinessLawGroupMember 2019-01-01 2019-06-30 0001640384 lmfa:BusinessLawGroupMember 2020-06-30 0001640384 lmfa:BusinessLawGroupMember 2019-12-31 0001640384 lmfa:BusinessLawGroupMember lmfa:OutOfPocketCollectionCostsMember 2020-04-01 2020-06-30 0001640384 lmfa:BusinessLawGroupMember lmfa:OutOfPocketCollectionCostsMember 2020-01-01 2020-06-30 0001640384 lmfa:BusinessLawGroupMember lmfa:OutOfPocketCollectionCostsMember 2019-04-01 2019-06-30 0001640384 lmfa:BusinessLawGroupMember lmfa:OutOfPocketCollectionCostsMember 2019-01-01 2019-06-30 0001640384 lmfa:BusinessLawGroupMember 2019-01-01 2019-12-31 0001640384 lmfa:CravenHoldingsNorthAmericaIncMember lmfa:PromissoryNotesMember 2019-12-20 0001640384 lmfa:CravenHoldingsNorthAmericaIncMember lmfa:PromissoryNotesMember 2019-12-19 2019-12-20 0001640384 lmfa:FinancialAgreementTwoMember 2019-12-31 0001640384 lmfa:PromissoryNoteTwoMember 2020-06-30 0001640384 lmfa:SeniorSecuredConvertiblePromissoryNoteMember 2019-12-31 0001640384 lmfa:PromissoryNoteOneMember 2019-12-31 0001640384 lmfa:PromissoryNoteMember 2019-12-31 0001640384 lmfa:FinancialAgreementTwoMember 2020-01-01 2020-06-30 0001640384 lmfa:FinancialAgreementTwoMember 2020-06-30 0001640384 lmfa:SeniorSecuredConvertiblePromissoryNoteMember 2020-06-30 0001640384 lmfa:SeniorSecuredConvertiblePromissoryNoteMember 2020-01-01 2020-06-30 0001640384 lmfa:PromissoryNoteOneMember 2020-06-30 0001640384 lmfa:PromissoryNoteOneMember 2020-01-01 2020-06-30 0001640384 lmfa:PromissoryNoteMember 2020-06-30 0001640384 lmfa:PromissoryNoteMember 2020-01-01 2020-06-30 0001640384 lmfa:PromissoryNoteTwoMember 2020-01-01 2020-06-30 0001640384 lmfa:PromissoryNoteTwoMember lmfa:USFederalGovernmentCoronavirusAidReliefAndEconomicSecurityActMember 2020-06-30 0001640384 lmfa:GoingConcernsMember 2020-04-01 2020-06-30 0001640384 lmfa:GoingConcernsMember 2020-06-30 0001640384 srt:MinimumMember 2020-06-30 0001640384 srt:MaximumMember 2020-06-30 0001640384 lmfa:NewOfficeLeaseMember 2020-01-01 2020-06-30 0001640384 lmfa:ShareExchangeAgreementMember 2020-03-23 2020-03-23 0001640384 2020-04-01 2020-04-30 0001640384 lmfa:MaximHoldingsLLCMember 2020-03-23 2020-03-23 0001640384 lmfa:MaximHoldingsLLCMember 2020-01-01 2020-06-30 0001640384 lmfa:StockPurchaseAgreementMember lmfa:CravenHouseCapitalNorthAmericaLLCMember 2020-01-07 2020-01-08 0001640384 lmfa:IIUIncMember lmfa:StockPurchaseAgreementMember 2019-12-31 0001640384 lmfa:IIUIncMember lmfa:StockPurchaseAgreementMember 2019-04-01 2019-06-30 0001640384 lmfa:IIUIncMember lmfa:StockPurchaseAgreementMember 2019-01-01 2019-06-30 10-Q false 2020-06-30 2020 Q2 Common Stock par value $0.001 per share NASDAQ LMFA LM FUNDING AMERICA, INC. 0001640384 --12-31 Non-accelerated Filer true true Yes Yes false false 5100000 001-37605 DE 47-3844457 1200 West Platt Street Suite 100 Tampa FL 33606 813 222-8996 true false 6238678 822909 212121 273711 97196 129272 97008 145267 125045 276953 6645003 1773157 6274 8288 13426 21084 209031 260260 1500000 4039586 10220 11021 27245 238951 5867484 6883954 7640641 69540 3461782 131940 210870 171501 98846 94235 280057 402287 4116484 121295 171648 185785 517584 307080 689232 709367 4805716 5069 3134 21653342 17326553 -15483824 -14494762 6174587 2834925 6883954 7640641 0.001 0.001 30000000 30000000 5068799 3134261 5068799 3134261 170174 463738 389688 878013 35423 43314 58468 82807 62362 4502 84990 26272 41235 74791 69164 115515 33344 72285 81424 219954 342538 658630 683734 1322561 312493 342186 628552 605331 479581 524764 986576 954073 38286 11920 40178 74728 83656 154951 183403 100000 200000 -7375 -7375 14108 100306 99450 297434 7954 19526 13766 37391 -20934 9786 -29255 -13301 6844 16191 10638 15256 774774 1127326 1676598 2112390 -432236 -468696 -992864 -789829 5732 52731 12626 53763 -437968 -521427 -1005490 -843592 -437968 -521427 -1005490 -843592 16428 70924 -63929 70924 16428 -63929 -437968 -450503 -989062 -907521 -0.11 -0.17 -0.28 -0.27 0.02 0.00 -0.02 -0.11 -0.14 -0.28 -0.29 -0.11 -0.17 -0.28 -0.27 0.02 0.00 -0.02 -0.11 -0.14 -0.28 -0.29 3915123 3134261 3575098 3133106 3915123 3134261 3575098 3133106 11727 32550 51229 4852 132244 6931 16426 -49059 -52389 21858 89329 496546 32395 48578 45742 4426 -14200 -488567 -659123 61590 95242 32076 79874 -2055 64101 246914 -1500000 51327 1344697 290544 185785 69540 80761 2946480 22320 1250000 4312725 -58441 5168855 -427020 1069823 3520753 6238678 3093733 12626 16743 26685 3124961 3125 17295408 -11489884 5808649 9300 9 22311 22320 3500 3500 -457018 -457018 3134261 3134 17321219 -11946902 5377451 3431 3431 -450503 -450503 3134261 3134 17324650 -12397405 4930379 3134261 3134 17326553 -14494762 186000 186 128661 128847 -551094 -551094 3320261 3320 17455214 -15045856 2412678 3397 3397 1227700 1228 2945252 2946480 520838 521 1249479 1250000 -437968 -437968 5068799 5069 21653342 -15483824 <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Nature of Operations</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LM Funding America, Inc. (&#8220;LMFA&#8221; or the &#8220;Company&#8221;) was formed as a Delaware corporation on April 20, 2015. LMFA was formed for the purpose of completing a public offering and related transactions in order to carry on the business of LM Funding, LLC and its subsidiaries (the &#8220;Predecessor&#8221;). LMFA is the sole member of LM Funding, LLC and operates and controls all of its businesses and affairs.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LM Funding, LLC a Florida limited liability company organized in January 2008 under the terms of an Operating Agreement effective January&#160;8, 2008 as amended, had two members: BRR Holding, LLC and CGR 63, LLC. The members contributed their equity interest to LMFA prior to the closing of its initial public offering. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company acquired IIU, Inc. on January 16, 2019 <font style="color:#000000;">(&#8220;IIU&#8221;)</font>, which provided <font style="color:#000000;">global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies were fully underwritten with no claim risk remaining with IIU. IIU was disposed of on January 8, 2020.</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are a specialty finance company that provides funding to nonprofit community associations primarily located in the state of Florida. We offer incorporated nonprofit community associations, which we refer to as &#8220;Associations,&#8221; a variety of financial products customized to each Association&#8217;s financial needs. Our original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. Historically, we provided funding against such delinquent accounts, which we refer to as &#8220;Accounts,&#8221; in exchange for a portion of the proceeds collected by the Associations from the account debtors on the Accounts. In addition to our original product offering, we have started purchasing Accounts on varying terms tailored to suit each Association&#8217;s financial needs, including under our New Neighbor Guaranty&#8482; program. </p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Specialty Finance Company</font></p> <p style="margin-top:6pt;margin-bottom:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We purchase an Association&#8217;s right to receive a portion of the Association&#8217;s collected proceeds from owners that are not paying their assessments. After taking assignment of an Association&#8217;s right to receive a portion of the Association&#8217;s proceeds from the collection of delinquent assessments, we engage law firms to perform collection work on a deferred billing basis wherein the law firms receive payment upon collection from the account debtors or a predetermined contracted amount if payment from account debtors is less than legal fees and costs owed. Under this business model, we typically fund an amount equal to or less than the statutory minimum an Association could recover on a delinquent account for each Account, which we refer to as the &#8220;Super Lien Amount&#8221;. Upon collection of an Account, the law firm working on the Account, on behalf of the Association, generally distributes to us the funded amount, interest, and administrative late fees, with the law firm retaining legal fees and costs collected, and the Association retaining the balance of the collection. In connection with this line of business, we have developed proprietary software for servicing Accounts, which we believe enables law firms to service Accounts efficiently and profitably.</p><p style="margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under our New Neighbor Guaranty program, an Association will generally assign substantially all of its outstanding indebtedness and accruals on its delinquent units to us in exchange for payment by us of monthly dues on each delinquent unit. This simultaneously eliminates a substantial portion of the Association&#8217;s balance sheet bad debts and assists the Association to meet its budget by receiving guaranteed monthly payments on its delinquent units and relieving the Association from paying legal fees and costs to collect its bad debts. We believe that the combined features of the program enhance the value of the underlying real estate in an Association and the value of an Association&#8217;s delinquent receivables. We intend to leverage our proprietary software platform, as well as our industry experience and knowledge gained from our original line of business, to expand the New Neighbor Guaranty program in certain situations and to potentially develop other new products in the future.</p><p style="margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because we acquire and collect on the delinquent receivables of Associations, the Account debtors are third parties about whom we have little or no information. Therefore, we cannot predict when any given Account will be paid off or how much it will yield. In assessing the risk of purchasing Accounts, we review the property values of the underlying units, the governing documents of the relevant Association, and the total number of delinquent receivables held by the Association.</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Specialty Finance Products</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Original Product</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our original product relies upon Florida statutory provisions that effectively protect the principal amount invested by us in each Account. In particular, Section 718.116(1), Florida Statutes, makes purchasers and sellers of a unit in an Association jointly and severally liable for all past due assessments, interest, late fees, legal fees, and costs payable to the Association. As discussed above, the Florida Statutes grants to Associations a so-called &#8220;super lien&#8221;, which is a category of lien that is given a statutorily higher priority than all other types of liens other than property tax liens. The amount of the Association&#8217;s priority over a first mortgage holder that takes title to a property through foreclosure (or deed in lieu), referred to as the Super Lien Amount, is limited to twelve months&#8217; past due assessments or, if less, one percent (1.0%) of the original mortgage amount. Under our contracts with Associations for our original product, we pay Associations an amount up to the Super Lien Amount for the right to receive all collected interest and late fees on Accounts purchased from the Associations.</p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Statutes specify that the rate of interest an association (or its assignor) may charge on delinquent assessments is equal to the rate set forth in the association&#8217;s declaration or bylaws. In Florida if a rate is not specified, the statutory rate is equal to 18% but may not exceed the maximum rate allowed by law. Similarly, the Statutes in Florida also stipulate that administrative late fees cannot be charged on delinquent assessments unless so provided by the association&#8217;s declaration or bylaws and may not exceed the greater of $25 or 5% of each delinquent assessment. </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In other states in which we have offered our original product, which are currently only in Washington, Colorado and Illinois, we rely on statutes that we believe are similar to the above-described Florida statutes in relevant respects. A total of approximately 22 U.S. states, Puerto Rico and the District of Columbia have super lien statutes that give Association assessments super lien status under some circumstances, and of these states, we believe that all of these jurisdictions other than Alaska have a regulatory and business environment that would enable us to offer our original product to Associations in those states on materially the same basis.</p> <p style="margin-top:12pt;margin-bottom:10pt;text-indent:0%;;font-weight:normal;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">New Neighbor Guaranty</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2012, we developed a new product, the New Neighbor Guaranty, wherein an Association assigns substantially all of its outstanding indebtedness and accruals on its delinquent units to us in exchange for payments in an amount equal to the regular ongoing monthly or quarterly assessments for delinquent units when those amounts would be due to the Association. We assume both the payment and collection obligations for these assigned Accounts under this product. This simultaneously eliminates an Association&#8217;s balance sheet bad debts and assists the Association to meet its budget by receiving guaranteed assessment payments on its delinquent units and relieving the Association from paying legal fees and costs to collect its bad debts. We believe that the combined features of the product enhance the value of the underlying real estate in an Association and the value of an Association&#8217;s delinquent receivables.</p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Before we implement the New Neighbor Guaranty program for an Association typically asks us to conduct a review of its accounts receivable. After we have conducted the review, we inform the Association which Accounts we are willing to purchase and the terms of such purchase. Once we implement the New Neighbor Guaranty program, we begin making scheduled payments to the Association on the Accounts as if the Association had non-delinquent residents occupying the units underlying the Accounts. Our New Neighbor Guaranty contracts typically allow us to retain all collection proceeds on each Account other than special assessments and accelerated assessment balances. Thus, the Association foregoes the potential benefit of a larger future collection in exchange for the certainty of a steady stream of immediate payments on the Account.</p><p style="margin-top:13pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Recent Developments</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">IIU Acquisition and Disposal</font></p> <p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On November 2, 2018, the Company invested cash by purchasing a Senior Convertible Promissory Note in the original principal amount of $1,500,000 (the &#8220;IIU Note&#8221;) from IIU, a synergistic Virginia based travel insurance brokerage company controlled by Craven House North America, LLC (&#8220;Craven&#8221;) N.A., (whose ownership excluding unexercised warrants was approximately 20% of the Company&#8217;s outstanding stock at the time of the acquisition).&nbsp;&nbsp;The maturity date of the IIU Note was 360 dates after the date of issuance (subject to acceleration upon an event of default).&nbsp;&nbsp;The IIU Note carried a 3.0% interest rate, with accrued but unpaid interest being payable on the IIU Note&#8217;s maturity date.&nbsp;&nbsp;</p><p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January 16, 2019, the Company entered into a Stock Purchase Agreement with <font style="color:#000000;">Craven</font> (the &#8220;IIU SPA&#8221;) to purchase all of the outstanding capital stock of <font style="color:#000000;">IIU</font> as a possible synergistic effort to diversify revenue sources that were believed to be accretive to earnings.&nbsp;&nbsp;IIU provided <font style="color:#000000;">global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies were fully underwritten with no claim risk remaining with IIU.</font></p> <p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company purchased <font style="color:#000000;">100</font>% of the issued and outstanding capital stock of IIU from Craven for $5,089,357 subject to adjustment as set forth in the IIU SPA.&nbsp;&nbsp;IIU was required to have a minimum net working capital of $15,000 and at least $152,000 in cash. The Company paid the purchase price under the IIU SPA at closing as follows: </p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company cancelled all principal and accrued interest of the IIU Note, which consisted of aggregate principal indebtedness and accrued interest of $1,507,375 as of January 16, 2019.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company issued to Craven a $3,581,982 Senior Convertible Promissory Note (the &#8220;Craven Convertible Note&#8221;) for the balance of the purchase price.&nbsp;&nbsp;At the option of Craven, the Craven Convertible Note could be paid in restricted shares of our common stock or cash.&nbsp;&nbsp;The Craven Convertible Note bore simple interest at 3% per annum.&nbsp;&nbsp;The Craven Convertible Note was due and payable 360 days from the closing date of the IIU SPA. If repaid by the Company in restricted common stock, the outstanding principal and interest of the Craven Convertible Note would be paid by the Company by issuing to Craven a number of restricted common shares equal to the adjusted principal and accrued interest owing to Craven under the Craven Convertible Note divided by $2.41. On the date of issuance of the Craven Convertible Note, the closing share price of the Company was $1.42.</p></td></tr></table></div><div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the terms of the IIU SPA, the purchase price was subsequently reduced by $120,200, to $<font style="color:#000000;">4,969,200</font>.</p></td></tr></table></div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December 20, 2019, the Company loaned $1.5 million to Craven (&#8220;Craven Secured Promissory Note&#8221;) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly. The Company subsequently extended the due date of the Craven Secured Promissory Note to August 1, 2021.&nbsp;&nbsp; The Craven Secured Promissory Note was secured by, among other things, a pledge of Craven&#8217;s 640,000 shares of common stock of the Company and the assignment of the assets of Craven in favor of the Company. On June 29, 2020, the Company received from Craven $1,503,719 as payment in full of all principal and accrued interest due from the Craven Secured Promissory Note.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January 8, 2020, the Company entered into a Stock Purchase Agreement (&#8220;<font style="font-weight:bold;">SPA</font>&#8221;) with Craven pursuant to which the Company sold back to Craven all of the issued and outstanding shares of IIU for $3,562,569.&nbsp;&nbsp;The purchase price was paid by Craven through the cancellation of the $3,461,782Craven Convertible Note plus forgiveness of $100,787 of accrued interest. The Company originally paid $<font style="color:#000000;">4,969,200</font> for the purchase of IIU in January 2019, which included a negative $720,386 net fair value of assets and $5,689,586 of goodwill. As a result, goodwill was impaired by $1.65 million. The sale of IIU resulted in a gain of $16,428.&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Specialty Health Insurance</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our former subsidiary IIU Inc. (&#8220;IIU&#8221;) through its wholly owned company Wallach and Company (&#8220;Wallach&#8221;) offered health insurance, travel insurance and other travel services to:</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:6pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States citizens and residents traveling abroad</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non United States citizens or residents who travel to the United States</p></td></tr></table></div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These services were typically sold through a policy offered by Wallach and fully underwritten by a third party insurance company.&nbsp;&nbsp;The policies offered included:</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HealthCare Abroad - <font style="Background-color:#FFFFFF;color:#000000;">Short term medical insurance, medical evacuation and international assistance for Americans traveling overseas. There is an age limit of 84 years old.</font></p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HealthCare Global &#8211; up to 6 months coverage for Americans traveling abroad and foreign nationals traveling outside their home countries to destinations other than the United States.&nbsp;&nbsp;There is an age limit of 70 years old. </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HealthCare America &#8211; up to 90 days coverage for foreign nationals visiting the United States. There is an age limit of 70 years old. </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HealthCare International &#8211; International medical insurance &amp; assistance for persons living outside their home country.&nbsp;&nbsp;There is an age limit of 70 years old. </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HealthCare War &#8211; up to 6 months coverage for Americans traveling abroad and foreign nationals traveling outside their home countries to identified war risk areas.&nbsp;&nbsp;There is an age limit of 70 years old. </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As such, IIU is considered a discontinued operation. <font style="color:#000000;">We did not report any activity from operations from IIU for the six months ended June 30, 2020.</font></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Entry into and Termination of Hanfor Share Exchange Agreement</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 23, 2020, the Company entered into a Share Exchange Agreement, dated March 23, 2020 (the &#8220;Share Exchange Agreement&#8221;), with <font style="color:#000000;">Hanfor (Cayman) Limited, a Cayman Islands exempted company (&#8220;Hanfor&#8221;), and BZ Industrial Limited, a British Virgin Islands business company and the sole stockholder of Hanfor (&#8220;Hanfor Owner&#8221;).</font>&nbsp;&nbsp;The Share Exchange Agreement contemplated a business combination transaction in which Hanfor Owner would transfer and assign to the Company all of the share capital of Hanfor in exchange for a number of shares of the Company&#8217;s common stock that would result in Hanfor Owner owning 86.5% of the outstanding common stock of the Company.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the agreement, Hanfor Owner was required to deliver to the Company audited financial statements for Hanfor for the 2019 and 2018 fiscal years, and such audited financial statements were required to be delivered by May 31, 2020 (subject to extension to June 30, 2020 under specified circumstances).&nbsp;&nbsp;In connection with the execution of the Share Exchange Agreement, the Company and Hanfor Owner entered into a Stock Purchase Agreement, dated March 23, 2020, pursuant to which Hanfor Owner purchased from the Company an aggregate of 520,838 shares of the <font style="color:#000000;">Company&#8217;s</font> common stock at a price of $2.40 per share. Hanfor Owner paid $250,000 cash on March 23, 2020 and the Company received an additional $1,000,000 in April 2020 at which time the Company issued the 520,838 shares. </p><p style="margin-top:6pt;margin-bottom:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On July 14, 2020, the Company notified Hanfor and Hanfor Owner that the Company had elected to terminate the Share Exchange Agreement due to Hanfor&#8217;s inability to provide audited financial statements by June 30, 2020.&nbsp;&nbsp;Although the Company believes that it properly terminated the Share Exchange Agreement, on July 21, 2020, counsel to Hanfor Owner informed the Company that Hanfor Owner believes that the Company&#8217;s termination of the Share Exchange Agreement was not effected in accordance with the terms of the Share Exchange Agreement.&nbsp;&nbsp;The Company and Hanfor Owner are engaged in discussions to resolve this disagreement, but there is no assurance that this disagreement will be promptly resolved or resolved on terms favorable to the Company, and there is no assurance that Hanfor Owner will not seek to take legal action.</p><p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Nasdaq Listing</font></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 27, 2020, the Company received a notification letter from the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) stating that the Company has not regained compliance with Nasdaq Continued Listing Rule 5550(a)(2), which requires the Company&#8217;s listed securities to maintain a minimum bid price of $1.00 per share (the "Minimum Bid Price Rule"). The notification stated that the Company&#8217;s securities would be delisted from the Nasdaq Capital Market on April 7, 2020 unless the Company timely requested a hearing before a Nasdaq Hearing Panel.&nbsp;&nbsp;The Company has timely requested a hearing.&nbsp;&nbsp;However, on April 16, 2020, Nasdaq suspended any enforcement actions relating to bid price issues through <font style="color:#000000;">June 30, 2020. On&#160;July 1, 2020, the Company received a letter from Nasdaq stating that the Company had regained compliance with the Minimum Bid Price Rule because the closing price for the Company&#8217;s common stock was&#160;$1.00&#160;per share or greater for ten (10) consecutive business days. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additionally, on January 3, 2020, the Company received a deficiency letter from Nasdaq, indicating that it was in violation of Listing Rules 5620(a) and 5810(c)(2)(G) by virtue of passing the applicable deadline for holding of its annual general meeting of shareholders for the financial year ended December 31, 2018.&nbsp;&nbsp;The Company resolved this issue by having its annual general meeting of shareholders on May 11, 2020.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Reverse Stock Split Approval</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On May 11, 2020, our shareholders voted in favor of the approval of an amendment to our Certificate of Incorporation, in the event it is deemed advisable by our Board of Directors, to effect an additional reverse stock split of the Company&#8217;s issued and outstanding common stock at a ratio within the range of one-for-two (1:2) and one-for-ten (1:10), as determined by the Board of Directors.&nbsp;&nbsp;However, a reverse stock split has not yet been effected pursuant to such approval.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Principles of Consolidation</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The condensed consolidated financial statements include the accounts of LMFA and its wholly-owned subsidiaries: LM Funding, LLC; LMF October 2010 Fund, LLC; REO Management Holdings, LLC (including all 100% owned subsidiary limited liability companies); LM Funding of Colorado, LLC; LM Funding of Washington, LLC; LM Funding of Illinois, LLC; and LMF SPE #2, LLC and various single purpose limited liability corporations owned by REO Management Holdings, LLC which own various properties. It also includes IIU and its wholly-owned subsidiary: Wallach &amp; Company for the time that the Company owned IIU. All significant intercompany balances have been eliminated in consolidation.</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Basis of Presentation</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). Certain information and note disclosures normally included in the annual consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. The interim condensed consolidated financial statements as of June 30, 2020 and for the three and six months ended June 30, 2020 and June 30, 2019, respectively are unaudited. In the opinion of management, the interim condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary to provide a fair statement of the results for the interim periods. The accompanying condensed consolidated balance sheet as of December 31, 2019, is derived from the audited consolidated financial statements presented in the Company&#8217;s Annual Report on Form 10-K for fiscal the year ended December 31, 2019.</p><p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Use of Estimates</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the evaluation of any probable losses on amounts funded under the Company&#8217;s <font style="font-style:italic;">New Neighbor Guaranty</font> program as disclosed below, the evaluation of probable losses on balances due from a related party, the realization of deferred tax assets, the evaluation of contingent losses related to litigation and fair value estimates of real estate assets owned.</p><p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are not presently aware of any events or circumstances arising from the COVID-19 pandemic that would require us to update our estimates or judgments or revise the carrying value of our assets or liabilities. Our estimates may change, however, as new events occur and additional information is obtained, and any such changes will be recognized in the condensed consolidated financial statements.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Revenue Recognition</font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Accounting Standards Codification<font style="font-style:normal;">&#160;(&#8220;ASC&#8221;) 606 of the Financial Accounting Standards Board (&#8220;FASB&#8221;) states </font><font style="font-style:normal;color:#000000;">an entity needs to conclude at the inception of the contract that collectability of the consideration to which it will be entitled in exchange for the goods and services that will be transferred to the customer is probable. </font><font style="font-style:normal;"> </font><font style="font-style:normal;color:#000000;">That is, in some circumstances, an entity may not need to assess its ability to collect all of the consideration in the contract. </font><font style="font-style:normal;">The Company provides funding to community associations by purchasing their rights under delinquent accounts from unpaid assessments due from property owners (the &#8220;accounts&#8221;). Collections on the accounts may vary greatly in both the timing and amount ultimately recovered compared with the total revenues earned on the accounts because of a variety of economic and social </font><font style="font-style:normal;color:#000000;">factors affecting the real estate environment in general. The Company&#8217;s contracts with its customers have very specific performance obligations.&nbsp;&nbsp;The Company has determined that the known amount of cash to be realized or realizable on its revenue generating activities cannot be reasonably estimated.&nbsp;&nbsp;</font><font style="font-style:normal;">The Company determined rental income from leasing arrangements is specifically excluded from the standard.&#160; The Company analyzed its remaining revenue streams and concluded there were no changes in revenue recognition with the adoption of the new standard.</font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under ASC 606, the Company applies the cash basis method to its original product and the cost recovery method to its special product as follows:</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Finance Receivables&#8212;Original Product<font style="font-style:normal;">: Under the Company&#8217;s original product, delinquent assessments are funded only up to the Super Lien Amount as discussed above. Recoverability of funded amounts is generally assured because of the protection of the Super Lien Amount. As such, payments by unit owners on the Company&#8217;s original product are recorded to income when received in accordance with the provisions of the Florida Statute (718.116(3))&#160;and the provisions of the purchase agreements entered into between the Company and community associations. Those provisions require that all payments be applied in the following order: first to interest, then to late fees, then to costs of collection, then to legal fees expended by the Company and then to assessments owed. In accordance with the cash basis method of recognizing revenue and the provisions of the statute, the Company records revenues for interest and late fees when cash is received. In the event the Company determines the ultimate collectability of amounts funded under its original product are in doubt, payments are applied to first reduce the funded or principal amount.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Finance Receivables&#8212;Special Product (New Neighbor Guaranty program)<font style="font-style:normal;">: During 2012, the Company began offering associations an alternative product under the </font>New Neighbor Guaranty<font style="font-style:normal;"> program where the Company will fund amounts in excess of the Super Lien Amount. Under this special product, the Company purchases substantially all of the delinquent assessments owed to the association, in addition to all accrued interest and late fees, in exchange for payment by the Company of (i)&#160;a negotiated amount or (ii)&#160;on a going forward basis, all monthly assessments due for a period up to 48 months. Under these arrangements, the Company considers the</font> collection of amounts funded is not assured and under the cost recovery method, cash collected is applied to first reduce the carrying value of the funded or principal amount with any remaining proceeds applied next to interest, late fees, legal fees, collection costs and any amounts due to the community association. Any excess proceeds still remaining are recognized as revenues. If the future proceeds collected are lower than the Company&#8217;s funded or principal amount, then a loss is recognized.</p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Net Commission Revenue:<font style="font-style:normal;">&#160;The Company acted as an agent in providing health travel insurance policies. As a result, the Company revenue was recorded at net. The Company has determined that the known amount of cash to be realized or realizable on its revenue generating activities can be reasonably estimated and as such, classifies its receivables as accrual and recognizes revenues in the accompanying statements of income on the accrual basis.&nbsp;&nbsp;If a policy is not effective as of the end of a period, then the associated revenue and underwriting costs are deferred until the effective date.</font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Cash</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company maintains cash balances at several financial institutions that are insured under the Federal Deposit Insurance Corporation&#8217;s (&#8220;FDIC&#8221;) Transition Account Guarantee Program. Balances with the financial institutions may exceed federally insured limits.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Finance Receivables</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance receivables are recorded at the amount funded or cost (by unit). The Company evaluates its finance receivables at each period end for losses that are considered probable and can be reasonably estimated in accordance with ASC 450-20. As discussed above, recoverability of funded amounts under the Company&#8217;s original product is generally assured because of the protection of the Super Lien Amount. However, the Company did have an accrual at June 30, 2020 and December 31, 2019 for an allowance for credit losses for this program of $112,027 and $112,027. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the&#160;<font style="font-style:italic;">New Neighbor Guaranty</font>&#160;program (special product), the Company funds amounts in excess of the Super Lien Amount. When evaluating the carrying value of its finance receivables, the Company looks at the likelihood of future cash flows based on historical payoffs, the fair value of the underlying real estate, the general condition of the community association in which the unit exists, and the general economic real estate environment in the local area.&#160;The Company estimated an allowance for credit losses for this program of $6,564 as of&#160;June 30, 2020 and $20,016 at December&#160;31, 2019 under ASC 450-20 related to its New Neighbor Guaranty program.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company will charge any receivable against the allowance for credit losses when management believes the collectability of the receivable is confirmed. The Company considers writing off a receivable when (i) a first mortgage holder who names the association in a foreclosure suit takes title and satisfies an estoppel letter for amounts owed which are less than amounts the Company funded to the association; (ii) a tax deed is issued with insufficient excess proceeds to pay amounts the Company funded to the association; (iii) an association settles an account for less than amounts the Company funded to the association or (iv) the association terminates its relationship with the Company&#8217;s designated legal counsel. Upon the occurrence of any of these events, the Company evaluates the potential recovery via a deficiency judgment against the prior owner and the ability to collect upon the deficiency judgment within the statute of limitations period or whether the deficiency judgment can be sold. If the Company determines that collection through a deficiency judgment or sale of a deficiency judgment is not feasible, the Company writes off the unrecoverable receivable amount. Any losses greater than the recorded allowance will be recognized as expenses. Under the Company&#8217;s revenue recognition policies, all finance receivables (original product and special product) are classified as nonaccrual.</p><p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the six months ended June 30, 2020 and 2019, write offs charged against the allowance for credit losses were $13,452 and $20,743, respectively. Any losses greater than the recorded allowance will be recognized as expenses. Under the Company&#8217;s revenue recognition policies, all finance receivables (original product and special product) are classified as nonaccrual.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Real Estate Assets Owned</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event collection of a delinquent assessment results in a unit being sold in a foreclosure auction, the Company has the right to bid (on behalf of the community association) for the delinquent unit as attorney in fact, applying any amounts owed for the delinquent assessment to the foreclosure price as well as any additional funds that the Company, in its sole discretion, decides to pay. If a delinquent unit becomes owned by the community association by acquiring title through an association lien foreclosure auction, by accepting a deed-in-lieu of foreclosure, or by any other way, the Company in its sole discretion may direct the community association to quitclaim title of the unit to the Company.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Properties quitclaimed to the Company are in most cases acquired subject to a first mortgage or other liens, and are recognized in the accompanying consolidated balance sheets solely at costs incurred by the Company in excess of original funding. At times, the Company will acquire properties through foreclosure actions free and clear of any mortgages or liens.&#160;In these cases, the Company records the estimated fair value of the properties in accordance with ASC 820-10,&#160;<font style="font-style:italic;">Fair Value Measurements</font>. Any real estate held for sale is adjusted to fair value less the cost to dispose in the event the carrying value of a unit or property exceeds its estimated net realizable value.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company capitalizes costs incurred to acquire real estate owned properties and any costs incurred to get the units in a condition to be rented.&#160;&#160;These costs include, but are not limited to, renovation/rehabilitation costs, legal costs, and delinquent taxes.&#160;&#160;These costs are depreciated over the estimated minimum time period the Company expects to maintain possession of the units.&#160;&#160;Costs incurred for unencumbered units are depreciated over 20 years and costs for units subject to a first mortgage are depreciated over 3 years.&#160;&#160;As of June 30, 2020 and December 31, 2019, capitalized real estate costs, net of accumulated depreciation, were $13,426 and $21,084, respectively.&#160;&#160;</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the three and six month period ended June 30, 2020 and 2019, depreciation expense was $4,110 and $9,713 for 2020 and $5,526 and $11,969 for 2019, respectively.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Company elects to take a quitclaim title to a unit or property held for sale, the Company is responsible to pay all future assessments on a current basis, until a change of ownership occurs. The community association must allow the Company to lease or sell the unit to satisfy obligations for delinquent assessments of the original debt. All proceeds collected from any sale of the unit shall be first applied to all amounts due the Company plus any additional funds paid by the Company to purchase the unit, if applicable. Rental revenues and sales proceeds related to real estate assets held for sale are recognized when earned and realizable. Expenditures for current assessments owed to associations, repairs and maintenance, utilities, etc. are expensed when incurred.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the community association elects (prior to the Company obtaining title through its own election) to maintain ownership and not quitclaim title to the Company, the community association must pay the Company all interest, late fees, collection costs, and legal fees expended, plus the original funding on the unit, which have accrued according to the purchase agreement entered into by the community association and the Company. In this event, the unit will be reassigned to the community association.<font style="color:#000000;"> </font></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Fixed Assets</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company capitalizes all acquisitions of fixed assets in excess of $500. Fixed assets are stated at cost. Depreciation is provided on the straight-line method over the estimated useful lives of the assets. Fixed assets are comprised of furniture, computer and office equipment with an assigned useful life of 3 to 5 years. Fixed assets also include capitalized software costs. Capitalized software costs include costs to develop software to be used solely to meet the Company&#8217;s internal needs, consist of employee salaries and benefits and fees paid to outside consultants during the application development stage, and are amortized over their estimated useful life of 5 years. As of June 30, 2020 and December 31, 2019, capitalized software costs, net of accumulated amortization, was nil. Amortization expense for capitalized software costs for the three and six month period ended June 30, 2020 and 2019 was $nil and $nil for 2020 and $5,815 and $11,630 for 2019, respectively.&#160;</p><p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Right to Use Assets</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company capitalizes all leased assets pursuant to <font style="color:#000000;">ASU 2016-02, "Leases (Topic 842)," which requires lessees to recognize right-of-use assets and lease liability, initially measured at present value of the lease payments, on its balance sheet for leases with terms longer than 12 months and classified as either financing or operating leases.&nbsp;&nbsp;</font>As of June 30, 2020 and December 31, 2019, right to use assets, net of accumulated amortization, was $209,031 and $260,260, respectively. Amortization expense for right to use assets for the three and six month period ended June 30, 2020 and 2019 was $26,136 and $51,229 for 2020 and was $2,426 and $4,852 for 2019, respectively while the payments totaled $45,742 for the six months ended June 30, 2020.&#160;</p><p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Other Investments &#8211; Note Receivable - Related Party</font></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December 20, 2019, the Company loaned $1.5 million to Craven (&#8220;Craven Secured Promissory Note&#8221;) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly. The Company subsequently extended the due date of the Craven Secured Promissory Note to August 1, 2021 and allowed for the deferral of monthly interest payments.&nbsp;&nbsp; The Craven Secured Promissory Note was secured by, among other things, Stock Pledge of Craven&#8217;s 640,000 Common Shares of the Company and the Assignment of the assets of Craven in favor of the Company. On June 29, 2020, the Company received from Craven $1,503,719 as payment in full of all principal and accrued interest due from the Craven Secured Promissory Note.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Goodwill</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Goodwill represents the excess purchase price of acquired businesses over the fair value of the net assets acquired. Goodwill is not amortized, but instead is tested for impairment annually </font><font style="color:#000000;">or whenever events or changes in circumstances indicate that the carrying amount may not be fully recoverable.</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2019, the Company recorded goodwill of approximately $5.7 million which represented amounts for the purchase of IIU. For purposes of the&#160;2019&#160;annual test, we will elect to perform a goodwill impairment analysis to assess whether it was more likely than not that the fair value of these reporting units exceeded their respective carrying values. In performing these assessments, management will rely on a number of factors including, but not limited to, macroeconomic conditions, industry and market considerations, cost factors that would have a negative effect on earnings and cash flows, overall financial performance compared with forecasted projections in prior periods, and other relevant reporting unit events, the impact of which are all significant judgments and estimates.&nbsp;&nbsp;This assessment was performed as of December 31, 2019 and showed a $1.65 million impairment due to the sale of IIU on January 8, 2020. The balance of goodwill as of June 30, 2020 and December 31, 2019 was approximately $0 million and $4.0 million, respectively.<font style="font-size:12pt;color:#000000;">&#160;</font></p><p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Stock Issued</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the execution of the Share Exchange Agreement, the Company and Hanfor Owner entered into a Stock Purchase Agreement, dated March 23, 2020, pursuant to which Hanfor Owner purchased from Company an aggregate of 520,838 shares of the <font style="color:#000000;">Company&#8217;s</font> common stock at a price of $2.40 per share for a total of $1,250,000 cash.&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Debt Issue Costs</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company capitalizes all debt issue costs and amortizes them on a method that approximates the effective interest method over the remaining term of the note payable. <font style="color:#000000;">The Company did not have any unamortized debt issue costs at June 30, 2020 and</font><font style="font-size:12pt;">&#160;</font><font style="color:#000000;">at December 31, 2019. Any costs will be presented in the accompanying condensed consolidated balance sheets as other assets until the loan proceeds are received which at that time will be reclassified as a direct deduction from the carrying amount of that debt liability in accordance with Accounting Standards Update (&#8220;ASU&#8221;) 2015-03 (see below).&#160;The Company adopted this new standard in the first quarter of fiscal 2016. The adoption of this standard did not have a material impact on the Company's consolidated financial position and had no impact on its consolidated income or cash flows. In addition, the amortization of debt issuance costs is to be reported as interest expense under</font><font style="color:#000000;">&#160;</font><font style="color:#000000;">ASU 2015-03 (ASC 835-30-45-3).&#160;&#160;</font><font style="font-size:12pt;">&#160;&#160;</font></p><p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Settlement Costs with Associations</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Community associations working with the Company will at times incur costs in connection with litigation initiated by the Company against property owners and or mortgage holders. These costs include settlement agreements whereby the community association agrees to pay some monetary compensation to the opposing party or judgments against the community associations for fees of opposing legal counsel or other damages awarded by the courts. The Company indemnifies the community association for these costs pursuant to the provisions of the agreement between the Company and the community association. Costs incurred by the Company for these indemnification obligations for the three and six months ended June 30, 2020 and 2019 were approximately $zero&nbsp;&nbsp;and $12,000 for 2020 and $38,000&nbsp;&nbsp;and $40,000 for 2019, respectively. The Company does not limit its indemnification based on amounts ultimately collected from property owners.&nbsp;&nbsp;</p><p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Income Taxes</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income taxes are provided for the tax effects of transactions reported in the consolidated financial statements and consist of taxes currently due plus deferred taxes resulting primarily from the tax effects of temporary differences between financial and income tax reporting. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under ASC 740-10-30-5, <font style="font-style:italic;">Income Taxes</font>, deferred tax assets should be reduced by a valuation allowance if, based on the weight of available evidence, it is more-likely-than-not (i.e., a likelihood of more than 50%) that some portion or all of the deferred tax assets will not be realized. The Company considers all positive and negative evidence available in determining the potential realization of deferred tax assets including, primarily, the recent history of taxable earnings or losses. Based on operating losses reported by the Company during 2018, 2017 and 2016, the Company concluded there was not sufficient positive evidence to overcome this recent operating history. As a result, the Company believes that a valuation allowance was necessary based on the more-likely-than-not threshold noted above. During the year ended December 31, 2019, the Company decreased the valuation allowance to $3,634,857 to reflect a change in deferred tax assets.</p><p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Loss Per Share</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic loss per share is calculated as net loss to common stockholders divided by the weighted average number of common shares outstanding during the period.&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company issued 2,500,000 shares at various times during the month of November 2018 and has weighted average these new shares in calculating loss per share.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On October 15, 2018, the Company effected a common share consolidation (&#8220;Reverse Stock Split&#8221;) by means of a one-for-ten (1:10) reverse split of its outstanding common stock, par value $0.001 per share which resulted in a decrease in outstanding common stock to 625,318 shares.&nbsp;&nbsp;<font style="color:#000000;">The Reverse Stock Split became effective on October 16, 2018 and the Company&#8217;s common stock began trading on The Nasdaq Global Market on a split-adjusted basis on October 16, 2018.</font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has restated all share amounts to reflect the Reverse Stock Split.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Diluted loss per share for the period equals basic loss per share as the effect of any convertible notes, stock based compensation awards or stock warrants would be anti-dilutive.&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The anti-dilutive stock based compensation awards and convertible notes consisted of:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="top" style="width:40%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="top" style="width:1%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td colspan="3" valign="bottom" style="width:14%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of June 30,</p></td> </tr> <tr> <td valign="top" style="width:40%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="top" style="width:1%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="bottom" style="width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="bottom" style="width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="width:40%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock Options</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:14%; border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:14%; border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> </tr> <tr> <td valign="top" style="width:40%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock Warrants</p></td> <td valign="top" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:14%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,731,587</p></td> <td valign="top" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:14%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,959,287</p></td> </tr> <tr> <td valign="top" style="width:40%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Convertible Note</p></td> <td valign="top" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:14%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:14%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> </tr> </table> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As part of its initial public offering, o<font style="color:#000000;">n October 23, 2015 the Company issued 1,200,000 warrants that allowed for the right to purchase 1,200,000 shares of common stock at an average exercise price of $12.50 per share. Due to the Reverse Stock Split on October 16, 2018, each warrant may only purchase one-tenth of one share of common stock at $12.50. These warrants have weighted average price of $12.50 per share and a weighted average remaining life of .44 years and .94 years as of June 30, 2020 and December 31, 2019, respectively. These warrants expire in the year 2020.&nbsp;&nbsp;</font>The aggregate intrinsic value of the outstanding common stock warrants as of June 30, 2020 and December 31, 2019 was $0 and $0, respectively.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On October 31, 2018, the Company issued warrants as part of its secondary offering that allowed for the right to purchase 2,500,000 shares of common stock at an exercise price of $2.40 per share. These warrants expire in the year 2023.&nbsp;&nbsp;During the six months ended June 30, 2020, warrants for 1,277,700 shares were exercised for $2,946,480.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As part of its underwriting agreement dated, <font style="color:#000000;">October 31, 2018, the Company issued additional warrants, effective May 1, 2019, to its underwriter as part of its secondary offering that allowed for the right to purchase 125,000 shares of common stock at an exercise price of $2.64 per share on or after May 1, 2019. These warrants expire on May 2, 2022.</font></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On April 2, 2018, the Company issued warrants that allowed for the right to purchase 40,000 shares of common stock at an exercise price of $6.605 per share. If the Company, at any time this warrant is outstanding, combines its outstanding shares of Common Stock into a smaller number of shares or enters into a corporate action or transaction to change the number of outstanding share of common stock, then the exercise price is adjusted along with the number of shares that can be purchased under this agreement. Due to the subsequent issuance of stock and warrants on October 31, 2018, these warrants now have the right to purchase 143,587 shares at an exercise price of $1.84 per share. These warrants expire in the year 2023.&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A senior secured convertible note to Craven House Capital North America LLC (Related Party), bearing interest at 3.0% was issued on January 16, 2019 and matures on either January 14, 2020 or convertible into 1,436,424 shares of the Company's common shares.<font style="color:#000000;"> On January 8, 2020, the Company entered into a Stock Purchase Agreement (&#8220;</font><font style="font-weight:bold;color:#000000;">SPA</font><font style="color:#000000;">&#8221;) with Craven pursuant to which the Company sold to Craven all of the issued and outstanding shares of IIU, Inc., a Virginia based travel insurance brokerage company and wholly owned subsidiary of LMFA (&#8220;IIU&#8221;), for $3,562,569.&nbsp;&nbsp;The purchase price was paid by Craven through the cancellation of the $3,461,782 Craven Convertible Note issued by LMFA to Craven dated January 16, 2019 plus forgiveness of $100,787 of accrued interest. </font>LMFA <font style="color:#000000;">originally paid $</font>4,969,200 for the purchase of IIU in January 2019, which included a negative $720,386 net fair value of assets and $5,689,586 of goodwill. The sale of IIU resulted in a gain of $16,428.&nbsp;&nbsp;<font style="color:#000000;"> </font></p></div><p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Stock-Based Compensation</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company records all equity-based incentive grants to employees and non-employee members of the Company&#8217;s Board of Directors in operating expenses in the Company&#8217;s Consolidated Statements of Operations based on their fair values determined on the date of grant. Stock-based compensation expense, reduced for estimated forfeitures, is recognized on a straight-line basis over the requisite service period of the award, which is generally the vesting term of the outstanding equity awards. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Contingencies</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accrues for contingent obligations, including estimated legal costs, when the obligation is probable and the amount is reasonably estimable. As facts concerning contingencies become known, the Company reassesses its position and makes appropriate adjustments to the consolidated financial statements. Estimates that are particularly sensitive to future changes include those related to tax, legal and other regulatory matters. &nbsp;&nbsp;&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Fair Value of Financial Instruments </font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">FASB ASC 825-10, Financial Instruments, requires disclosure of fair value information about financial instruments, whether or not recognized in the balance sheet. The Company engages a third-party valuation firm to assist in estimating the fair value of its finance receivables. </font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Risks and Uncertainties </font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Funding amounts are secured by a priority lien position provided under Florida law (see discussion above regarding Florida Statute 718.116). However, in the event the first mortgage holder takes title to the property, the amount payable by the mortgagee to satisfy the priority lien is capped under this same statute and would generally only be sufficient to reimburse the Company for funding amounts noted above for delinquent assessments. Amounts paid by the mortgagee would not generally reimburse the Company for interest, administrative late fees and collection costs. Even though the Company does not recognize these charges as revenues until collected, its business model and long-term viability is dependent on its ability to collect these charges.&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event a delinquent unit owner files for bankruptcy protection, the Company may at its option be reimbursed by the association for the amounts funded (i.e., purchase price) and all collection rights are re-assigned to the association.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Non-cash Financing and Investing Activities</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the six months ended June 30, 2020 and 2019, the Company acquired unencumbered title to certain properties as a result of foreclosure proceedings.&#160;&#160;Properties were recorded at fair value less cost to dispose of approximately $0 and $0, respectively.&#160;&#160;The fair value of these properties was first applied to recover the Company&#8217;s initial investment with any remaining proceeds applied to interest, late fees, and other amounts owed by the property owner.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the six months ended June 30, 2020, the Company disposed of IIU which included assets and liabilities listed in Note 10.&nbsp;&nbsp;</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Recent Accounting Pronouncements</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016, the FASB issued ASU 2016-13, <font style="font-style:italic;">Financial Instruments - Credit Losses,</font> which establishes a new approach for credit impairment based on an expected loss model rather than an incurred loss model. The standard requires the consideration of all available relevant information when estimating expected credit losses, including past events, current conditions and forecasts and their implications for expected credit losses.&nbsp;&nbsp;The guidance is effective January 1, 2020 with a one-year early adoption permitted.&nbsp;&nbsp;<font style="color:#000000;">We adopted this new standard on January 1, 2020 and determined that this did not impact our consolidated financial statements.</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Recent accounting guidance not discussed above is not applicable, did not have, or is not expected to have a material impact to the Company.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Reclassifications</font></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain prior period amounts have been reclassified to conform to the current period presentation.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Subsequent Events</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has evaluated subsequent events through the date which the condensed consolidated financial statements were issued.&#160; </p> <p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Note 2. Goodwill and Acquisition </font></p> <p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On November 2, 2018, the Company invested cash by purchasing stock under a Securities Purchase Agreement (the &#8220;IIU SPA&#8221;) from IIU, a synergistic Virginia based travel insurance brokerage company controlled by Craven House N.A. (whose ownership excluding unexercised warrants is approximately 20% of the Company&#8217;s outstanding stock as of the date of acquisition), pursuant to which IIU issued to the Company a Senior Convertible Promissory Note (&#8220;IIU Note&#8221;) in the original principal amount of $1,500,000 in exchange for a purchase price of $1,500,000.&nbsp;&nbsp;The maturity date of the Note is 360 dates after the date of issuance (subject to acceleration upon an event of default).&nbsp;&nbsp;The Note carries a 3.0% interest rate, with accrued but unpaid interest being payable on the Note&#8217;s maturity date.&nbsp;&nbsp;</p><p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The IIU Note allows the Company the right on or after the maturity date to convert any unpaid principal and accrued and unpaid interest of the IIU Note into shares of IIU based on a conversion amount which is the fair value of the common shares of IIU at the time. The conversion price will be reset if IIU issues or sells common shares, convertibles securities or options at a price per share that is less than the conversion price in effect immediately prior to such issue or sale or deemed issuance or sale of such dilutive issuance.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January 16, 2019, the Company entered into a Stock Purchase Agreement with Craven House North America, LLC (<font style="color:#000000;">&#8220;Craven&#8221;</font>) to purchase all of the outstanding shares of <font style="color:#000000;">IIU</font> as a possible synergistic effort to diversify revenue sources that were believed to be accretive to earnings.&nbsp;&nbsp;IIU provided <font style="color:#000000;">global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies are fully underwritten with no claim risk remaining with IIU.</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Board of Directors of LMFA approved the purchase of IIU. LMFA purchased 100% of the outstanding stock of IIU for $5,089,357.&nbsp;&nbsp;LMFA paid the Purchase Price at closing as follows: </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&nbsp;</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cancellation by LMFA of all principal and accrued interest of IIU&#8217;s Promissory Note dated November 3, 2018 and issued to LMFA for principal indebtedness and accrued interest of $1,507,375.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LMFA issued to Craven a $3,581,982 Senior Convertible Promissory Note (&#8220;Craven Convertible Note&#8221;) for the balance of the Purchase Price.&nbsp;&nbsp;At the option of Craven, the Convertible Note may be paid in restricted common shares of LMFA or cash.&nbsp;&nbsp;The Craven Convertible Note shall bear simple interest at 3% per annum.&nbsp;&nbsp;The Craven Convertible Note shall be due and payable 360 days from the Closing Date. If repaid by LMFA in restricted common stock, the outstanding principal and interest of the Craven Convertible Note shall be paid by LMFA by issuing to Seller a number of restricted common shares equal to the adjusted principal and accrued interest owing on the Craven Convertible Note divided by $2.41. On the date of issuance of the Craven Convertible Note, the closing share price of the Company was $1.42. The note principal was subsequently reduced by $120,200 arising from lower than expected Closing Cash and Net Working Capital. Craven had verbally agreed to extend repayment of this Craven Convertible Note 12 months from April 15, 2019.</p></td></tr></table></div><div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Net cash received in the business acquisition was $51,327.</font><font style="color:#000000;">As such, the $1.5 million note receivable was cancelled as of January 16, 2019.</font></p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the approximate consideration paid and the amounts of the identified assets acquired and liabilities assumed at the acquisition date:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:60%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.9%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.44%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">January 16, 2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.4%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total adjusted purchase price </p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,969,200</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Recognized preliminary amounts of identifiable assets acquired and (liabilities assumed), at fair value:</p></td> <td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51,300</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid and other current assets</p></td> <td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,200</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Profit on purchased policies</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,600</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property, plant and equipment</p></td> <td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,100</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,100</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses and other liabilities</p></td> <td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(62,686</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income taxes</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(28,500</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</p></td> <td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,300</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.9%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(703,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.4%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preliminary estimate of the fair value of assets and liabilities assumed</p></td> <td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(720,386</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.9%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.4%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.9%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,689,586</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.4%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We performed an assessment effective as of December 31, 2019 in light of the Company&#8217;s sale of IIU on January 8, 2020 which resulted in a $1.65 million goodwill impairment.&nbsp;&nbsp;<font style="color:#000000;">On January 8, 2020, the Company entered into a SPA with Craven pursuant to which the Company sold to Craven all of the issued and outstanding shares of IIU for $3,562,569.&nbsp;&nbsp;The purchase price was paid by Craven through the cancellation of the $3,461,782 Convertible Promissory Note issued by LMFA to Craven dated January 16, 2019 plus forgiveness of $100,787 of accrued interest. </font>See Note 10 Discontinued Operations. </p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Note 3. Finance Receivables &#8211; Original Product</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">The Company&#8217;s original funding product provides financing to community associations only up to the secured or &#8220;Super Lien Amount&#8221; as discussed in Note 1.&nbsp;&nbsp;Finance receivables for the original product as of June 30, 2020 and December 31, 2019 based on the year of funding are approximately as follows:</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019&#160;(Audited)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Funded during the current year</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1-2 years outstanding</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2-3 years outstanding</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3-4 years outstanding</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Greater than 4 years outstanding</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">267,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">300,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">324,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">386,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reserve for credit losses</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(112,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(112,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">212,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">274,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number of active units with delinquent assessments</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">511</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">598</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amount of outstanding interest and late fees on active units</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,727,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,167,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></div> <p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Note 4. Finance Receivables &#8211; Special Product (New Neighbor Guaranty program)</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company typically funds amounts equal to or less than the &#8220;Super Lien Amount&#8221;.&nbsp;&nbsp;During 2012 the Company began offering Associations an alternative product under the New Neighbor Guaranty program where the Company funds amounts in excess of the &#8220;Super Lien Amount&#8221;.&nbsp;&nbsp;</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under this special product, the Company purchases substantially all of the outstanding past due assessments due from delinquent property owners, in addition to all interest, late fees and other charges in exchange for the Company&#8217;s commitment to pay monthly assessments on a going forward basis up to 48 months.&nbsp;&nbsp;</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of June 30, 2020, maximum future contingent payments under these arrangements was approximately $45,000.&#160;&#160;</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Delinquent assessments and accrued charges under these arrangements as of June 30, 2020 and December 31, 2019, are as follows:&#160;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019&#160;(Audited)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance receivables, net</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">129,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Delinquent assessments</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">209,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">374,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued interest and late fees</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">235,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number of active units with delinquent assessments</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Allowance for credit losses are recorded for losses that are considered &#8220;probable&#8221; and can be &#8220;reasonably estimated&#8221; in accordance with ASC 450-20.&nbsp;&nbsp;Recoverability of the Company&#8217;s Original Product is generally assured because of the protection of the Super Lien under Florida statute and as such no allowance is recorded.&nbsp;&nbsp;&nbsp;&nbsp;</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Credit losses on the NNG product were estimated by the Company based on analyzing the investment in each unit and comparing that balance to the average payout for completed units for the past 12 months. The allowance for losses based on these analyses, had a remaining balance of $7,000 and $20,000 as of June 30, 2020 and December 31, 2019, respectively.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 5. Due to Related Party</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Legal services for the Company associated with the collection of delinquent assessments from property owners are performed by a law firm, Business Law Group (&#8220;BLG&#8221;), which was owned solely by Bruce M. Rodgers, the Chief Executive Officer of LMFA until and through the date of the initial public offering. Following the offering, Mr. Rodgers transferred his interest in BLG to other attorneys at the firm through a redemption of his interest in the firm, and BLG is now under control of those lawyers. <font style="color:#000000;">The law firm has historically performed collection work primarily on a deferred billing basis wherein the law firm receives payment for services rendered upon collection from the property owners or at amounts ultimately subject to negotiations with the Company. </font></p><p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During 2016, the Company experienced a decline in collection events that affected revenues both to the Company and BLG.&nbsp;&nbsp;That resulted in an increase in the related party receivable and reflects the decision by the Company to advance funds to BLG based on the amount of their unpaid legal fees due from property owners.&nbsp;&nbsp;Effective January 1, 2017, the Company entered into a new services agreement with BLG which partially alters the traditional deferred billing arrangement noted above.&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the new agreement, the Company pays BLG a fixed monthly fee of $82,000 for services rendered.&nbsp;&nbsp;The Company will continue to pay BLG a minimum per unit fee of $700 in any case where there is a collection event and BLG receives no payment from the property owner.&nbsp;&nbsp;This provision has been expanded to also include any unit where the Company has taken title to the unit or where the association has terminated its contract with either BLG or the Company.&nbsp;&nbsp;<font style="color:#000000;">&nbsp;&nbsp;</font></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amounts expensed by the Company to BLG for the three and six months ended June 30, 2020 and 2019, respectively were approximately $250,000 and $509,000 for 2020 and $291,000 and $536,000 for 2019, respectively.&nbsp;&nbsp;As of June 30, 2020 and December 31, 2019, receivables from property owners for charges ultimately payable to BLG approximate $1,375,000 and $1,883,000, respectively.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the related party agreement with BLG in effect during 2020 and 2019, the Company pays all costs (lien filing fees, process and serve costs) incurred in connection with the collection of amounts due from property owners.&nbsp;&nbsp;Any recovery of these collection costs is accounted for as a reduction in expense incurred.&nbsp;&nbsp;<font style="color:#000000;">The Company incurred expenses related to these types of costs for the three and six months ended June 30, 2020 and 2019 were $31,000 and $67,000 for 2020 and $62,000 and $109,000 for 2019, respectively.</font> Recoveries during the three and six months ended June 30, 2020 and 2019, related to those costs were approximately $51,000 and $96,000 for 2020 and $52,000 and $122,000 for 2019, respectively.&nbsp;&nbsp; </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company also shares office space and related common expenses with BLG.&nbsp;&nbsp;All shared expenses, including rent, are charged to the legal firm based on an estimate of actual usage.&nbsp;&nbsp;Any expenses of BLG paid by the Company that have not been reimbursed or settled against other amounts are reflected as due from related parties in the accompanying consolidated balance sheet. BLG was charged approximately $30,000 for the office sub-lease. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amounts (payable) receivable from BLG as of June 30, 2020 and December 31, 2019 were approximately ($171,500) and $152,800, respectively. <font style="color:#000000;">In the first six months of June 30, 2020, the Company subsequently recouped $200,000 of previously write-off amounts to BLG.</font></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December 20, 2019, the Company loaned $1.5 million to Craven in the form of a secured promissory note (the &#8220;Craven Secured</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Promissory Note&#8221;) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly. </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company subsequently extended the due date of the Craven Secured Promissory Note and the monthly interest payments to August 1, 2021. The Craven Secured Promissory Note is secured by, among other things, stock pledge of Craven&#8217;s 640,000 common stock of the Company and the assignment of the assets of Craven in favor of the Company.&nbsp;&nbsp;This loan and the accrued interest was repaid on June 29, 2020.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 6. Debt and Other Financing Arrangements </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">June 30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019&#160;(Audited)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing agreement with FlatIron capital that is unsecured.&nbsp;&nbsp;Down payment of $19,170 was required upfront and equal installment payments of $11,590 to be made over a 11 month period. The note matures June 1, 2020. Annualized interest is 6.8%</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69,540</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Promissory note issued by a financial institution, bearing interest at 1.0%, interest and no principal payments.&nbsp;&nbsp; The note matures April 30, 2022. Annualized interest is 1.0%. This is a U.S. Small Business Administration&#8217;s Paycheck Protection Program (the &#8220;PPP Loan&#8221;)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">185,785</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior secured convertible note to Craven House Capital North America LLC (Related Party), bearing interest at 3.0%.&nbsp;&nbsp;Note was issued on January 16, 2019 and either matured on January 14, 2020 or became convertible into 1,436,424 shares of the Company's common shares. The value of the beneficial conversion feature as of January 16, 2019 was zero*.</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,461,782</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Promissory note issued by a financial institution, bearing interest at 9.09%, interest and principal payments due monthly of $323.&nbsp;&nbsp;Note is secured by an automobile and was issued on July 26, 2019 with original borrowings of $12,892.&nbsp;&nbsp;The note matures on August 26, 2023.</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,802</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Promissory note issued by a financial institution, bearing interest at 5.85%, interest and principal payments due monthly of $10,932. Note was issued on May 31, 2018 with original borrowings of $608,000 and subsequent borrowings of $141,000 and repayments of $51,000.&nbsp;&nbsp;The note matures on May 30, 2025 and can be prepaid at any time without penalty. This note is secured by the Company&#8217;s inventory, chattel paper, accounts, equipment and general intangible intangibles and deposit accounts.</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">606,454</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">185,785</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,149,578</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of June 30, 2020, minimum annual principal payments are as follows:</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.1%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Years Ending</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.7%;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.1%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.7%;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.1%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.7%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.1%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.7%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.1%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.7%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">185,785</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.1%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.7%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.1%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.7%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.1%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">After 2024</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.1%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">185,785</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On April 30, 2020, the company obtained a $185,785 Paycheck Protection Program loan. These business loans were established by the 2020 US Federal government Coronavirus Aid, Relief, and Economic Security Act (&#8220;CARES Act&#8221;) to help certain businesses, self-employed workers, sole proprietors, certain nonprofit organizations, and tribal businesses continue paying their workers. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Paycheck Protection Program allows entities to apply for low interest private loans to pay for their payroll and certain other costs. The loan proceeds will be used to cover payroll costs, rent, interest, and utilities. The loan may be partially or fully forgiven if the Company keeps its employee counts and employee wages stable. The program was implemented by the U.S. Small Business Administration. The interest rate is 1.0% and has a maturity date of 2 years. We anticipate applying for loan and interest forgiveness in the third quarter of 2020.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 7.&#160;Going Concern</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:6pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;<font style="Background-color:#FFFFFF;font-size:10pt;">The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are issued. </font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">In accordance with Financial Accounting Standards Board, or the FASB, Accounting Standards Update No. 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40), our management evaluates whether there are conditions or events, considered in aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued.</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has experienced significant operating losses over the past 4 years (2016 through June 30, 2020) with cumulative losses of approximately $15,046,000 and negative cashflows from operations.&#160;These losses resulted in the usage of all cash proceeds from the Company&#8217;s initial public offering in 2015. For the year ended December 31, 2019, the Company disclosed the substantial doubt about the Company&#8217;s ability to continue as a going concern</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company received a total of approximately $5.7 million during the three months ended June 30, 2020 due to a number of factors including:</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Holders of our warrants exercised such warrants for 1.2 million shares in June 2020 which resulted in the Company receiving approximately $2.9 million. </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company was repaid approximately $1.5 million on a related party receivable. </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company received $1.25 million for the issuance of 520,838 common shares.</p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As such, we have $6.2 million of cash which will be enough to satisfy our estimated liquidity needs for the 12 months from the issuance of these financial statements. These factors mitigated the substantial doubt about the Company&#8217;s ability to continue as a going concern as defined by ASU 2014-15.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;&#160;</p> <p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Note 8. Commitments and Contingencies</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Leases</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company leases certain office space, construction and office equipment, vehicles and temporary housing generally&#160;under non-cancelable operating leases.&#160;Leases with an initial term of one year or less are not recorded on the balance sheet, and the Company generally recognizes lease expense for these leases on a straight-line basis over the lease term.&#160;As of June 30, 2020,&#160;the Company&#8217;s operating leases have remaining lease terms ranging from less than one year to 3 years, some of which include options to renew the leases. The exercise of lease renewal options is generally at the Company&#8217;s sole discretion. The Company&#8217;s leases do not contain any material residual value guarantees or material restrictive covenants.</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company determines if an arrangement is a lease at inception. Operating lease ROU assets and current and long-term operating lease liabilities are separately stated on the Consolidated Balance Sheet as of June 30, 2020. ROU assets represent the Company&#8217;s right to use an underlying asset for the lease term and lease liabilities represent the Company&#8217;s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. The present value of future lease payments are discounted using either the implicit rate in the lease, if known, or the Company&#8217;s incremental borrowing rate for the specific lease as of the lease commencement date. <font style="color:#000000;">The rate was determined as a fair value of the lease over a 37 month period using a 6.5% interest rate for the present value calculation.</font><font style="font-size:12pt;color:#000000;"> </font>The ROU asset is also adjusted for any prepayments made or incentives received. The lease terms include options to extend or terminate the lease only to the extent it is reasonably certain any of those options will be exercised. Lease expense is recognized on a straight-line basis over the lease term. The Company accounts for lease components (e.g., fixed payments) separate from the non-lease components (e.g., common-area maintenance costs).<font style="font-size:11pt;font-family:Calibri;">&#160;</font>The Company does not have any material financing leases.</p><p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company leased its office under an operating lease beginning March 1, 2014 and ending July 31, 2019. The Company&#8217;s new office lease began July 15, 2019 and ends July 31, 2022. It also had a month to month lease for its IIU operations in 2019. A related party has a sub-lease for approximately $4,900 per month plus operating expenses.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company shares this space and the related costs associated with this operating lease with a related party (see Note 5) that also performs legal services associated with the collection of delinquent assessments.&nbsp;&nbsp;Net rent expense recognized for the three and six months ended June 30, 2020 and 2019 were approximately $20,000 and $50,000 for 2020 and $38,000 and $97,000 for 2019, respectively.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents components of lease expense excluding discontinued operations for the three and six months ended June 30, 2020 and 2019:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76.5%;"> <tr> <td valign="top" style="width:49.86%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&nbsp;</p></td> <td valign="top" style="width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="top" style="width:13.26%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three&#160;Months</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="top" style="width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="top" style="width:10.6%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six&#160;Months</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="top" style="width:13.26%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three&#160;Months</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td valign="top" style="width:10.6%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six&#160;Months</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="width:49.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease expense</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:13.26%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,377</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:10.6%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,109</p></td> <td valign="top" bgcolor="#CCECFF" style="width:13.26%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:1.11%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,457</p></td> <td valign="top" bgcolor="#CCECFF" style="width:10.6%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:1.11%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97,301</p></td> </tr> <tr> <td valign="top" style="width:49.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:1.22%; border-bottom:double 2.5pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="top" style="width:13.26%; border-bottom:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,377</p></td> <td valign="top" style="width:1.22%; border-bottom:double 2.5pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="top" style="width:10.6%; border-bottom:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,109</p></td> <td valign="top" style="width:13.26%; border-bottom:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:1.11%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,457</p></td> <td valign="top" style="width:10.6%; border-bottom:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:1.11%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97,301</p></td> </tr> </table> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p></div> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents supplemental balance sheet information related to operating leases as of June 30, 2020 and December 31, 2019<font style="color:#000000;">:</font></p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance Sheet Line Item</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.1%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">As of June 30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.1%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Assets</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ROU assets</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right of use asset, net</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">209,031</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">260,260</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.64%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease assets</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.96%; border-bottom:double 2.5pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">209,031</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">260,260</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Liabilities</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current lease liabilities</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease liability</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,846</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94,235</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term lease liabilities</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease liability</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">121,295</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">171,648</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.64%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease liabilities</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.96%; border-bottom:double 2.5pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">220,141</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">265,883</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average remaining lease term (in years)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.13</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.60</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average discount rate</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.55</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.55</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents supplemental cash flow information and non-cash activity related to operating leases for the six months ended June 30, 2020 and 2019:</p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:70%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.1%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Six Months Ended June 30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.1%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Six Months Ended June 30, 2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Operating cash flow information</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for amounts included in the measurement of lease liabilities</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(45,742</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,426</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Supplemental Disclosure of non-cashflow information</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ROU assets and operating lease obligation recognized</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,685</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents maturities of operating lease liabilities on an undiscounted basis as of June 30, 2020:</p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:38.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.92%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:38.58%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:15.52%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Operating Leases</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.92%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:38.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020 (excluding the six months ended June 30, 2020)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48,493</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:38.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,646</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:38.58%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:15.52%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68,002</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.92%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:38.58%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:15.52%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">220,141</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.92%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.56%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></div> <p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Legal Proceedings </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other than the lawsuits described below, we are not currently a party to material litigation proceedings. However, we frequently become party to litigation in the ordinary course of business, including either the prosecution or defense of claims arising from contracts by and between us and client Associations. Regardless of the outcome, litigation can have an adverse impact on us because of prosecution, defense, and settlement costs, diversion of management resources and other factors.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accrues for contingent obligations, including estimated legal costs, when the obligation is probable and the amount is reasonably estimable. As facts concerning contingencies become known, the Company reassesses its position and makes appropriate adjustments to the consolidated financial statements. Estimates that are particularly sensitive to future changes include those related to tax, legal, and other regulatory matters.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Note&#160;9. Stockholders&#8217; Equity</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Stock Options</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The 2015 Omnibus Incentive Plan provides for the issuance of stock options, stock appreciation rights, performance shares,</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">performance units, restricted stock, restricted stock units, shares of our common stock, dividend equivalent units, incentive cash</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">awards or other awards based on our common stock. Awards may be granted alone or in addition to, in tandem with, or (subject to the</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2015 Omnibus Incentive Plan&#8217;s prohibitions on repricing) in substitution for any other award (or any other award granted under</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">another plan of ours or of any of our affiliates).</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following is a summary of the stock option plan activity during the six months ended June 30, 2020 and 2019:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.98%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.32%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.72%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.74%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.72%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.74%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options Outstanding at Beginning of the year</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60.51</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60.51</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjustment</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options Outstanding at June 30,</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60.51</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60.51</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options Exercisable at June 30,</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,800</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84.49</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,634</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113.81</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Compensation expense recognized from the vesting of stock options was approximately $6,800 and $7,800 for the three months ended June 30, 2020 and 2019. The remaining unrecognized compensation cost associated with unvested stock options as of June 30, 2020 is approximately $11,400. </p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The aggregate intrinsic value of the outstanding common stock options as of June 30, 2020 and December 31, 2019 was $0 and $0 respectively.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Warrants</font></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following is a summary of the warrant activity during the six months ended June 30, 2020 and 2019:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:71.96%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.26%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.62%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.3%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Warrants</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.34%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.6%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Warrants</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.66%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.3%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants Outstanding at Beginning of the year</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,959,287</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.36</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,843,587</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.44</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.64</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,227,700</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.40</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,300</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.40</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.34%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.66%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.3%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants Outstanding at June 30,</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.32%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,731,587</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.34%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.83</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,959,287</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.66%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.36</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.3%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During June 2020, the Company received approximately $2,946,480 upon the exercise by warrant holders of warrants for 1,227,700 shares.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Common Share Issuance</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 23, 2020, the Company entered into a Share Exchange Agreement, dated March 23, 2020 (the &#8220;Share Exchange Agreement&#8221;), with <font style="color:#000000;">Hanfor (Cayman) Limited, a Cayman Islands exempted company (&#8220;Hanfor&#8221;), and BZ Industrial Limited, a British Virgin Islands business company and the sole stockholder of Hanfor (&#8220;Hanfor Owner&#8221;).</font>&nbsp;&nbsp;In connection with the execution of the Share Exchange Agreement, the Company and Hanfor Owner entered into a Stock Purchase Agreement, dated March 23, 2020, pursuant to which Hanfor Owner purchased from Company an aggregate of 520,833 shares of the <font style="color:#000000;">Company&#8217;s</font> common stock at a price of $2.40 per share. Hanfor Owner paid $250,000 cash on March 23, 2020 and the Company received the remaining $1.0 million in April 2020 2020 at which time the Company issued the 520,838 shares. </p><p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 23, 2020, the Company issued 186,000 shares to Maxim Holdings LLC for services and recognized $125,450 as stock compensation expense for the six months ended June 30, 2020.</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Note&#160;10. Discontinued Operations</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January 8, 2020, the Company entered into a Stock Purchase Agreement (&#8220;<font style="font-weight:bold;">SPA</font>&#8221;) with Craven pursuant to which the Company sold to Craven all of the issued and outstanding shares of IIU for $3,562,569.&nbsp;&nbsp;The purchase price was paid by Craven through the cancellation of the $3,461,782 Craven Convertible Note plus forgiveness of $100,787 of accrued interest.<font style="color:#000000;"> The Company originally paid $4,969,586 of goodwill. As a result, goodwill was impaired by $1.65 million. The sale of IIU resulted in a gain of $16,428.</font>&nbsp;&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The impact of this transaction is reflected as a discontinued operation in the consolidated financial statements. Pursuant to ASU 2014-08, the major classes <font style="Background-color:#FFFFFF;">of assets and liabilities of IIU were as follows:</font></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:67.67%;"> <tr> <td style="width:55.17%;"></td> <td style="width:12.5%;"></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2019</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Major classes of assets</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp; 246,914</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Related party receivable</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,738</p></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,301</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total major classes of current assets &#8211; discontinued assets</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">276,953</p></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fixed assets, net</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,245</p></td> </tr> <tr> <td valign="top" style=" border-bottom:double 2.5pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total major classes of assets &#8211; discontinued assets</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp; 304,198</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style=" border-top:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable and accrued expenses</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp; 144,006</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Note payable &#8211; short term</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,672</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other liabilities</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,153</p></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income taxes payable</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,226</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total major classes of current liabilities &#8211; discontinued liabilities</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">280,057</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">517,584</p></td> </tr> <tr> <td valign="top" style=" border-bottom:double 2.5pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total major classes of liabilities - discontinued liabilities</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp; 797,641</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style=" border-top:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The operating results for IIU, Inc. have been presented in the accompanying consolidated financial statements of operations for the three and six months ended June 30, 2020 and 2019 as discontinued operations are summarized below:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:102%;"> <tr> <td style="width:53.3%;"></td> <td style="width:12.01%;"></td> <td style="width:12.01%;"></td> <td style="width:12.34%;"></td> <td style="width:12.34%;"></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended June 30, 2020</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended June 30, 2019</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:10pt;">&nbsp;</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six Months Ended June 30, 2020</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:10pt;">&nbsp;</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six Months Ended June 30, 2019</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;181,391</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 280,159</p></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating costs and expenses</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,511</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">327,377</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gain (Loss) from discontinued operations</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80,880</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(47,218)</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other expense, net</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,956</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,711</p></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gain on disposal of discontinued operations</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,428</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net gain (loss) from discontinued operations</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;70,924</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp; 16,428</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;(63,929)</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash provided by operating activities</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$ 169,009</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113,829</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash (used in) provided by investing activities</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(246,914)</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51,327</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash used in financing activities</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18,452)</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(37,886)</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;font-family:Times New Roman;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Nature of Operations</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LM Funding America, Inc. (&#8220;LMFA&#8221; or the &#8220;Company&#8221;) was formed as a Delaware corporation on April 20, 2015. LMFA was formed for the purpose of completing a public offering and related transactions in order to carry on the business of LM Funding, LLC and its subsidiaries (the &#8220;Predecessor&#8221;). LMFA is the sole member of LM Funding, LLC and operates and controls all of its businesses and affairs.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">LM Funding, LLC a Florida limited liability company organized in January 2008 under the terms of an Operating Agreement effective January&#160;8, 2008 as amended, had two members: BRR Holding, LLC and CGR 63, LLC. The members contributed their equity interest to LMFA prior to the closing of its initial public offering. </p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company acquired IIU, Inc. on January 16, 2019 <font style="color:#000000;">(&#8220;IIU&#8221;)</font>, which provided <font style="color:#000000;">global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies were fully underwritten with no claim risk remaining with IIU. IIU was disposed of on January 8, 2020.</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are a specialty finance company that provides funding to nonprofit community associations primarily located in the state of Florida. We offer incorporated nonprofit community associations, which we refer to as &#8220;Associations,&#8221; a variety of financial products customized to each Association&#8217;s financial needs. Our original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. Historically, we provided funding against such delinquent accounts, which we refer to as &#8220;Accounts,&#8221; in exchange for a portion of the proceeds collected by the Associations from the account debtors on the Accounts. In addition to our original product offering, we have started purchasing Accounts on varying terms tailored to suit each Association&#8217;s financial needs, including under our New Neighbor Guaranty&#8482; program. </p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Specialty Finance Company</font></p> <p style="margin-top:6pt;margin-bottom:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We purchase an Association&#8217;s right to receive a portion of the Association&#8217;s collected proceeds from owners that are not paying their assessments. After taking assignment of an Association&#8217;s right to receive a portion of the Association&#8217;s proceeds from the collection of delinquent assessments, we engage law firms to perform collection work on a deferred billing basis wherein the law firms receive payment upon collection from the account debtors or a predetermined contracted amount if payment from account debtors is less than legal fees and costs owed. Under this business model, we typically fund an amount equal to or less than the statutory minimum an Association could recover on a delinquent account for each Account, which we refer to as the &#8220;Super Lien Amount&#8221;. Upon collection of an Account, the law firm working on the Account, on behalf of the Association, generally distributes to us the funded amount, interest, and administrative late fees, with the law firm retaining legal fees and costs collected, and the Association retaining the balance of the collection. In connection with this line of business, we have developed proprietary software for servicing Accounts, which we believe enables law firms to service Accounts efficiently and profitably.</p><p style="margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under our New Neighbor Guaranty program, an Association will generally assign substantially all of its outstanding indebtedness and accruals on its delinquent units to us in exchange for payment by us of monthly dues on each delinquent unit. This simultaneously eliminates a substantial portion of the Association&#8217;s balance sheet bad debts and assists the Association to meet its budget by receiving guaranteed monthly payments on its delinquent units and relieving the Association from paying legal fees and costs to collect its bad debts. We believe that the combined features of the program enhance the value of the underlying real estate in an Association and the value of an Association&#8217;s delinquent receivables. We intend to leverage our proprietary software platform, as well as our industry experience and knowledge gained from our original line of business, to expand the New Neighbor Guaranty program in certain situations and to potentially develop other new products in the future.</p><p style="margin-bottom:6pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Because we acquire and collect on the delinquent receivables of Associations, the Account debtors are third parties about whom we have little or no information. Therefore, we cannot predict when any given Account will be paid off or how much it will yield. In assessing the risk of purchasing Accounts, we review the property values of the underlying units, the governing documents of the relevant Association, and the total number of delinquent receivables held by the Association.</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Specialty Finance Products</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Original Product</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our original product relies upon Florida statutory provisions that effectively protect the principal amount invested by us in each Account. In particular, Section 718.116(1), Florida Statutes, makes purchasers and sellers of a unit in an Association jointly and severally liable for all past due assessments, interest, late fees, legal fees, and costs payable to the Association. As discussed above, the Florida Statutes grants to Associations a so-called &#8220;super lien&#8221;, which is a category of lien that is given a statutorily higher priority than all other types of liens other than property tax liens. The amount of the Association&#8217;s priority over a first mortgage holder that takes title to a property through foreclosure (or deed in lieu), referred to as the Super Lien Amount, is limited to twelve months&#8217; past due assessments or, if less, one percent (1.0%) of the original mortgage amount. Under our contracts with Associations for our original product, we pay Associations an amount up to the Super Lien Amount for the right to receive all collected interest and late fees on Accounts purchased from the Associations.</p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Statutes specify that the rate of interest an association (or its assignor) may charge on delinquent assessments is equal to the rate set forth in the association&#8217;s declaration or bylaws. In Florida if a rate is not specified, the statutory rate is equal to 18% but may not exceed the maximum rate allowed by law. Similarly, the Statutes in Florida also stipulate that administrative late fees cannot be charged on delinquent assessments unless so provided by the association&#8217;s declaration or bylaws and may not exceed the greater of $25 or 5% of each delinquent assessment. </p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In other states in which we have offered our original product, which are currently only in Washington, Colorado and Illinois, we rely on statutes that we believe are similar to the above-described Florida statutes in relevant respects. A total of approximately 22 U.S. states, Puerto Rico and the District of Columbia have super lien statutes that give Association assessments super lien status under some circumstances, and of these states, we believe that all of these jurisdictions other than Alaska have a regulatory and business environment that would enable us to offer our original product to Associations in those states on materially the same basis.</p> <p style="margin-top:12pt;margin-bottom:10pt;text-indent:0%;;font-weight:normal;font-style:italic;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">New Neighbor Guaranty</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In 2012, we developed a new product, the New Neighbor Guaranty, wherein an Association assigns substantially all of its outstanding indebtedness and accruals on its delinquent units to us in exchange for payments in an amount equal to the regular ongoing monthly or quarterly assessments for delinquent units when those amounts would be due to the Association. We assume both the payment and collection obligations for these assigned Accounts under this product. This simultaneously eliminates an Association&#8217;s balance sheet bad debts and assists the Association to meet its budget by receiving guaranteed assessment payments on its delinquent units and relieving the Association from paying legal fees and costs to collect its bad debts. We believe that the combined features of the product enhance the value of the underlying real estate in an Association and the value of an Association&#8217;s delinquent receivables.</p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Before we implement the New Neighbor Guaranty program for an Association typically asks us to conduct a review of its accounts receivable. After we have conducted the review, we inform the Association which Accounts we are willing to purchase and the terms of such purchase. Once we implement the New Neighbor Guaranty program, we begin making scheduled payments to the Association on the Accounts as if the Association had non-delinquent residents occupying the units underlying the Accounts. Our New Neighbor Guaranty contracts typically allow us to retain all collection proceeds on each Account other than special assessments and accelerated assessment balances. Thus, the Association foregoes the potential benefit of a larger future collection in exchange for the certainty of a steady stream of immediate payments on the Account.</p><p style="margin-top:13pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Recent Developments</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">IIU Acquisition and Disposal</font></p> <p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On November 2, 2018, the Company invested cash by purchasing a Senior Convertible Promissory Note in the original principal amount of $1,500,000 (the &#8220;IIU Note&#8221;) from IIU, a synergistic Virginia based travel insurance brokerage company controlled by Craven House North America, LLC (&#8220;Craven&#8221;) N.A., (whose ownership excluding unexercised warrants was approximately 20% of the Company&#8217;s outstanding stock at the time of the acquisition).&nbsp;&nbsp;The maturity date of the IIU Note was 360 dates after the date of issuance (subject to acceleration upon an event of default).&nbsp;&nbsp;The IIU Note carried a 3.0% interest rate, with accrued but unpaid interest being payable on the IIU Note&#8217;s maturity date.&nbsp;&nbsp;</p><p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January 16, 2019, the Company entered into a Stock Purchase Agreement with <font style="color:#000000;">Craven</font> (the &#8220;IIU SPA&#8221;) to purchase all of the outstanding capital stock of <font style="color:#000000;">IIU</font> as a possible synergistic effort to diversify revenue sources that were believed to be accretive to earnings.&nbsp;&nbsp;IIU provided <font style="color:#000000;">global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies were fully underwritten with no claim risk remaining with IIU.</font></p> <p style="Background-color:#FFFFFF;margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company purchased <font style="color:#000000;">100</font>% of the issued and outstanding capital stock of IIU from Craven for $5,089,357 subject to adjustment as set forth in the IIU SPA.&nbsp;&nbsp;IIU was required to have a minimum net working capital of $15,000 and at least $152,000 in cash. The Company paid the purchase price under the IIU SPA at closing as follows: </p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:6pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-top:6pt;margin-bottom:0pt;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company cancelled all principal and accrued interest of the IIU Note, which consisted of aggregate principal indebtedness and accrued interest of $1,507,375 as of January 16, 2019.</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company issued to Craven a $3,581,982 Senior Convertible Promissory Note (the &#8220;Craven Convertible Note&#8221;) for the balance of the purchase price.&nbsp;&nbsp;At the option of Craven, the Craven Convertible Note could be paid in restricted shares of our common stock or cash.&nbsp;&nbsp;The Craven Convertible Note bore simple interest at 3% per annum.&nbsp;&nbsp;The Craven Convertible Note was due and payable 360 days from the closing date of the IIU SPA. If repaid by the Company in restricted common stock, the outstanding principal and interest of the Craven Convertible Note would be paid by the Company by issuing to Craven a number of restricted common shares equal to the adjusted principal and accrued interest owing to Craven under the Craven Convertible Note divided by $2.41. On the date of issuance of the Craven Convertible Note, the closing share price of the Company was $1.42.</p></td></tr></table></div><div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Pursuant to the terms of the IIU SPA, the purchase price was subsequently reduced by $120,200, to $<font style="color:#000000;">4,969,200</font>.</p></td></tr></table></div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December 20, 2019, the Company loaned $1.5 million to Craven (&#8220;Craven Secured Promissory Note&#8221;) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly. The Company subsequently extended the due date of the Craven Secured Promissory Note to August 1, 2021.&nbsp;&nbsp; The Craven Secured Promissory Note was secured by, among other things, a pledge of Craven&#8217;s 640,000 shares of common stock of the Company and the assignment of the assets of Craven in favor of the Company. On June 29, 2020, the Company received from Craven $1,503,719 as payment in full of all principal and accrued interest due from the Craven Secured Promissory Note.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On January 8, 2020, the Company entered into a Stock Purchase Agreement (&#8220;<font style="font-weight:bold;">SPA</font>&#8221;) with Craven pursuant to which the Company sold back to Craven all of the issued and outstanding shares of IIU for $3,562,569.&nbsp;&nbsp;The purchase price was paid by Craven through the cancellation of the $3,461,782Craven Convertible Note plus forgiveness of $100,787 of accrued interest. The Company originally paid $<font style="color:#000000;">4,969,200</font> for the purchase of IIU in January 2019, which included a negative $720,386 net fair value of assets and $5,689,586 of goodwill. As a result, goodwill was impaired by $1.65 million. The sale of IIU resulted in a gain of $16,428.&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Specialty Health Insurance</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Our former subsidiary IIU Inc. (&#8220;IIU&#8221;) through its wholly owned company Wallach and Company (&#8220;Wallach&#8221;) offered health insurance, travel insurance and other travel services to:</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:6pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:6pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">United States citizens and residents traveling abroad</p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Non United States citizens or residents who travel to the United States</p></td></tr></table></div> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">These services were typically sold through a policy offered by Wallach and fully underwritten by a third party insurance company.&nbsp;&nbsp;The policies offered included:</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HealthCare Abroad - <font style="Background-color:#FFFFFF;color:#000000;">Short term medical insurance, medical evacuation and international assistance for Americans traveling overseas. There is an age limit of 84 years old.</font></p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HealthCare Global &#8211; up to 6 months coverage for Americans traveling abroad and foreign nationals traveling outside their home countries to destinations other than the United States.&nbsp;&nbsp;There is an age limit of 70 years old. </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HealthCare America &#8211; up to 90 days coverage for foreign nationals visiting the United States. There is an age limit of 70 years old. </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-bottom:0pt;margin-top:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HealthCare International &#8211; International medical insurance &amp; assistance for persons living outside their home country.&nbsp;&nbsp;There is an age limit of 70 years old. </p></td></tr></table></div> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:100%;"> <tr> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="top" style="width:3.33%;white-space:nowrap"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:'Times New Roman';font-size:15pt;line-height:11pt;">&#x2022;</p></td> <td valign="top"> <p style="margin-top:0pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">HealthCare War &#8211; up to 6 months coverage for Americans traveling abroad and foreign nationals traveling outside their home countries to identified war risk areas.&nbsp;&nbsp;There is an age limit of 70 years old. </p></td></tr></table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As such, IIU is considered a discontinued operation. <font style="color:#000000;">We did not report any activity from operations from IIU for the six months ended June 30, 2020.</font></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:11pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Entry into and Termination of Hanfor Share Exchange Agreement</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 23, 2020, the Company entered into a Share Exchange Agreement, dated March 23, 2020 (the &#8220;Share Exchange Agreement&#8221;), with <font style="color:#000000;">Hanfor (Cayman) Limited, a Cayman Islands exempted company (&#8220;Hanfor&#8221;), and BZ Industrial Limited, a British Virgin Islands business company and the sole stockholder of Hanfor (&#8220;Hanfor Owner&#8221;).</font>&nbsp;&nbsp;The Share Exchange Agreement contemplated a business combination transaction in which Hanfor Owner would transfer and assign to the Company all of the share capital of Hanfor in exchange for a number of shares of the Company&#8217;s common stock that would result in Hanfor Owner owning 86.5% of the outstanding common stock of the Company.</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the agreement, Hanfor Owner was required to deliver to the Company audited financial statements for Hanfor for the 2019 and 2018 fiscal years, and such audited financial statements were required to be delivered by May 31, 2020 (subject to extension to June 30, 2020 under specified circumstances).&nbsp;&nbsp;In connection with the execution of the Share Exchange Agreement, the Company and Hanfor Owner entered into a Stock Purchase Agreement, dated March 23, 2020, pursuant to which Hanfor Owner purchased from the Company an aggregate of 520,838 shares of the <font style="color:#000000;">Company&#8217;s</font> common stock at a price of $2.40 per share. Hanfor Owner paid $250,000 cash on March 23, 2020 and the Company received an additional $1,000,000 in April 2020 at which time the Company issued the 520,838 shares. </p><p style="margin-top:6pt;margin-bottom:6pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On July 14, 2020, the Company notified Hanfor and Hanfor Owner that the Company had elected to terminate the Share Exchange Agreement due to Hanfor&#8217;s inability to provide audited financial statements by June 30, 2020.&nbsp;&nbsp;Although the Company believes that it properly terminated the Share Exchange Agreement, on July 21, 2020, counsel to Hanfor Owner informed the Company that Hanfor Owner believes that the Company&#8217;s termination of the Share Exchange Agreement was not effected in accordance with the terms of the Share Exchange Agreement.&nbsp;&nbsp;The Company and Hanfor Owner are engaged in discussions to resolve this disagreement, but there is no assurance that this disagreement will be promptly resolved or resolved on terms favorable to the Company, and there is no assurance that Hanfor Owner will not seek to take legal action.</p><p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Nasdaq Listing</font></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On March 27, 2020, the Company received a notification letter from the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) stating that the Company has not regained compliance with Nasdaq Continued Listing Rule 5550(a)(2), which requires the Company&#8217;s listed securities to maintain a minimum bid price of $1.00 per share (the "Minimum Bid Price Rule"). The notification stated that the Company&#8217;s securities would be delisted from the Nasdaq Capital Market on April 7, 2020 unless the Company timely requested a hearing before a Nasdaq Hearing Panel.&nbsp;&nbsp;The Company has timely requested a hearing.&nbsp;&nbsp;However, on April 16, 2020, Nasdaq suspended any enforcement actions relating to bid price issues through <font style="color:#000000;">June 30, 2020. On&#160;July 1, 2020, the Company received a letter from Nasdaq stating that the Company had regained compliance with the Minimum Bid Price Rule because the closing price for the Company&#8217;s common stock was&#160;$1.00&#160;per share or greater for ten (10) consecutive business days. </font></p><p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Additionally, on January 3, 2020, the Company received a deficiency letter from Nasdaq, indicating that it was in violation of Listing Rules 5620(a) and 5810(c)(2)(G) by virtue of passing the applicable deadline for holding of its annual general meeting of shareholders for the financial year ended December 31, 2018.&nbsp;&nbsp;The Company resolved this issue by having its annual general meeting of shareholders on May 11, 2020.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Reverse Stock Split Approval</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On May 11, 2020, our shareholders voted in favor of the approval of an amendment to our Certificate of Incorporation, in the event it is deemed advisable by our Board of Directors, to effect an additional reverse stock split of the Company&#8217;s issued and outstanding common stock at a ratio within the range of one-for-two (1:2) and one-for-ten (1:10), as determined by the Board of Directors.&nbsp;&nbsp;However, a reverse stock split has not yet been effected pursuant to such approval.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="margin-top:8pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Principles of Consolidation</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The condensed consolidated financial statements include the accounts of LMFA and its wholly-owned subsidiaries: LM Funding, LLC; LMF October 2010 Fund, LLC; REO Management Holdings, LLC (including all 100% owned subsidiary limited liability companies); LM Funding of Colorado, LLC; LM Funding of Washington, LLC; LM Funding of Illinois, LLC; and LMF SPE #2, LLC and various single purpose limited liability corporations owned by REO Management Holdings, LLC which own various properties. It also includes IIU and its wholly-owned subsidiary: Wallach &amp; Company for the time that the Company owned IIU. All significant intercompany balances have been eliminated in consolidation.</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Basis of Presentation</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (&#8220;SEC&#8221;). Certain information and note disclosures normally included in the annual consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. The interim condensed consolidated financial statements as of June 30, 2020 and for the three and six months ended June 30, 2020 and June 30, 2019, respectively are unaudited. In the opinion of management, the interim condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary to provide a fair statement of the results for the interim periods. The accompanying condensed consolidated balance sheet as of December 31, 2019, is derived from the audited consolidated financial statements presented in the Company&#8217;s Annual Report on Form 10-K for fiscal the year ended December 31, 2019.</p><p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Use of Estimates</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the evaluation of any probable losses on amounts funded under the Company&#8217;s <font style="font-style:italic;">New Neighbor Guaranty</font> program as disclosed below, the evaluation of probable losses on balances due from a related party, the realization of deferred tax assets, the evaluation of contingent losses related to litigation and fair value estimates of real estate assets owned.</p><p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">We are not presently aware of any events or circumstances arising from the COVID-19 pandemic that would require us to update our estimates or judgments or revise the carrying value of our assets or liabilities. Our estimates may change, however, as new events occur and additional information is obtained, and any such changes will be recognized in the condensed consolidated financial statements.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Revenue Recognition</font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Accounting Standards Codification<font style="font-style:normal;">&#160;(&#8220;ASC&#8221;) 606 of the Financial Accounting Standards Board (&#8220;FASB&#8221;) states </font><font style="font-style:normal;color:#000000;">an entity needs to conclude at the inception of the contract that collectability of the consideration to which it will be entitled in exchange for the goods and services that will be transferred to the customer is probable. </font><font style="font-style:normal;"> </font><font style="font-style:normal;color:#000000;">That is, in some circumstances, an entity may not need to assess its ability to collect all of the consideration in the contract. </font><font style="font-style:normal;">The Company provides funding to community associations by purchasing their rights under delinquent accounts from unpaid assessments due from property owners (the &#8220;accounts&#8221;). Collections on the accounts may vary greatly in both the timing and amount ultimately recovered compared with the total revenues earned on the accounts because of a variety of economic and social </font><font style="font-style:normal;color:#000000;">factors affecting the real estate environment in general. The Company&#8217;s contracts with its customers have very specific performance obligations.&nbsp;&nbsp;The Company has determined that the known amount of cash to be realized or realizable on its revenue generating activities cannot be reasonably estimated.&nbsp;&nbsp;</font><font style="font-style:normal;">The Company determined rental income from leasing arrangements is specifically excluded from the standard.&#160; The Company analyzed its remaining revenue streams and concluded there were no changes in revenue recognition with the adoption of the new standard.</font></p><p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under ASC 606, the Company applies the cash basis method to its original product and the cost recovery method to its special product as follows:</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Finance Receivables&#8212;Original Product<font style="font-style:normal;">: Under the Company&#8217;s original product, delinquent assessments are funded only up to the Super Lien Amount as discussed above. Recoverability of funded amounts is generally assured because of the protection of the Super Lien Amount. As such, payments by unit owners on the Company&#8217;s original product are recorded to income when received in accordance with the provisions of the Florida Statute (718.116(3))&#160;and the provisions of the purchase agreements entered into between the Company and community associations. Those provisions require that all payments be applied in the following order: first to interest, then to late fees, then to costs of collection, then to legal fees expended by the Company and then to assessments owed. In accordance with the cash basis method of recognizing revenue and the provisions of the statute, the Company records revenues for interest and late fees when cash is received. In the event the Company determines the ultimate collectability of amounts funded under its original product are in doubt, payments are applied to first reduce the funded or principal amount.</font></p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Finance Receivables&#8212;Special Product (New Neighbor Guaranty program)<font style="font-style:normal;">: During 2012, the Company began offering associations an alternative product under the </font>New Neighbor Guaranty<font style="font-style:normal;"> program where the Company will fund amounts in excess of the Super Lien Amount. Under this special product, the Company purchases substantially all of the delinquent assessments owed to the association, in addition to all accrued interest and late fees, in exchange for payment by the Company of (i)&#160;a negotiated amount or (ii)&#160;on a going forward basis, all monthly assessments due for a period up to 48 months. Under these arrangements, the Company considers the</font> collection of amounts funded is not assured and under the cost recovery method, cash collected is applied to first reduce the carrying value of the funded or principal amount with any remaining proceeds applied next to interest, late fees, legal fees, collection costs and any amounts due to the community association. Any excess proceeds still remaining are recognized as revenues. If the future proceeds collected are lower than the Company&#8217;s funded or principal amount, then a loss is recognized.</p><p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-style:italic;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;text-transform:none;font-variant: normal;">Net Commission Revenue:<font style="font-style:normal;">&#160;The Company acted as an agent in providing health travel insurance policies. As a result, the Company revenue was recorded at net. The Company has determined that the known amount of cash to be realized or realizable on its revenue generating activities can be reasonably estimated and as such, classifies its receivables as accrual and recognizes revenues in the accompanying statements of income on the accrual basis.&nbsp;&nbsp;If a policy is not effective as of the end of a period, then the associated revenue and underwriting costs are deferred until the effective date.</font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Cash</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company maintains cash balances at several financial institutions that are insured under the Federal Deposit Insurance Corporation&#8217;s (&#8220;FDIC&#8221;) Transition Account Guarantee Program. Balances with the financial institutions may exceed federally insured limits.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Finance Receivables</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance receivables are recorded at the amount funded or cost (by unit). The Company evaluates its finance receivables at each period end for losses that are considered probable and can be reasonably estimated in accordance with ASC 450-20. As discussed above, recoverability of funded amounts under the Company&#8217;s original product is generally assured because of the protection of the Super Lien Amount. However, the Company did have an accrual at June 30, 2020 and December 31, 2019 for an allowance for credit losses for this program of $112,027 and $112,027. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under the&#160;<font style="font-style:italic;">New Neighbor Guaranty</font>&#160;program (special product), the Company funds amounts in excess of the Super Lien Amount. When evaluating the carrying value of its finance receivables, the Company looks at the likelihood of future cash flows based on historical payoffs, the fair value of the underlying real estate, the general condition of the community association in which the unit exists, and the general economic real estate environment in the local area.&#160;The Company estimated an allowance for credit losses for this program of $6,564 as of&#160;June 30, 2020 and $20,016 at December&#160;31, 2019 under ASC 450-20 related to its New Neighbor Guaranty program.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company will charge any receivable against the allowance for credit losses when management believes the collectability of the receivable is confirmed. The Company considers writing off a receivable when (i) a first mortgage holder who names the association in a foreclosure suit takes title and satisfies an estoppel letter for amounts owed which are less than amounts the Company funded to the association; (ii) a tax deed is issued with insufficient excess proceeds to pay amounts the Company funded to the association; (iii) an association settles an account for less than amounts the Company funded to the association or (iv) the association terminates its relationship with the Company&#8217;s designated legal counsel. Upon the occurrence of any of these events, the Company evaluates the potential recovery via a deficiency judgment against the prior owner and the ability to collect upon the deficiency judgment within the statute of limitations period or whether the deficiency judgment can be sold. If the Company determines that collection through a deficiency judgment or sale of a deficiency judgment is not feasible, the Company writes off the unrecoverable receivable amount. Any losses greater than the recorded allowance will be recognized as expenses. Under the Company&#8217;s revenue recognition policies, all finance receivables (original product and special product) are classified as nonaccrual.</p><p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the six months ended June 30, 2020 and 2019, write offs charged against the allowance for credit losses were $13,452 and $20,743, respectively. Any losses greater than the recorded allowance will be recognized as expenses. Under the Company&#8217;s revenue recognition policies, all finance receivables (original product and special product) are classified as nonaccrual.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Real Estate Assets Owned</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event collection of a delinquent assessment results in a unit being sold in a foreclosure auction, the Company has the right to bid (on behalf of the community association) for the delinquent unit as attorney in fact, applying any amounts owed for the delinquent assessment to the foreclosure price as well as any additional funds that the Company, in its sole discretion, decides to pay. If a delinquent unit becomes owned by the community association by acquiring title through an association lien foreclosure auction, by accepting a deed-in-lieu of foreclosure, or by any other way, the Company in its sole discretion may direct the community association to quitclaim title of the unit to the Company.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Properties quitclaimed to the Company are in most cases acquired subject to a first mortgage or other liens, and are recognized in the accompanying consolidated balance sheets solely at costs incurred by the Company in excess of original funding. At times, the Company will acquire properties through foreclosure actions free and clear of any mortgages or liens.&#160;In these cases, the Company records the estimated fair value of the properties in accordance with ASC 820-10,&#160;<font style="font-style:italic;">Fair Value Measurements</font>. Any real estate held for sale is adjusted to fair value less the cost to dispose in the event the carrying value of a unit or property exceeds its estimated net realizable value.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company capitalizes costs incurred to acquire real estate owned properties and any costs incurred to get the units in a condition to be rented.&#160;&#160;These costs include, but are not limited to, renovation/rehabilitation costs, legal costs, and delinquent taxes.&#160;&#160;These costs are depreciated over the estimated minimum time period the Company expects to maintain possession of the units.&#160;&#160;Costs incurred for unencumbered units are depreciated over 20 years and costs for units subject to a first mortgage are depreciated over 3 years.&#160;&#160;As of June 30, 2020 and December 31, 2019, capitalized real estate costs, net of accumulated depreciation, were $13,426 and $21,084, respectively.&#160;&#160;</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the three and six month period ended June 30, 2020 and 2019, depreciation expense was $4,110 and $9,713 for 2020 and $5,526 and $11,969 for 2019, respectively.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the Company elects to take a quitclaim title to a unit or property held for sale, the Company is responsible to pay all future assessments on a current basis, until a change of ownership occurs. The community association must allow the Company to lease or sell the unit to satisfy obligations for delinquent assessments of the original debt. All proceeds collected from any sale of the unit shall be first applied to all amounts due the Company plus any additional funds paid by the Company to purchase the unit, if applicable. Rental revenues and sales proceeds related to real estate assets held for sale are recognized when earned and realizable. Expenditures for current assessments owed to associations, repairs and maintenance, utilities, etc. are expensed when incurred.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">If the community association elects (prior to the Company obtaining title through its own election) to maintain ownership and not quitclaim title to the Company, the community association must pay the Company all interest, late fees, collection costs, and legal fees expended, plus the original funding on the unit, which have accrued according to the purchase agreement entered into by the community association and the Company. In this event, the unit will be reassigned to the community association.<font style="color:#000000;"> </font></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Fixed Assets</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company capitalizes all acquisitions of fixed assets in excess of $500. Fixed assets are stated at cost. Depreciation is provided on the straight-line method over the estimated useful lives of the assets. Fixed assets are comprised of furniture, computer and office equipment with an assigned useful life of 3 to 5 years. Fixed assets also include capitalized software costs. Capitalized software costs include costs to develop software to be used solely to meet the Company&#8217;s internal needs, consist of employee salaries and benefits and fees paid to outside consultants during the application development stage, and are amortized over their estimated useful life of 5 years. As of June 30, 2020 and December 31, 2019, capitalized software costs, net of accumulated amortization, was nil. Amortization expense for capitalized software costs for the three and six month period ended June 30, 2020 and 2019 was $nil and $nil for 2020 and $5,815 and $11,630 for 2019, respectively.&#160;</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Right to Use Assets</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company capitalizes all leased assets pursuant to <font style="color:#000000;">ASU 2016-02, "Leases (Topic 842)," which requires lessees to recognize right-of-use assets and lease liability, initially measured at present value of the lease payments, on its balance sheet for leases with terms longer than 12 months and classified as either financing or operating leases.&nbsp;&nbsp;</font>As of June 30, 2020 and December 31, 2019, right to use assets, net of accumulated amortization, was $209,031 and $260,260, respectively. Amortization expense for right to use assets for the three and six month period ended June 30, 2020 and 2019 was $26,136 and $51,229 for 2020 and was $2,426 and $4,852 for 2019, respectively while the payments totaled $45,742 for the six months ended June 30, 2020.&#160;</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Other Investments &#8211; Note Receivable - Related Party</font></p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On December 20, 2019, the Company loaned $1.5 million to Craven (&#8220;Craven Secured Promissory Note&#8221;) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly. The Company subsequently extended the due date of the Craven Secured Promissory Note to August 1, 2021 and allowed for the deferral of monthly interest payments.&nbsp;&nbsp; The Craven Secured Promissory Note was secured by, among other things, Stock Pledge of Craven&#8217;s 640,000 Common Shares of the Company and the Assignment of the assets of Craven in favor of the Company. On June 29, 2020, the Company received from Craven $1,503,719 as payment in full of all principal and accrued interest due from the Craven Secured Promissory Note.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Goodwill</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">Goodwill represents the excess purchase price of acquired businesses over the fair value of the net assets acquired. Goodwill is not amortized, but instead is tested for impairment annually </font><font style="color:#000000;">or whenever events or changes in circumstances indicate that the carrying amount may not be fully recoverable.</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the year ended December 31, 2019, the Company recorded goodwill of approximately $5.7 million which represented amounts for the purchase of IIU. For purposes of the&#160;2019&#160;annual test, we will elect to perform a goodwill impairment analysis to assess whether it was more likely than not that the fair value of these reporting units exceeded their respective carrying values. In performing these assessments, management will rely on a number of factors including, but not limited to, macroeconomic conditions, industry and market considerations, cost factors that would have a negative effect on earnings and cash flows, overall financial performance compared with forecasted projections in prior periods, and other relevant reporting unit events, the impact of which are all significant judgments and estimates.&nbsp;&nbsp;This assessment was performed as of December 31, 2019 and showed a $1.65 million impairment due to the sale of IIU on January 8, 2020. The balance of goodwill as of June 30, 2020 and December 31, 2019 was approximately $0 million and $4.0 million, respectively.<font style="font-size:12pt;color:#000000;">&#160;</font></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Stock Issued</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In connection with the execution of the Share Exchange Agreement, the Company and Hanfor Owner entered into a Stock Purchase Agreement, dated March 23, 2020, pursuant to which Hanfor Owner purchased from Company an aggregate of 520,838 shares of the <font style="color:#000000;">Company&#8217;s</font> common stock at a price of $2.40 per share for a total of $1,250,000 cash.&nbsp;&nbsp; &nbsp;&nbsp;&nbsp;&nbsp; </p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company capitalizes all debt issue costs and amortizes them on a method that approximates the effective interest method over the remaining term of the note payable. <font style="color:#000000;">The Company did not have any unamortized debt issue costs at June 30, 2020 and</font><font style="font-size:12pt;">&#160;</font><font style="color:#000000;">at December 31, 2019. Any costs will be presented in the accompanying condensed consolidated balance sheets as other assets until the loan proceeds are received which at that time will be reclassified as a direct deduction from the carrying amount of that debt liability in accordance with Accounting Standards Update (&#8220;ASU&#8221;) 2015-03 (see below).&#160;The Company adopted this new standard in the first quarter of fiscal 2016. The adoption of this standard did not have a material impact on the Company's consolidated financial position and had no impact on its consolidated income or cash flows. In addition, the amortization of debt issuance costs is to be reported as interest expense under</font><font style="color:#000000;">&#160;</font><font style="color:#000000;">ASU 2015-03 (ASC 835-30-45-3).&#160;&#160;</font><font style="font-size:12pt;">&#160;&#160;</font></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Settlement Costs with Associations</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Community associations working with the Company will at times incur costs in connection with litigation initiated by the Company against property owners and or mortgage holders. These costs include settlement agreements whereby the community association agrees to pay some monetary compensation to the opposing party or judgments against the community associations for fees of opposing legal counsel or other damages awarded by the courts. The Company indemnifies the community association for these costs pursuant to the provisions of the agreement between the Company and the community association. Costs incurred by the Company for these indemnification obligations for the three and six months ended June 30, 2020 and 2019 were approximately $zero&nbsp;&nbsp;and $12,000 for 2020 and $38,000&nbsp;&nbsp;and $40,000 for 2019, respectively. The Company does not limit its indemnification based on amounts ultimately collected from property owners.&nbsp;&nbsp;</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Income Taxes</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income taxes are provided for the tax effects of transactions reported in the consolidated financial statements and consist of taxes currently due plus deferred taxes resulting primarily from the tax effects of temporary differences between financial and income tax reporting. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:12pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Under ASC 740-10-30-5, <font style="font-style:italic;">Income Taxes</font>, deferred tax assets should be reduced by a valuation allowance if, based on the weight of available evidence, it is more-likely-than-not (i.e., a likelihood of more than 50%) that some portion or all of the deferred tax assets will not be realized. The Company considers all positive and negative evidence available in determining the potential realization of deferred tax assets including, primarily, the recent history of taxable earnings or losses. Based on operating losses reported by the Company during 2018, 2017 and 2016, the Company concluded there was not sufficient positive evidence to overcome this recent operating history. As a result, the Company believes that a valuation allowance was necessary based on the more-likely-than-not threshold noted above. During the year ended December 31, 2019, the Company decreased the valuation allowance to $3,634,857 to reflect a change in deferred tax assets.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Loss Per Share</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Basic loss per share is calculated as net loss to common stockholders divided by the weighted average number of common shares outstanding during the period.&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company issued 2,500,000 shares at various times during the month of November 2018 and has weighted average these new shares in calculating loss per share.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On October 15, 2018, the Company effected a common share consolidation (&#8220;Reverse Stock Split&#8221;) by means of a one-for-ten (1:10) reverse split of its outstanding common stock, par value $0.001 per share which resulted in a decrease in outstanding common stock to 625,318 shares.&nbsp;&nbsp;<font style="color:#000000;">The Reverse Stock Split became effective on October 16, 2018 and the Company&#8217;s common stock began trading on The Nasdaq Global Market on a split-adjusted basis on October 16, 2018.</font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has restated all share amounts to reflect the Reverse Stock Split.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Diluted loss per share for the period equals basic loss per share as the effect of any convertible notes, stock based compensation awards or stock warrants would be anti-dilutive.&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The anti-dilutive stock based compensation awards and convertible notes consisted of:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="top" style="width:40%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="top" style="width:1%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td colspan="3" valign="bottom" style="width:14%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of June 30,</p></td> </tr> <tr> <td valign="top" style="width:40%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="top" style="width:1%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="bottom" style="width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="bottom" style="width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="width:40%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock Options</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:14%; border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:14%; border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> </tr> <tr> <td valign="top" style="width:40%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock Warrants</p></td> <td valign="top" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:14%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,731,587</p></td> <td valign="top" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:14%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,959,287</p></td> </tr> <tr> <td valign="top" style="width:40%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Convertible Note</p></td> <td valign="top" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:14%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:14%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As part of its initial public offering, o<font style="color:#000000;">n October 23, 2015 the Company issued 1,200,000 warrants that allowed for the right to purchase 1,200,000 shares of common stock at an average exercise price of $12.50 per share. Due to the Reverse Stock Split on October 16, 2018, each warrant may only purchase one-tenth of one share of common stock at $12.50. These warrants have weighted average price of $12.50 per share and a weighted average remaining life of .44 years and .94 years as of June 30, 2020 and December 31, 2019, respectively. These warrants expire in the year 2020.&nbsp;&nbsp;</font>The aggregate intrinsic value of the outstanding common stock warrants as of June 30, 2020 and December 31, 2019 was $0 and $0, respectively.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On October 31, 2018, the Company issued warrants as part of its secondary offering that allowed for the right to purchase 2,500,000 shares of common stock at an exercise price of $2.40 per share. These warrants expire in the year 2023.&nbsp;&nbsp;During the six months ended June 30, 2020, warrants for 1,277,700 shares were exercised for $2,946,480.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As part of its underwriting agreement dated, <font style="color:#000000;">October 31, 2018, the Company issued additional warrants, effective May 1, 2019, to its underwriter as part of its secondary offering that allowed for the right to purchase 125,000 shares of common stock at an exercise price of $2.64 per share on or after May 1, 2019. These warrants expire on May 2, 2022.</font></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">On April 2, 2018, the Company issued warrants that allowed for the right to purchase 40,000 shares of common stock at an exercise price of $6.605 per share. If the Company, at any time this warrant is outstanding, combines its outstanding shares of Common Stock into a smaller number of shares or enters into a corporate action or transaction to change the number of outstanding share of common stock, then the exercise price is adjusted along with the number of shares that can be purchased under this agreement. Due to the subsequent issuance of stock and warrants on October 31, 2018, these warrants now have the right to purchase 143,587 shares at an exercise price of $1.84 per share. These warrants expire in the year 2023.&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">A senior secured convertible note to Craven House Capital North America LLC (Related Party), bearing interest at 3.0% was issued on January 16, 2019 and matures on either January 14, 2020 or convertible into 1,436,424 shares of the Company's common shares.<font style="color:#000000;"> On January 8, 2020, the Company entered into a Stock Purchase Agreement (&#8220;</font><font style="font-weight:bold;color:#000000;">SPA</font><font style="color:#000000;">&#8221;) with Craven pursuant to which the Company sold to Craven all of the issued and outstanding shares of IIU, Inc., a Virginia based travel insurance brokerage company and wholly owned subsidiary of LMFA (&#8220;IIU&#8221;), for $3,562,569.&nbsp;&nbsp;The purchase price was paid by Craven through the cancellation of the $3,461,782 Craven Convertible Note issued by LMFA to Craven dated January 16, 2019 plus forgiveness of $100,787 of accrued interest. </font>LMFA <font style="color:#000000;">originally paid $</font>4,969,200 for the purchase of IIU in January 2019, which included a negative $720,386 net fair value of assets and $5,689,586 of goodwill. The sale of IIU resulted in a gain of $16,428.&nbsp;&nbsp;<font style="color:#000000;"> </font></p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Stock-Based Compensation</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company records all equity-based incentive grants to employees and non-employee members of the Company&#8217;s Board of Directors in operating expenses in the Company&#8217;s Consolidated Statements of Operations based on their fair values determined on the date of grant. Stock-based compensation expense, reduced for estimated forfeitures, is recognized on a straight-line basis over the requisite service period of the award, which is generally the vesting term of the outstanding equity awards. </p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Contingencies</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company accrues for contingent obligations, including estimated legal costs, when the obligation is probable and the amount is reasonably estimable. As facts concerning contingencies become known, the Company reassesses its position and makes appropriate adjustments to the consolidated financial statements. Estimates that are particularly sensitive to future changes include those related to tax, legal and other regulatory matters. &nbsp;&nbsp;&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Fair Value of Financial Instruments </font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">FASB ASC 825-10, Financial Instruments, requires disclosure of fair value information about financial instruments, whether or not recognized in the balance sheet. The Company engages a third-party valuation firm to assist in estimating the fair value of its finance receivables. </font></p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Risks and Uncertainties </font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Funding amounts are secured by a priority lien position provided under Florida law (see discussion above regarding Florida Statute 718.116). However, in the event the first mortgage holder takes title to the property, the amount payable by the mortgagee to satisfy the priority lien is capped under this same statute and would generally only be sufficient to reimburse the Company for funding amounts noted above for delinquent assessments. Amounts paid by the mortgagee would not generally reimburse the Company for interest, administrative late fees and collection costs. Even though the Company does not recognize these charges as revenues until collected, its business model and long-term viability is dependent on its ability to collect these charges.&nbsp;&nbsp;</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In the event a delinquent unit owner files for bankruptcy protection, the Company may at its option be reimbursed by the association for the amounts funded (i.e., purchase price) and all collection rights are re-assigned to the association.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Non-cash Financing and Investing Activities</font></p> <p style="margin-bottom:0pt;margin-top:6pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the six months ended June 30, 2020 and 2019, the Company acquired unencumbered title to certain properties as a result of foreclosure proceedings.&#160;&#160;Properties were recorded at fair value less cost to dispose of approximately $0 and $0, respectively.&#160;&#160;The fair value of these properties was first applied to recover the Company&#8217;s initial investment with any remaining proceeds applied to interest, late fees, and other amounts owed by the property owner.</p> <p style="margin-bottom:0pt;margin-top:12pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">During the six months ended June 30, 2020, the Company disposed of IIU which included assets and liabilities listed in Note 10.&nbsp;&nbsp;</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Recent Accounting Pronouncements</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">In June 2016, the FASB issued ASU 2016-13, <font style="font-style:italic;">Financial Instruments - Credit Losses,</font> which establishes a new approach for credit impairment based on an expected loss model rather than an incurred loss model. The standard requires the consideration of all available relevant information when estimating expected credit losses, including past events, current conditions and forecasts and their implications for expected credit losses.&nbsp;&nbsp;The guidance is effective January 1, 2020 with a one-year early adoption permitted.&nbsp;&nbsp;<font style="color:#000000;">We adopted this new standard on January 1, 2020 and determined that this did not impact our consolidated financial statements.</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Recent accounting guidance not discussed above is not applicable, did not have, or is not expected to have a material impact to the Company.</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;font-style:italic;color:#000000;font-family:Times New Roman;font-size:10pt;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Reclassifications</font></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:6pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Certain prior period amounts have been reclassified to conform to the current period presentation.</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Subsequent Events</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The Company has evaluated subsequent events through the date which the condensed consolidated financial statements were issued.&#160; </p> The anti-dilutive stock based compensation awards and convertible notes consisted of: <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="top" style="width:40%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="top" style="width:1%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td colspan="3" valign="bottom" style="width:14%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of June 30,</p></td> </tr> <tr> <td valign="top" style="width:40%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="top" style="width:1%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="bottom" style="width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" style="width:1%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="bottom" style="width:14%; border-top:solid 0.75pt #000000; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="width:40%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock Options</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:14%; border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:14%; border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> </tr> <tr> <td valign="top" style="width:40%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Stock Warrants</p></td> <td valign="top" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:14%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,731,587</p></td> <td valign="top" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:14%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,959,287</p></td> </tr> <tr> <td valign="top" style="width:40%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Convertible Note</p></td> <td valign="top" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:14%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style="width:1%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:14%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table summarizes the approximate consideration paid and the amounts of the identified assets acquired and liabilities assumed at the acquisition date:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:60%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.9%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:25.44%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">January 16, 2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.4%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total adjusted purchase price </p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,969,200</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Recognized preliminary amounts of identifiable assets acquired and (liabilities assumed), at fair value:</p></td> <td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51,300</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid and other current assets</p></td> <td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,200</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Profit on purchased policies</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,600</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Property, plant and equipment</p></td> <td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">17,100</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(5,100</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued expenses and other liabilities</p></td> <td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(62,686</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income taxes</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(28,500</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Deferred revenue</p></td> <td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(9,300</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.9%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(703,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.4%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:72.9%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Preliminary estimate of the fair value of assets and liabilities assumed</p></td> <td valign="top" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(720,386</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.4%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.9%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.4%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:72.9%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Goodwill</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:2.54%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.9%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5,689,586</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.26%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.4%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><font style="Background-color:#FFFFFF;">The Company&#8217;s original funding product provides financing to community associations only up to the secured or &#8220;Super Lien Amount&#8221; as discussed in Note 1.&nbsp;&nbsp;Finance receivables for the original product as of June 30, 2020 and December 31, 2019 based on the year of funding are approximately as follows:</font></p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019&#160;(Audited)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Funded during the current year</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">40,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1-2 years outstanding</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">15,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2-3 years outstanding</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3-4 years outstanding</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">18,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Greater than 4 years outstanding</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">267,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">300,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">324,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">386,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Reserve for credit losses</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(112,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(112,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">212,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">274,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number of active units with delinquent assessments</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">511</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">598</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Amount of outstanding interest and late fees on active units</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">8,727,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,167,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Delinquent assessments and accrued charges under these arrangements as of June 30, 2020 and December 31, 2019, are as follows:&#160;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019&#160;(Audited)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Finance receivables, net</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">129,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Delinquent assessments</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">209,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">374,000</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accrued interest and late fees</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">91,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">235,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Number of active units with delinquent assessments</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">24</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">31</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">June 30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.88%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">December&#160;31,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019&#160;(Audited)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Financing agreement with FlatIron capital that is unsecured.&nbsp;&nbsp;Down payment of $19,170 was required upfront and equal installment payments of $11,590 to be made over a 11 month period. The note matures June 1, 2020. Annualized interest is 6.8%</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">69,540</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Promissory note issued by a financial institution, bearing interest at 1.0%, interest and no principal payments.&nbsp;&nbsp; The note matures April 30, 2022. Annualized interest is 1.0%. This is a U.S. Small Business Administration&#8217;s Paycheck Protection Program (the &#8220;PPP Loan&#8221;)</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">185,785</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Senior secured convertible note to Craven House Capital North America LLC (Related Party), bearing interest at 3.0%.&nbsp;&nbsp;Note was issued on January 16, 2019 and either matured on January 14, 2020 or became convertible into 1,436,424 shares of the Company's common shares. The value of the beneficial conversion feature as of January 16, 2019 was zero*.</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,461,782</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Promissory note issued by a financial institution, bearing interest at 9.09%, interest and principal payments due monthly of $323.&nbsp;&nbsp;Note is secured by an automobile and was issued on July 26, 2019 with original borrowings of $12,892.&nbsp;&nbsp;The note matures on August 26, 2023.</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,802</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:66.98%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Promissory note issued by a financial institution, bearing interest at 5.85%, interest and principal payments due monthly of $10,932. Note was issued on May 31, 2018 with original borrowings of $608,000 and subsequent borrowings of $141,000 and repayments of $51,000.&nbsp;&nbsp;The note matures on May 30, 2025 and can be prepaid at any time without penalty. This note is secured by the Company&#8217;s inventory, chattel paper, accounts, equipment and general intangible intangibles and deposit accounts.</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">606,454</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:66.98%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">185,785</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.88%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">4,149,578</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;"><br /></p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">As of June 30, 2020, minimum annual principal payments are as follows:</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.1%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Years Ending</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.7%;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.1%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">December 31,</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.7%;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:9pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.1%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.7%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.1%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.7%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.1%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.7%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">185,785</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.1%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2023</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.7%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:80.1%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2024</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.8%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.7%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.88%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.1%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">After 2024</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.7%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:80.1%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.8%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.52%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.7%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">185,785</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.88%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents components of lease expense excluding discontinued operations for the three and six months ended June 30, 2020 and 2019:</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:76.5%;"> <tr> <td valign="top" style="width:49.86%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:9pt;">&nbsp;</p></td> <td valign="top" style="width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="top" style="width:13.26%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three&#160;Months</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="top" style="width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:9pt;">&nbsp;</p></td> <td valign="top" style="width:10.6%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six&#160;Months</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="top" style="width:13.26%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three&#160;Months</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td valign="top" style="width:10.6%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six&#160;Months</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Ended</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">June 30,</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;font-size:9pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="width:49.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Operating lease expense</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:13.26%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,377</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:1.22%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="top" bgcolor="#CFF0FC" style="width:10.6%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,109</p></td> <td valign="top" bgcolor="#CCECFF" style="width:13.26%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:1.11%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,457</p></td> <td valign="top" bgcolor="#CCECFF" style="width:10.6%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:1.11%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97,301</p></td> </tr> <tr> <td valign="top" style="width:49.86%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="top" style="width:1.22%; border-bottom:double 2.5pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="top" style="width:13.26%; border-bottom:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">20,377</p></td> <td valign="top" style="width:1.22%; border-bottom:double 2.5pt #000000;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="top" style="width:10.6%; border-bottom:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">50,109</p></td> <td valign="top" style="width:13.26%; border-bottom:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:1.11%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">38,457</p></td> <td valign="top" style="width:10.6%; border-bottom:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;margin-right:1.11%;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">97,301</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&#160;</p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents supplemental balance sheet information related to operating leases as of June 30, 2020 and December 31, 2019<font style="color:#000000;">:</font></p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Balance Sheet Line Item</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.1%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">As of June 30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.1%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Assets</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ROU assets</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Right of use asset, net</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">209,031</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">260,260</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.64%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease assets</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.96%; border-bottom:double 2.5pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">209,031</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">260,260</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Liabilities</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Current lease liabilities</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease liability</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">98,846</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">94,235</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Long-term lease liabilities</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Lease liability</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">121,295</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">171,648</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.64%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total lease liabilities</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.96%; border-bottom:double 2.5pt transparent;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">220,141</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">265,883</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average remaining lease term (in years)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.13</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.60</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Weighted-average discount rate</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.55</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.55</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">%</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents supplemental cash flow information and non-cash activity related to operating leases for the six months ended June 30, 2020 and 2019:</p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:70%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:44.64%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:17.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.1%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Six Months Ended June 30, 2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.1%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Six Months Ended June 30, 2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.7%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Operating cash flow information</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash paid for amounts included in the measurement of lease liabilities</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(45,742</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(4,426</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Supplemental Disclosure of non-cashflow information</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:44.64%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">ROU assets and operating lease obligation recognized</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:17.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:14.1%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">26,685</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.7%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following table presents maturities of operating lease liabilities on an undiscounted basis as of June 30, 2020:</p> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:38.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;white-space:nowrap;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.92%;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:38.58%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:15.52%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:12.92%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Operating Leases</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.92%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:38.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2020 (excluding the six months ended June 30, 2020)</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">48,493</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:38.58%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2021</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:15.52%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">103,646</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.92%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.46%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:13.56%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:38.58%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2022</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:15.52%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">68,002</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.92%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.56%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="top" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:38.58%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:15.52%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.92%; border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">220,141</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.92%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.46%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:13.56%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-top:2pt;margin-bottom:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following is a summary of the stock option plan activity during the six months ended June 30, 2020 and 2019:</p> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:70%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:22.98%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.32%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.72%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.74%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.72%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.74%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Options</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.54%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options Outstanding at Beginning of the year</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60.51</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60.51</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Adjustment</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.28%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.72%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options Outstanding at June 30,</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60.51</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">19,300</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">60.51</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:50.28%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.76%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.78%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.08%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.72%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:50.28%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Options Exercisable at June 30,</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">11,800</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.76%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">84.49</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.78%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.96%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:8.78%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">7,634</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:1.08%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.96%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.54%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.98%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113.81</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.72%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:1pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-family:Times New Roman;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;"><font style="text-decoration:underline;">Warrants</font></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-weight:bold;;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The following is a summary of the warrant activity during the six months ended June 30, 2020 and 2019:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <div> <table border="0" cellspacing="0" cellpadding="0" align="center" style="border-collapse:collapse; width:71.96%;"> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.26%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2020</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="6" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:23.62%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">2019</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.3%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Number of</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-top:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Weighted Average</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Warrants</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.34%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.6%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Calibri;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:11.56%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Warrants</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.66%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:solid 0.75pt transparent;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td colspan="2" valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.76%; border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Exercise Price</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.3%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants Outstanding at Beginning of the year</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,959,287</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.36</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,843,587</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.44</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Granted</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">125,000</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.64</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Exercised</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">1,227,700</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.40</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,300</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2.40</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:13.7pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Forfeited</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.32%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.34%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.6%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.66%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-family:Times New Roman;font-size:10pt;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:solid 0.75pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-bottom:solid 0.75pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.3%; border-bottom:solid 0.75pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-top:solid 0.75pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:48.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Warrants Outstanding at June 30,</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:3.32%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,731,587</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.34%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.6%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">6.83</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.28%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">3,959,287</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.66%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.62%; border-bottom:double 2.5pt transparent;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-bottom:double 2.5pt #000000;white-space:nowrap;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">5.36</p></td> <td valign="bottom" bgcolor="#CFF0FC" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;width:0.3%; border-bottom:double 2.5pt transparent;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> <tr> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:48.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:3.32%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.34%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.6%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.28%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.28%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:11pt;font-family:Calibri;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.06%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:10.48%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.66%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.62%;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:1.5%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:9.26%; border-top:double 2.5pt #000000;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> <td valign="bottom" bgcolor="#FFFFFF" style="padding-left:0pt;padding-Right:0.75pt;padding-Top:0.75pt;padding-Bottom:0pt;width:0.3%;white-space:nowrap;"> <p style="margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The impact of this transaction is reflected as a discontinued operation in the consolidated financial statements. Pursuant to ASU 2014-08, the major classes <font style="Background-color:#FFFFFF;">of assets and liabilities of IIU were as follows:</font></p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:67.67%;"> <tr> <td style="width:55.17%;"></td> <td style="width:12.5%;"></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">As of December 31, 2019</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Major classes of assets</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Cash</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp; 246,914</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Related party receivable</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,738</p></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Prepaid expenses</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">2,301</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total major classes of current assets &#8211; discontinued assets</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">276,953</p></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Fixed assets, net</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">27,245</p></td> </tr> <tr> <td valign="top" style=" border-bottom:double 2.5pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total major classes of assets &#8211; discontinued assets</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp; 304,198</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style=" border-top:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Accounts payable and accrued expenses</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp; 144,006</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Note payable &#8211; short term</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,672</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other liabilities</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">21,153</p></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Income taxes payable</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">14,226</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total major classes of current liabilities &#8211; discontinued liabilities</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">280,057</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Debt</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">517,584</p></td> </tr> <tr> <td valign="top" style=" border-bottom:double 2.5pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total major classes of liabilities - discontinued liabilities</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000; border-bottom:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp; 797,641</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style=" border-top:double 2.5pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> </table></div> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The operating results for IIU, Inc. have been presented in the accompanying consolidated financial statements of operations for the three and six months ended June 30, 2020 and 2019 as discontinued operations are summarized below:</p> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;text-indent:0%;font-size:10pt;">&nbsp;</p> <div align="left"> <table border="0" cellspacing="0" cellpadding="0" style="border-collapse:collapse; width:102%;"> <tr> <td style="width:53.3%;"></td> <td style="width:12.01%;"></td> <td style="width:12.01%;"></td> <td style="width:12.34%;"></td> <td style="width:12.34%;"></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended June 30, 2020</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Three Months Ended June 30, 2019</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:10pt;">&nbsp;</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six Months Ended June 30, 2020</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;;font-size:10pt;">&nbsp;</p> <p style="text-align:center;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-weight:bold;color:#000000;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Six Months Ended June 30, 2019</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Revenue</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;181,391</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; 280,159</p></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Total operating costs and expenses</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">100,511</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">327,377</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gain (Loss) from discontinued operations</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">80,880</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(47,218)</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Other expense, net</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">9,956</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,711</p></td> </tr> <tr> <td valign="top" style=" border-bottom:solid 0.75pt transparent;"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Gain on disposal of discontinued operations</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">16,428</p></td> <td valign="top" style=" border-bottom:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:21.6pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net gain (loss) from discontinued operations</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; -</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;70,924</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp; 16,428</p></td> <td valign="top" style=" border-top:solid 0.75pt #000000;"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;(63,929)</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:14.4pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash provided by operating activities</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$ 169,009</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">113,829</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash (used in) provided by investing activities</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">&nbsp;&nbsp;-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(246,914)</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">51,327</p></td> </tr> <tr> <td valign="top"> <p style="text-align:justify;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Net cash used in financing activities</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">-</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(18,452)</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;font-size:10pt;">&nbsp;</p></td> <td valign="top"> <p style="text-align:right;margin-bottom:0pt;margin-top:0pt;margin-left:0pt;;text-indent:0pt;;color:#000000;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">(37,886)</p></td> </tr> </table></div> 2 0.010 0.18 25 0.05 0.20 1500000 P360D 0.030 1.00 5089357 15000 152000 1507375 3581982 0.03 P360D 2.41 1.42 -120200 4969200 1500000 2020-04-15 0.005 640000 2021-08-01 1503719 3562569 3461782 100787 4969200 -720386 5689586 1650000 16428 P84Y P6M P70Y P90D P70Y P70Y P6M P70Y 0.865 520838 2.40 250000 1000000 1.00 1.00 On May 11, 2020, our shareholders voted in favor of the approval of an amendment to our Certificate of Incorporation, in the event it is deemed advisable by our Board of Directors, to effect an additional reverse stock split of the Company’s issued and outstanding common stock at a ratio within the range of one-for-two (1:2) and one-for-ten (1:10), as determined by the Board of Directors 0.1 0.5 1.00 P48M 112027 112027 6564 20016 13452 20743 P20Y P3Y 13426 21084 4110 5526 9713 11969 500 P3Y P5Y P3Y P5Y P3Y P5Y P5Y 0 0 0 5815 0 11630 209031 260260 26136 2426 51229 4852 45742 1500000 2020-04-15 0.005 640000 5700000 0 4000000 520838 2.40 1250000 0 0 0 38000 12000 40000 3634857 2500000 one-for-ten 0.1 0.001 625318 19300 19300 2731587 3959287 1200000 12.50 one-tenth 12.50 12.50 P44Y P94Y 2020 0 0 2500000 2.40 1277700 2946480 2023 125000 2.64 2022-05-02 40000 143587 6.605 1.84 2023 1436424 0.030 2020-01-14 3461782 4969200 720386 5689586 16428 0 0 1500000 1.00 5089357 1507375 3581982 0.03 P360D 2.41 1.42 120200 P12M 51327 1500000 4969200 51300 5200 14600 17100 5100 62686 28500 9300 703000 720386 5689586 1650000 14000 40000 16000 15000 9000 20000 18000 11000 267000 300000 324000 386000 112000 112000 212000 274000 511 598 8727000 9167000 P48M 45000 97000 129000 209000 374000 91000 235000 24 31 7000 20000 82000 700 250000 509000 291000 536000 1375000 1883000 31000 67000 62000 109000 51000 96000 52000 122000 30000 -171500 152800 200000 1500000 0.005 2020-04-15 2021-08-01 640000 69540 185785 3461782 11802 606454 185785 4149578 19170 11590 2020-06-01 0.068 0.030 2019-01-16 2020-01-14 1436424 0 0.0909 323 2019-07-26 12892 2023-08-26 0.0585 10932 2018-05-31 608000 141000 51000 2025-05-30 0.010 2022-04-30 185785 185785 185785 P2Y 15046000 5700000 1200000 2900000 1500000 1250000 520838 6200000 P1Y P3Y P37M 0.065 2014-03-01 2019-07-31 2019-07-15 2022-07-31 4900 20000 50000 38000 97000 20377 50109 38457 97301 20377 50109 38457 97301 us-gaap:OperatingLeaseRightOfUseAsset us-gaap:OperatingLeaseRightOfUseAsset us-gaap:OperatingLeaseLiability us-gaap:OperatingLeaseLiability us-gaap:OperatingLeaseLiability 220141 265883 P2Y1M17D P2Y7M6D 0.0655 0.0655 48493 103646 68002 220141 19300 19300 19300 19300 11800 7634 60.51 60.51 60.51 60.51 84.49 113.81 6800 7800 11400 0 0 3959287 3843587 125000 1227700 9300 2731587 3959287 5.36 5.44 2.64 2.40 2.40 6.83 5.36 2946480 1227700 520833 2.40 250000 1.0 186000 125450 4969586 1650000 246914 27738 2301 276953 27245 304198 144006 100672 21153 14226 280057 517584 797641 181391 280159 100511 327377 80880 -47218 9956 16711 16428 70924 16428 -63929 169009 113829 -246914 51327 -18452 -37886 EX-101.SCH 6 lmfa-20200630.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000 - Document - Template Link link:presentationLink link:calculationLink link:definitionLink 100000 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 100010 - Statement - Condensed Consolidated Balance Sheets link:calculationLink link:presentationLink link:definitionLink 100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 100030 - Statement - Condensed Consolidated Statements of Operations link:calculationLink link:presentationLink link:definitionLink 100040 - Statement - Condensed Consolidated Statements of Cash Flows link:calculationLink link:presentationLink link:definitionLink 100050 - Statement - Consolidated Statements of Changes in Stockholders' Equity link:calculationLink link:presentationLink link:definitionLink 100060 - Disclosure - Summary of Significant Accounting Policies link:calculationLink link:presentationLink link:definitionLink 100070 - Disclosure - Goodwill and Acquisition link:calculationLink link:presentationLink link:definitionLink 100080 - Disclosure - Finance Receivables - Original Product link:calculationLink link:presentationLink link:definitionLink 100090 - Disclosure - Finance Receivables - Special Product (New Neighbor Guaranty program) link:calculationLink link:presentationLink link:definitionLink 100100 - Disclosure - Due to Related Party link:calculationLink link:presentationLink link:definitionLink 100110 - Disclosure - Debt and Other Financing Arrangements link:calculationLink link:presentationLink link:definitionLink 100120 - Disclosure - Going Concern link:calculationLink link:presentationLink link:definitionLink 100130 - Disclosure - Commitments and Contingencies link:calculationLink link:presentationLink link:definitionLink 100140 - Disclosure - Stockholders' Equity link:calculationLink link:presentationLink link:definitionLink 100150 - Disclosure - Discontinued Operations link:calculationLink link:presentationLink link:definitionLink 100160 - Disclosure - Subsequent Events link:calculationLink link:presentationLink link:definitionLink 100170 - Disclosure - Summary of Significant Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 100180 - Disclosure - Summary of Significant Accounting Policies (Tables) link:calculationLink link:presentationLink link:definitionLink 100190 - Disclosure - Goodwill and Acquisition (Tables) link:calculationLink link:presentationLink link:definitionLink 100200 - Disclosure - Finance Receivables - Original Product (Tables) link:calculationLink link:presentationLink link:definitionLink 100210 - Disclosure - Finance Receivables - Special Product (New Neighbor Guaranty program) (Tables) link:calculationLink link:presentationLink link:definitionLink 100220 - Disclosure - Debt and Other Financing Arrangements (Tables) link:calculationLink link:presentationLink link:definitionLink 100230 - Disclosure - Commitments and Contingencies (Tables) link:calculationLink link:presentationLink link:definitionLink 100240 - Disclosure - Stockholders' Equity (Tables) link:calculationLink link:presentationLink link:definitionLink 100250 - Disclosure - Discontinued Operations (Tables) link:calculationLink link:presentationLink link:definitionLink 100260 - Disclosure - Summary of Significant Accounting Policies - Additional information (Detail) link:calculationLink link:presentationLink link:definitionLink 100270 - Disclosure - Summary of Significant Accounting Policies - Summary of Anti-dilutive Stock Based Compensation Awards and Convertible Notes (Detail) link:calculationLink link:presentationLink link:definitionLink 100280 - Disclosure - Goodwill and Acquisition - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100290 - Disclosure - Goodwill and Acquisition - Summary of Consideration Paid and Amounts of Identified Assets Acquired and Liabilities Assumed (Details) link:calculationLink link:presentationLink link:definitionLink 100300 - Disclosure - Finance Receivables - Original Product - Schedule of Finance Receivables for Original Product (Detail) link:calculationLink link:presentationLink link:definitionLink 100310 - Disclosure - Finance Receivables - Special Product (New Neighbor Guaranty program) - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100320 - Disclosure - Finance Receivables - Special Product (New Neighbor Guaranty program) - Schedule of Delinquent Assessments and Accrued Charges (Detail) link:calculationLink link:presentationLink link:definitionLink 100330 - Disclosure - Due to Related Party - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100340 - Disclosure - Debt and Other Financing Arrangements - Schedule of Debt (Detail) link:calculationLink link:presentationLink link:definitionLink 100350 - Disclosure - Debt and Other Financing Arrangements - Schedule of Debt (Parenthetical) (Detail) link:calculationLink link:presentationLink link:definitionLink 100360 - Disclosure - Debt and Other Financing Arrangements - Schedule of Principal Payments of Debt (Detail) link:calculationLink link:presentationLink link:definitionLink 100370 - Disclosure - Debt and Other Financing Arrangements - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100380 - Disclosure - Going Concern - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100390 - Disclosure - Commitments and Contingencies - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100400 - Disclosure - Commitments and Contingencies - Components of Lease Expense (Detail) link:calculationLink link:presentationLink link:definitionLink 100410 - Disclosure - Commitments and Contingencies - Summary of Supplemental Balance Sheet Information Related to Operating Leases (Detail) link:calculationLink link:presentationLink link:definitionLink 100420 - Disclosure - Commitments and Contingencies - Summary of Supplemental Cash Flow Information and Non-cash Activity Related to Operating Leases (Detail) link:calculationLink link:presentationLink link:definitionLink 100430 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payment Due (Detail) link:calculationLink link:presentationLink link:definitionLink 100440 - Disclosure - Stockholders' Equity - Summary of Stock Option Plan Activity (Detail) link:calculationLink link:presentationLink link:definitionLink 100450 - Disclosure - Stockholders' Equity - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 100460 - Disclosure - Stockholders' Equity - Summary of Stock Warrants (Detail) link:calculationLink link:presentationLink link:definitionLink 100470 - Disclosure - Discontinued Operations - Additional Information (Details) link:calculationLink link:presentationLink link:definitionLink 100480 - Disclosure - Discontinued Operations - Summary of major classes of assets and liabilities and operating results of IIU (Detail) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 7 lmfa-20200630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 lmfa-20200630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 lmfa-20200630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Entity Central Index Key Cover [Abstract] Document Type Document Type Amendment Flag Amendment Flag Document Period End Date Document Period End Date Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Title of 12(b) Security Security12b Title Security Exchange Name Security Exchange Name Trading Symbol Trading Symbol Entity Registrant Name Entity Registrant Name Entity Central Index Key Current Fiscal Year End Date Current Fiscal Year End Date Entity Filer Category Entity Filer Category Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Current Reporting Status Entity Current Reporting Status Entity Interactive Data Current Entity Interactive Data Current Entity Shell Company Entity Shell Company Entity Ex Transition Period Entity Ex Transition Period Entity Common Stock, Shares Outstanding Entity Common Stock Shares Outstanding Entity File Number Entity File Number Entity Incorporation, State or Country Code Entity Incorporation State Country Code Entity Tax Identification Number Entity Tax Identification Number Entity Address, Address Line One Entity Address Address Line1 Entity Address, Address Line Two Entity Address Address Line2 Entity Address, City or Town Entity Address City Or Town Entity Address, State or Province Entity Address State Or Province Entity Address, Postal Zip Code Entity Address Postal Zip Code City Area Code City Area Code Local Phone Number Local Phone Number Document Quarterly Report Document Quarterly Report Document Transition Report Document Transition Report Finance receivables original product. Finance receivables special product. Statement Of Financial Position [Abstract] ASSETS Assets [Abstract] Cash Cash Finance receivables: Notes Receivable Net [Abstract] Original product - net (Note 3) Finance Receivables Original Product Special product - New Neighbor Guaranty program, net of allowance for credit losses of (Note 4) Finance Receivables Special Product Prepaid expenses and other assets Prepaid Expense And Other Assets Current Due from related party (Note 5) Due From Related Parties Current Discontinued operations - current assets (Note 10) Assets Of Disposal Group Including Discontinued Operation Current Current assets Assets Current Fixed assets, net (Note 1) Property Plant And Equipment Net Real estate assets owned (Note 1) Real Estate Investments Other Operating lease - right of use assets (Note 8) Operating Lease Right Of Use Asset Other investments - related party (Note 1) Other Investments Goodwill (Note 2) Goodwill Other Assets Other Assets Noncurrent Discontinued operations - long-term assets, net (Note 10) Disposal Group Including Discontinued Operation Assets Noncurrent Long-term assets Assets Noncurrent Total assets Assets LIABILITIES AND STOCKHOLDERS' EQUITY Liabilities And Stockholders Equity [Abstract] Note payable (Note 6) Short Term Borrowings Related party convertible note payable Notes Payable Related Parties Classified Current Accounts payable and accrued expenses Accounts Payable And Accrued Liabilities Current Due to related party (Note 5) Due To Related Parties Current Current portion of lease liability (Note 8) Operating Lease Liability Current Discontinued operations - current liabilities (Note 10) Liabilities Of Disposal Group Including Discontinued Operation Current Total current liabilities Liabilities Current Lease liability - long-term (Note 8) Operating Lease Liability Noncurrent Note payable - long-term (Note 6) Long Term Debt Discontinued operations - long-term liabilities (Note 10) Liabilities Of Disposal Group Including Discontinued Operation Noncurrent Long-term liabilities Liabilities Noncurrent Total liabilities Liabilities Stockholders’ equity: Stockholders Equity [Abstract] Common stock, par value $.001; 30,000,000 shares authorized; 5,068,799 and 3,134,261 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively Common Stock Value Additional paid-in capital Additional Paid In Capital Common Stock Accumulated deficit Retained Earnings Accumulated Deficit Total stockholders’ equity Stockholders Equity Total liabilities and stockholders’ equity Liabilities And Stockholders Equity Common stock, par value Common Stock Par Or Stated Value Per Share Common stock, shares authorized Common Stock Shares Authorized Common stock, shares issued Common Stock Shares Issued Common stock, shares outstanding Common Stock Shares Outstanding Interest on delinquent association fees. Administrative and late fees. Recoveries on collection of assessments in excess of cost. Underwriting fees and other revenues. Rental revenue. Real estate management and disposal. Collection cost. Income Statement [Abstract] Statement [Table] Statement [Table] Product and Service Product Or Service [Axis] Product and Service Products And Services [Domain] Service [Member] Service [Member] Statement [Line Items] Statement [Line Items] Revenues: Revenues [Abstract] Interest on delinquent association fees Interest On Delinquent Association Fees Administrative and late fees Administrative And Late Fees Recoveries in excess of cost - special product Recoveries On Collection Of Assessments In Excess Of Cost Underwriting and other revenues Underwriting Fees And Other Revenues Rental revenue Rental Revenue Total revenues Revenues Operating Expenses: Operating Expenses [Abstract] Staff costs and payroll Cost Direct Labor Professional fees Professional Fees Settlement costs with associations Litigation Settlement Expense Selling, general and administrative Selling General And Administrative Expense Recovery of cost from related party receivable Allowance For Doubtful Accounts Receivable Recoveries Provision for credit losses Provision For Doubtful Accounts Real estate management and disposal Real Estate Management And Disposal Depreciation and amortization Depreciation And Amortization Collection costs Collection Cost Other operating expenses Other Cost And Expense Operating Total operating expenses Operating Expenses Operating loss from continuing operations Operating Income Loss Interest expense Interest Expense Loss from continuing operations before income taxes Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest Income tax benefit Income Tax Expense Benefit Net loss from continuing operations Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest Gain on disposal of discontinued operations Discontinued Operation Gain Loss From Disposal Of Discontinued Operation Before Income Tax Gain (loss) from operations of discontinued operations Discontinued Operation Income Loss From Discontinued Operation Before Income Tax Net gain/(loss) from discontinued operations Income Loss From Discontinued Operations Net Of Tax Net loss Profit Loss Earnings/(loss) per share: Earnings Per Share [Abstract] Basic loss per common share - continuing operations Income Loss From Continuing Operations Per Basic Share Basic earnings/(loss) per common share - discontinued operations Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Basic Share Basic loss per common share - net loss Earnings Per Share Basic Diluted loss per common share - continuing operations Income Loss From Continuing Operations Per Diluted Share Diluted earnings/(loss) per common share - discontinued operations Discontinued Operation Income Loss From Discontinued Operation Net Of Tax Per Diluted Share Diluted loss per common share - net loss Earnings Per Share Diluted Weighted average number of common shares outstanding: Weighted Average Number Of Shares Outstanding [Abstract] Basic Weighted Average Number Of Shares Outstanding Basic Diluted Weighted Average Number Of Diluted Shares Outstanding Right to use asset depreciation. Increase decrease in deferred taxes. Proceeds from (payments) to sale and collection of finance receivables. Proceeds from (payments) for real estate assets owned. Net cash received from business acquisition. Statement Of Cash Flows [Abstract] Financing Receivable Portfolio Segment Financing Receivable Portfolio Segment [Axis] Financing Receivable Portfolio Segment Financing Receivable Portfolio Segment [Domain] Original product. Original Product [Member] Original Product [Member] Special product. Special Product [Member] Special Product [Member] CASH FLOWS FROM OPERATING ACTIVITIES: Net Cash Provided By Used In Operating Activities [Abstract] Net loss Adjustments to reconcile net loss to cash used in operating activities Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Depreciation and amortization Depreciation Depletion And Amortization Right to use asset depreciation Right To Use Asset Depreciation Stock compensation Share Based Compensation Gain on disposal of business unit Change in assets and liabilities Increase Decrease In Operating Capital [Abstract] Prepaid expenses and other assets Increase Decrease In Prepaid Deferred Expense And Other Assets Accounts payable and accrued expenses Increase Decrease In Accounts Payable And Accrued Liabilities Repayments from related party Increase Decrease In Due To Related Parties Other liabilities Increase Decrease In Other Operating Liabilities Lease liability payments Operating Lease Payments Deferred taxes Increase Decrease In Deferred Taxes Net cash used in operating activities Net Cash Provided By Used In Operating Activities CASH FLOWS FROM INVESTING ACTIVITIES: Net Cash Provided By Used In Investing Activities [Abstract] Net collections of finance receivables Proceeds From Payments To Sale And Collection Of Finance Receivables (Payments)/proceeds for real estate assets owned Proceeds From Payments For Real Estate Assets Owned Net cash payment for IIU disposal Cash Divested From Deconsolidation Investment in note receivable - related party Payments To Acquire Notes Receivable Net cash received from business acquisition Net Cash Received From Business Acquisition Net cash provided by investing activities Net Cash Provided By Used In Investing Activities CASH FLOWS FROM FINANCING ACTIVITIES: Net Cash Provided By Used In Financing Activities [Abstract] Borrowings Proceeds From Issuance Of Debt Principal repayments Repayments Of Debt Exercise of warrants Proceeds From Warrant Exercises Proceeds from stock subscription Proceeds From Issuance Of Common Stock Net cash provided by (used in) financing activities Net Cash Provided By Used In Financing Activities NET INCREASE (DECREASE) IN CASH Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CASH - BEGINNING OF YEAR Cash And Cash Equivalents At Carrying Value CASH - END OF YEAR SUPPLEMENTAL DISCLOSURES OF CASHFLOW INFORMATION Supplemental Cash Flow Information [Abstract] Cash paid for interest Interest Paid Net Income taxes Income Taxes Paid Net SUPPLEMENTAL DISCLOSURES OF NON-CASHFLOW INFORMATION Noncash Investing And Financing Items [Abstract] ROU asset obligation recognized Right Of Use Asset Obtained In Exchange For Operating Lease Liability Stock issued shares for warrants exercised. Stock issued for warrants exercised. Stock option issuance. Common stock shares issued for cash. Common stock value issued for cash. Statement Of Stockholders Equity [Abstract] Equity Components Statement Equity Components [Axis] Equity Component Equity Component [Domain] Common Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Additional Paid In Capital [Member] Accumulated Deficit [Member] Retained Earnings [Member] Balance Balance, shares Shares Outstanding Warrants exercised for cash Stock Issued For Warrants Exercised Warrants exercised for cash, shares Stock Issued Shares For Warrants Exercised Stock compensation expense Adjustments To Additional Paid In Capital Share Based Compensation Stock Options Requisite Service Period Recognition Stock compensation expense, shares Stock Option Issuance Common stock issued for cash Common Stock Value Issued For Cash Common stock issued for cash, Shares Common Stock Shares Issued For Cash Net loss Net Income Loss Balance Balance, shares Accounting Policies [Abstract] Summary of Significant Accounting Policies Significant Accounting Policies [Text Block] The entire disclosure for goodwill and business combination. Business Combinations [Abstract] Goodwill and Acquisition Goodwill And Business Combination Disclosure [Text Block] Receivables [Abstract] Finance Receivables Financing Receivables [Text Block] Schedule Of Accounts Notes Loans And Financing Receivable [Table] Schedule Of Accounts Notes Loans And Financing Receivable [Table] Special Product (New Neighbor Guaranty Program) [Member] Accounts Notes And Loans Receivable [Line Items] Accounts Notes And Loans Receivable [Line Items] Related Party Transactions [Abstract] Due to Related Party Related Party Transactions Disclosure [Text Block] Debt Disclosure [Abstract] Debt and Other Financing Arrangements Debt Disclosure [Text Block] Organization Consolidation And Presentation Of Financial Statements [Abstract] Going Concern Substantial Doubt About Going Concern [Text Block] Commitments And Contingencies Disclosure [Abstract] Commitments and Contingencies Commitments And Contingencies Disclosure [Text Block] Equity [Abstract] Stockholders' Equity Stockholders Equity Note Disclosure [Text Block] Discontinued Operations And Disposal Groups [Abstract] Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Table] Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Table] Disposal Group Name Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Axis] Disposal Group Name Disposal Groups Including Discontinued Operations Name [Domain] IIU Inc. I I U Inc I I U Inc [Member] Collaborative Arrangement and Arrangement Other than Collaborative Type Of Arrangement [Axis] Collaborative Arrangement and Arrangement Other than Collaborative Arrangements And Nonarrangement Transactions [Member] Stock purchase agreement Stock Purchase Agreement Stock Purchase Agreement [Member] Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items] Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items] Discontinued Operations Disposal Groups Including Discontinued Operations Disclosure [Text Block] Subsequent Events [Abstract] Subsequent Events Subsequent Events [Text Block] Nature of operation. Nature of Operations Nature Of Operation Policy [Text Block] Principles of Consolidation Consolidation Policy [Text Block] Basis of Presentation Basis Of Accounting Policy Policy [Text Block] Use of Estimates Use Of Estimates Revenue Recognition Revenue Recognition Policy [Text Block] Cash Cash And Cash Equivalents Policy [Text Block] Disclosure of accounting policy for financing receivables. Financing Receivables Financing Receivables Policy [Text Block] Real Estate Assets Owned Real Estate Held For Development And Sale Policy Fixed Assets Property Plant And Equipment Policy [Text Block] Disclosure of accounting policy related to Right to use assets. Right to Use Assets Right To Use Assets Policy [Text Block] Other investments policy. Other Investments - Note Receivable - Related Party Other Investments Policy [Text Block] Goodwill Goodwill And Intangible Assets Goodwill Policy Stock Issuable. Stock Issued Stock Issuable Policy [Text Block] Debt Issue Costs Debt Policy [Text Block] Settlement costs with associations. Settlement Costs with Associations Settlement Costs With Associations Policy [Text Block] Income Taxes Income Tax Policy [Text Block] Loss Per Share Earnings Per Share Policy [Text Block] Stock-Based Compensation Share Based Compensation Option And Incentive Plans Policy Contingencies Commitments And Contingencies Policy [Text Block] Fair Value of Financial Instruments Fair Value Of Financial Instruments Policy Risks and uncertainties policy. Risks and Uncertainties Risks And Uncertainties Policy [Text Block] Non cash financing and investing activities policy. Non-cash Financing and Investing Activities Non Cash Financing And Investing Activities Policy Policy [Text Block] Recent Accounting Pronouncements Not Yet Adopted New Accounting Pronouncements Policy Policy [Text Block] Reclassifications policy. Reclassifications Reclassifications Policy Policy [Text Block] Subsequent Events Subsequent Events Policy Policy [Text Block] Summary of Anti-dilutive Stock Based Compensation Awards and Convertible Notes Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Text Block] Summary of Consideration Paid and Amounts of Identified Assets Acquired and Liabilities Assumed Schedule Of Recognized Identified Assets Acquired And Liabilities Assumed Table [Text Block] Finance receivables outstanding. Schedule of Finance Receivables for Original Product Finance Receivables Outstanding Table [Text Block] Schedule of delinquent assessments and accrued charges. Schedule of Delinquent Assessments and Accrued Charges Schedule Of Delinquent Assessments And Accrued Charges Table [Text Block] Schedule of Debt Schedule Of Debt Table [Text Block] Schedule of Principal Payments of Debt Schedule Of Maturities Of Long Term Debt Table [Text Block] Components of Lease Expense Lease Cost Table [Text Block] Schedule of supplemental balance sheet information related to operating leases. Summary of Supplemental Balance Sheet Information Related to Operating Leases Schedule Of Supplemental Balance Sheet Information Related To Operating Leases Table [Text Block] Schedule of supplemental cash flow information and non cash activity related to operating leases. Summary of Supplemental Cash Flow Information and Non-cash Activity Related to Operating Leases Schedule Of Supplemental Cash Flow Information And Non Cash Activity Related To Operating Leases Table [Text Block] Schedule of Future Minimum Lease Payment Due Lessee Operating Lease Liability Maturity Table [Text Block] Summary of Stock Option Plan Activity Schedule Of Share Based Compensation Stock Options Activity Table [Text Block] Summary of Stock Warrants Schedule Of Stockholders Equity Note Warrants Or Rights [Text Block] Summary of major classes of assets and liabilities and operating results of IIU Schedule Of Disposal Groups Including Discontinued Operations Income Statement Balance Sheet And Additional Disclosures [Text Block] Number of owners. Summary of significant accounting policies. Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Summary Of Significant Accounting Policies [Table] Consolidated Entities Consolidated Entities [Axis] Consolidated Entities Consolidated Entities [Domain] Subsidiaries [Member] Subsidiaries [Member] Securities purchase agreement. Securities Purchase Agreement [Member] Securities Purchase Agreement [Member] Debt Instrument Debt Instrument [Axis] Debt Instrument, Name Debt Instrument Name [Domain] Senior convertible promissory notes. Senior Convertible Promissory Notes [Member] Senior Convertible Promissory Notes [Member] Statistical Measurement Range [Axis] Statistical Measurement Range [Member] Minimum [Member] Minimum [Member] Maximum [Member] Maximum [Member] Convertible promissory note. Convertible Promissory Note [Member] Convertible Promissory Note [Member] Business Acquisition Business Acquisition [Axis] Business Acquisition, Acquiree Business Acquisition Acquiree [Domain] Counterparty Name Counterparty Name [Axis] Counterparty Name Repurchase Agreement Counterparty Name [Domain] Craven House Capital North America LLC. Craven House Capital North America LLC [Member] Craven House Capital North America L L C [Member] HealthCare abroad. HealthCare Abroad [Member] Health Care Abroad [Member] HealthCAre Global. HealthCare Global [Member] Health C Are Global [Member] HealthCare America. HealthCare America [Member] Health Care America [Member] HealthCare International. HealthCare International [Member] Health Care International [Member] HealthCare War. HealthCare War [Member] Health Care War [Member] Hanfor (Cayman) Limited. Hanfor-Owner [Member] Hanfor Cayman Limited [Member] REO Management Holdings Llc. REO Management Holdings, LLC [Member] R E O Management Holdings Llc [Member] Ownership Ownership [Axis] Ownership Ownership [Domain] Subsidiary limited liability. Subsidiary Limited Liability [Member] Subsidiary Limited Liability [Member] SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Loan Category Mortgage Loans On Real Estate Description Loan Category [Axis] SEC Schedule, 12-29, Real Estate Companies, Investment in Mortgage Loans on Real Estate, Loan Category Mortgage Loans On Real Estate Loan Category [Domain] First Mortgage [Member] First Mortgage [Member] Long-Lived Tangible Asset Property Plant And Equipment By Type [Axis] Long-Lived Tangible Asset Property Plant And Equipment Type [Domain] Furniture [Member] Furniture And Fixtures [Member] Computer [Member] Computer Equipment [Member] Office Equipment [Member] Office Equipment [Member] Finite-Lived Intangible Assets by Major Class Finite Lived Intangible Assets By Major Class [Axis] Finite-Lived Intangible Assets, Major Class Name Finite Lived Intangible Assets Major Class Name [Domain] Capitalized Software [Member] Computer Software Intangible Asset [Member] Accounting Standards Update Adjustments For New Accounting Pronouncements [Axis] Accounting Standards Update Type Of Adoption [Member] ASU 2016-02 [Member] Accounting Standards Update201602 [Member] Investment Type Investment Type [Axis] Investments Investment Type Categorization [Member] Promissory notes. Secured Promissory Note [Member] Promissory Notes [Member] Share Exchange Agreement [Member] Craven House Capital North America Inc. Craven [member] Craven House Capital North America Inc [Member] Hanfor (Cayman) Ltd Share exchange agreement. Share Exchange Agreement [Member] Share Exchange Agreement [Member] Stock Warrants [Member] Warrant [Member] Sale of Stock Subsidiary Sale Of Stock [Axis] Sale of Stock Sale Of Stock Name Of Transaction [Domain] Initial Public Offering [Member] I P O [Member] Secondary offering. Secondary Offering [Member] Secondary Offering [Member] Additional warrant. Additional Warrants [Member] Additional Warrant [Member] Antidilutive Securities Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis] Antidilutive Securities, Name Antidilutive Securities Name [Domain] Convertible Notes [Member] Convertible Notes Payable [Member] Summary Of Significant Accounting Policies [Line Items] Summary Of Significant Accounting Policies [Line Items] Number of members Number Of Owners Minimum percentage of original principal amount on mortgage. Minimum percentage of original principal amount on mortgage Minimum Percentage Of Original Principal Amount On Mortgage Maximum statutory delinquent assessments rate. Maximum administrative late fees per assessment. Percentage of maximum administrative late fees on delinquent assessment. Maximum statutory delinquent assessments rate Maximum Statutory Delinquent Assessments Rate Maximum administrative late fees Maximum Administrative Late Fees Per Assessment Percentage of maximum administrative late fees on delinquent assessment Percentage Of Maximum Administrative Late Fees On Delinquent Assessment Ownership excluding unexercised warrants percentage Equity Method Investment Ownership Percentage Principal amount Debt Instrument Carrying Amount Debt instrument term Debt Instrument Term Debt instrument, interest rate percentage Debt Instrument Interest Rate Stated Percentage Business combination working capital. Denominator for conversion of convertible note to restricted common stock. Percentage of stock purchased Business Acquisition Percentage Of Voting Interests Acquired Purchase price Business Combination Consideration Transferred1 Working capital Business Combination Working Capital Extinguishment of principal indebtedness and accrued interest Extinguishment Of Debt Amount Face amount of debt instrument Debt Instrument Face Amount Denominator for conversion of convertible note to restricted common shares Denominator For Conversion Of Convertible Note To Restricted Common Stock Closing price of share price Share Price Debt instrument reduced amount Debt Instrument Increase Decrease For Period Net Common stock shares pledge. Loans receivable principal and interest income amount. Loan amount Secured Debt Debt instrument, maturity date Debt Instrument Maturity Date Common shares pledge Common Stock Shares Pledge Full principal and accrued interest amount received Loans Receivable Principal And Interest Income Amount Proceeds from issuance of debt funded in repurchase and cancellation of debt. Sale of stock under agreement Common Unit Issuance Value Proceeds from issuance of debt funded in repurchase and cancellation of debt Proceeds From Issuance Of Debt Funded In Repurchase And Cancellation Of Debt Forgave amount accrued interest Debt Instrument Decrease Forgiveness Net fair value of assets Fair Value Net Asset Liability Goodwill impairment loss Goodwill Impairment Loss Goodwill impairment Goodwill Impaired Accumulated Impairment Loss Health insurance coverage age limit. Health insurance coverage period. Age limit Health Insurance Coverage Age Limit Coverage period Health Insurance Coverage Period Minimum bid price. Closing bid price of common stock. Purchase of outstanding warrants Class Of Warrant Or Right Outstanding Sale of stock price per share Sale Of Stock Price Per Share Proceeds from issuance of stock Proceeds From Issuance Or Sale Of Equity Notes receivable Notes Receivable Related Parties Minimum bid price Minimum Bid Price Closing bid price of common stock Closing Bid Price Of Common Stock Reverse stock split percentage of issued common stock. Reverse stock split percentage of outstanding common stock. Reverse stock split, description Stockholders Equity Reverse Stock Split Reverse stock split percentage of issued common stock Reverse Stock Split Percentage Of Issued Common Stock Reverse stock split percentage of outstanding common stock Reverse Stock Split Percentage Of Outstanding Common Stock Percentage of ownership in subsidiary limited liability companies Subsidiary Of Limited Liability Company Or Limited Partnership Ownership Interest Delinquent assessments maximum due period purchases basis. Delinquent assessments maximum due period purchases basis Delinquent Assessments Maximum Due Period Purchases Basis Allowance for credit losses Financing Receivable Allowance For Credit Losses Finance receivables, allowance for credit losses, write offs Financing Receivable Allowance For Credit Losses Write Offs Capitalized real estate costs accumulated depreciation net. Estimated useful lives Property Plant And Equipment Useful Life Capitalized real estate costs, net of accumulated depreciation Capitalized Real Estate Costs Accumulated Depreciation Net Depreciation expense Depreciation Minimum acquisition cost of fixed assets that requires capitalization to fixed asset accounts. Minimum acquisition cost that requires capitalization to fixed assets Minimum Acquisition Amount Limit For Capitalization Of Fixed Assets Estimated useful life Finite Lived Intangible Asset Useful Life Capitalized software costs, net of accumulated amortization Capitalized Computer Software Net Amortization expense for capitalized software costs Capitalized Computer Software Amortization1 Financing and operating lease right of use asset. Finance and operating lease right of use asset amortization. Right of use asset, net Financing And Operating Lease Right Of Use Asset Amortization expense for right to use assets Finance And Operating Lease Right Of Use Asset Amortization Operating lease, payments Stock pledge against secured Investment. Maturity period. Loaned to related party Loans And Leases Receivable Related Parties Maturity of note Maturity Period Interest rate Loans Receivable Basis Spread On Variable Rate Stock pledge against investment Stock Pledge Against Secured Investment Common stock sold Stock Issued During Period Shares New Issues Common stock price per share Shares Issued Price Per Share Unamortized debt issue costs Unamortized Debt Issuance Expense Settlement costs with associations Valuation allowance deferred tax assets Deferred Tax Assets Valuation Allowance Reverse stock split, conversion ratio Stockholders Equity Note Stock Split Conversion Ratio1 Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Schedule Of Antidilutive Securities Excluded From Computation Of Earnings Per Share [Table] Stock Options [Member] Employee Stock Option [Member] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items] Anti-dilutive stock based compensation awards Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount Class of warrant or right weighted average exercise price. Class of warrants and rights weighted average remaining contractual terms. Class of warrants expiration year. Class of warrant or right exercise price of warrants or rights aggregate intrinsic value outstanding. Warrants issued to purchase of common stock Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights Warrants issued to purchase of common stock average exercise price per share Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1 Warrants, weighted average price Class Of Warrant Or Right Weighted Average Exercise Price Warrants, weighted average remaining life Class Of Warrants And Rights Weighted Average Remaining Contractual Terms Warrants, year of expiration Class Of Warrants Expiration Year Warrants, aggregate intrinsic value outstanding Class Of Warrant Or Right Exercise Price Of Warrants Or Rights Aggregate Intrinsic Value Outstanding Class of warrant or right, exercised. Warrants Class Of Warrant Or Right Exercised Class of warrants expiration period. Warrants, year of expiration Class Of Warrants Expiration Period Business combination, adjusted consideration transferred. Disposal Group Including Discontinued Operation Gain On Disposal Of Business Convertible notes conversion to common shares Interest rate Short Term Debt Percentage Bearing Fixed Interest Rate Maturity period Total adjusted purchase price Business Combination Adjusted Consideration Transferred Preliminary estimate of the fair value of assets and liabilities assumed Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Net Gain on disposal of discontinued operations Disposal Group Including Discontinued Operation Gain On Disposal Of Business Fair value of property, plant and equipment less the cost to dispose. Fair value of properties Fair Value Property Plant And Equipment Less Cost To Dispose Closing share price of company. Schedule Of Business Acquisitions By Acquisition [Table] Schedule Of Business Acquisitions By Acquisition [Table] Promissory note. Promissory Notes [Member] Promissory Note [Member] Business Acquisition [Line Items] Business Acquisition [Line Items] Principal amount Purchase price of notes issued Proceeds From Convertible Debt Closing share price Closing Share Price Net cash received from business acquisition Cash Acquired From Acquisition Business combination recognized identifiable assets acquired and liabilities assumed profit on purchased policies. Business combination recognized identifiable assets acquired and liabilities assumed accrued expenses and other liabilities. Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets [Abstract] I I U Inc and Wallach and Company. IIU, Inc and Wallach and Company [Member] I I U Inc And Wallach And Company [Member] Cash Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Cash And Equivalents Prepaid and other current assets Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Assets Prepaid Expense And Other Assets Profit on purchased policies Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Profit On Purchased Policies Property, plant and equipment Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment Accounts payable Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Accounts Payable Accrued expenses and other liabilities Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Accrued Expenses And Other Liabilities Income taxes Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities Noncurrent Deferred revenue Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Deferred Revenue Debt Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Current Liabilities Long Term Debt Preliminary estimate of the fair value of assets and liabilities assumed Goodwill Number of units with delinquent assessment. Outstanding interest and late fees on active units. Information by period in which financing receivables are outstanding. Financing Receivables Period Outstanding Financing Receivables Period Outstanding [Axis] Period in which financing receivables are outstanding. Financing Receivables Period Outstanding Financing Receivables Period Outstanding [Domain] Current year. Funded During The Current Year [Member] Current Year [Member] Fund for next one to two years. 1-2 Years Outstanding [Member] Fund For Next One To Two Years [Member] Fund for next two to three years. 2-3 Years Outstanding [Member] Fund For Next Two To Three Years [Member] Fund for next three to four years. 3-4 Years Outstanding [Member] Fund For Next Three To Four Years [Member] Fund for greater than four years. Greater Than 4 Years Outstanding [Member] Fund For Greater Than Four Years [Member] Finance receivables outstanding Notes Receivable Gross Reserve for credit losses Finance receivables, net Notes Receivable Net Number of active units with delinquent assessments Number Of Units With Delinquent Assessment Amount of outstanding interest and late fees on active units Outstanding Interest And Late Fees On Active Units New neighbor guaranty. New Neighbor Guaranty (NNG) [Member] New Neighbor Guaranty [Member] Maximum future contingent payments. Maximum future contingent payments Maximum Future Contingent Payments Delinquent assessments. Accrued interest and late fee. Finance receivables, net Delinquent assessments Delinquent Assessments Accrued interest and late fees Accrued Interest And Late Fee Minimum fee paid per unit. Schedule Of Related Party Transactions By Related Party [Table] Schedule Of Related Party Transactions By Related Party [Table] Related Party Related Party Transactions By Related Party [Axis] Related Party Related Party [Domain] Business law group. Business Law Group [Member] Business Law Group [Member] Related Party Transaction Related Party Transaction [Axis] Related Party Transaction Related Party Transaction [Domain] Out of pocket collection costs. Out of Pocket Collection Costs [Member] Out Of Pocket Collection Costs [Member] Craven Holdings North America Inc. Craven Holdings North America Inc [Member] Craven Holdings North America Inc [Member] Related Party Transaction [Line Items] Related Party Transaction [Line Items] Monthly payment for cases Payments For Legal Settlements Minimum fee paid per unit Minimum Fee Paid Per Unit Payment for law firm service. Service amount paid Payment For Law Firm Service Expenses incurred by company Related Party Transaction Expenses From Transactions With Related Party Recoveries incurred Proceeds From Customers Office sub lease income Operating Lease Lease Income Recoupment of amount written off. Debt Instruments Maturity Date . Debt instrument extended maturity period. Stock issued during period shares for payment on promissory notes issued in exchange for shares of common stock. Receivable (Payable)from related party Proceeds From Repayments Of Related Party Debt Amount written-off regained Recoupment Of Amount Written Off Debt instrument, due date Debt Instruments Maturity Date Debt Instrument, extended maturity date Debt Instrument Extended Maturity Period Common shares pledged other than secured promissory notes Stock Issued During Period Shares For Payment On Promissory Notes Issued In Exchange For Shares Of Common Stock Debt Instruments [Abstract] Debt Instrument [Table] Debt Instrument [Table] Financial agreement two. Financing agreement with FlatIron capital maturing in June 1, 2020 [Member] Financial Agreement Two [Member] Promissory note two. Promissory note issued by a financial institution maturing in April 30, 2022 [Member] Promissory Note Two [Member] Senior secured convertible promissory note. Convertible Senior Note [Member] Senior Secured Convertible Promissory Note [Member] Promissory note one. Promissory note issued by a financial institution maturing in August 26, 2023 [Member] Promissory Note One [Member] Promissory note issued by a financial institution maturing in May 30, 2025 [Member] Debt Instrument [Line Items] Debt Instrument [Line Items] Notes payable Notes Payable Subsequent borrowings. Down payment for note payable Repayments Of Notes Payable Debt instrument, periodic payment Debt Instrument Periodic Payment Debt instrument, issuance date Debt Instrument Issuance Date1 Debt instrument, to be converted shares Debt Instrument Convertible Number Of Equity Instruments Debt instrument, convertible, beneficial conversion feature Debt Instrument Convertible Beneficial Conversion Feature Subsequent borrowings Subsequent Borrowings Repayments Repayments Of Medium Term Notes 2020 Long Term Debt Maturities Repayments Of Principal In Next Twelve Months 2021 Long Term Debt Maturities Repayments Of Principal In Year Two 2022 Long Term Debt Maturities Repayments Of Principal In Year Three 2023 Long Term Debt Maturities Repayments Of Principal In Year Four 2024 Long Term Debt Maturities Repayments Of Principal In Year Five After 2024 Long Term Debt Maturities Repayments Of Principal After Year Five Debt Instrument Carrying Amount Debt instrument maturity period. Unusual Risk or Uncertainty, Nature Unusual Risk Or Uncertainty By Nature [Axis] Unusual Risk or Uncertainty, Nature Unusual Risk Or Uncertainty Nature [Domain] US Federal Government Coronavirus Aid, Relief, and Economic Security Act [Member] U S Federal Government Coronavirus Aid Relief And Economic Security Act [Member] Debt Instrument Maturity Period Debt Instrument Maturity Period Cumulative operating losses. Financial Support For Nonconsolidated Legal Entity [Table] Financial Support For Nonconsolidated Legal Entity [Table] Scenario Statement Scenario [Axis] Scenario Scenario Unspecified [Domain] Going concerns [Member]. Going Concerns [Member] Going Concerns [Member] Financial Support For Nonconsolidated Legal Entity [Line Items] Financial Support For Nonconsolidated Legal Entity [Line Items] Cumulative operating losses Cumulative Operating Losses Proceeds from issuance of common stock, warrants exercised and related party receivable. Proceeds from issuance of common stock, warrants exercised and related party receivable Proceeds From Issuance Of Common Stock Warrants Exercised And Related Party Receivable Warrants Exercised Proceeds from warrants exercised Related party receivable Accounts Receivable Related Parties Loss Contingencies [Table] Loss Contingencies [Table] Lease Contractual Term Lease Contractual Term [Axis] Lease Contractual Term Lease Contractual Term [Domain] New Office Lease. New Office Lease [Member] New Office Lease [Member] Loss Contingencies [Line Items] Loss Contingencies [Line Items] Operating lease remaining lease term Operating Lease Weighted Average Remaining Lease Term1 Lease expiration period. Lease expiration period Lease Expiration Period Operating lease discount rate Lessee Operating Lease Discount Rate Lease contract beginning date. Operating lease beginning date Lease Contract Beginning Date Operating lease ending date Lease Expiration Date1 Sublease Income Sublease Income Rent expense Lease And Rental Expense Lease Cost [Abstract] Operating lease expense Operating Lease Cost Lease cost Lease Cost Assets And Liabilities Lessee [Abstract] ROU assets Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] Operating Lease Right Of Use Asset Statement Of Financial Position Extensible List Current lease liabilities Operating Lease, Liability, Current, Statement of Financial Position [Extensible List] Operating Lease Liability Current Statement Of Financial Position Extensible List Long-term lease liabilities Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] Operating Lease Liability Noncurrent Statement Of Financial Position Extensible List Total lease liabilities Operating Lease Liability Weighted-average remaining lease term (in years) Weighted-average discount rate Operating Lease Weighted Average Discount Rate Percent Cash flows operating activities lessee. Leases [Abstract] Operating cash flow information Cash Flows Operating Activities Lessee [Abstract] 2020 (excluding the six months ended June 30, 2020) Lessee Operating Lease Liability Payments Remainder Of Fiscal Year 2021 Lessee Operating Lease Liability Payments Due Year Two 2022 Lessee Operating Lease Liability Payments Due Year Three Total future minimum lease payments due Lessee Operating Lease Liability Payments Due Share based compensation arrangement by share based payment award options adjustments in period adjustment. Number of Options Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Roll Forward Number of Options, Outstanding at Beginning of the year Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number Number of Options, Granted Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross Number of Options, Exercised Stock Issued During Period Shares Stock Options Exercised Number of Options, Adjustment Share Based Compensation Arrangement By Share Based Payment Award Options Adjustments In Period Adjustment Number of Options, Forfeited Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period Number of Options, Outstanding at End of Year Number of Options, Exercisable at End of Year Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number Share based compensation arrangements by share based payment award options adjustments in period weighted average exercise price. Weighted Average Exercise Price Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Rollforward Weighted Average Exercise Price, Outstanding at Beginning Balance Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price Weighted Average Exercise Price, Granted Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price Weighted Average Exercise Price, Exercised Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price Weighted Average Exercise Price, Adjustment Share Based Compensation Arrangements By Share Based Payment Award Options Adjustments In Period Weighted Average Exercise Price Weighted Average Exercise Price, Forfeited Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price Weighted Average Exercise Price, Outstanding at Ending Balance Weighted Average Exercise Price, Exercisable Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price Schedule Of Stock By Class [Table] Schedule Of Stock By Class [Table] Maxim Holdings LLC. Maxim Holdings LLC [Member] Maxim Holdings L L C [Member] Class Of Stock [Line Items] Class Of Stock [Line Items] Recognized compensation expense of stock options Allocated Share Based Compensation Expense Remaining unrecognized compensation cost Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options Aggregate intrinsic value of outstanding common stock options Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value Share based compensation arrangement by share based payment award equity instruments other than options exercised in period. Number of Warrants, beginning balance Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number Number of warrants, granted Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Number of warrants, exercised Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Number of warrants, forfeited Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period Number of Warrants, ending balance Share based compensation arrangement by share based payment award equity instruments other than options exercised in period weighted average grant date fair value. Weighted Average Exercise Price, Outstanding at Ending Balance Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value Weighted Average Exercise Price, granted Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value Weighted Average Exercise Price, exercised Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Exercised In Period Weighted Average Grant Date Fair Value Weighted Average Exercise Price, forfeited Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value Weighted Average Exercise Price, Outstanding at Ending Balance Common stock issued Stock Issued During Period Shares Issued For Services Cash received for shares issued Stock Issued During Period Value Issued For Services Goodwill paid Disposal Group Including Discontinued Operation Goodwill1 Current assets of disposal group including discontinued operation. Disposal group including discontinued operation short term notes payable.. Current liabilities of disposal group including discontinued operation. Disposal group including discontinued operation debt. Major classes of assets Assets Of Disposal Group Including Discontinued Operation [Abstract] Cash Disposal Group Including Discontinued Operation Cash And Cash Equivalents Related party receivable Disposal Group Including Discontinued Operation Accounts Notes And Loans Receivable Net Prepaid expenses Disposal Group Including Discontinued Operation Prepaid And Other Assets Total major classes of current assets – discontinued assets Current Assets Of Disposal Group Including Discontinued Operation Fixed assets, net Disposal Group Including Discontinued Operation Property Plant And Equipment Total major classes of assets – discontinued assets Assets Of Disposal Group Including Discontinued Operation Accounts payable and accrued expenses Disposal Group Including Discontinued Operation Accounts Payable And Accrued Liabilities Note payable – short term Disposal Group Including Discontinued Operation Short Term Notes Payable Other liabilities Disposal Group Including Discontinued Operation Other Liabilities Income taxes payable Disposal Group Including Discontinued Operation Accrued Income Tax Payable Total major classes of current liabilities – discontinued liabilities Current Liabilities Of Disposal Group Including Discontinued Operation Debt Disposal Group Including Discontinued Operation Debt Total major classes of liabilities - discontinued liabilities Liabilities Of Disposal Group Including Discontinued Operation Disposal Group Including Discontinued Operation Loss On Disposal Of Business. Revenue Disposal Group Including Discontinued Operation Revenue Total operating costs and expenses Disposal Group Including Discontinued Operation Operating Expense Gain (Loss) from discontinued operations Disposal Group Including Discontinued Operation Loss On Disposal Of Business Other expense, net Disposal Group Including Discontinued Operation Other Expense Net gain (loss) from discontinued operations Net cash provided by operating activities Cash Provided By Used In Operating Activities Discontinued Operations Net cash (used in) provided by investing activities Cash Provided By Used In Investing Activities Discontinued Operations Net cash used in financing activities Cash Provided By Used In Financing Activities Discontinued Operations EX-101.PRE 10 lmfa-20200630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R1.htm IDEA: XBRL DOCUMENT v3.20.2
Document and Entity Information - shares
shares in Millions
6 Months Ended
Jun. 30, 2020
Aug. 06, 2020
Cover [Abstract]    
Document Type 10-Q  
Amendment Flag false  
Document Period End Date Jun. 30, 2020  
Document Fiscal Year Focus 2020  
Document Fiscal Period Focus Q2  
Title of 12(b) Security Common Stock par value $0.001 per share  
Security Exchange Name NASDAQ  
Trading Symbol LMFA  
Entity Registrant Name LM FUNDING AMERICA, INC.  
Entity Central Index Key 0001640384  
Current Fiscal Year End Date --12-31  
Entity Filer Category Non-accelerated Filer  
Entity Small Business true  
Entity Emerging Growth Company true  
Entity Current Reporting Status Yes  
Entity Interactive Data Current Yes  
Entity Shell Company false  
Entity Ex Transition Period false  
Entity Common Stock, Shares Outstanding   5.1
Entity File Number 001-37605  
Entity Incorporation, State or Country Code DE  
Entity Tax Identification Number 47-3844457  
Entity Address, Address Line One 1200 West Platt Street  
Entity Address, Address Line Two Suite 100  
Entity Address, City or Town Tampa  
Entity Address, State or Province FL  
Entity Address, Postal Zip Code 33606  
City Area Code 813  
Local Phone Number 222-8996  
Document Quarterly Report true  
Document Transition Report false  
XML 12 R2.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets - USD ($)
Jun. 30, 2020
Dec. 31, 2019
ASSETS    
Cash $ 6,238,678 $ 822,909
Finance receivables:    
Original product - net (Note 3) 212,121 273,711
Special product - New Neighbor Guaranty program, net of allowance for credit losses of (Note 4) 97,196 129,272
Prepaid expenses and other assets 97,008 145,267
Due from related party (Note 5)   125,045
Discontinued operations - current assets (Note 10)   276,953
Current assets 6,645,003 1,773,157
Fixed assets, net (Note 1) 6,274 8,288
Real estate assets owned (Note 1) 13,426 21,084
Operating lease - right of use assets (Note 8) 209,031 260,260
Other investments - related party (Note 1)   1,500,000
Goodwill (Note 2)   4,039,586
Other Assets 10,220 11,021
Discontinued operations - long-term assets, net (Note 10)   27,245
Long-term assets 238,951 5,867,484
Total assets 6,883,954 7,640,641
LIABILITIES AND STOCKHOLDERS' EQUITY    
Note payable (Note 6)   69,540
Related party convertible note payable   3,461,782
Accounts payable and accrued expenses 131,940 210,870
Due to related party (Note 5) 171,501  
Current portion of lease liability (Note 8) 98,846 94,235
Discontinued operations - current liabilities (Note 10)   280,057
Total current liabilities 402,287 4,116,484
Lease liability - long-term (Note 8) 121,295 171,648
Note payable - long-term (Note 6) 185,785  
Discontinued operations - long-term liabilities (Note 10)   517,584
Long-term liabilities 307,080 689,232
Total liabilities 709,367 4,805,716
Stockholders’ equity:    
Common stock, par value $.001; 30,000,000 shares authorized; 5,068,799 and 3,134,261 shares issued and outstanding as of June 30, 2020 and December 31, 2019, respectively 5,069 3,134
Additional paid-in capital 21,653,342 17,326,553
Accumulated deficit (15,483,824) (14,494,762)
Total stockholders’ equity 6,174,587 2,834,925
Total liabilities and stockholders’ equity $ 6,883,954 $ 7,640,641
XML 13 R3.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Balance Sheets (Parenthetical) - $ / shares
Jun. 30, 2020
Dec. 31, 2019
Statement Of Financial Position [Abstract]    
Common stock, par value $ 0.001 $ 0.001
Common stock, shares authorized 30,000,000 30,000,000
Common stock, shares issued 5,068,799 3,134,261
Common stock, shares outstanding 5,068,799 3,134,261
XML 14 R4.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Operations - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Revenues:        
Interest on delinquent association fees $ 170,174 $ 463,738 $ 389,688 $ 878,013
Administrative and late fees 35,423 43,314 58,468 82,807
Recoveries in excess of cost - special product 62,362 4,502 84,990 26,272
Underwriting and other revenues 41,235 74,791 69,164 115,515
Rental revenue 33,344 72,285 81,424 219,954
Total revenues 342,538 658,630 683,734 1,322,561
Operating Expenses:        
Professional fees 479,581 524,764 986,576 954,073
Settlement costs with associations   38,286 11,920 40,178
Selling, general and administrative 74,728 83,656 154,951 183,403
Recovery of cost from related party receivable (100,000)   (200,000)  
Provision for credit losses   (7,375)   (7,375)
Real estate management and disposal 14,108 100,306 99,450 297,434
Depreciation and amortization 7,954 19,526 13,766 37,391
Collection costs (20,934) 9,786 (29,255) (13,301)
Other operating expenses 6,844 16,191 10,638 15,256
Total operating expenses 774,774 1,127,326 1,676,598 2,112,390
Operating loss from continuing operations (432,236) (468,696) (992,864) (789,829)
Interest expense 5,732 52,731 12,626 53,763
Loss from continuing operations before income taxes (437,968) (521,427) (1,005,490) (843,592)
Net loss from continuing operations (437,968) (521,427) (1,005,490) (843,592)
Gain on disposal of discontinued operations     16,428  
Gain (loss) from operations of discontinued operations   70,924 16,426 (63,929)
Net gain/(loss) from discontinued operations   70,924 16,428 (63,929)
Net loss $ (437,968) $ (450,503) $ (989,062) $ (907,521)
Earnings/(loss) per share:        
Basic loss per common share - continuing operations $ (0.11) $ (0.17) $ (0.28) $ (0.27)
Basic earnings/(loss) per common share - discontinued operations   0.02 0.00 (0.02)
Basic loss per common share - net loss (0.11) (0.14) (0.28) (0.29)
Diluted loss per common share - continuing operations (0.11) (0.17) (0.28) (0.27)
Diluted earnings/(loss) per common share - discontinued operations   0.02 0.00 (0.02)
Diluted loss per common share - net loss $ (0.11) $ (0.14) $ (0.28) $ (0.29)
Weighted average number of common shares outstanding:        
Basic 3,915,123 3,134,261 3,575,098 3,133,106
Diluted 3,915,123 3,134,261 3,575,098 3,133,106
Service [Member]        
Operating Expenses:        
Staff costs and payroll $ 312,493 $ 342,186 $ 628,552 $ 605,331
XML 15 R5.htm IDEA: XBRL DOCUMENT v3.20.2
Condensed Consolidated Statements of Cash Flows - USD ($)
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
CASH FLOWS FROM OPERATING ACTIVITIES:    
Net loss $ (989,062) $ (907,521)
Adjustments to reconcile net loss to cash used in operating activities    
Depreciation and amortization 11,727 32,550
Right to use asset depreciation 51,229 4,852
Stock compensation 132,244 6,931
Recovery of cost from related party receivable (200,000)  
Gain on disposal of business unit (16,426) 63,929
Change in assets and liabilities    
Prepaid expenses and other assets 49,059 52,389
Accounts payable and accrued expenses 21,858 89,329
Repayments from related party 496,546 32,395
Other liabilities   48,578
Lease liability payments (45,742) (4,426)
Deferred taxes   (14,200)
Net cash used in operating activities (488,567) (659,123)
CASH FLOWS FROM INVESTING ACTIVITIES:    
(Payments)/proceeds for real estate assets owned (2,055) 64,101
Net cash payment for IIU disposal (246,914)  
Investment in note receivable - related party 1,500,000  
Net cash received from business acquisition   51,327
Net cash provided by investing activities 1,344,697 290,544
CASH FLOWS FROM FINANCING ACTIVITIES:    
Borrowings 185,785  
Principal repayments (69,540) (80,761)
Exercise of warrants 2,946,480 22,320
Proceeds from stock subscription 1,250,000  
Net cash provided by (used in) financing activities 4,312,725 (58,441)
NET INCREASE (DECREASE) IN CASH 5,168,855 (427,020)
CASH - BEGINNING OF YEAR 1,069,823 3,520,753
CASH - END OF YEAR 6,238,678 3,093,733
SUPPLEMENTAL DISCLOSURES OF CASHFLOW INFORMATION    
Cash paid for interest 12,626 16,743
Income taxes
SUPPLEMENTAL DISCLOSURES OF NON-CASHFLOW INFORMATION    
ROU asset obligation recognized   26,685
Original Product [Member]    
CASH FLOWS FROM INVESTING ACTIVITIES:    
Net collections of finance receivables 61,590 95,242
Special Product [Member]    
CASH FLOWS FROM INVESTING ACTIVITIES:    
Net collections of finance receivables $ 32,076 $ 79,874
XML 16 R6.htm IDEA: XBRL DOCUMENT v3.20.2
Consolidated Statements of Changes in Stockholders' Equity - USD ($)
Total
Common Stock [Member]
Additional Paid-in Capital [Member]
Accumulated Deficit [Member]
Balance at Dec. 31, 2018 $ 5,808,649 $ 3,125 $ 17,295,408 $ (11,489,884)
Balance, shares at Dec. 31, 2018   3,124,961    
Warrants exercised for cash 22,320 $ 9 22,311  
Warrants exercised for cash, shares   9,300    
Stock compensation expense 3,500   3,500  
Net loss (457,018)     (457,018)
Balance at Mar. 31, 2019 5,377,451 $ 3,134 17,321,219 (11,946,902)
Balance, shares at Mar. 31, 2019   3,134,261    
Stock compensation expense 3,431   3,431  
Net loss (450,503)     (450,503)
Balance at Jun. 30, 2019 4,930,379 $ 3,134 17,324,650 (12,397,405)
Balance, shares at Jun. 30, 2019   3,134,261    
Balance at Dec. 31, 2019 2,834,925 $ 3,134 17,326,553 (14,494,762)
Balance, shares at Dec. 31, 2019   3,134,261    
Stock compensation expense 128,847 $ 186 128,661  
Stock compensation expense, shares   186,000    
Net loss (551,094)     (551,094)
Balance at Mar. 31, 2020 2,412,678 $ 3,320 17,455,214 (15,045,856)
Balance, shares at Mar. 31, 2020   3,320,261    
Warrants exercised for cash 2,946,480 $ 1,228 2,945,252  
Warrants exercised for cash, shares   1,227,700    
Stock compensation expense 3,397   3,397  
Common stock issued for cash 1,250,000 $ 521 1,249,479  
Common stock issued for cash, Shares   520,838    
Net loss (437,968)     (437,968)
Balance at Jun. 30, 2020 $ 6,174,587 $ 5,069 $ 21,653,342 $ (15,483,824)
Balance, shares at Jun. 30, 2020   5,068,799    
XML 17 R7.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies
6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
Summary of Significant Accounting Policies

Note 1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Nature of Operations

LM Funding America, Inc. (“LMFA” or the “Company”) was formed as a Delaware corporation on April 20, 2015. LMFA was formed for the purpose of completing a public offering and related transactions in order to carry on the business of LM Funding, LLC and its subsidiaries (the “Predecessor”). LMFA is the sole member of LM Funding, LLC and operates and controls all of its businesses and affairs.

LM Funding, LLC a Florida limited liability company organized in January 2008 under the terms of an Operating Agreement effective January 8, 2008 as amended, had two members: BRR Holding, LLC and CGR 63, LLC. The members contributed their equity interest to LMFA prior to the closing of its initial public offering.

The Company acquired IIU, Inc. on January 16, 2019 (“IIU”), which provided global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies were fully underwritten with no claim risk remaining with IIU. IIU was disposed of on January 8, 2020.

We are a specialty finance company that provides funding to nonprofit community associations primarily located in the state of Florida. We offer incorporated nonprofit community associations, which we refer to as “Associations,” a variety of financial products customized to each Association’s financial needs. Our original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. Historically, we provided funding against such delinquent accounts, which we refer to as “Accounts,” in exchange for a portion of the proceeds collected by the Associations from the account debtors on the Accounts. In addition to our original product offering, we have started purchasing Accounts on varying terms tailored to suit each Association’s financial needs, including under our New Neighbor Guaranty™ program.

 

Specialty Finance Company

We purchase an Association’s right to receive a portion of the Association’s collected proceeds from owners that are not paying their assessments. After taking assignment of an Association’s right to receive a portion of the Association’s proceeds from the collection of delinquent assessments, we engage law firms to perform collection work on a deferred billing basis wherein the law firms receive payment upon collection from the account debtors or a predetermined contracted amount if payment from account debtors is less than legal fees and costs owed. Under this business model, we typically fund an amount equal to or less than the statutory minimum an Association could recover on a delinquent account for each Account, which we refer to as the “Super Lien Amount”. Upon collection of an Account, the law firm working on the Account, on behalf of the Association, generally distributes to us the funded amount, interest, and administrative late fees, with the law firm retaining legal fees and costs collected, and the Association retaining the balance of the collection. In connection with this line of business, we have developed proprietary software for servicing Accounts, which we believe enables law firms to service Accounts efficiently and profitably.

Under our New Neighbor Guaranty program, an Association will generally assign substantially all of its outstanding indebtedness and accruals on its delinquent units to us in exchange for payment by us of monthly dues on each delinquent unit. This simultaneously eliminates a substantial portion of the Association’s balance sheet bad debts and assists the Association to meet its budget by receiving guaranteed monthly payments on its delinquent units and relieving the Association from paying legal fees and costs to collect its bad debts. We believe that the combined features of the program enhance the value of the underlying real estate in an Association and the value of an Association’s delinquent receivables. We intend to leverage our proprietary software platform, as well as our industry experience and knowledge gained from our original line of business, to expand the New Neighbor Guaranty program in certain situations and to potentially develop other new products in the future.

Because we acquire and collect on the delinquent receivables of Associations, the Account debtors are third parties about whom we have little or no information. Therefore, we cannot predict when any given Account will be paid off or how much it will yield. In assessing the risk of purchasing Accounts, we review the property values of the underlying units, the governing documents of the relevant Association, and the total number of delinquent receivables held by the Association.

Specialty Finance Products

Original Product

Our original product relies upon Florida statutory provisions that effectively protect the principal amount invested by us in each Account. In particular, Section 718.116(1), Florida Statutes, makes purchasers and sellers of a unit in an Association jointly and severally liable for all past due assessments, interest, late fees, legal fees, and costs payable to the Association. As discussed above, the Florida Statutes grants to Associations a so-called “super lien”, which is a category of lien that is given a statutorily higher priority than all other types of liens other than property tax liens. The amount of the Association’s priority over a first mortgage holder that takes title to a property through foreclosure (or deed in lieu), referred to as the Super Lien Amount, is limited to twelve months’ past due assessments or, if less, one percent (1.0%) of the original mortgage amount. Under our contracts with Associations for our original product, we pay Associations an amount up to the Super Lien Amount for the right to receive all collected interest and late fees on Accounts purchased from the Associations.

The Statutes specify that the rate of interest an association (or its assignor) may charge on delinquent assessments is equal to the rate set forth in the association’s declaration or bylaws. In Florida if a rate is not specified, the statutory rate is equal to 18% but may not exceed the maximum rate allowed by law. Similarly, the Statutes in Florida also stipulate that administrative late fees cannot be charged on delinquent assessments unless so provided by the association’s declaration or bylaws and may not exceed the greater of $25 or 5% of each delinquent assessment.

In other states in which we have offered our original product, which are currently only in Washington, Colorado and Illinois, we rely on statutes that we believe are similar to the above-described Florida statutes in relevant respects. A total of approximately 22 U.S. states, Puerto Rico and the District of Columbia have super lien statutes that give Association assessments super lien status under some circumstances, and of these states, we believe that all of these jurisdictions other than Alaska have a regulatory and business environment that would enable us to offer our original product to Associations in those states on materially the same basis.

New Neighbor Guaranty

In 2012, we developed a new product, the New Neighbor Guaranty, wherein an Association assigns substantially all of its outstanding indebtedness and accruals on its delinquent units to us in exchange for payments in an amount equal to the regular ongoing monthly or quarterly assessments for delinquent units when those amounts would be due to the Association. We assume both the payment and collection obligations for these assigned Accounts under this product. This simultaneously eliminates an Association’s balance sheet bad debts and assists the Association to meet its budget by receiving guaranteed assessment payments on its delinquent units and relieving the Association from paying legal fees and costs to collect its bad debts. We believe that the combined features of the product enhance the value of the underlying real estate in an Association and the value of an Association’s delinquent receivables.

Before we implement the New Neighbor Guaranty program for an Association typically asks us to conduct a review of its accounts receivable. After we have conducted the review, we inform the Association which Accounts we are willing to purchase and the terms of such purchase. Once we implement the New Neighbor Guaranty program, we begin making scheduled payments to the Association on the Accounts as if the Association had non-delinquent residents occupying the units underlying the Accounts. Our New Neighbor Guaranty contracts typically allow us to retain all collection proceeds on each Account other than special assessments and accelerated assessment balances. Thus, the Association foregoes the potential benefit of a larger future collection in exchange for the certainty of a steady stream of immediate payments on the Account.

Recent Developments

IIU Acquisition and Disposal

On November 2, 2018, the Company invested cash by purchasing a Senior Convertible Promissory Note in the original principal amount of $1,500,000 (the “IIU Note”) from IIU, a synergistic Virginia based travel insurance brokerage company controlled by Craven House North America, LLC (“Craven”) N.A., (whose ownership excluding unexercised warrants was approximately 20% of the Company’s outstanding stock at the time of the acquisition).  The maturity date of the IIU Note was 360 dates after the date of issuance (subject to acceleration upon an event of default).  The IIU Note carried a 3.0% interest rate, with accrued but unpaid interest being payable on the IIU Note’s maturity date.  

On January 16, 2019, the Company entered into a Stock Purchase Agreement with Craven (the “IIU SPA”) to purchase all of the outstanding capital stock of IIU as a possible synergistic effort to diversify revenue sources that were believed to be accretive to earnings.  IIU provided global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies were fully underwritten with no claim risk remaining with IIU.

The Company purchased 100% of the issued and outstanding capital stock of IIU from Craven for $5,089,357 subject to adjustment as set forth in the IIU SPA.  IIU was required to have a minimum net working capital of $15,000 and at least $152,000 in cash. The Company paid the purchase price under the IIU SPA at closing as follows:

 

The Company cancelled all principal and accrued interest of the IIU Note, which consisted of aggregate principal indebtedness and accrued interest of $1,507,375 as of January 16, 2019.

 

The Company issued to Craven a $3,581,982 Senior Convertible Promissory Note (the “Craven Convertible Note”) for the balance of the purchase price.  At the option of Craven, the Craven Convertible Note could be paid in restricted shares of our common stock or cash.  The Craven Convertible Note bore simple interest at 3% per annum.  The Craven Convertible Note was due and payable 360 days from the closing date of the IIU SPA. If repaid by the Company in restricted common stock, the outstanding principal and interest of the Craven Convertible Note would be paid by the Company by issuing to Craven a number of restricted common shares equal to the adjusted principal and accrued interest owing to Craven under the Craven Convertible Note divided by $2.41. On the date of issuance of the Craven Convertible Note, the closing share price of the Company was $1.42.

 

Pursuant to the terms of the IIU SPA, the purchase price was subsequently reduced by $120,200, to $4,969,200.

On December 20, 2019, the Company loaned $1.5 million to Craven (“Craven Secured Promissory Note”) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly. The Company subsequently extended the due date of the Craven Secured Promissory Note to August 1, 2021.   The Craven Secured Promissory Note was secured by, among other things, a pledge of Craven’s 640,000 shares of common stock of the Company and the assignment of the assets of Craven in favor of the Company. On June 29, 2020, the Company received from Craven $1,503,719 as payment in full of all principal and accrued interest due from the Craven Secured Promissory Note.

On January 8, 2020, the Company entered into a Stock Purchase Agreement (“SPA”) with Craven pursuant to which the Company sold back to Craven all of the issued and outstanding shares of IIU for $3,562,569.  The purchase price was paid by Craven through the cancellation of the $3,461,782Craven Convertible Note plus forgiveness of $100,787 of accrued interest. The Company originally paid $4,969,200 for the purchase of IIU in January 2019, which included a negative $720,386 net fair value of assets and $5,689,586 of goodwill. As a result, goodwill was impaired by $1.65 million. The sale of IIU resulted in a gain of $16,428.  

Specialty Health Insurance

Our former subsidiary IIU Inc. (“IIU”) through its wholly owned company Wallach and Company (“Wallach”) offered health insurance, travel insurance and other travel services to:

 

United States citizens and residents traveling abroad

 

Non United States citizens or residents who travel to the United States

These services were typically sold through a policy offered by Wallach and fully underwritten by a third party insurance company.  The policies offered included:

 

HealthCare Abroad - Short term medical insurance, medical evacuation and international assistance for Americans traveling overseas. There is an age limit of 84 years old.

 

HealthCare Global – up to 6 months coverage for Americans traveling abroad and foreign nationals traveling outside their home countries to destinations other than the United States.  There is an age limit of 70 years old.

 

HealthCare America – up to 90 days coverage for foreign nationals visiting the United States. There is an age limit of 70 years old.

 

HealthCare International – International medical insurance & assistance for persons living outside their home country.  There is an age limit of 70 years old.

 

HealthCare War – up to 6 months coverage for Americans traveling abroad and foreign nationals traveling outside their home countries to identified war risk areas.  There is an age limit of 70 years old.

 

As such, IIU is considered a discontinued operation. We did not report any activity from operations from IIU for the six months ended June 30, 2020.

 

Entry into and Termination of Hanfor Share Exchange Agreement

On March 23, 2020, the Company entered into a Share Exchange Agreement, dated March 23, 2020 (the “Share Exchange Agreement”), with Hanfor (Cayman) Limited, a Cayman Islands exempted company (“Hanfor”), and BZ Industrial Limited, a British Virgin Islands business company and the sole stockholder of Hanfor (“Hanfor Owner”).  The Share Exchange Agreement contemplated a business combination transaction in which Hanfor Owner would transfer and assign to the Company all of the share capital of Hanfor in exchange for a number of shares of the Company’s common stock that would result in Hanfor Owner owning 86.5% of the outstanding common stock of the Company.

Under the agreement, Hanfor Owner was required to deliver to the Company audited financial statements for Hanfor for the 2019 and 2018 fiscal years, and such audited financial statements were required to be delivered by May 31, 2020 (subject to extension to June 30, 2020 under specified circumstances).  In connection with the execution of the Share Exchange Agreement, the Company and Hanfor Owner entered into a Stock Purchase Agreement, dated March 23, 2020, pursuant to which Hanfor Owner purchased from the Company an aggregate of 520,838 shares of the Company’s common stock at a price of $2.40 per share. Hanfor Owner paid $250,000 cash on March 23, 2020 and the Company received an additional $1,000,000 in April 2020 at which time the Company issued the 520,838 shares.

On July 14, 2020, the Company notified Hanfor and Hanfor Owner that the Company had elected to terminate the Share Exchange Agreement due to Hanfor’s inability to provide audited financial statements by June 30, 2020.  Although the Company believes that it properly terminated the Share Exchange Agreement, on July 21, 2020, counsel to Hanfor Owner informed the Company that Hanfor Owner believes that the Company’s termination of the Share Exchange Agreement was not effected in accordance with the terms of the Share Exchange Agreement.  The Company and Hanfor Owner are engaged in discussions to resolve this disagreement, but there is no assurance that this disagreement will be promptly resolved or resolved on terms favorable to the Company, and there is no assurance that Hanfor Owner will not seek to take legal action.

Nasdaq Listing

On March 27, 2020, the Company received a notification letter from the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has not regained compliance with Nasdaq Continued Listing Rule 5550(a)(2), which requires the Company’s listed securities to maintain a minimum bid price of $1.00 per share (the "Minimum Bid Price Rule"). The notification stated that the Company’s securities would be delisted from the Nasdaq Capital Market on April 7, 2020 unless the Company timely requested a hearing before a Nasdaq Hearing Panel.  The Company has timely requested a hearing.  However, on April 16, 2020, Nasdaq suspended any enforcement actions relating to bid price issues through June 30, 2020. On July 1, 2020, the Company received a letter from Nasdaq stating that the Company had regained compliance with the Minimum Bid Price Rule because the closing price for the Company’s common stock was $1.00 per share or greater for ten (10) consecutive business days.

Additionally, on January 3, 2020, the Company received a deficiency letter from Nasdaq, indicating that it was in violation of Listing Rules 5620(a) and 5810(c)(2)(G) by virtue of passing the applicable deadline for holding of its annual general meeting of shareholders for the financial year ended December 31, 2018.  The Company resolved this issue by having its annual general meeting of shareholders on May 11, 2020.

Reverse Stock Split Approval

On May 11, 2020, our shareholders voted in favor of the approval of an amendment to our Certificate of Incorporation, in the event it is deemed advisable by our Board of Directors, to effect an additional reverse stock split of the Company’s issued and outstanding common stock at a ratio within the range of one-for-two (1:2) and one-for-ten (1:10), as determined by the Board of Directors.  However, a reverse stock split has not yet been effected pursuant to such approval.

 

Principles of Consolidation

The condensed consolidated financial statements include the accounts of LMFA and its wholly-owned subsidiaries: LM Funding, LLC; LMF October 2010 Fund, LLC; REO Management Holdings, LLC (including all 100% owned subsidiary limited liability companies); LM Funding of Colorado, LLC; LM Funding of Washington, LLC; LM Funding of Illinois, LLC; and LMF SPE #2, LLC and various single purpose limited liability corporations owned by REO Management Holdings, LLC which own various properties. It also includes IIU and its wholly-owned subsidiary: Wallach & Company for the time that the Company owned IIU. All significant intercompany balances have been eliminated in consolidation.

 

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and note disclosures normally included in the annual consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. The interim condensed consolidated financial statements as of June 30, 2020 and for the three and six months ended June 30, 2020 and June 30, 2019, respectively are unaudited. In the opinion of management, the interim condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary to provide a fair statement of the results for the interim periods. The accompanying condensed consolidated balance sheet as of December 31, 2019, is derived from the audited consolidated financial statements presented in the Company’s Annual Report on Form 10-K for fiscal the year ended December 31, 2019.

 

Use of Estimates

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the evaluation of any probable losses on amounts funded under the Company’s New Neighbor Guaranty program as disclosed below, the evaluation of probable losses on balances due from a related party, the realization of deferred tax assets, the evaluation of contingent losses related to litigation and fair value estimates of real estate assets owned.

We are not presently aware of any events or circumstances arising from the COVID-19 pandemic that would require us to update our estimates or judgments or revise the carrying value of our assets or liabilities. Our estimates may change, however, as new events occur and additional information is obtained, and any such changes will be recognized in the condensed consolidated financial statements.

 

Revenue Recognition

Accounting Standards Codification (“ASC”) 606 of the Financial Accounting Standards Board (“FASB”) states an entity needs to conclude at the inception of the contract that collectability of the consideration to which it will be entitled in exchange for the goods and services that will be transferred to the customer is probable. That is, in some circumstances, an entity may not need to assess its ability to collect all of the consideration in the contract. The Company provides funding to community associations by purchasing their rights under delinquent accounts from unpaid assessments due from property owners (the “accounts”). Collections on the accounts may vary greatly in both the timing and amount ultimately recovered compared with the total revenues earned on the accounts because of a variety of economic and social factors affecting the real estate environment in general. The Company’s contracts with its customers have very specific performance obligations.  The Company has determined that the known amount of cash to be realized or realizable on its revenue generating activities cannot be reasonably estimated.  The Company determined rental income from leasing arrangements is specifically excluded from the standard.  The Company analyzed its remaining revenue streams and concluded there were no changes in revenue recognition with the adoption of the new standard.

 

Under ASC 606, the Company applies the cash basis method to its original product and the cost recovery method to its special product as follows:

Finance Receivables—Original Product: Under the Company’s original product, delinquent assessments are funded only up to the Super Lien Amount as discussed above. Recoverability of funded amounts is generally assured because of the protection of the Super Lien Amount. As such, payments by unit owners on the Company’s original product are recorded to income when received in accordance with the provisions of the Florida Statute (718.116(3)) and the provisions of the purchase agreements entered into between the Company and community associations. Those provisions require that all payments be applied in the following order: first to interest, then to late fees, then to costs of collection, then to legal fees expended by the Company and then to assessments owed. In accordance with the cash basis method of recognizing revenue and the provisions of the statute, the Company records revenues for interest and late fees when cash is received. In the event the Company determines the ultimate collectability of amounts funded under its original product are in doubt, payments are applied to first reduce the funded or principal amount.

Finance Receivables—Special Product (New Neighbor Guaranty program): During 2012, the Company began offering associations an alternative product under the New Neighbor Guaranty program where the Company will fund amounts in excess of the Super Lien Amount. Under this special product, the Company purchases substantially all of the delinquent assessments owed to the association, in addition to all accrued interest and late fees, in exchange for payment by the Company of (i) a negotiated amount or (ii) on a going forward basis, all monthly assessments due for a period up to 48 months. Under these arrangements, the Company considers the collection of amounts funded is not assured and under the cost recovery method, cash collected is applied to first reduce the carrying value of the funded or principal amount with any remaining proceeds applied next to interest, late fees, legal fees, collection costs and any amounts due to the community association. Any excess proceeds still remaining are recognized as revenues. If the future proceeds collected are lower than the Company’s funded or principal amount, then a loss is recognized.

Net Commission Revenue: The Company acted as an agent in providing health travel insurance policies. As a result, the Company revenue was recorded at net. The Company has determined that the known amount of cash to be realized or realizable on its revenue generating activities can be reasonably estimated and as such, classifies its receivables as accrual and recognizes revenues in the accompanying statements of income on the accrual basis.  If a policy is not effective as of the end of a period, then the associated revenue and underwriting costs are deferred until the effective date.

Cash

The Company maintains cash balances at several financial institutions that are insured under the Federal Deposit Insurance Corporation’s (“FDIC”) Transition Account Guarantee Program. Balances with the financial institutions may exceed federally insured limits.

Finance Receivables

Finance receivables are recorded at the amount funded or cost (by unit). The Company evaluates its finance receivables at each period end for losses that are considered probable and can be reasonably estimated in accordance with ASC 450-20. As discussed above, recoverability of funded amounts under the Company’s original product is generally assured because of the protection of the Super Lien Amount. However, the Company did have an accrual at June 30, 2020 and December 31, 2019 for an allowance for credit losses for this program of $112,027 and $112,027.

Under the New Neighbor Guaranty program (special product), the Company funds amounts in excess of the Super Lien Amount. When evaluating the carrying value of its finance receivables, the Company looks at the likelihood of future cash flows based on historical payoffs, the fair value of the underlying real estate, the general condition of the community association in which the unit exists, and the general economic real estate environment in the local area. The Company estimated an allowance for credit losses for this program of $6,564 as of June 30, 2020 and $20,016 at December 31, 2019 under ASC 450-20 related to its New Neighbor Guaranty program.

The Company will charge any receivable against the allowance for credit losses when management believes the collectability of the receivable is confirmed. The Company considers writing off a receivable when (i) a first mortgage holder who names the association in a foreclosure suit takes title and satisfies an estoppel letter for amounts owed which are less than amounts the Company funded to the association; (ii) a tax deed is issued with insufficient excess proceeds to pay amounts the Company funded to the association; (iii) an association settles an account for less than amounts the Company funded to the association or (iv) the association terminates its relationship with the Company’s designated legal counsel. Upon the occurrence of any of these events, the Company evaluates the potential recovery via a deficiency judgment against the prior owner and the ability to collect upon the deficiency judgment within the statute of limitations period or whether the deficiency judgment can be sold. If the Company determines that collection through a deficiency judgment or sale of a deficiency judgment is not feasible, the Company writes off the unrecoverable receivable amount. Any losses greater than the recorded allowance will be recognized as expenses. Under the Company’s revenue recognition policies, all finance receivables (original product and special product) are classified as nonaccrual.

During the six months ended June 30, 2020 and 2019, write offs charged against the allowance for credit losses were $13,452 and $20,743, respectively. Any losses greater than the recorded allowance will be recognized as expenses. Under the Company’s revenue recognition policies, all finance receivables (original product and special product) are classified as nonaccrual.

Real Estate Assets Owned

In the event collection of a delinquent assessment results in a unit being sold in a foreclosure auction, the Company has the right to bid (on behalf of the community association) for the delinquent unit as attorney in fact, applying any amounts owed for the delinquent assessment to the foreclosure price as well as any additional funds that the Company, in its sole discretion, decides to pay. If a delinquent unit becomes owned by the community association by acquiring title through an association lien foreclosure auction, by accepting a deed-in-lieu of foreclosure, or by any other way, the Company in its sole discretion may direct the community association to quitclaim title of the unit to the Company.

Properties quitclaimed to the Company are in most cases acquired subject to a first mortgage or other liens, and are recognized in the accompanying consolidated balance sheets solely at costs incurred by the Company in excess of original funding. At times, the Company will acquire properties through foreclosure actions free and clear of any mortgages or liens. In these cases, the Company records the estimated fair value of the properties in accordance with ASC 820-10, Fair Value Measurements. Any real estate held for sale is adjusted to fair value less the cost to dispose in the event the carrying value of a unit or property exceeds its estimated net realizable value.

The Company capitalizes costs incurred to acquire real estate owned properties and any costs incurred to get the units in a condition to be rented.  These costs include, but are not limited to, renovation/rehabilitation costs, legal costs, and delinquent taxes.  These costs are depreciated over the estimated minimum time period the Company expects to maintain possession of the units.  Costs incurred for unencumbered units are depreciated over 20 years and costs for units subject to a first mortgage are depreciated over 3 years.  As of June 30, 2020 and December 31, 2019, capitalized real estate costs, net of accumulated depreciation, were $13,426 and $21,084, respectively.  

During the three and six month period ended June 30, 2020 and 2019, depreciation expense was $4,110 and $9,713 for 2020 and $5,526 and $11,969 for 2019, respectively.

If the Company elects to take a quitclaim title to a unit or property held for sale, the Company is responsible to pay all future assessments on a current basis, until a change of ownership occurs. The community association must allow the Company to lease or sell the unit to satisfy obligations for delinquent assessments of the original debt. All proceeds collected from any sale of the unit shall be first applied to all amounts due the Company plus any additional funds paid by the Company to purchase the unit, if applicable. Rental revenues and sales proceeds related to real estate assets held for sale are recognized when earned and realizable. Expenditures for current assessments owed to associations, repairs and maintenance, utilities, etc. are expensed when incurred.

If the community association elects (prior to the Company obtaining title through its own election) to maintain ownership and not quitclaim title to the Company, the community association must pay the Company all interest, late fees, collection costs, and legal fees expended, plus the original funding on the unit, which have accrued according to the purchase agreement entered into by the community association and the Company. In this event, the unit will be reassigned to the community association.

Fixed Assets

The Company capitalizes all acquisitions of fixed assets in excess of $500. Fixed assets are stated at cost. Depreciation is provided on the straight-line method over the estimated useful lives of the assets. Fixed assets are comprised of furniture, computer and office equipment with an assigned useful life of 3 to 5 years. Fixed assets also include capitalized software costs. Capitalized software costs include costs to develop software to be used solely to meet the Company’s internal needs, consist of employee salaries and benefits and fees paid to outside consultants during the application development stage, and are amortized over their estimated useful life of 5 years. As of June 30, 2020 and December 31, 2019, capitalized software costs, net of accumulated amortization, was nil. Amortization expense for capitalized software costs for the three and six month period ended June 30, 2020 and 2019 was $nil and $nil for 2020 and $5,815 and $11,630 for 2019, respectively. 

Right to Use Assets

The Company capitalizes all leased assets pursuant to ASU 2016-02, "Leases (Topic 842)," which requires lessees to recognize right-of-use assets and lease liability, initially measured at present value of the lease payments, on its balance sheet for leases with terms longer than 12 months and classified as either financing or operating leases.  As of June 30, 2020 and December 31, 2019, right to use assets, net of accumulated amortization, was $209,031 and $260,260, respectively. Amortization expense for right to use assets for the three and six month period ended June 30, 2020 and 2019 was $26,136 and $51,229 for 2020 and was $2,426 and $4,852 for 2019, respectively while the payments totaled $45,742 for the six months ended June 30, 2020. 

Other Investments – Note Receivable - Related Party

On December 20, 2019, the Company loaned $1.5 million to Craven (“Craven Secured Promissory Note”) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly. The Company subsequently extended the due date of the Craven Secured Promissory Note to August 1, 2021 and allowed for the deferral of monthly interest payments.   The Craven Secured Promissory Note was secured by, among other things, Stock Pledge of Craven’s 640,000 Common Shares of the Company and the Assignment of the assets of Craven in favor of the Company. On June 29, 2020, the Company received from Craven $1,503,719 as payment in full of all principal and accrued interest due from the Craven Secured Promissory Note.

Goodwill

Goodwill represents the excess purchase price of acquired businesses over the fair value of the net assets acquired. Goodwill is not amortized, but instead is tested for impairment annually or whenever events or changes in circumstances indicate that the carrying amount may not be fully recoverable.

During the year ended December 31, 2019, the Company recorded goodwill of approximately $5.7 million which represented amounts for the purchase of IIU. For purposes of the 2019 annual test, we will elect to perform a goodwill impairment analysis to assess whether it was more likely than not that the fair value of these reporting units exceeded their respective carrying values. In performing these assessments, management will rely on a number of factors including, but not limited to, macroeconomic conditions, industry and market considerations, cost factors that would have a negative effect on earnings and cash flows, overall financial performance compared with forecasted projections in prior periods, and other relevant reporting unit events, the impact of which are all significant judgments and estimates.  This assessment was performed as of December 31, 2019 and showed a $1.65 million impairment due to the sale of IIU on January 8, 2020. The balance of goodwill as of June 30, 2020 and December 31, 2019 was approximately $0 million and $4.0 million, respectively. 

Stock Issued

In connection with the execution of the Share Exchange Agreement, the Company and Hanfor Owner entered into a Stock Purchase Agreement, dated March 23, 2020, pursuant to which Hanfor Owner purchased from Company an aggregate of 520,838 shares of the Company’s common stock at a price of $2.40 per share for a total of $1,250,000 cash.       

Debt Issue Costs

The Company capitalizes all debt issue costs and amortizes them on a method that approximates the effective interest method over the remaining term of the note payable. The Company did not have any unamortized debt issue costs at June 30, 2020 and at December 31, 2019. Any costs will be presented in the accompanying condensed consolidated balance sheets as other assets until the loan proceeds are received which at that time will be reclassified as a direct deduction from the carrying amount of that debt liability in accordance with Accounting Standards Update (“ASU”) 2015-03 (see below). The Company adopted this new standard in the first quarter of fiscal 2016. The adoption of this standard did not have a material impact on the Company's consolidated financial position and had no impact on its consolidated income or cash flows. In addition, the amortization of debt issuance costs is to be reported as interest expense under ASU 2015-03 (ASC 835-30-45-3).    

Settlement Costs with Associations

Community associations working with the Company will at times incur costs in connection with litigation initiated by the Company against property owners and or mortgage holders. These costs include settlement agreements whereby the community association agrees to pay some monetary compensation to the opposing party or judgments against the community associations for fees of opposing legal counsel or other damages awarded by the courts. The Company indemnifies the community association for these costs pursuant to the provisions of the agreement between the Company and the community association. Costs incurred by the Company for these indemnification obligations for the three and six months ended June 30, 2020 and 2019 were approximately $zero  and $12,000 for 2020 and $38,000  and $40,000 for 2019, respectively. The Company does not limit its indemnification based on amounts ultimately collected from property owners.  

Income Taxes

Income taxes are provided for the tax effects of transactions reported in the consolidated financial statements and consist of taxes currently due plus deferred taxes resulting primarily from the tax effects of temporary differences between financial and income tax reporting. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.

 

Under ASC 740-10-30-5, Income Taxes, deferred tax assets should be reduced by a valuation allowance if, based on the weight of available evidence, it is more-likely-than-not (i.e., a likelihood of more than 50%) that some portion or all of the deferred tax assets will not be realized. The Company considers all positive and negative evidence available in determining the potential realization of deferred tax assets including, primarily, the recent history of taxable earnings or losses. Based on operating losses reported by the Company during 2018, 2017 and 2016, the Company concluded there was not sufficient positive evidence to overcome this recent operating history. As a result, the Company believes that a valuation allowance was necessary based on the more-likely-than-not threshold noted above. During the year ended December 31, 2019, the Company decreased the valuation allowance to $3,634,857 to reflect a change in deferred tax assets.

Loss Per Share

Basic loss per share is calculated as net loss to common stockholders divided by the weighted average number of common shares outstanding during the period.  

The Company issued 2,500,000 shares at various times during the month of November 2018 and has weighted average these new shares in calculating loss per share.

On October 15, 2018, the Company effected a common share consolidation (“Reverse Stock Split”) by means of a one-for-ten (1:10) reverse split of its outstanding common stock, par value $0.001 per share which resulted in a decrease in outstanding common stock to 625,318 shares.  The Reverse Stock Split became effective on October 16, 2018 and the Company’s common stock began trading on The Nasdaq Global Market on a split-adjusted basis on October 16, 2018.

The Company has restated all share amounts to reflect the Reverse Stock Split.

Diluted loss per share for the period equals basic loss per share as the effect of any convertible notes, stock based compensation awards or stock warrants would be anti-dilutive.  

The anti-dilutive stock based compensation awards and convertible notes consisted of:

 

 

 

As of June 30,

 

 

2020

 

2019

Stock Options

 

19,300

 

19,300

Stock Warrants

 

2,731,587

 

3,959,287

Convertible Note

 

-

 

-

 

As part of its initial public offering, on October 23, 2015 the Company issued 1,200,000 warrants that allowed for the right to purchase 1,200,000 shares of common stock at an average exercise price of $12.50 per share. Due to the Reverse Stock Split on October 16, 2018, each warrant may only purchase one-tenth of one share of common stock at $12.50. These warrants have weighted average price of $12.50 per share and a weighted average remaining life of .44 years and .94 years as of June 30, 2020 and December 31, 2019, respectively. These warrants expire in the year 2020.  The aggregate intrinsic value of the outstanding common stock warrants as of June 30, 2020 and December 31, 2019 was $0 and $0, respectively.

 

On October 31, 2018, the Company issued warrants as part of its secondary offering that allowed for the right to purchase 2,500,000 shares of common stock at an exercise price of $2.40 per share. These warrants expire in the year 2023.  During the six months ended June 30, 2020, warrants for 1,277,700 shares were exercised for $2,946,480.

 

As part of its underwriting agreement dated, October 31, 2018, the Company issued additional warrants, effective May 1, 2019, to its underwriter as part of its secondary offering that allowed for the right to purchase 125,000 shares of common stock at an exercise price of $2.64 per share on or after May 1, 2019. These warrants expire on May 2, 2022.

 

On April 2, 2018, the Company issued warrants that allowed for the right to purchase 40,000 shares of common stock at an exercise price of $6.605 per share. If the Company, at any time this warrant is outstanding, combines its outstanding shares of Common Stock into a smaller number of shares or enters into a corporate action or transaction to change the number of outstanding share of common stock, then the exercise price is adjusted along with the number of shares that can be purchased under this agreement. Due to the subsequent issuance of stock and warrants on October 31, 2018, these warrants now have the right to purchase 143,587 shares at an exercise price of $1.84 per share. These warrants expire in the year 2023.  

 

A senior secured convertible note to Craven House Capital North America LLC (Related Party), bearing interest at 3.0% was issued on January 16, 2019 and matures on either January 14, 2020 or convertible into 1,436,424 shares of the Company's common shares. On January 8, 2020, the Company entered into a Stock Purchase Agreement (“SPA”) with Craven pursuant to which the Company sold to Craven all of the issued and outstanding shares of IIU, Inc., a Virginia based travel insurance brokerage company and wholly owned subsidiary of LMFA (“IIU”), for $3,562,569.  The purchase price was paid by Craven through the cancellation of the $3,461,782 Craven Convertible Note issued by LMFA to Craven dated January 16, 2019 plus forgiveness of $100,787 of accrued interest. LMFA originally paid $4,969,200 for the purchase of IIU in January 2019, which included a negative $720,386 net fair value of assets and $5,689,586 of goodwill. The sale of IIU resulted in a gain of $16,428.  

Stock-Based Compensation

The Company records all equity-based incentive grants to employees and non-employee members of the Company’s Board of Directors in operating expenses in the Company’s Consolidated Statements of Operations based on their fair values determined on the date of grant. Stock-based compensation expense, reduced for estimated forfeitures, is recognized on a straight-line basis over the requisite service period of the award, which is generally the vesting term of the outstanding equity awards.

Contingencies

The Company accrues for contingent obligations, including estimated legal costs, when the obligation is probable and the amount is reasonably estimable. As facts concerning contingencies become known, the Company reassesses its position and makes appropriate adjustments to the consolidated financial statements. Estimates that are particularly sensitive to future changes include those related to tax, legal and other regulatory matters.     

Fair Value of Financial Instruments

FASB ASC 825-10, Financial Instruments, requires disclosure of fair value information about financial instruments, whether or not recognized in the balance sheet. The Company engages a third-party valuation firm to assist in estimating the fair value of its finance receivables.

Risks and Uncertainties

Funding amounts are secured by a priority lien position provided under Florida law (see discussion above regarding Florida Statute 718.116). However, in the event the first mortgage holder takes title to the property, the amount payable by the mortgagee to satisfy the priority lien is capped under this same statute and would generally only be sufficient to reimburse the Company for funding amounts noted above for delinquent assessments. Amounts paid by the mortgagee would not generally reimburse the Company for interest, administrative late fees and collection costs. Even though the Company does not recognize these charges as revenues until collected, its business model and long-term viability is dependent on its ability to collect these charges.  

In the event a delinquent unit owner files for bankruptcy protection, the Company may at its option be reimbursed by the association for the amounts funded (i.e., purchase price) and all collection rights are re-assigned to the association.

Non-cash Financing and Investing Activities

During the six months ended June 30, 2020 and 2019, the Company acquired unencumbered title to certain properties as a result of foreclosure proceedings.  Properties were recorded at fair value less cost to dispose of approximately $0 and $0, respectively.  The fair value of these properties was first applied to recover the Company’s initial investment with any remaining proceeds applied to interest, late fees, and other amounts owed by the property owner.

During the six months ended June 30, 2020, the Company disposed of IIU which included assets and liabilities listed in Note 10.  

Recent Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses, which establishes a new approach for credit impairment based on an expected loss model rather than an incurred loss model. The standard requires the consideration of all available relevant information when estimating expected credit losses, including past events, current conditions and forecasts and their implications for expected credit losses.  The guidance is effective January 1, 2020 with a one-year early adoption permitted.  We adopted this new standard on January 1, 2020 and determined that this did not impact our consolidated financial statements.

Recent accounting guidance not discussed above is not applicable, did not have, or is not expected to have a material impact to the Company.

 

Reclassifications

 

Certain prior period amounts have been reclassified to conform to the current period presentation.

Subsequent Events

The Company has evaluated subsequent events through the date which the condensed consolidated financial statements were issued. 

XML 18 R8.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Acquisition
6 Months Ended
Jun. 30, 2020
Business Combinations [Abstract]  
Goodwill and Acquisition

Note 2. Goodwill and Acquisition

On November 2, 2018, the Company invested cash by purchasing stock under a Securities Purchase Agreement (the “IIU SPA”) from IIU, a synergistic Virginia based travel insurance brokerage company controlled by Craven House N.A. (whose ownership excluding unexercised warrants is approximately 20% of the Company’s outstanding stock as of the date of acquisition), pursuant to which IIU issued to the Company a Senior Convertible Promissory Note (“IIU Note”) in the original principal amount of $1,500,000 in exchange for a purchase price of $1,500,000.  The maturity date of the Note is 360 dates after the date of issuance (subject to acceleration upon an event of default).  The Note carries a 3.0% interest rate, with accrued but unpaid interest being payable on the Note’s maturity date.  

The IIU Note allows the Company the right on or after the maturity date to convert any unpaid principal and accrued and unpaid interest of the IIU Note into shares of IIU based on a conversion amount which is the fair value of the common shares of IIU at the time. The conversion price will be reset if IIU issues or sells common shares, convertibles securities or options at a price per share that is less than the conversion price in effect immediately prior to such issue or sale or deemed issuance or sale of such dilutive issuance.

On January 16, 2019, the Company entered into a Stock Purchase Agreement with Craven House North America, LLC (“Craven”) to purchase all of the outstanding shares of IIU as a possible synergistic effort to diversify revenue sources that were believed to be accretive to earnings.  IIU provided global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies are fully underwritten with no claim risk remaining with IIU.

The Board of Directors of LMFA approved the purchase of IIU. LMFA purchased 100% of the outstanding stock of IIU for $5,089,357.  LMFA paid the Purchase Price at closing as follows:

 

 

Cancellation by LMFA of all principal and accrued interest of IIU’s Promissory Note dated November 3, 2018 and issued to LMFA for principal indebtedness and accrued interest of $1,507,375.

 

LMFA issued to Craven a $3,581,982 Senior Convertible Promissory Note (“Craven Convertible Note”) for the balance of the Purchase Price.  At the option of Craven, the Convertible Note may be paid in restricted common shares of LMFA or cash.  The Craven Convertible Note shall bear simple interest at 3% per annum.  The Craven Convertible Note shall be due and payable 360 days from the Closing Date. If repaid by LMFA in restricted common stock, the outstanding principal and interest of the Craven Convertible Note shall be paid by LMFA by issuing to Seller a number of restricted common shares equal to the adjusted principal and accrued interest owing on the Craven Convertible Note divided by $2.41. On the date of issuance of the Craven Convertible Note, the closing share price of the Company was $1.42. The note principal was subsequently reduced by $120,200 arising from lower than expected Closing Cash and Net Working Capital. Craven had verbally agreed to extend repayment of this Craven Convertible Note 12 months from April 15, 2019.

 

Net cash received in the business acquisition was $51,327.As such, the $1.5 million note receivable was cancelled as of January 16, 2019.

 

The following table summarizes the approximate consideration paid and the amounts of the identified assets acquired and liabilities assumed at the acquisition date:

 

 

January 16, 2019

 

 

Total adjusted purchase price

$

4,969,200

 

 

Recognized preliminary amounts of identifiable assets acquired and (liabilities assumed), at fair value:

 

 

 

 

Cash

 

51,300

 

 

Prepaid and other current assets

 

5,200

 

 

Profit on purchased policies

 

14,600

 

 

Property, plant and equipment

 

17,100

 

 

Accounts payable

 

(5,100

)

 

Accrued expenses and other liabilities

 

(62,686

)

 

Income taxes

 

(28,500

)

 

Deferred revenue

 

(9,300

)

 

Debt

 

(703,000

)

 

Preliminary estimate of the fair value of assets and liabilities assumed

 

(720,386

)

 

 

 

 

 

 

Goodwill

$

5,689,586

 

 

 

We performed an assessment effective as of December 31, 2019 in light of the Company’s sale of IIU on January 8, 2020 which resulted in a $1.65 million goodwill impairment.  On January 8, 2020, the Company entered into a SPA with Craven pursuant to which the Company sold to Craven all of the issued and outstanding shares of IIU for $3,562,569.  The purchase price was paid by Craven through the cancellation of the $3,461,782 Convertible Promissory Note issued by LMFA to Craven dated January 16, 2019 plus forgiveness of $100,787 of accrued interest. See Note 10 Discontinued Operations.

 

XML 19 R9.htm IDEA: XBRL DOCUMENT v3.20.2
Finance Receivables - Original Product
6 Months Ended
Jun. 30, 2020
Original Product [Member]  
Finance Receivables

Note 3. Finance Receivables – Original Product

The Company’s original funding product provides financing to community associations only up to the secured or “Super Lien Amount” as discussed in Note 1.  Finance receivables for the original product as of June 30, 2020 and December 31, 2019 based on the year of funding are approximately as follows:

 

 

 

June 30, 2020

 

 

December 31,

2019 (Audited)

 

Funded during the current year

 

$

14,000

 

 

$

40,000

 

1-2 years outstanding

 

 

16,000

 

 

 

15,000

 

2-3 years outstanding

 

 

9,000

 

 

 

20,000

 

3-4 years outstanding

 

 

18,000

 

 

 

11,000

 

Greater than 4 years outstanding

 

 

267,000

 

 

 

300,000

 

 

 

 

324,000

 

 

 

386,000

 

Reserve for credit losses

 

 

(112,000

)

 

 

(112,000

)

 

 

$

212,000

 

 

$

274,000

 

Number of active units with delinquent assessments

 

 

511

 

 

 

598

 

Amount of outstanding interest and late fees on active units

 

$

8,727,000

 

 

$

9,167,000

 

 

XML 20 R10.htm IDEA: XBRL DOCUMENT v3.20.2
Finance Receivables - Special Product (New Neighbor Guaranty program)
6 Months Ended
Jun. 30, 2020
Special Product (New Neighbor Guaranty Program) [Member]  
Accounts Notes And Loans Receivable [Line Items]  
Finance Receivables

Note 4. Finance Receivables – Special Product (New Neighbor Guaranty program)

The Company typically funds amounts equal to or less than the “Super Lien Amount”.  During 2012 the Company began offering Associations an alternative product under the New Neighbor Guaranty program where the Company funds amounts in excess of the “Super Lien Amount”.  

Under this special product, the Company purchases substantially all of the outstanding past due assessments due from delinquent property owners, in addition to all interest, late fees and other charges in exchange for the Company’s commitment to pay monthly assessments on a going forward basis up to 48 months.  

As of June 30, 2020, maximum future contingent payments under these arrangements was approximately $45,000.  

Delinquent assessments and accrued charges under these arrangements as of June 30, 2020 and December 31, 2019, are as follows: 

 

 

 

June 30, 2020

 

 

December 31,

2019 (Audited)

 

Finance receivables, net

 

$

97,000

 

 

$

129,000

 

Delinquent assessments

 

 

209,000

 

 

 

374,000

 

Accrued interest and late fees

 

 

91,000

 

 

 

235,000

 

Number of active units with delinquent assessments

 

 

24

 

 

 

31

 

 

Allowance for credit losses are recorded for losses that are considered “probable” and can be “reasonably estimated” in accordance with ASC 450-20.  Recoverability of the Company’s Original Product is generally assured because of the protection of the Super Lien under Florida statute and as such no allowance is recorded.    

Credit losses on the NNG product were estimated by the Company based on analyzing the investment in each unit and comparing that balance to the average payout for completed units for the past 12 months. The allowance for losses based on these analyses, had a remaining balance of $7,000 and $20,000 as of June 30, 2020 and December 31, 2019, respectively.

 

XML 21 R11.htm IDEA: XBRL DOCUMENT v3.20.2
Due to Related Party
6 Months Ended
Jun. 30, 2020
Related Party Transactions [Abstract]  
Due to Related Party

Note 5. Due to Related Party

Legal services for the Company associated with the collection of delinquent assessments from property owners are performed by a law firm, Business Law Group (“BLG”), which was owned solely by Bruce M. Rodgers, the Chief Executive Officer of LMFA until and through the date of the initial public offering. Following the offering, Mr. Rodgers transferred his interest in BLG to other attorneys at the firm through a redemption of his interest in the firm, and BLG is now under control of those lawyers. The law firm has historically performed collection work primarily on a deferred billing basis wherein the law firm receives payment for services rendered upon collection from the property owners or at amounts ultimately subject to negotiations with the Company.

During 2016, the Company experienced a decline in collection events that affected revenues both to the Company and BLG.  That resulted in an increase in the related party receivable and reflects the decision by the Company to advance funds to BLG based on the amount of their unpaid legal fees due from property owners.  Effective January 1, 2017, the Company entered into a new services agreement with BLG which partially alters the traditional deferred billing arrangement noted above.  

 

Under the new agreement, the Company pays BLG a fixed monthly fee of $82,000 for services rendered.  The Company will continue to pay BLG a minimum per unit fee of $700 in any case where there is a collection event and BLG receives no payment from the property owner.  This provision has been expanded to also include any unit where the Company has taken title to the unit or where the association has terminated its contract with either BLG or the Company.    

Amounts expensed by the Company to BLG for the three and six months ended June 30, 2020 and 2019, respectively were approximately $250,000 and $509,000 for 2020 and $291,000 and $536,000 for 2019, respectively.  As of June 30, 2020 and December 31, 2019, receivables from property owners for charges ultimately payable to BLG approximate $1,375,000 and $1,883,000, respectively.

Under the related party agreement with BLG in effect during 2020 and 2019, the Company pays all costs (lien filing fees, process and serve costs) incurred in connection with the collection of amounts due from property owners.  Any recovery of these collection costs is accounted for as a reduction in expense incurred.  The Company incurred expenses related to these types of costs for the three and six months ended June 30, 2020 and 2019 were $31,000 and $67,000 for 2020 and $62,000 and $109,000 for 2019, respectively. Recoveries during the three and six months ended June 30, 2020 and 2019, related to those costs were approximately $51,000 and $96,000 for 2020 and $52,000 and $122,000 for 2019, respectively.  

The Company also shares office space and related common expenses with BLG.  All shared expenses, including rent, are charged to the legal firm based on an estimate of actual usage.  Any expenses of BLG paid by the Company that have not been reimbursed or settled against other amounts are reflected as due from related parties in the accompanying consolidated balance sheet. BLG was charged approximately $30,000 for the office sub-lease.

Amounts (payable) receivable from BLG as of June 30, 2020 and December 31, 2019 were approximately ($171,500) and $152,800, respectively. In the first six months of June 30, 2020, the Company subsequently recouped $200,000 of previously write-off amounts to BLG.

On December 20, 2019, the Company loaned $1.5 million to Craven in the form of a secured promissory note (the “Craven Secured

Promissory Note”) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly.

The Company subsequently extended the due date of the Craven Secured Promissory Note and the monthly interest payments to August 1, 2021. The Craven Secured Promissory Note is secured by, among other things, stock pledge of Craven’s 640,000 common stock of the Company and the assignment of the assets of Craven in favor of the Company.  This loan and the accrued interest was repaid on June 29, 2020.

XML 22 R12.htm IDEA: XBRL DOCUMENT v3.20.2
Debt and Other Financing Arrangements
6 Months Ended
Jun. 30, 2020
Debt Disclosure [Abstract]  
Debt and Other Financing Arrangements

Note 6. Debt and Other Financing Arrangements

 

 

 

 

June 30, 2020

 

 

December 31,

2019 (Audited)

 

Financing agreement with FlatIron capital that is unsecured.  Down payment of $19,170 was required upfront and equal installment payments of $11,590 to be made over a 11 month period. The note matures June 1, 2020. Annualized interest is 6.8%

 

$

-

 

 

$

69,540

 

 

 

 

 

 

 

 

 

 

Promissory note issued by a financial institution, bearing interest at 1.0%, interest and no principal payments.   The note matures April 30, 2022. Annualized interest is 1.0%. This is a U.S. Small Business Administration’s Paycheck Protection Program (the “PPP Loan”)

 

$

185,785

 

 

$

-

 

 

 

 

 

 

 

 

 

 

Senior secured convertible note to Craven House Capital North America LLC (Related Party), bearing interest at 3.0%.  Note was issued on January 16, 2019 and either matured on January 14, 2020 or became convertible into 1,436,424 shares of the Company's common shares. The value of the beneficial conversion feature as of January 16, 2019 was zero*.

 

 

-

 

 

 

3,461,782

 

 

 

 

 

 

 

 

 

 

Promissory note issued by a financial institution, bearing interest at 9.09%, interest and principal payments due monthly of $323.  Note is secured by an automobile and was issued on July 26, 2019 with original borrowings of $12,892.  The note matures on August 26, 2023.

 

 

-

 

 

 

11,802

 

 

 

 

 

 

 

 

 

 

Promissory note issued by a financial institution, bearing interest at 5.85%, interest and principal payments due monthly of $10,932. Note was issued on May 31, 2018 with original borrowings of $608,000 and subsequent borrowings of $141,000 and repayments of $51,000.  The note matures on May 30, 2025 and can be prepaid at any time without penalty. This note is secured by the Company’s inventory, chattel paper, accounts, equipment and general intangible intangibles and deposit accounts.

 

 

-

 

 

 

606,454

 

 

 

 

 

 

 

 

 

 

 

 

$

185,785

 

 

$

4,149,578

 

 

 

 


As of June 30, 2020, minimum annual principal payments are as follows:

Years Ending

 

 

 

 

December 31,

 

 

 

 

2020

 

 

-

 

2021

 

 

-

 

2022

 

 

185,785

 

2023

 

 

-

 

2024

 

 

-

 

After 2024

 

 

-

 

 

 

$

185,785

 

 

On April 30, 2020, the company obtained a $185,785 Paycheck Protection Program loan. These business loans were established by the 2020 US Federal government Coronavirus Aid, Relief, and Economic Security Act (“CARES Act”) to help certain businesses, self-employed workers, sole proprietors, certain nonprofit organizations, and tribal businesses continue paying their workers.

 

The Paycheck Protection Program allows entities to apply for low interest private loans to pay for their payroll and certain other costs. The loan proceeds will be used to cover payroll costs, rent, interest, and utilities. The loan may be partially or fully forgiven if the Company keeps its employee counts and employee wages stable. The program was implemented by the U.S. Small Business Administration. The interest rate is 1.0% and has a maturity date of 2 years. We anticipate applying for loan and interest forgiveness in the third quarter of 2020.

 

 

XML 23 R13.htm IDEA: XBRL DOCUMENT v3.20.2
Going Concern
6 Months Ended
Jun. 30, 2020
Organization Consolidation And Presentation Of Financial Statements [Abstract]  
Going Concern

Note 7. Going Concern

 The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern, which contemplates realization of assets and the satisfaction of liabilities in the normal course of business within one year after the date the consolidated financial statements are issued.

In accordance with Financial Accounting Standards Board, or the FASB, Accounting Standards Update No. 2014-15, Presentation of Financial Statements - Going Concern (Subtopic 205-40), our management evaluates whether there are conditions or events, considered in aggregate, that raise substantial doubt about our ability to continue as a going concern within one year after the date that the financial statements are issued.

The Company has experienced significant operating losses over the past 4 years (2016 through June 30, 2020) with cumulative losses of approximately $15,046,000 and negative cashflows from operations. These losses resulted in the usage of all cash proceeds from the Company’s initial public offering in 2015. For the year ended December 31, 2019, the Company disclosed the substantial doubt about the Company’s ability to continue as a going concern

The Company received a total of approximately $5.7 million during the three months ended June 30, 2020 due to a number of factors including:

 

Holders of our warrants exercised such warrants for 1.2 million shares in June 2020 which resulted in the Company receiving approximately $2.9 million.

 

The Company was repaid approximately $1.5 million on a related party receivable.

 

The Company received $1.25 million for the issuance of 520,838 common shares.

 

As such, we have $6.2 million of cash which will be enough to satisfy our estimated liquidity needs for the 12 months from the issuance of these financial statements. These factors mitigated the substantial doubt about the Company’s ability to continue as a going concern as defined by ASU 2014-15.

  

XML 24 R14.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments and Contingencies
6 Months Ended
Jun. 30, 2020
Commitments And Contingencies Disclosure [Abstract]  
Commitments and Contingencies

Note 8. Commitments and Contingencies

Leases

The Company leases certain office space, construction and office equipment, vehicles and temporary housing generally under non-cancelable operating leases. Leases with an initial term of one year or less are not recorded on the balance sheet, and the Company generally recognizes lease expense for these leases on a straight-line basis over the lease term. As of June 30, 2020, the Company’s operating leases have remaining lease terms ranging from less than one year to 3 years, some of which include options to renew the leases. The exercise of lease renewal options is generally at the Company’s sole discretion. The Company’s leases do not contain any material residual value guarantees or material restrictive covenants.

The Company determines if an arrangement is a lease at inception. Operating lease ROU assets and current and long-term operating lease liabilities are separately stated on the Consolidated Balance Sheet as of June 30, 2020. ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. ROU assets and lease liabilities are recognized at the commencement date based on the present value of lease payments over the lease term. The present value of future lease payments are discounted using either the implicit rate in the lease, if known, or the Company’s incremental borrowing rate for the specific lease as of the lease commencement date. The rate was determined as a fair value of the lease over a 37 month period using a 6.5% interest rate for the present value calculation. The ROU asset is also adjusted for any prepayments made or incentives received. The lease terms include options to extend or terminate the lease only to the extent it is reasonably certain any of those options will be exercised. Lease expense is recognized on a straight-line basis over the lease term. The Company accounts for lease components (e.g., fixed payments) separate from the non-lease components (e.g., common-area maintenance costs). The Company does not have any material financing leases.

The Company leased its office under an operating lease beginning March 1, 2014 and ending July 31, 2019. The Company’s new office lease began July 15, 2019 and ends July 31, 2022. It also had a month to month lease for its IIU operations in 2019. A related party has a sub-lease for approximately $4,900 per month plus operating expenses.

 

The Company shares this space and the related costs associated with this operating lease with a related party (see Note 5) that also performs legal services associated with the collection of delinquent assessments.  Net rent expense recognized for the three and six months ended June 30, 2020 and 2019 were approximately $20,000 and $50,000 for 2020 and $38,000 and $97,000 for 2019, respectively.

 

The following table presents components of lease expense excluding discontinued operations for the three and six months ended June 30, 2020 and 2019:

 

 

Three Months

Ended

June 30,

2020

 

Six Months

Ended

June 30,

2020

Three Months

Ended

June 30,

2019

Six Months

Ended

June 30,

2019

Operating lease expense

$

20,377

$

50,109

38,457

97,301

 

$

20,377

$

50,109

38,457

97,301

 

The following table presents supplemental balance sheet information related to operating leases as of June 30, 2020 and December 31, 2019:

 

 

 

Balance Sheet Line Item

As of June 30, 2020

 

As of December 31, 2019

 

 

 

Assets

 

 

 

 

 

 

 

 

 

 

ROU assets

 

Right of use asset, net

$

209,031

 

$

260,260

 

 

 

Total lease assets

 

 

$

209,031

 

$

260,260

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

Current lease liabilities

 

Lease liability

$

98,846

 

$

94,235

 

 

 

Long-term lease liabilities

 

Lease liability

 

121,295

 

 

171,648

 

 

 

Total lease liabilities

 

 

$

220,141

 

$

265,883

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average remaining lease term (in years)

 

 

 

2.13

 

 

2.60

 

 

 

Weighted-average discount rate

 

 

 

6.55

%

 

6.55

%

 

 

 

The following table presents supplemental cash flow information and non-cash activity related to operating leases for the six months ended June 30, 2020 and 2019:

 

 

 

 

Six Months Ended June 30, 2020

 

Six Months Ended June 30, 2019

 

 

 

Operating cash flow information

 

 

 

 

 

 

 

 

 

 

Cash paid for amounts included in the measurement of lease liabilities

 

 

$

(45,742

)

$

(4,426

)

 

 

Supplemental Disclosure of non-cashflow information

 

 

 

 

 

 

 

 

 

 

ROU assets and operating lease obligation recognized

 

 

$

-

 

$

26,685

 

 

 

 

The following table presents maturities of operating lease liabilities on an undiscounted basis as of June 30, 2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Leases

 

 

 

 

 

2020 (excluding the six months ended June 30, 2020)

 

 

$

48,493

 

 

 

 

 

2021

 

 

 

103,646

 

 

 

 

 

2022

 

 

 

68,002

 

 

 

 

 

 

 

 

$

220,141

 

 

 

 

 

 

Legal Proceedings

Other than the lawsuits described below, we are not currently a party to material litigation proceedings. However, we frequently become party to litigation in the ordinary course of business, including either the prosecution or defense of claims arising from contracts by and between us and client Associations. Regardless of the outcome, litigation can have an adverse impact on us because of prosecution, defense, and settlement costs, diversion of management resources and other factors.

 

The Company accrues for contingent obligations, including estimated legal costs, when the obligation is probable and the amount is reasonably estimable. As facts concerning contingencies become known, the Company reassesses its position and makes appropriate adjustments to the consolidated financial statements. Estimates that are particularly sensitive to future changes include those related to tax, legal, and other regulatory matters.

 

XML 25 R15.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity
6 Months Ended
Jun. 30, 2020
Equity [Abstract]  
Stockholders' Equity

Note 9. Stockholders’ Equity

Stock Options

The 2015 Omnibus Incentive Plan provides for the issuance of stock options, stock appreciation rights, performance shares,

performance units, restricted stock, restricted stock units, shares of our common stock, dividend equivalent units, incentive cash

awards or other awards based on our common stock. Awards may be granted alone or in addition to, in tandem with, or (subject to the

2015 Omnibus Incentive Plan’s prohibitions on repricing) in substitution for any other award (or any other award granted under

another plan of ours or of any of our affiliates).

 

The following is a summary of the stock option plan activity during the six months ended June 30, 2020 and 2019:

 

 

 

2020

 

 

2019

 

 

 

Number of

 

 

Weighted Average

 

 

Number of

 

 

Weighted Average

 

 

 

Options

 

 

Exercise Price

 

 

Options

 

 

Exercise Price

 

Options Outstanding at Beginning of the year

 

 

19,300

 

 

$

60.51

 

 

 

19,300

 

 

$

60.51

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Adjustment

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Forfeited

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding at June 30,

 

 

19,300

 

 

$

60.51

 

 

 

19,300

 

 

$

60.51

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Exercisable at June 30,

 

 

11,800

 

 

$

84.49

 

 

 

7,634

 

 

$

113.81

 

 

Compensation expense recognized from the vesting of stock options was approximately $6,800 and $7,800 for the three months ended June 30, 2020 and 2019. The remaining unrecognized compensation cost associated with unvested stock options as of June 30, 2020 is approximately $11,400.

 

The aggregate intrinsic value of the outstanding common stock options as of June 30, 2020 and December 31, 2019 was $0 and $0 respectively.

 

Warrants

 

The following is a summary of the warrant activity during the six months ended June 30, 2020 and 2019:

 

 

 

2020

 

 

2019

 

 

 

Number of

 

 

Weighted Average

 

 

Number of

 

 

Weighted Average

 

 

 

Warrants

 

 

Exercise Price

 

 

Warrants

 

 

Exercise Price

 

Warrants Outstanding at Beginning of the year

 

 

3,959,287

 

 

$

5.36

 

 

 

3,843,587

 

 

$

5.44

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

-

 

 

 

-

 

 

 

125,000

 

 

 

2.64

 

Exercised

 

 

1,227,700

 

 

 

2.40

 

 

 

9,300

 

 

 

2.40

 

Forfeited

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Warrants Outstanding at June 30,

 

 

2,731,587

 

 

$

6.83

 

 

 

3,959,287

 

 

$

5.36

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

During June 2020, the Company received approximately $2,946,480 upon the exercise by warrant holders of warrants for 1,227,700 shares.

 

Common Share Issuance

On March 23, 2020, the Company entered into a Share Exchange Agreement, dated March 23, 2020 (the “Share Exchange Agreement”), with Hanfor (Cayman) Limited, a Cayman Islands exempted company (“Hanfor”), and BZ Industrial Limited, a British Virgin Islands business company and the sole stockholder of Hanfor (“Hanfor Owner”).  In connection with the execution of the Share Exchange Agreement, the Company and Hanfor Owner entered into a Stock Purchase Agreement, dated March 23, 2020, pursuant to which Hanfor Owner purchased from Company an aggregate of 520,833 shares of the Company’s common stock at a price of $2.40 per share. Hanfor Owner paid $250,000 cash on March 23, 2020 and the Company received the remaining $1.0 million in April 2020 2020 at which time the Company issued the 520,838 shares.

 

On March 23, 2020, the Company issued 186,000 shares to Maxim Holdings LLC for services and recognized $125,450 as stock compensation expense for the six months ended June 30, 2020.

 

XML 26 R16.htm IDEA: XBRL DOCUMENT v3.20.2
Discontinued Operations
6 Months Ended
Jun. 30, 2020
I I U Inc | Stock Purchase Agreement  
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]  
Discontinued Operations

Note 10. Discontinued Operations

On January 8, 2020, the Company entered into a Stock Purchase Agreement (“SPA”) with Craven pursuant to which the Company sold to Craven all of the issued and outstanding shares of IIU for $3,562,569.  The purchase price was paid by Craven through the cancellation of the $3,461,782 Craven Convertible Note plus forgiveness of $100,787 of accrued interest. The Company originally paid $4,969,586 of goodwill. As a result, goodwill was impaired by $1.65 million. The sale of IIU resulted in a gain of $16,428.  

 

The impact of this transaction is reflected as a discontinued operation in the consolidated financial statements. Pursuant to ASU 2014-08, the major classes of assets and liabilities of IIU were as follows:

 

 

As of December 31, 2019

Major classes of assets

 

Cash

$   246,914

Related party receivable

27,738

Prepaid expenses

2,301

Total major classes of current assets – discontinued assets

276,953

Fixed assets, net

27,245

Total major classes of assets – discontinued assets

$   304,198

 

 

Accounts payable and accrued expenses

$   144,006

Note payable – short term

100,672

Other liabilities

21,153

Income taxes payable

14,226

Total major classes of current liabilities – discontinued liabilities

280,057

 

 

Debt

517,584

Total major classes of liabilities - discontinued liabilities

$   797,641

 

 

 

The operating results for IIU, Inc. have been presented in the accompanying consolidated financial statements of operations for the three and six months ended June 30, 2020 and 2019 as discontinued operations are summarized below:

 

 

Three Months Ended June 30, 2020

Three Months Ended June 30, 2019

 

Six Months Ended June 30, 2020

 

Six Months Ended June 30, 2019

Revenue

$              -

$      181,391

$              -

$       280,159

Total operating costs and expenses

-

100,511

-

327,377

Gain (Loss) from discontinued operations

-

80,880

-

(47,218)

Other expense, net

-

9,956

-

16,711

Gain on disposal of discontinued operations

-

-

16,428

-

Net gain (loss) from discontinued operations

$               -

$  70,924

$     16,428

$  (63,929)

 

 

 

 

 

Net cash provided by operating activities

$                -

$ 169,009

$                -

113,829

Net cash (used in) provided by investing activities

  -

-

(246,914)

51,327

Net cash used in financing activities

-

(18,452)

 

(37,886)

 

XML 27 R17.htm IDEA: XBRL DOCUMENT v3.20.2
Subsequent Events
6 Months Ended
Jun. 30, 2020
Subsequent Events [Abstract]  
Subsequent Events

 

 

XML 28 R18.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies (Policies)
6 Months Ended
Jun. 30, 2020
Accounting Policies [Abstract]  
Nature of Operations

Nature of Operations

LM Funding America, Inc. (“LMFA” or the “Company”) was formed as a Delaware corporation on April 20, 2015. LMFA was formed for the purpose of completing a public offering and related transactions in order to carry on the business of LM Funding, LLC and its subsidiaries (the “Predecessor”). LMFA is the sole member of LM Funding, LLC and operates and controls all of its businesses and affairs.

LM Funding, LLC a Florida limited liability company organized in January 2008 under the terms of an Operating Agreement effective January 8, 2008 as amended, had two members: BRR Holding, LLC and CGR 63, LLC. The members contributed their equity interest to LMFA prior to the closing of its initial public offering.

The Company acquired IIU, Inc. on January 16, 2019 (“IIU”), which provided global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies were fully underwritten with no claim risk remaining with IIU. IIU was disposed of on January 8, 2020.

We are a specialty finance company that provides funding to nonprofit community associations primarily located in the state of Florida. We offer incorporated nonprofit community associations, which we refer to as “Associations,” a variety of financial products customized to each Association’s financial needs. Our original product offering consists of providing funding to Associations by purchasing their rights under delinquent accounts that are selected by the Associations arising from unpaid Association assessments. Historically, we provided funding against such delinquent accounts, which we refer to as “Accounts,” in exchange for a portion of the proceeds collected by the Associations from the account debtors on the Accounts. In addition to our original product offering, we have started purchasing Accounts on varying terms tailored to suit each Association’s financial needs, including under our New Neighbor Guaranty™ program.

 

Specialty Finance Company

We purchase an Association’s right to receive a portion of the Association’s collected proceeds from owners that are not paying their assessments. After taking assignment of an Association’s right to receive a portion of the Association’s proceeds from the collection of delinquent assessments, we engage law firms to perform collection work on a deferred billing basis wherein the law firms receive payment upon collection from the account debtors or a predetermined contracted amount if payment from account debtors is less than legal fees and costs owed. Under this business model, we typically fund an amount equal to or less than the statutory minimum an Association could recover on a delinquent account for each Account, which we refer to as the “Super Lien Amount”. Upon collection of an Account, the law firm working on the Account, on behalf of the Association, generally distributes to us the funded amount, interest, and administrative late fees, with the law firm retaining legal fees and costs collected, and the Association retaining the balance of the collection. In connection with this line of business, we have developed proprietary software for servicing Accounts, which we believe enables law firms to service Accounts efficiently and profitably.

Under our New Neighbor Guaranty program, an Association will generally assign substantially all of its outstanding indebtedness and accruals on its delinquent units to us in exchange for payment by us of monthly dues on each delinquent unit. This simultaneously eliminates a substantial portion of the Association’s balance sheet bad debts and assists the Association to meet its budget by receiving guaranteed monthly payments on its delinquent units and relieving the Association from paying legal fees and costs to collect its bad debts. We believe that the combined features of the program enhance the value of the underlying real estate in an Association and the value of an Association’s delinquent receivables. We intend to leverage our proprietary software platform, as well as our industry experience and knowledge gained from our original line of business, to expand the New Neighbor Guaranty program in certain situations and to potentially develop other new products in the future.

Because we acquire and collect on the delinquent receivables of Associations, the Account debtors are third parties about whom we have little or no information. Therefore, we cannot predict when any given Account will be paid off or how much it will yield. In assessing the risk of purchasing Accounts, we review the property values of the underlying units, the governing documents of the relevant Association, and the total number of delinquent receivables held by the Association.

Specialty Finance Products

Original Product

Our original product relies upon Florida statutory provisions that effectively protect the principal amount invested by us in each Account. In particular, Section 718.116(1), Florida Statutes, makes purchasers and sellers of a unit in an Association jointly and severally liable for all past due assessments, interest, late fees, legal fees, and costs payable to the Association. As discussed above, the Florida Statutes grants to Associations a so-called “super lien”, which is a category of lien that is given a statutorily higher priority than all other types of liens other than property tax liens. The amount of the Association’s priority over a first mortgage holder that takes title to a property through foreclosure (or deed in lieu), referred to as the Super Lien Amount, is limited to twelve months’ past due assessments or, if less, one percent (1.0%) of the original mortgage amount. Under our contracts with Associations for our original product, we pay Associations an amount up to the Super Lien Amount for the right to receive all collected interest and late fees on Accounts purchased from the Associations.

The Statutes specify that the rate of interest an association (or its assignor) may charge on delinquent assessments is equal to the rate set forth in the association’s declaration or bylaws. In Florida if a rate is not specified, the statutory rate is equal to 18% but may not exceed the maximum rate allowed by law. Similarly, the Statutes in Florida also stipulate that administrative late fees cannot be charged on delinquent assessments unless so provided by the association’s declaration or bylaws and may not exceed the greater of $25 or 5% of each delinquent assessment.

In other states in which we have offered our original product, which are currently only in Washington, Colorado and Illinois, we rely on statutes that we believe are similar to the above-described Florida statutes in relevant respects. A total of approximately 22 U.S. states, Puerto Rico and the District of Columbia have super lien statutes that give Association assessments super lien status under some circumstances, and of these states, we believe that all of these jurisdictions other than Alaska have a regulatory and business environment that would enable us to offer our original product to Associations in those states on materially the same basis.

New Neighbor Guaranty

In 2012, we developed a new product, the New Neighbor Guaranty, wherein an Association assigns substantially all of its outstanding indebtedness and accruals on its delinquent units to us in exchange for payments in an amount equal to the regular ongoing monthly or quarterly assessments for delinquent units when those amounts would be due to the Association. We assume both the payment and collection obligations for these assigned Accounts under this product. This simultaneously eliminates an Association’s balance sheet bad debts and assists the Association to meet its budget by receiving guaranteed assessment payments on its delinquent units and relieving the Association from paying legal fees and costs to collect its bad debts. We believe that the combined features of the product enhance the value of the underlying real estate in an Association and the value of an Association’s delinquent receivables.

Before we implement the New Neighbor Guaranty program for an Association typically asks us to conduct a review of its accounts receivable. After we have conducted the review, we inform the Association which Accounts we are willing to purchase and the terms of such purchase. Once we implement the New Neighbor Guaranty program, we begin making scheduled payments to the Association on the Accounts as if the Association had non-delinquent residents occupying the units underlying the Accounts. Our New Neighbor Guaranty contracts typically allow us to retain all collection proceeds on each Account other than special assessments and accelerated assessment balances. Thus, the Association foregoes the potential benefit of a larger future collection in exchange for the certainty of a steady stream of immediate payments on the Account.

Recent Developments

IIU Acquisition and Disposal

On November 2, 2018, the Company invested cash by purchasing a Senior Convertible Promissory Note in the original principal amount of $1,500,000 (the “IIU Note”) from IIU, a synergistic Virginia based travel insurance brokerage company controlled by Craven House North America, LLC (“Craven”) N.A., (whose ownership excluding unexercised warrants was approximately 20% of the Company’s outstanding stock at the time of the acquisition).  The maturity date of the IIU Note was 360 dates after the date of issuance (subject to acceleration upon an event of default).  The IIU Note carried a 3.0% interest rate, with accrued but unpaid interest being payable on the IIU Note’s maturity date.  

On January 16, 2019, the Company entered into a Stock Purchase Agreement with Craven (the “IIU SPA”) to purchase all of the outstanding capital stock of IIU as a possible synergistic effort to diversify revenue sources that were believed to be accretive to earnings.  IIU provided global medical insurance products for international travelers, specializing in policies covering high-risk destinations, emerging markets and foreign travelers coming to the United States. All policies were fully underwritten with no claim risk remaining with IIU.

The Company purchased 100% of the issued and outstanding capital stock of IIU from Craven for $5,089,357 subject to adjustment as set forth in the IIU SPA.  IIU was required to have a minimum net working capital of $15,000 and at least $152,000 in cash. The Company paid the purchase price under the IIU SPA at closing as follows:

 

The Company cancelled all principal and accrued interest of the IIU Note, which consisted of aggregate principal indebtedness and accrued interest of $1,507,375 as of January 16, 2019.

 

The Company issued to Craven a $3,581,982 Senior Convertible Promissory Note (the “Craven Convertible Note”) for the balance of the purchase price.  At the option of Craven, the Craven Convertible Note could be paid in restricted shares of our common stock or cash.  The Craven Convertible Note bore simple interest at 3% per annum.  The Craven Convertible Note was due and payable 360 days from the closing date of the IIU SPA. If repaid by the Company in restricted common stock, the outstanding principal and interest of the Craven Convertible Note would be paid by the Company by issuing to Craven a number of restricted common shares equal to the adjusted principal and accrued interest owing to Craven under the Craven Convertible Note divided by $2.41. On the date of issuance of the Craven Convertible Note, the closing share price of the Company was $1.42.

 

Pursuant to the terms of the IIU SPA, the purchase price was subsequently reduced by $120,200, to $4,969,200.

On December 20, 2019, the Company loaned $1.5 million to Craven (“Craven Secured Promissory Note”) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly. The Company subsequently extended the due date of the Craven Secured Promissory Note to August 1, 2021.   The Craven Secured Promissory Note was secured by, among other things, a pledge of Craven’s 640,000 shares of common stock of the Company and the assignment of the assets of Craven in favor of the Company. On June 29, 2020, the Company received from Craven $1,503,719 as payment in full of all principal and accrued interest due from the Craven Secured Promissory Note.

On January 8, 2020, the Company entered into a Stock Purchase Agreement (“SPA”) with Craven pursuant to which the Company sold back to Craven all of the issued and outstanding shares of IIU for $3,562,569.  The purchase price was paid by Craven through the cancellation of the $3,461,782Craven Convertible Note plus forgiveness of $100,787 of accrued interest. The Company originally paid $4,969,200 for the purchase of IIU in January 2019, which included a negative $720,386 net fair value of assets and $5,689,586 of goodwill. As a result, goodwill was impaired by $1.65 million. The sale of IIU resulted in a gain of $16,428.  

Specialty Health Insurance

Our former subsidiary IIU Inc. (“IIU”) through its wholly owned company Wallach and Company (“Wallach”) offered health insurance, travel insurance and other travel services to:

 

United States citizens and residents traveling abroad

 

Non United States citizens or residents who travel to the United States

These services were typically sold through a policy offered by Wallach and fully underwritten by a third party insurance company.  The policies offered included:

 

HealthCare Abroad - Short term medical insurance, medical evacuation and international assistance for Americans traveling overseas. There is an age limit of 84 years old.

 

HealthCare Global – up to 6 months coverage for Americans traveling abroad and foreign nationals traveling outside their home countries to destinations other than the United States.  There is an age limit of 70 years old.

 

HealthCare America – up to 90 days coverage for foreign nationals visiting the United States. There is an age limit of 70 years old.

 

HealthCare International – International medical insurance & assistance for persons living outside their home country.  There is an age limit of 70 years old.

 

HealthCare War – up to 6 months coverage for Americans traveling abroad and foreign nationals traveling outside their home countries to identified war risk areas.  There is an age limit of 70 years old.

 

As such, IIU is considered a discontinued operation. We did not report any activity from operations from IIU for the six months ended June 30, 2020.

 

Entry into and Termination of Hanfor Share Exchange Agreement

On March 23, 2020, the Company entered into a Share Exchange Agreement, dated March 23, 2020 (the “Share Exchange Agreement”), with Hanfor (Cayman) Limited, a Cayman Islands exempted company (“Hanfor”), and BZ Industrial Limited, a British Virgin Islands business company and the sole stockholder of Hanfor (“Hanfor Owner”).  The Share Exchange Agreement contemplated a business combination transaction in which Hanfor Owner would transfer and assign to the Company all of the share capital of Hanfor in exchange for a number of shares of the Company’s common stock that would result in Hanfor Owner owning 86.5% of the outstanding common stock of the Company.

Under the agreement, Hanfor Owner was required to deliver to the Company audited financial statements for Hanfor for the 2019 and 2018 fiscal years, and such audited financial statements were required to be delivered by May 31, 2020 (subject to extension to June 30, 2020 under specified circumstances).  In connection with the execution of the Share Exchange Agreement, the Company and Hanfor Owner entered into a Stock Purchase Agreement, dated March 23, 2020, pursuant to which Hanfor Owner purchased from the Company an aggregate of 520,838 shares of the Company’s common stock at a price of $2.40 per share. Hanfor Owner paid $250,000 cash on March 23, 2020 and the Company received an additional $1,000,000 in April 2020 at which time the Company issued the 520,838 shares.

On July 14, 2020, the Company notified Hanfor and Hanfor Owner that the Company had elected to terminate the Share Exchange Agreement due to Hanfor’s inability to provide audited financial statements by June 30, 2020.  Although the Company believes that it properly terminated the Share Exchange Agreement, on July 21, 2020, counsel to Hanfor Owner informed the Company that Hanfor Owner believes that the Company’s termination of the Share Exchange Agreement was not effected in accordance with the terms of the Share Exchange Agreement.  The Company and Hanfor Owner are engaged in discussions to resolve this disagreement, but there is no assurance that this disagreement will be promptly resolved or resolved on terms favorable to the Company, and there is no assurance that Hanfor Owner will not seek to take legal action.

Nasdaq Listing

On March 27, 2020, the Company received a notification letter from the Nasdaq Listing Qualifications department of The Nasdaq Stock Market LLC (“Nasdaq”) stating that the Company has not regained compliance with Nasdaq Continued Listing Rule 5550(a)(2), which requires the Company’s listed securities to maintain a minimum bid price of $1.00 per share (the "Minimum Bid Price Rule"). The notification stated that the Company’s securities would be delisted from the Nasdaq Capital Market on April 7, 2020 unless the Company timely requested a hearing before a Nasdaq Hearing Panel.  The Company has timely requested a hearing.  However, on April 16, 2020, Nasdaq suspended any enforcement actions relating to bid price issues through June 30, 2020. On July 1, 2020, the Company received a letter from Nasdaq stating that the Company had regained compliance with the Minimum Bid Price Rule because the closing price for the Company’s common stock was $1.00 per share or greater for ten (10) consecutive business days.

Additionally, on January 3, 2020, the Company received a deficiency letter from Nasdaq, indicating that it was in violation of Listing Rules 5620(a) and 5810(c)(2)(G) by virtue of passing the applicable deadline for holding of its annual general meeting of shareholders for the financial year ended December 31, 2018.  The Company resolved this issue by having its annual general meeting of shareholders on May 11, 2020.

Reverse Stock Split Approval

On May 11, 2020, our shareholders voted in favor of the approval of an amendment to our Certificate of Incorporation, in the event it is deemed advisable by our Board of Directors, to effect an additional reverse stock split of the Company’s issued and outstanding common stock at a ratio within the range of one-for-two (1:2) and one-for-ten (1:10), as determined by the Board of Directors.  However, a reverse stock split has not yet been effected pursuant to such approval.

 

Principles of Consolidation

Principles of Consolidation

The condensed consolidated financial statements include the accounts of LMFA and its wholly-owned subsidiaries: LM Funding, LLC; LMF October 2010 Fund, LLC; REO Management Holdings, LLC (including all 100% owned subsidiary limited liability companies); LM Funding of Colorado, LLC; LM Funding of Washington, LLC; LM Funding of Illinois, LLC; and LMF SPE #2, LLC and various single purpose limited liability corporations owned by REO Management Holdings, LLC which own various properties. It also includes IIU and its wholly-owned subsidiary: Wallach & Company for the time that the Company owned IIU. All significant intercompany balances have been eliminated in consolidation.

 

Basis of Presentation

Basis of Presentation

The accompanying unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and note disclosures normally included in the annual consolidated financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. The interim condensed consolidated financial statements as of June 30, 2020 and for the three and six months ended June 30, 2020 and June 30, 2019, respectively are unaudited. In the opinion of management, the interim condensed consolidated financial statements include all adjustments, consisting only of normal recurring adjustments, necessary to provide a fair statement of the results for the interim periods. The accompanying condensed consolidated balance sheet as of December 31, 2019, is derived from the audited consolidated financial statements presented in the Company’s Annual Report on Form 10-K for fiscal the year ended December 31, 2019.

 

Use of Estimates

Use of Estimates

The preparation of consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. Significant estimates include the evaluation of any probable losses on amounts funded under the Company’s New Neighbor Guaranty program as disclosed below, the evaluation of probable losses on balances due from a related party, the realization of deferred tax assets, the evaluation of contingent losses related to litigation and fair value estimates of real estate assets owned.

We are not presently aware of any events or circumstances arising from the COVID-19 pandemic that would require us to update our estimates or judgments or revise the carrying value of our assets or liabilities. Our estimates may change, however, as new events occur and additional information is obtained, and any such changes will be recognized in the condensed consolidated financial statements.

Revenue Recognition

Revenue Recognition

Accounting Standards Codification (“ASC”) 606 of the Financial Accounting Standards Board (“FASB”) states an entity needs to conclude at the inception of the contract that collectability of the consideration to which it will be entitled in exchange for the goods and services that will be transferred to the customer is probable. That is, in some circumstances, an entity may not need to assess its ability to collect all of the consideration in the contract. The Company provides funding to community associations by purchasing their rights under delinquent accounts from unpaid assessments due from property owners (the “accounts”). Collections on the accounts may vary greatly in both the timing and amount ultimately recovered compared with the total revenues earned on the accounts because of a variety of economic and social factors affecting the real estate environment in general. The Company’s contracts with its customers have very specific performance obligations.  The Company has determined that the known amount of cash to be realized or realizable on its revenue generating activities cannot be reasonably estimated.  The Company determined rental income from leasing arrangements is specifically excluded from the standard.  The Company analyzed its remaining revenue streams and concluded there were no changes in revenue recognition with the adoption of the new standard.

 

Under ASC 606, the Company applies the cash basis method to its original product and the cost recovery method to its special product as follows:

Finance Receivables—Original Product: Under the Company’s original product, delinquent assessments are funded only up to the Super Lien Amount as discussed above. Recoverability of funded amounts is generally assured because of the protection of the Super Lien Amount. As such, payments by unit owners on the Company’s original product are recorded to income when received in accordance with the provisions of the Florida Statute (718.116(3)) and the provisions of the purchase agreements entered into between the Company and community associations. Those provisions require that all payments be applied in the following order: first to interest, then to late fees, then to costs of collection, then to legal fees expended by the Company and then to assessments owed. In accordance with the cash basis method of recognizing revenue and the provisions of the statute, the Company records revenues for interest and late fees when cash is received. In the event the Company determines the ultimate collectability of amounts funded under its original product are in doubt, payments are applied to first reduce the funded or principal amount.

Finance Receivables—Special Product (New Neighbor Guaranty program): During 2012, the Company began offering associations an alternative product under the New Neighbor Guaranty program where the Company will fund amounts in excess of the Super Lien Amount. Under this special product, the Company purchases substantially all of the delinquent assessments owed to the association, in addition to all accrued interest and late fees, in exchange for payment by the Company of (i) a negotiated amount or (ii) on a going forward basis, all monthly assessments due for a period up to 48 months. Under these arrangements, the Company considers the collection of amounts funded is not assured and under the cost recovery method, cash collected is applied to first reduce the carrying value of the funded or principal amount with any remaining proceeds applied next to interest, late fees, legal fees, collection costs and any amounts due to the community association. Any excess proceeds still remaining are recognized as revenues. If the future proceeds collected are lower than the Company’s funded or principal amount, then a loss is recognized.

Net Commission Revenue: The Company acted as an agent in providing health travel insurance policies. As a result, the Company revenue was recorded at net. The Company has determined that the known amount of cash to be realized or realizable on its revenue generating activities can be reasonably estimated and as such, classifies its receivables as accrual and recognizes revenues in the accompanying statements of income on the accrual basis.  If a policy is not effective as of the end of a period, then the associated revenue and underwriting costs are deferred until the effective date.

Cash

Cash

The Company maintains cash balances at several financial institutions that are insured under the Federal Deposit Insurance Corporation’s (“FDIC”) Transition Account Guarantee Program. Balances with the financial institutions may exceed federally insured limits.

Financing Receivables

Finance Receivables

Finance receivables are recorded at the amount funded or cost (by unit). The Company evaluates its finance receivables at each period end for losses that are considered probable and can be reasonably estimated in accordance with ASC 450-20. As discussed above, recoverability of funded amounts under the Company’s original product is generally assured because of the protection of the Super Lien Amount. However, the Company did have an accrual at June 30, 2020 and December 31, 2019 for an allowance for credit losses for this program of $112,027 and $112,027.

Under the New Neighbor Guaranty program (special product), the Company funds amounts in excess of the Super Lien Amount. When evaluating the carrying value of its finance receivables, the Company looks at the likelihood of future cash flows based on historical payoffs, the fair value of the underlying real estate, the general condition of the community association in which the unit exists, and the general economic real estate environment in the local area. The Company estimated an allowance for credit losses for this program of $6,564 as of June 30, 2020 and $20,016 at December 31, 2019 under ASC 450-20 related to its New Neighbor Guaranty program.

The Company will charge any receivable against the allowance for credit losses when management believes the collectability of the receivable is confirmed. The Company considers writing off a receivable when (i) a first mortgage holder who names the association in a foreclosure suit takes title and satisfies an estoppel letter for amounts owed which are less than amounts the Company funded to the association; (ii) a tax deed is issued with insufficient excess proceeds to pay amounts the Company funded to the association; (iii) an association settles an account for less than amounts the Company funded to the association or (iv) the association terminates its relationship with the Company’s designated legal counsel. Upon the occurrence of any of these events, the Company evaluates the potential recovery via a deficiency judgment against the prior owner and the ability to collect upon the deficiency judgment within the statute of limitations period or whether the deficiency judgment can be sold. If the Company determines that collection through a deficiency judgment or sale of a deficiency judgment is not feasible, the Company writes off the unrecoverable receivable amount. Any losses greater than the recorded allowance will be recognized as expenses. Under the Company’s revenue recognition policies, all finance receivables (original product and special product) are classified as nonaccrual.

During the six months ended June 30, 2020 and 2019, write offs charged against the allowance for credit losses were $13,452 and $20,743, respectively. Any losses greater than the recorded allowance will be recognized as expenses. Under the Company’s revenue recognition policies, all finance receivables (original product and special product) are classified as nonaccrual.

Real Estate Assets Owned

Real Estate Assets Owned

In the event collection of a delinquent assessment results in a unit being sold in a foreclosure auction, the Company has the right to bid (on behalf of the community association) for the delinquent unit as attorney in fact, applying any amounts owed for the delinquent assessment to the foreclosure price as well as any additional funds that the Company, in its sole discretion, decides to pay. If a delinquent unit becomes owned by the community association by acquiring title through an association lien foreclosure auction, by accepting a deed-in-lieu of foreclosure, or by any other way, the Company in its sole discretion may direct the community association to quitclaim title of the unit to the Company.

Properties quitclaimed to the Company are in most cases acquired subject to a first mortgage or other liens, and are recognized in the accompanying consolidated balance sheets solely at costs incurred by the Company in excess of original funding. At times, the Company will acquire properties through foreclosure actions free and clear of any mortgages or liens. In these cases, the Company records the estimated fair value of the properties in accordance with ASC 820-10, Fair Value Measurements. Any real estate held for sale is adjusted to fair value less the cost to dispose in the event the carrying value of a unit or property exceeds its estimated net realizable value.

The Company capitalizes costs incurred to acquire real estate owned properties and any costs incurred to get the units in a condition to be rented.  These costs include, but are not limited to, renovation/rehabilitation costs, legal costs, and delinquent taxes.  These costs are depreciated over the estimated minimum time period the Company expects to maintain possession of the units.  Costs incurred for unencumbered units are depreciated over 20 years and costs for units subject to a first mortgage are depreciated over 3 years.  As of June 30, 2020 and December 31, 2019, capitalized real estate costs, net of accumulated depreciation, were $13,426 and $21,084, respectively.  

During the three and six month period ended June 30, 2020 and 2019, depreciation expense was $4,110 and $9,713 for 2020 and $5,526 and $11,969 for 2019, respectively.

If the Company elects to take a quitclaim title to a unit or property held for sale, the Company is responsible to pay all future assessments on a current basis, until a change of ownership occurs. The community association must allow the Company to lease or sell the unit to satisfy obligations for delinquent assessments of the original debt. All proceeds collected from any sale of the unit shall be first applied to all amounts due the Company plus any additional funds paid by the Company to purchase the unit, if applicable. Rental revenues and sales proceeds related to real estate assets held for sale are recognized when earned and realizable. Expenditures for current assessments owed to associations, repairs and maintenance, utilities, etc. are expensed when incurred.

If the community association elects (prior to the Company obtaining title through its own election) to maintain ownership and not quitclaim title to the Company, the community association must pay the Company all interest, late fees, collection costs, and legal fees expended, plus the original funding on the unit, which have accrued according to the purchase agreement entered into by the community association and the Company. In this event, the unit will be reassigned to the community association.

Fixed Assets

Fixed Assets

The Company capitalizes all acquisitions of fixed assets in excess of $500. Fixed assets are stated at cost. Depreciation is provided on the straight-line method over the estimated useful lives of the assets. Fixed assets are comprised of furniture, computer and office equipment with an assigned useful life of 3 to 5 years. Fixed assets also include capitalized software costs. Capitalized software costs include costs to develop software to be used solely to meet the Company’s internal needs, consist of employee salaries and benefits and fees paid to outside consultants during the application development stage, and are amortized over their estimated useful life of 5 years. As of June 30, 2020 and December 31, 2019, capitalized software costs, net of accumulated amortization, was nil. Amortization expense for capitalized software costs for the three and six month period ended June 30, 2020 and 2019 was $nil and $nil for 2020 and $5,815 and $11,630 for 2019, respectively. 

Right to Use Assets

Right to Use Assets

The Company capitalizes all leased assets pursuant to ASU 2016-02, "Leases (Topic 842)," which requires lessees to recognize right-of-use assets and lease liability, initially measured at present value of the lease payments, on its balance sheet for leases with terms longer than 12 months and classified as either financing or operating leases.  As of June 30, 2020 and December 31, 2019, right to use assets, net of accumulated amortization, was $209,031 and $260,260, respectively. Amortization expense for right to use assets for the three and six month period ended June 30, 2020 and 2019 was $26,136 and $51,229 for 2020 and was $2,426 and $4,852 for 2019, respectively while the payments totaled $45,742 for the six months ended June 30, 2020. 

Other Investments - Note Receivable - Related Party

Other Investments – Note Receivable - Related Party

On December 20, 2019, the Company loaned $1.5 million to Craven (“Craven Secured Promissory Note”) which had an initial maturity date of April 15, 2020 and carried an interest rate of 0.5% that was to be paid monthly. The Company subsequently extended the due date of the Craven Secured Promissory Note to August 1, 2021 and allowed for the deferral of monthly interest payments.   The Craven Secured Promissory Note was secured by, among other things, Stock Pledge of Craven’s 640,000 Common Shares of the Company and the Assignment of the assets of Craven in favor of the Company. On June 29, 2020, the Company received from Craven $1,503,719 as payment in full of all principal and accrued interest due from the Craven Secured Promissory Note.

Goodwill

Goodwill

Goodwill represents the excess purchase price of acquired businesses over the fair value of the net assets acquired. Goodwill is not amortized, but instead is tested for impairment annually or whenever events or changes in circumstances indicate that the carrying amount may not be fully recoverable.

During the year ended December 31, 2019, the Company recorded goodwill of approximately $5.7 million which represented amounts for the purchase of IIU. For purposes of the 2019 annual test, we will elect to perform a goodwill impairment analysis to assess whether it was more likely than not that the fair value of these reporting units exceeded their respective carrying values. In performing these assessments, management will rely on a number of factors including, but not limited to, macroeconomic conditions, industry and market considerations, cost factors that would have a negative effect on earnings and cash flows, overall financial performance compared with forecasted projections in prior periods, and other relevant reporting unit events, the impact of which are all significant judgments and estimates.  This assessment was performed as of December 31, 2019 and showed a $1.65 million impairment due to the sale of IIU on January 8, 2020. The balance of goodwill as of June 30, 2020 and December 31, 2019 was approximately $0 million and $4.0 million, respectively. 

Stock Issued

Stock Issued

In connection with the execution of the Share Exchange Agreement, the Company and Hanfor Owner entered into a Stock Purchase Agreement, dated March 23, 2020, pursuant to which Hanfor Owner purchased from Company an aggregate of 520,838 shares of the Company’s common stock at a price of $2.40 per share for a total of $1,250,000 cash.       

Debt Issue Costs

The Company capitalizes all debt issue costs and amortizes them on a method that approximates the effective interest method over the remaining term of the note payable. The Company did not have any unamortized debt issue costs at June 30, 2020 and at December 31, 2019. Any costs will be presented in the accompanying condensed consolidated balance sheets as other assets until the loan proceeds are received which at that time will be reclassified as a direct deduction from the carrying amount of that debt liability in accordance with Accounting Standards Update (“ASU”) 2015-03 (see below). The Company adopted this new standard in the first quarter of fiscal 2016. The adoption of this standard did not have a material impact on the Company's consolidated financial position and had no impact on its consolidated income or cash flows. In addition, the amortization of debt issuance costs is to be reported as interest expense under ASU 2015-03 (ASC 835-30-45-3).    

Settlement Costs with Associations

Settlement Costs with Associations

Community associations working with the Company will at times incur costs in connection with litigation initiated by the Company against property owners and or mortgage holders. These costs include settlement agreements whereby the community association agrees to pay some monetary compensation to the opposing party or judgments against the community associations for fees of opposing legal counsel or other damages awarded by the courts. The Company indemnifies the community association for these costs pursuant to the provisions of the agreement between the Company and the community association. Costs incurred by the Company for these indemnification obligations for the three and six months ended June 30, 2020 and 2019 were approximately $zero  and $12,000 for 2020 and $38,000  and $40,000 for 2019, respectively. The Company does not limit its indemnification based on amounts ultimately collected from property owners.  

Income Taxes

Income Taxes

Income taxes are provided for the tax effects of transactions reported in the consolidated financial statements and consist of taxes currently due plus deferred taxes resulting primarily from the tax effects of temporary differences between financial and income tax reporting. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled.

 

Under ASC 740-10-30-5, Income Taxes, deferred tax assets should be reduced by a valuation allowance if, based on the weight of available evidence, it is more-likely-than-not (i.e., a likelihood of more than 50%) that some portion or all of the deferred tax assets will not be realized. The Company considers all positive and negative evidence available in determining the potential realization of deferred tax assets including, primarily, the recent history of taxable earnings or losses. Based on operating losses reported by the Company during 2018, 2017 and 2016, the Company concluded there was not sufficient positive evidence to overcome this recent operating history. As a result, the Company believes that a valuation allowance was necessary based on the more-likely-than-not threshold noted above. During the year ended December 31, 2019, the Company decreased the valuation allowance to $3,634,857 to reflect a change in deferred tax assets.

Loss Per Share

Loss Per Share

Basic loss per share is calculated as net loss to common stockholders divided by the weighted average number of common shares outstanding during the period.  

The Company issued 2,500,000 shares at various times during the month of November 2018 and has weighted average these new shares in calculating loss per share.

On October 15, 2018, the Company effected a common share consolidation (“Reverse Stock Split”) by means of a one-for-ten (1:10) reverse split of its outstanding common stock, par value $0.001 per share which resulted in a decrease in outstanding common stock to 625,318 shares.  The Reverse Stock Split became effective on October 16, 2018 and the Company’s common stock began trading on The Nasdaq Global Market on a split-adjusted basis on October 16, 2018.

The Company has restated all share amounts to reflect the Reverse Stock Split.

Diluted loss per share for the period equals basic loss per share as the effect of any convertible notes, stock based compensation awards or stock warrants would be anti-dilutive.  

The anti-dilutive stock based compensation awards and convertible notes consisted of:

 

 

 

As of June 30,

 

 

2020

 

2019

Stock Options

 

19,300

 

19,300

Stock Warrants

 

2,731,587

 

3,959,287

Convertible Note

 

-

 

-

 

As part of its initial public offering, on October 23, 2015 the Company issued 1,200,000 warrants that allowed for the right to purchase 1,200,000 shares of common stock at an average exercise price of $12.50 per share. Due to the Reverse Stock Split on October 16, 2018, each warrant may only purchase one-tenth of one share of common stock at $12.50. These warrants have weighted average price of $12.50 per share and a weighted average remaining life of .44 years and .94 years as of June 30, 2020 and December 31, 2019, respectively. These warrants expire in the year 2020.  The aggregate intrinsic value of the outstanding common stock warrants as of June 30, 2020 and December 31, 2019 was $0 and $0, respectively.

 

On October 31, 2018, the Company issued warrants as part of its secondary offering that allowed for the right to purchase 2,500,000 shares of common stock at an exercise price of $2.40 per share. These warrants expire in the year 2023.  During the six months ended June 30, 2020, warrants for 1,277,700 shares were exercised for $2,946,480.

 

As part of its underwriting agreement dated, October 31, 2018, the Company issued additional warrants, effective May 1, 2019, to its underwriter as part of its secondary offering that allowed for the right to purchase 125,000 shares of common stock at an exercise price of $2.64 per share on or after May 1, 2019. These warrants expire on May 2, 2022.

 

On April 2, 2018, the Company issued warrants that allowed for the right to purchase 40,000 shares of common stock at an exercise price of $6.605 per share. If the Company, at any time this warrant is outstanding, combines its outstanding shares of Common Stock into a smaller number of shares or enters into a corporate action or transaction to change the number of outstanding share of common stock, then the exercise price is adjusted along with the number of shares that can be purchased under this agreement. Due to the subsequent issuance of stock and warrants on October 31, 2018, these warrants now have the right to purchase 143,587 shares at an exercise price of $1.84 per share. These warrants expire in the year 2023.  

 

A senior secured convertible note to Craven House Capital North America LLC (Related Party), bearing interest at 3.0% was issued on January 16, 2019 and matures on either January 14, 2020 or convertible into 1,436,424 shares of the Company's common shares. On January 8, 2020, the Company entered into a Stock Purchase Agreement (“SPA”) with Craven pursuant to which the Company sold to Craven all of the issued and outstanding shares of IIU, Inc., a Virginia based travel insurance brokerage company and wholly owned subsidiary of LMFA (“IIU”), for $3,562,569.  The purchase price was paid by Craven through the cancellation of the $3,461,782 Craven Convertible Note issued by LMFA to Craven dated January 16, 2019 plus forgiveness of $100,787 of accrued interest. LMFA originally paid $4,969,200 for the purchase of IIU in January 2019, which included a negative $720,386 net fair value of assets and $5,689,586 of goodwill. The sale of IIU resulted in a gain of $16,428.  

Stock-Based Compensation

Stock-Based Compensation

The Company records all equity-based incentive grants to employees and non-employee members of the Company’s Board of Directors in operating expenses in the Company’s Consolidated Statements of Operations based on their fair values determined on the date of grant. Stock-based compensation expense, reduced for estimated forfeitures, is recognized on a straight-line basis over the requisite service period of the award, which is generally the vesting term of the outstanding equity awards.

Contingencies

Contingencies

The Company accrues for contingent obligations, including estimated legal costs, when the obligation is probable and the amount is reasonably estimable. As facts concerning contingencies become known, the Company reassesses its position and makes appropriate adjustments to the consolidated financial statements. Estimates that are particularly sensitive to future changes include those related to tax, legal and other regulatory matters.     

Fair Value of Financial Instruments

Fair Value of Financial Instruments

FASB ASC 825-10, Financial Instruments, requires disclosure of fair value information about financial instruments, whether or not recognized in the balance sheet. The Company engages a third-party valuation firm to assist in estimating the fair value of its finance receivables.

Risks and Uncertainties

Risks and Uncertainties

Funding amounts are secured by a priority lien position provided under Florida law (see discussion above regarding Florida Statute 718.116). However, in the event the first mortgage holder takes title to the property, the amount payable by the mortgagee to satisfy the priority lien is capped under this same statute and would generally only be sufficient to reimburse the Company for funding amounts noted above for delinquent assessments. Amounts paid by the mortgagee would not generally reimburse the Company for interest, administrative late fees and collection costs. Even though the Company does not recognize these charges as revenues until collected, its business model and long-term viability is dependent on its ability to collect these charges.  

In the event a delinquent unit owner files for bankruptcy protection, the Company may at its option be reimbursed by the association for the amounts funded (i.e., purchase price) and all collection rights are re-assigned to the association.

Non-cash Financing and Investing Activities

Non-cash Financing and Investing Activities

During the six months ended June 30, 2020 and 2019, the Company acquired unencumbered title to certain properties as a result of foreclosure proceedings.  Properties were recorded at fair value less cost to dispose of approximately $0 and $0, respectively.  The fair value of these properties was first applied to recover the Company’s initial investment with any remaining proceeds applied to interest, late fees, and other amounts owed by the property owner.

During the six months ended June 30, 2020, the Company disposed of IIU which included assets and liabilities listed in Note 10.  

Recent Accounting Pronouncements Not Yet Adopted

Recent Accounting Pronouncements

In June 2016, the FASB issued ASU 2016-13, Financial Instruments - Credit Losses, which establishes a new approach for credit impairment based on an expected loss model rather than an incurred loss model. The standard requires the consideration of all available relevant information when estimating expected credit losses, including past events, current conditions and forecasts and their implications for expected credit losses.  The guidance is effective January 1, 2020 with a one-year early adoption permitted.  We adopted this new standard on January 1, 2020 and determined that this did not impact our consolidated financial statements.

Recent accounting guidance not discussed above is not applicable, did not have, or is not expected to have a material impact to the Company.

Reclassifications

Reclassifications

 

Certain prior period amounts have been reclassified to conform to the current period presentation.

Subsequent Events

Subsequent Events

The Company has evaluated subsequent events through the date which the condensed consolidated financial statements were issued. 

XML 29 R19.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies (Tables)
6 Months Ended
Jun. 30, 2020
Earnings Per Share [Abstract]  
Summary of Anti-dilutive Stock Based Compensation Awards and Convertible Notes The anti-dilutive stock based compensation awards and convertible notes consisted of:

 

 

As of June 30,

 

 

2020

 

2019

Stock Options

 

19,300

 

19,300

Stock Warrants

 

2,731,587

 

3,959,287

Convertible Note

 

-

 

-

XML 30 R20.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Acquisition (Tables)
6 Months Ended
Jun. 30, 2020
Business Combinations [Abstract]  
Summary of Consideration Paid and Amounts of Identified Assets Acquired and Liabilities Assumed

The following table summarizes the approximate consideration paid and the amounts of the identified assets acquired and liabilities assumed at the acquisition date:

 

 

January 16, 2019

 

 

Total adjusted purchase price

$

4,969,200

 

 

Recognized preliminary amounts of identifiable assets acquired and (liabilities assumed), at fair value:

 

 

 

 

Cash

 

51,300

 

 

Prepaid and other current assets

 

5,200

 

 

Profit on purchased policies

 

14,600

 

 

Property, plant and equipment

 

17,100

 

 

Accounts payable

 

(5,100

)

 

Accrued expenses and other liabilities

 

(62,686

)

 

Income taxes

 

(28,500

)

 

Deferred revenue

 

(9,300

)

 

Debt

 

(703,000

)

 

Preliminary estimate of the fair value of assets and liabilities assumed

 

(720,386

)

 

 

 

 

 

 

Goodwill

$

5,689,586

 

 

XML 31 R21.htm IDEA: XBRL DOCUMENT v3.20.2
Finance Receivables - Original Product (Tables)
6 Months Ended
Jun. 30, 2020
Receivables [Abstract]  
Schedule of Finance Receivables for Original Product

The Company’s original funding product provides financing to community associations only up to the secured or “Super Lien Amount” as discussed in Note 1.  Finance receivables for the original product as of June 30, 2020 and December 31, 2019 based on the year of funding are approximately as follows:

 

 

 

June 30, 2020

 

 

December 31,

2019 (Audited)

 

Funded during the current year

 

$

14,000

 

 

$

40,000

 

1-2 years outstanding

 

 

16,000

 

 

 

15,000

 

2-3 years outstanding

 

 

9,000

 

 

 

20,000

 

3-4 years outstanding

 

 

18,000

 

 

 

11,000

 

Greater than 4 years outstanding

 

 

267,000

 

 

 

300,000

 

 

 

 

324,000

 

 

 

386,000

 

Reserve for credit losses

 

 

(112,000

)

 

 

(112,000

)

 

 

$

212,000

 

 

$

274,000

 

Number of active units with delinquent assessments

 

 

511

 

 

 

598

 

Amount of outstanding interest and late fees on active units

 

$

8,727,000

 

 

$

9,167,000

 

 

XML 32 R22.htm IDEA: XBRL DOCUMENT v3.20.2
Finance Receivables - Special Product (New Neighbor Guaranty program) (Tables)
6 Months Ended
Jun. 30, 2020
Receivables [Abstract]  
Schedule of Delinquent Assessments and Accrued Charges

Delinquent assessments and accrued charges under these arrangements as of June 30, 2020 and December 31, 2019, are as follows: 

 

 

June 30, 2020

 

 

December 31,

2019 (Audited)

 

Finance receivables, net

 

$

97,000

 

 

$

129,000

 

Delinquent assessments

 

 

209,000

 

 

 

374,000

 

Accrued interest and late fees

 

 

91,000

 

 

 

235,000

 

Number of active units with delinquent assessments

 

 

24

 

 

 

31

 

XML 33 R23.htm IDEA: XBRL DOCUMENT v3.20.2
Debt and Other Financing Arrangements (Tables)
6 Months Ended
Jun. 30, 2020
Debt Disclosure [Abstract]  
Schedule of Debt

 

 

 

June 30, 2020

 

 

December 31,

2019 (Audited)

 

Financing agreement with FlatIron capital that is unsecured.  Down payment of $19,170 was required upfront and equal installment payments of $11,590 to be made over a 11 month period. The note matures June 1, 2020. Annualized interest is 6.8%

 

$

-

 

 

$

69,540

 

 

 

 

 

 

 

 

 

 

Promissory note issued by a financial institution, bearing interest at 1.0%, interest and no principal payments.   The note matures April 30, 2022. Annualized interest is 1.0%. This is a U.S. Small Business Administration’s Paycheck Protection Program (the “PPP Loan”)

 

$

185,785

 

 

$

-

 

 

 

 

 

 

 

 

 

 

Senior secured convertible note to Craven House Capital North America LLC (Related Party), bearing interest at 3.0%.  Note was issued on January 16, 2019 and either matured on January 14, 2020 or became convertible into 1,436,424 shares of the Company's common shares. The value of the beneficial conversion feature as of January 16, 2019 was zero*.

 

 

-

 

 

 

3,461,782

 

 

 

 

 

 

 

 

 

 

Promissory note issued by a financial institution, bearing interest at 9.09%, interest and principal payments due monthly of $323.  Note is secured by an automobile and was issued on July 26, 2019 with original borrowings of $12,892.  The note matures on August 26, 2023.

 

 

-

 

 

 

11,802

 

 

 

 

 

 

 

 

 

 

Promissory note issued by a financial institution, bearing interest at 5.85%, interest and principal payments due monthly of $10,932. Note was issued on May 31, 2018 with original borrowings of $608,000 and subsequent borrowings of $141,000 and repayments of $51,000.  The note matures on May 30, 2025 and can be prepaid at any time without penalty. This note is secured by the Company’s inventory, chattel paper, accounts, equipment and general intangible intangibles and deposit accounts.

 

 

-

 

 

 

606,454

 

 

 

 

 

 

 

 

 

 

 

 

$

185,785

 

 

$

4,149,578

 

 

Schedule of Principal Payments of Debt

 


As of June 30, 2020, minimum annual principal payments are as follows:

Years Ending

 

 

 

 

December 31,

 

 

 

 

2020

 

 

-

 

2021

 

 

-

 

2022

 

 

185,785

 

2023

 

 

-

 

2024

 

 

-

 

After 2024

 

 

-

 

 

 

$

185,785

 

 

XML 34 R24.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments and Contingencies (Tables)
6 Months Ended
Jun. 30, 2020
Commitments And Contingencies Disclosure [Abstract]  
Components of Lease Expense

The following table presents components of lease expense excluding discontinued operations for the three and six months ended June 30, 2020 and 2019:

 

 

Three Months

Ended

June 30,

2020

 

Six Months

Ended

June 30,

2020

Three Months

Ended

June 30,

2019

Six Months

Ended

June 30,

2019

Operating lease expense

$

20,377

$

50,109

38,457

97,301

 

$

20,377

$

50,109

38,457

97,301

 

Summary of Supplemental Balance Sheet Information Related to Operating Leases

The following table presents supplemental balance sheet information related to operating leases as of June 30, 2020 and December 31, 2019:

 

 

 

Balance Sheet Line Item

As of June 30, 2020

 

As of December 31, 2019

 

 

 

Assets

 

 

 

 

 

 

 

 

 

 

ROU assets

 

Right of use asset, net

$

209,031

 

$

260,260

 

 

 

Total lease assets

 

 

$

209,031

 

$

260,260

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Liabilities

 

 

 

 

 

 

 

 

 

 

Current lease liabilities

 

Lease liability

$

98,846

 

$

94,235

 

 

 

Long-term lease liabilities

 

Lease liability

 

121,295

 

 

171,648

 

 

 

Total lease liabilities

 

 

$

220,141

 

$

265,883

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Weighted-average remaining lease term (in years)

 

 

 

2.13

 

 

2.60

 

 

 

Weighted-average discount rate

 

 

 

6.55

%

 

6.55

%

 

 

 

Summary of Supplemental Cash Flow Information and Non-cash Activity Related to Operating Leases

The following table presents supplemental cash flow information and non-cash activity related to operating leases for the six months ended June 30, 2020 and 2019:

 

 

 

 

Six Months Ended June 30, 2020

 

Six Months Ended June 30, 2019

 

 

 

Operating cash flow information

 

 

 

 

 

 

 

 

 

 

Cash paid for amounts included in the measurement of lease liabilities

 

 

$

(45,742

)

$

(4,426

)

 

 

Supplemental Disclosure of non-cashflow information

 

 

 

 

 

 

 

 

 

 

ROU assets and operating lease obligation recognized

 

 

$

-

 

$

26,685

 

 

 

Schedule of Future Minimum Lease Payment Due

The following table presents maturities of operating lease liabilities on an undiscounted basis as of June 30, 2020:

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Operating Leases

 

 

 

 

 

2020 (excluding the six months ended June 30, 2020)

 

 

$

48,493

 

 

 

 

 

2021

 

 

 

103,646

 

 

 

 

 

2022

 

 

 

68,002

 

 

 

 

 

 

 

 

$

220,141

 

 

 

 

 

 

XML 35 R25.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity (Tables)
6 Months Ended
Jun. 30, 2020
Equity [Abstract]  
Summary of Stock Option Plan Activity

The following is a summary of the stock option plan activity during the six months ended June 30, 2020 and 2019:

 

 

 

2020

 

 

2019

 

 

 

Number of

 

 

Weighted Average

 

 

Number of

 

 

Weighted Average

 

 

 

Options

 

 

Exercise Price

 

 

Options

 

 

Exercise Price

 

Options Outstanding at Beginning of the year

 

 

19,300

 

 

$

60.51

 

 

 

19,300

 

 

$

60.51

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Exercised

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Adjustment

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

Forfeited

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Outstanding at June 30,

 

 

19,300

 

 

$

60.51

 

 

 

19,300

 

 

$

60.51

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Options Exercisable at June 30,

 

 

11,800

 

 

$

84.49

 

 

 

7,634

 

 

$

113.81

 

 

Summary of Stock Warrants

 

Warrants

 

The following is a summary of the warrant activity during the six months ended June 30, 2020 and 2019:

 

 

 

2020

 

 

2019

 

 

 

Number of

 

 

Weighted Average

 

 

Number of

 

 

Weighted Average

 

 

 

Warrants

 

 

Exercise Price

 

 

Warrants

 

 

Exercise Price

 

Warrants Outstanding at Beginning of the year

 

 

3,959,287

 

 

$

5.36

 

 

 

3,843,587

 

 

$

5.44

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Granted

 

 

-

 

 

 

-

 

 

 

125,000

 

 

 

2.64

 

Exercised

 

 

1,227,700

 

 

 

2.40

 

 

 

9,300

 

 

 

2.40

 

Forfeited

 

 

-

 

 

 

-

 

 

 

-

 

 

 

-

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Warrants Outstanding at June 30,

 

 

2,731,587

 

 

$

6.83

 

 

 

3,959,287

 

 

$

5.36

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

XML 36 R26.htm IDEA: XBRL DOCUMENT v3.20.2
Discontinued Operations (Tables)
6 Months Ended
Jun. 30, 2020
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]  
Summary of major classes of assets and liabilities and operating results of IIU

 

Three Months Ended June 30, 2020

Three Months Ended June 30, 2019

 

Six Months Ended June 30, 2020

 

Six Months Ended June 30, 2019

Revenue

$              -

$      181,391

$              -

$       280,159

Total operating costs and expenses

-

100,511

-

327,377

Gain (Loss) from discontinued operations

-

80,880

-

(47,218)

Other expense, net

-

9,956

-

16,711

Gain on disposal of discontinued operations

-

-

16,428

-

Net gain (loss) from discontinued operations

$               -

$  70,924

$     16,428

$  (63,929)

 

 

 

 

 

Net cash provided by operating activities

$                -

$ 169,009

$                -

113,829

Net cash (used in) provided by investing activities

  -

-

(246,914)

51,327

Net cash used in financing activities

-

(18,452)

 

(37,886)

I I U Inc | Stock Purchase Agreement  
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]  
Summary of major classes of assets and liabilities and operating results of IIU

The impact of this transaction is reflected as a discontinued operation in the consolidated financial statements. Pursuant to ASU 2014-08, the major classes of assets and liabilities of IIU were as follows:

 

 

As of December 31, 2019

Major classes of assets

 

Cash

$   246,914

Related party receivable

27,738

Prepaid expenses

2,301

Total major classes of current assets – discontinued assets

276,953

Fixed assets, net

27,245

Total major classes of assets – discontinued assets

$   304,198

 

 

Accounts payable and accrued expenses

$   144,006

Note payable – short term

100,672

Other liabilities

21,153

Income taxes payable

14,226

Total major classes of current liabilities – discontinued liabilities

280,057

 

 

Debt

517,584

Total major classes of liabilities - discontinued liabilities

$   797,641

 

 

The operating results for IIU, Inc. have been presented in the accompanying consolidated financial statements of operations for the three and six months ended June 30, 2020 and 2019 as discontinued operations are summarized below:

 

XML 37 R27.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies - Additional information (Detail)
1 Months Ended 3 Months Ended 6 Months Ended 9 Months Ended 12 Months Ended
May 11, 2020
Mar. 27, 2020
$ / shares
Mar. 23, 2020
USD ($)
$ / shares
shares
Jan. 10, 2020
USD ($)
Jan. 08, 2020
USD ($)
Dec. 20, 2019
USD ($)
shares
Jan. 16, 2019
USD ($)
$ / shares
shares
Nov. 02, 2018
USD ($)
Oct. 31, 2018
$ / shares
shares
Oct. 16, 2018
$ / shares
Oct. 15, 2018
$ / shares
shares
Jan. 31, 2019
USD ($)
Jun. 30, 2020
USD ($)
$ / shares
shares
Jun. 30, 2019
USD ($)
Jun. 30, 2020
USD ($)
Ownership
$ / shares
$ / Assessment
shares
Jun. 30, 2019
USD ($)
Sep. 30, 2019
Dec. 31, 2019
USD ($)
$ / shares
shares
Jun. 29, 2020
USD ($)
Nov. 30, 2018
shares
Apr. 02, 2018
$ / shares
shares
Oct. 23, 2015
$ / shares
shares
Summary Of Significant Accounting Policies [Line Items]                                            
Principal amount                                   $ 185,785        
Cash                         $ 6,238,678   $ 6,238,678     822,909        
Goodwill (Note 2)                                   $ 4,039,586        
Goodwill impairment loss       $ 1,650,000                                    
Common stock, shares outstanding | shares                     625,318   5,068,799   5,068,799     3,134,261        
Minimum bid price | $ / shares   $ 1.00                                        
Reverse stock split, description On May 11, 2020, our shareholders voted in favor of the approval of an amendment to our Certificate of Incorporation, in the event it is deemed advisable by our Board of Directors, to effect an additional reverse stock split of the Company’s issued and outstanding common stock at a ratio within the range of one-for-two (1:2) and one-for-ten (1:10), as determined by the Board of Directors                           one-for-ten              
Reverse stock split percentage of issued common stock 0.1                                          
Reverse stock split percentage of outstanding common stock 0.5                                          
Finance receivables, allowance for credit losses, write offs                             $ 13,452 $ 20,743            
Capitalized real estate costs, net of accumulated depreciation                         $ 13,426   13,426     $ 21,084        
Depreciation expense                         $ 4,110 $ 5,526 9,713 11,969            
Operating lease, payments                             45,742 4,426            
Settlement costs with associations                           38,286 $ 11,920 40,178            
Valuation allowance deferred tax assets                                   $ 3,634,857        
Common stock, shares issued | shares                         5,068,799   5,068,799     3,134,261   2,500,000    
Reverse stock split, conversion ratio                     0.1                      
Common stock, par value | $ / shares                     $ 0.001   $ 0.001   $ 0.001     $ 0.001        
Exercise of warrants                             $ 2,946,480 22,320            
Stock Warrants [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Reverse stock split, description                   one-tenth                        
Warrants issued to purchase of common stock | shares                 143,587                       40,000  
Warrants issued to purchase of common stock average exercise price per share | $ / shares                 $ 1.84 $ 12.50                     $ 6.605  
Warrants, weighted average price | $ / shares                         $ 12.50   $ 12.50              
Warrants, weighted average remaining life                             44 years     94 years        
Warrants, year of expiration                             2020   2023          
Warrants, aggregate intrinsic value outstanding                         $ 0   $ 0     $ 0        
Exercise of warrants                             $ 2,946,480              
Stock Warrants [Member] | Initial Public Offering [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Warrants issued to purchase of common stock | shares                                           1,200,000
Warrants issued to purchase of common stock average exercise price per share | $ / shares                                           $ 12.50
Stock Warrants [Member] | Secondary Offering [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Warrants issued to purchase of common stock | shares                 2,500,000                          
Warrants issued to purchase of common stock average exercise price per share | $ / shares                 $ 2.40                          
Warrants, year of expiration                 2023                          
Warrants | shares                             1,277,700              
Exercise of warrants                             $ 2,946,480              
Additional Warrants [Member] | Secondary Offering [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Warrants issued to purchase of common stock | shares                 125,000                          
Warrants issued to purchase of common stock average exercise price per share | $ / shares                 $ 2.64                          
Warrants, year of expiration                 May 02, 2022                          
ASU 2016-02 [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Right of use asset, net                         209,031   209,031     260,260        
Amortization expense for right to use assets                         26,136 2,426 51,229 4,852            
Operating lease, payments                             $ 45,742              
Special Product [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Delinquent assessments maximum due period purchases basis                             48 months              
Original Product [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Allowance for credit losses                         112,000   $ 112,000     112,000        
Hanfor (Cayman) Ltd | Share Exchange Agreement [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Loaned to related party           $ 1,500,000                                
Maturity of note           Apr. 15, 2020                                
Interest rate           0.50%                                
Stock pledge against investment | shares           640,000                                
I I U Inc                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Purchase price                       $ 4,969,200                    
Net fair value of assets                       720,386                    
Goodwill (Note 2)                       5,689,586           5,700,000        
Goodwill impairment loss         $ 1,650,000                   $ 0     4,000,000        
Goodwill impairment                       $ 16,428                    
Minimum [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Estimated useful lives                             20 years              
Minimum [Member] | First Mortgage [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Estimated useful lives                             3 years              
Minimum [Member] | I I U Inc                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Working capital                             $ 15,000              
Cash                         $ 152,000   $ 152,000              
Maximum [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Closing bid price of common stock | $ / shares                             $ 1.00              
Senior Convertible Promissory Notes [Member] | Craven House Capital North America LLC [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Debt instrument, interest rate percentage           0.50%                                
Loan amount           $ 1,500,000                                
Debt instrument, maturity date           Apr. 15, 2020                 Aug. 01, 2021              
Common shares pledge | shares           640,000                                
Full principal and accrued interest amount received                                     $ 1,503,719      
Maturity period           Apr. 15, 2020                 Aug. 01, 2021              
Convertible Promissory Note [Member] | I I U Inc                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Debt instrument term             360 days                              
Debt instrument, interest rate percentage             3.00%                              
Extinguishment of principal indebtedness and accrued interest             $ 1,507,375                              
Face amount of debt instrument             $ 3,581,982                              
Denominator for conversion of convertible note to restricted common shares | $ / shares             $ 2.41                              
Closing price of share price | $ / shares                         $ 1.42   $ 1.42              
Debt instrument reduced amount             $ (120,200)                              
Securities Purchase Agreement [Member] | Hanfor-Owner [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Ownership excluding unexercised warrants percentage     86.50%                                      
Common stock, shares outstanding | shares                         520,838   520,838              
Sale of stock price per share | $ / shares                         $ 2.40   $ 2.40              
Proceeds from issuance of stock     $ 250,000                                      
Notes receivable     $ 1,000,000                                      
Securities Purchase Agreement [Member] | I I U Inc                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Percentage of stock purchased             100.00%                              
Purchase price             $ 5,089,357               $ 4,969,200              
Securities Purchase Agreement [Member] | Senior Convertible Promissory Notes [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Ownership excluding unexercised warrants percentage               20.00%                            
Principal amount               $ 1,500,000                            
Debt instrument term               360 days                            
Debt instrument, interest rate percentage               3.00%                            
Stock Purchase Agreement | I I U Inc                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Goodwill (Note 2)             5,689,586                              
Total adjusted purchase price             4,969,200                              
Preliminary estimate of the fair value of assets and liabilities assumed             720,386                              
Gain on disposal of discontinued operations             $ 16,428               $ 16,428              
Stock Purchase Agreement | Convertible Notes [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Debt instrument, maturity date             Jan. 14, 2020                              
Convertible notes conversion to common shares | shares             1,436,424                              
Interest rate             3.00%                              
Maturity period             Jan. 14, 2020                              
Stock Purchase Agreement | Craven House Capital North America LLC [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Sale of stock under agreement         3,562,569                                  
Goodwill impairment loss         1,650,000                                  
Stock Purchase Agreement | I I U Inc                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Percentage of stock purchased                         100.00%   100.00%              
Purchase price                             $ 5,089,357              
Stock Purchase Agreement | Senior Convertible Promissory Notes [Member] | Craven House Capital North America LLC [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Proceeds from issuance of debt funded in repurchase and cancellation of debt         $ 3,461,782   $ 3,461,782                              
Forgave amount accrued interest             $ 100,787                              
Share Exchange Agreement [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Denominator for conversion of convertible note to restricted common shares | $ / shares     $ 2.40                                      
Share Exchange Agreement [Member] | Hanfor-Owner [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Proceeds from issuance of stock     $ 1,250,000                                      
Common stock sold | shares     520,838                                      
Common stock price per share | $ / shares     $ 2.40                                      
Subsidiaries [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Number of members | Ownership                             2              
Minimum percentage of original principal amount on mortgage                             1.00%              
Maximum statutory delinquent assessments rate                             18.00%              
Maximum administrative late fees | $ / Assessment                             25              
Percentage of maximum administrative late fees on delinquent assessment                             5.00%              
Minimum acquisition cost that requires capitalization to fixed assets                         $ 500   $ 500              
Capitalized software costs, net of accumulated amortization                         0   0     0        
Amortization expense for capitalized software costs                         0 5,815 0 11,630            
Unamortized debt issue costs                         0   0     0        
Settlement costs with associations                         0 $ 38,000 12,000 40,000            
Fair value of properties                             $ 0 $ 0            
Subsidiaries [Member] | Capitalized Software [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Estimated useful life                             5 years              
Subsidiaries [Member] | HealthCare Abroad [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Age limit                             84 years              
Subsidiaries [Member] | HealthCare Global [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Age limit                             70 years              
Subsidiaries [Member] | HealthCare America [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Age limit                             70 years              
Subsidiaries [Member] | HealthCare International [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Age limit                             70 years              
Subsidiaries [Member] | HealthCare War [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Age limit                             70 years              
Subsidiaries [Member] | Special Product [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Delinquent assessments maximum due period purchases basis                             48 months              
Allowance for credit losses                         6,564   $ 6,564     20,016        
Subsidiaries [Member] | Original Product [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Allowance for credit losses                         $ 112,027   $ 112,027     $ 112,027        
Subsidiaries [Member] | Minimum [Member] | Furniture [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Estimated useful lives                             3 years              
Subsidiaries [Member] | Minimum [Member] | Computer [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Estimated useful lives                             3 years              
Subsidiaries [Member] | Minimum [Member] | Office Equipment [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Estimated useful lives                             3 years              
Subsidiaries [Member] | Maximum [Member] | Furniture [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Estimated useful lives                             5 years              
Subsidiaries [Member] | Maximum [Member] | Computer [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Estimated useful lives                             5 years              
Subsidiaries [Member] | Maximum [Member] | Office Equipment [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Estimated useful lives                             5 years              
Subsidiaries [Member] | Maximum [Member] | HealthCare Global [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Coverage period                             6 months              
Subsidiaries [Member] | Maximum [Member] | HealthCare America [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Coverage period                             90 days              
Subsidiaries [Member] | Maximum [Member] | HealthCare War [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Coverage period                             6 months              
REO Management Holdings, LLC [Member] | Maximum [Member] | Subsidiary Limited Liability [Member]                                            
Summary Of Significant Accounting Policies [Line Items]                                            
Percentage of ownership in subsidiary limited liability companies                             100.00%              
XML 38 R28.htm IDEA: XBRL DOCUMENT v3.20.2
Summary of Significant Accounting Policies - Summary of Anti-dilutive Stock Based Compensation Awards and Convertible Notes (Detail) - shares
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Stock Options [Member]    
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Anti-dilutive stock based compensation awards 19,300 19,300
Stock Warrants [Member]    
Antidilutive Securities Excluded From Computation Of Earnings Per Share [Line Items]    
Anti-dilutive stock based compensation awards 2,731,587 3,959,287
XML 39 R29.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Acquisition - Additional Information (Details) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended 12 Months Ended
Jan. 10, 2020
Jan. 08, 2020
Apr. 15, 2019
Jan. 16, 2019
Nov. 02, 2018
Jan. 31, 2019
Mar. 31, 2019
Jun. 30, 2020
Dec. 31, 2019
Dec. 20, 2019
Business Acquisition [Line Items]                    
Principal amount                 $ 185,785  
Net cash received from business acquisition             $ 51,327      
Goodwill impairment loss $ 1,650,000                  
I I U Inc                    
Business Acquisition [Line Items]                    
Purchase price           $ 4,969,200        
Goodwill impairment loss   $ 1,650,000           $ 0 $ 4,000,000  
Senior Convertible Promissory Notes [Member]                    
Business Acquisition [Line Items]                    
Closing share price       $ 1.42            
Senior Convertible Promissory Notes [Member] | Craven House Capital North America LLC [Member]                    
Business Acquisition [Line Items]                    
Debt instrument, interest rate percentage                   0.50%
Securities Purchase Agreement [Member] | I I U Inc                    
Business Acquisition [Line Items]                    
Percentage of stock purchased       100.00%            
Purchase price       $ 5,089,357       $ 4,969,200    
Securities Purchase Agreement [Member] | Senior Convertible Promissory Notes [Member]                    
Business Acquisition [Line Items]                    
Ownership excluding unexercised warrants percentage         20.00%          
Principal amount         $ 1,500,000          
Purchase price of notes issued         $ 1,500,000          
Debt instrument term         360 days          
Debt instrument, interest rate percentage         3.00%          
Promissory Notes [Member] | I I U Inc                    
Business Acquisition [Line Items]                    
Extinguishment of principal indebtedness and accrued interest       $ 1,507,375            
Convertible Promissory Note [Member] | I I U Inc                    
Business Acquisition [Line Items]                    
Debt instrument term     12 months 360 days            
Debt instrument, interest rate percentage       3.00%            
Extinguishment of principal indebtedness and accrued interest       $ 1,500,000            
Face amount of debt instrument       $ 3,581,982            
Denominator for conversion of convertible note to restricted common shares       $ 2.41            
Debt instrument reduced amount       $ 120,200            
Stock Purchase Agreement | Craven House Capital North America LLC [Member]                    
Business Acquisition [Line Items]                    
Goodwill impairment loss   1,650,000                
Sale of stock under agreement   3,562,569                
Stock Purchase Agreement | I I U Inc                    
Business Acquisition [Line Items]                    
Percentage of stock purchased               100.00%    
Purchase price               $ 5,089,357    
Stock Purchase Agreement | Senior Convertible Promissory Notes [Member] | Craven House Capital North America LLC [Member]                    
Business Acquisition [Line Items]                    
Proceeds from issuance of debt funded in repurchase and cancellation of debt   $ 3,461,782   3,461,782            
Forgave amount accrued interest       $ 100,787            
XML 40 R30.htm IDEA: XBRL DOCUMENT v3.20.2
Goodwill and Acquisition - Summary of Consideration Paid and Amounts of Identified Assets Acquired and Liabilities Assumed (Details) - USD ($)
Jan. 16, 2019
Dec. 31, 2019
Business Acquisition [Line Items]    
Goodwill   $ 4,039,586
IIU, Inc and Wallach and Company [Member]    
Business Acquisition [Line Items]    
Total adjusted purchase price $ 4,969,200  
Cash 51,300  
Prepaid and other current assets 5,200  
Profit on purchased policies 14,600  
Property, plant and equipment 17,100  
Accounts payable (5,100)  
Accrued expenses and other liabilities (62,686)  
Income taxes (28,500)  
Deferred revenue (9,300)  
Debt (703,000)  
Preliminary estimate of the fair value of assets and liabilities assumed (720,386)  
Goodwill $ 5,689,586  
XML 41 R31.htm IDEA: XBRL DOCUMENT v3.20.2
Finance Receivables - Original Product - Schedule of Finance Receivables for Original Product (Detail) - Original Product [Member]
6 Months Ended 12 Months Ended
Jun. 30, 2020
USD ($)
Unit
Dec. 31, 2019
USD ($)
Unit
Accounts Notes And Loans Receivable [Line Items]    
Finance receivables outstanding $ 324,000 $ 386,000
Reserve for credit losses (112,000) (112,000)
Finance receivables, net $ 212,000 $ 274,000
Number of active units with delinquent assessments | Unit 511 598
Amount of outstanding interest and late fees on active units $ 8,727,000 $ 9,167,000
Funded During The Current Year [Member]    
Accounts Notes And Loans Receivable [Line Items]    
Finance receivables outstanding 14,000 40,000
1-2 Years Outstanding [Member]    
Accounts Notes And Loans Receivable [Line Items]    
Finance receivables outstanding 16,000 15,000
2-3 Years Outstanding [Member]    
Accounts Notes And Loans Receivable [Line Items]    
Finance receivables outstanding 9,000 20,000
3-4 Years Outstanding [Member]    
Accounts Notes And Loans Receivable [Line Items]    
Finance receivables outstanding 18,000 11,000
Greater Than 4 Years Outstanding [Member]    
Accounts Notes And Loans Receivable [Line Items]    
Finance receivables outstanding $ 267,000 $ 300,000
XML 42 R32.htm IDEA: XBRL DOCUMENT v3.20.2
Finance Receivables - Special Product (New Neighbor Guaranty program) - Additional Information (Detail) - USD ($)
6 Months Ended
Jun. 30, 2020
Dec. 31, 2019
Special Product [Member]    
Accounts Notes And Loans Receivable [Line Items]    
Delinquent assessments maximum due period purchases basis 48 months  
Maximum future contingent payments $ 45,000  
New Neighbor Guaranty (NNG) [Member]    
Accounts Notes And Loans Receivable [Line Items]    
Allowance for credit losses $ 7,000 $ 20,000
XML 43 R33.htm IDEA: XBRL DOCUMENT v3.20.2
Finance Receivables - Special Product (New Neighbor Guaranty program) - Schedule of Delinquent Assessments and Accrued Charges (Detail) - Special Product [Member]
6 Months Ended 12 Months Ended
Jun. 30, 2020
USD ($)
Unit
Dec. 31, 2019
USD ($)
Unit
Accounts Notes And Loans Receivable [Line Items]    
Finance receivables, net $ 97,000 $ 129,000
Delinquent assessments 209,000 374,000
Accrued interest and late fees $ 91,000 $ 235,000
Number of active units with delinquent assessments | Unit 24 31
XML 44 R34.htm IDEA: XBRL DOCUMENT v3.20.2
Due to Related Party - Additional Information (Detail)
3 Months Ended 6 Months Ended 12 Months Ended
Dec. 20, 2019
USD ($)
shares
Jan. 02, 2017
USD ($)
$ / Unit
Jun. 30, 2020
USD ($)
Jun. 30, 2019
USD ($)
Jun. 30, 2020
USD ($)
Jun. 30, 2019
USD ($)
Dec. 31, 2019
USD ($)
Related Party Transaction [Line Items]              
Due to related party (Note 5)     $ 171,501   $ 171,501    
Principal amount             $ 185,785
Subsidiaries [Member]              
Related Party Transaction [Line Items]              
Recoveries incurred     51,000 $ 52,000 96,000 $ 122,000  
Business Law Group [Member]              
Related Party Transaction [Line Items]              
Monthly payment for cases   $ 82,000          
Minimum fee paid per unit | $ / Unit   700          
Service amount paid     250,000 291,000 509,000 536,000  
Due to related party (Note 5)     1,375,000   1,375,000   1,883,000
Office sub lease income         30,000    
Receivable (Payable)from related party         (171,500)   $ 152,800
Amount written-off regained         200,000    
Business Law Group [Member] | Out of Pocket Collection Costs [Member]              
Related Party Transaction [Line Items]              
Expenses incurred by company     $ 31,000 $ 62,000 $ 67,000 $ 109,000  
Craven Holdings North America Inc [Member] | Share Exchange Agreement [Member]              
Related Party Transaction [Line Items]              
Principal amount $ 1,500,000            
Debt instrument, interest rate percentage 0.50%            
Debt instrument, due date Apr. 15, 2020            
Debt Instrument, extended maturity date Aug. 01, 2021            
Common shares pledged other than secured promissory notes | shares 640,000            
XML 45 R35.htm IDEA: XBRL DOCUMENT v3.20.2
Debt and Other Financing Arrangements - Schedule of Debt (Detail) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Debt Instrument [Line Items]    
Notes payable $ 185,785 $ 4,149,578
Financing agreement with FlatIron capital maturing in June 1, 2020 [Member]    
Debt Instrument [Line Items]    
Notes payable   69,540
Promissory note issued by a financial institution maturing in April 30, 2022 [Member]    
Debt Instrument [Line Items]    
Notes payable $ 185,785  
Convertible Senior Note [Member]    
Debt Instrument [Line Items]    
Notes payable   3,461,782
Promissory note issued by a financial institution maturing in August 26, 2023 [Member]    
Debt Instrument [Line Items]    
Notes payable   11,802
Promissory note issued by a financial institution maturing in May 30, 2025 [Member]    
Debt Instrument [Line Items]    
Notes payable   $ 606,454
XML 46 R36.htm IDEA: XBRL DOCUMENT v3.20.2
Debt and Other Financing Arrangements - Schedule of Debt (Parenthetical) (Detail)
6 Months Ended
Jun. 30, 2020
USD ($)
shares
Dec. 31, 2019
USD ($)
Debt Instrument [Line Items]    
Principal amount   $ 185,785
Financing agreement with FlatIron capital maturing in June 1, 2020 [Member]    
Debt Instrument [Line Items]    
Down payment for note payable $ 19,170  
Debt instrument, periodic payment $ 11,590  
Debt instrument, maturity date Jun. 01, 2020  
Debt instrument, interest rate percentage 6.80%  
Convertible Senior Note [Member]    
Debt Instrument [Line Items]    
Debt instrument, maturity date Jan. 14, 2020  
Debt instrument, interest rate percentage 3.00%  
Debt instrument, issuance date Jan. 16, 2019  
Debt instrument, to be converted shares | shares 1,436,424  
Debt instrument, convertible, beneficial conversion feature $ 0  
Promissory note issued by a financial institution maturing in August 26, 2023 [Member]    
Debt Instrument [Line Items]    
Debt instrument, periodic payment $ 323  
Debt instrument, maturity date Aug. 26, 2023  
Debt instrument, interest rate percentage 9.09%  
Debt instrument, issuance date Jul. 26, 2019  
Principal amount $ 12,892  
Promissory Notes [Member]    
Debt Instrument [Line Items]    
Debt instrument, periodic payment $ 10,932  
Debt instrument, maturity date May 30, 2025  
Debt instrument, interest rate percentage 5.85%  
Debt instrument, issuance date May 31, 2018  
Principal amount $ 608,000  
Subsequent borrowings 141,000  
Repayments $ 51,000  
Promissory note issued by a financial institution maturing in April 30, 2022 [Member]    
Debt Instrument [Line Items]    
Debt instrument, maturity date Apr. 30, 2022  
Debt instrument, interest rate percentage 1.00%  
XML 47 R37.htm IDEA: XBRL DOCUMENT v3.20.2
Debt and Other Financing Arrangements - Schedule of Principal Payments of Debt (Detail)
Dec. 31, 2019
USD ($)
Debt Instruments [Abstract]  
2022 $ 185,785
Debt Instrument Carrying Amount $ 185,785
XML 48 R38.htm IDEA: XBRL DOCUMENT v3.20.2
Debt and Other Financing Arrangements - Additional Information (Detail) - USD ($)
6 Months Ended
Jun. 30, 2020
Dec. 31, 2019
Debt Instrument [Line Items]    
Notes payable $ 185,785 $ 4,149,578
Promissory note issued by a financial institution maturing in April 30, 2022 [Member]    
Debt Instrument [Line Items]    
Notes payable $ 185,785  
Debt instrument, interest rate percentage 1.00%  
Debt Instrument Maturity Period 2 years  
Promissory note issued by a financial institution maturing in April 30, 2022 [Member] | US Federal Government Coronavirus Aid, Relief, and Economic Security Act [Member]    
Debt Instrument [Line Items]    
Notes payable $ 185,785  
XML 49 R39.htm IDEA: XBRL DOCUMENT v3.20.2
Going Concern - Additional Information (Detail) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2020
Jun. 30, 2019
Mar. 31, 2020
Dec. 31, 2019
Nov. 30, 2018
Financial Support For Nonconsolidated Legal Entity [Line Items]            
Cumulative operating losses       $ 15,046,000    
Proceeds from warrants exercised   $ 2,946,480 $ 22,320      
Proceeds from stock subscription   $ 1,250,000        
Common stock, shares issued 5,068,799 5,068,799     3,134,261 2,500,000
Cash $ 6,238,678 $ 6,238,678     $ 822,909  
Going Concerns [Member]            
Financial Support For Nonconsolidated Legal Entity [Line Items]            
Proceeds from issuance of common stock, warrants exercised and related party receivable $ 5,700,000          
Warrants Exercised 1,200,000          
Proceeds from warrants exercised $ 2,900,000          
Related party receivable 1,500,000 $ 1,500,000        
Proceeds from stock subscription $ 1,250,000          
Common stock, shares issued 520,838 520,838        
Cash $ 6,200,000 $ 6,200,000        
XML 50 R40.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments and Contingencies - Additional Information (Detail) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Loss Contingencies [Line Items]          
Operating lease remaining lease term 2 years 1 month 17 days   2 years 1 month 17 days   2 years 7 months 6 days
Lease expiration period     37 months    
Operating lease discount rate 6.50%   6.50%    
Operating lease beginning date     Mar. 01, 2014    
Operating lease ending date     Jul. 31, 2019    
Rent expense $ 20,000 $ 38,000 $ 50,000 $ 97,000  
New Office Lease [Member]          
Loss Contingencies [Line Items]          
Operating lease beginning date     Jul. 15, 2019    
Operating lease ending date     Jul. 31, 2022    
Business Law Group [Member]          
Loss Contingencies [Line Items]          
Sublease Income     $ 4,900    
Minimum [Member]          
Loss Contingencies [Line Items]          
Operating lease remaining lease term 1 year   1 year    
Maximum [Member]          
Loss Contingencies [Line Items]          
Operating lease remaining lease term 3 years   3 years    
XML 51 R41.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments and Contingencies - Components of Lease Expense (Detail) - USD ($)
3 Months Ended 6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Lease Cost [Abstract]        
Operating lease expense $ 20,377 $ 38,457 $ 50,109 $ 97,301
Lease cost $ 20,377 $ 38,457 $ 50,109 $ 97,301
XML 52 R42.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments and Contingencies - Summary of Supplemental Balance Sheet Information Related to Operating Leases (Detail) - USD ($)
Jun. 30, 2020
Dec. 31, 2019
Assets And Liabilities Lessee [Abstract]    
ROU assets $ 209,031 $ 260,260
Operating Lease, Right-of-Use Asset, Statement of Financial Position [Extensible List] us-gaap:OperatingLeaseRightOfUseAsset us-gaap:OperatingLeaseRightOfUseAsset
Current lease liabilities $ 98,846 $ 94,235
Operating Lease, Liability, Current, Statement of Financial Position [Extensible List]   us-gaap:OperatingLeaseLiability
Long-term lease liabilities $ 121,295 $ 171,648
Operating Lease, Liability, Noncurrent, Statement of Financial Position [Extensible List] us-gaap:OperatingLeaseLiability us-gaap:OperatingLeaseLiability
Total lease liabilities $ 220,141 $ 265,883
Weighted-average remaining lease term (in years) 2 years 1 month 17 days 2 years 7 months 6 days
Weighted-average discount rate 6.55% 6.55%
XML 53 R43.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments and Contingencies - Summary of Supplemental Cash Flow Information and Non-cash Activity Related to Operating Leases (Detail) - USD ($)
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Operating cash flow information    
Lease liability payments $ (45,742) $ (4,426)
SUPPLEMENTAL DISCLOSURES OF NON-CASHFLOW INFORMATION    
ROU asset obligation recognized   $ 26,685
XML 54 R44.htm IDEA: XBRL DOCUMENT v3.20.2
Commitments and Contingencies - Schedule of Future Minimum Lease Payment Due (Detail)
Jun. 30, 2020
USD ($)
Commitments And Contingencies Disclosure [Abstract]  
2020 (excluding the six months ended June 30, 2020) $ 48,493
2021 103,646
2022 68,002
Total future minimum lease payments due $ 220,141
XML 55 R45.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity - Summary of Stock Option Plan Activity (Detail) - $ / shares
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Number of Options    
Number of Options, Outstanding at Beginning of the year 19,300 19,300
Number of Options, Granted
Number of Options, Exercised
Number of Options, Adjustment
Number of Options, Forfeited
Number of Options, Outstanding at End of Year 19,300 19,300
Number of Options, Exercisable at End of Year 11,800 7,634
Weighted Average Exercise Price    
Weighted Average Exercise Price, Outstanding at Beginning Balance $ 60.51 $ 60.51
Weighted Average Exercise Price, Granted
Weighted Average Exercise Price, Exercised
Weighted Average Exercise Price, Adjustment
Weighted Average Exercise Price, Forfeited
Weighted Average Exercise Price, Outstanding at Ending Balance 60.51 60.51
Weighted Average Exercise Price, Exercisable $ 84.49 $ 113.81
XML 56 R46.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity - Additional Information (Detail) - USD ($)
1 Months Ended 3 Months Ended 6 Months Ended
Mar. 23, 2020
Apr. 30, 2020
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Class Of Stock [Line Items]              
Recognized compensation expense of stock options     $ 6,800 $ 7,800      
Remaining unrecognized compensation cost     11,400   $ 11,400    
Aggregate intrinsic value of outstanding common stock options     $ 0   0   $ 0
Proceeds from warrants exercised         $ 2,946,480 $ 22,320  
Number of warrants, exercised         1,227,700 9,300  
Cash received for shares issued   $ 1.0          
Share Exchange Agreement [Member]              
Class Of Stock [Line Items]              
Common stock issued 520,833            
Denominator for conversion of convertible note to restricted common shares $ 2.40            
Cash received for shares issued $ 250,000            
Maxim Holdings LLC [Member]              
Class Of Stock [Line Items]              
Recognized compensation expense of stock options         $ 125,450    
Common stock sold 186,000            
Stock Warrants [Member]              
Class Of Stock [Line Items]              
Proceeds from warrants exercised         $ 2,946,480    
Number of warrants, exercised         1,227,700    
XML 57 R47.htm IDEA: XBRL DOCUMENT v3.20.2
Stockholders' Equity - Summary of Stock Warrants (Detail) - $ / shares
6 Months Ended
Jun. 30, 2020
Jun. 30, 2019
Equity [Abstract]    
Number of Warrants, beginning balance 3,959,287 3,843,587
Number of warrants, granted   125,000
Number of warrants, exercised 1,227,700 9,300
Number of Warrants, ending balance 2,731,587 3,959,287
Weighted Average Exercise Price, Outstanding at Ending Balance $ 5.36 $ 5.44
Weighted Average Exercise Price, granted   2.64
Weighted Average Exercise Price, exercised 2.40 2.40
Weighted Average Exercise Price, Outstanding at Ending Balance $ 6.83 $ 5.36
XML 58 R48.htm IDEA: XBRL DOCUMENT v3.20.2
Discontinued Operations - Additional Information (Details) - USD ($)
6 Months Ended
Jan. 10, 2020
Jan. 08, 2020
Jan. 16, 2019
Jun. 30, 2020
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]        
Goodwill impairment loss $ 1,650,000      
Stock Purchase Agreement | I I U Inc        
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]        
Gain on disposal of discontinued operations     $ 16,428 $ 16,428
Stock Purchase Agreement | Craven House Capital North America LLC [Member]        
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]        
Sale of stock under agreement   $ 3,562,569    
Goodwill paid   4,969,586    
Goodwill impairment loss   1,650,000    
Stock Purchase Agreement | Craven House Capital North America LLC [Member] | Senior Convertible Promissory Notes [Member]        
Income Statement Balance Sheet And Additional Disclosures By Disposal Groups Including Discontinued Operations [Line Items]        
Proceeds from issuance of debt funded in repurchase and cancellation of debt   $ 3,461,782 3,461,782  
Forgave amount accrued interest     $ 100,787  
XML 59 R49.htm IDEA: XBRL DOCUMENT v3.20.2
Discontinued Operations - Summary of major classes of assets and liabilities and operating results of IIU (Detail) - USD ($)
3 Months Ended 6 Months Ended
Jan. 16, 2019
Jun. 30, 2019
Jun. 30, 2020
Jun. 30, 2019
Dec. 31, 2019
Major classes of assets          
Net gain (loss) from discontinued operations   $ 70,924 $ 16,428 $ (63,929)  
I I U Inc | Stock Purchase Agreement          
Major classes of assets          
Cash         $ 246,914
Related party receivable         27,738
Prepaid expenses         2,301
Total major classes of current assets – discontinued assets         276,953
Fixed assets, net         27,245
Total major classes of assets – discontinued assets         304,198
Accounts payable and accrued expenses         144,006
Note payable – short term         100,672
Other liabilities         21,153
Income taxes payable         14,226
Total major classes of current liabilities – discontinued liabilities         280,057
Debt         517,584
Total major classes of liabilities - discontinued liabilities         $ 797,641
Revenue   181,391   280,159  
Total operating costs and expenses   100,511   327,377  
Gain (Loss) from discontinued operations   80,880   (47,218)  
Other expense, net   9,956   16,711  
Gain on disposal of discontinued operations $ 16,428   16,428    
Net gain (loss) from discontinued operations   70,924 16,428 (63,929)  
Net cash provided by operating activities   169,009   113,829  
Net cash (used in) provided by investing activities     $ (246,914) 51,327  
Net cash used in financing activities   $ (18,452)   $ (37,886)  
EXCEL 60 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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�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how.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 62 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 63 FilingSummary.xml IDEA: XBRL DOCUMENT 3.20.2 html 217 428 1 false 64 0 false 8 false false R1.htm 100000 - Document - Document and Entity Information Sheet http://www.lmfunding.com/20200630/taxonomy/role/DocumentDocumentAndEntityInformation Document and Entity Information Cover 1 false false R2.htm 100010 - Statement - Condensed Consolidated Balance Sheets Sheet http://www.lmfunding.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheets Condensed Consolidated Balance Sheets Statements 2 false false R3.htm 100020 - Statement - Condensed Consolidated Balance Sheets (Parenthetical) Sheet http://www.lmfunding.com/20200630/taxonomy/role/StatementCondensedConsolidatedBalanceSheetsParenthetical Condensed Consolidated Balance Sheets (Parenthetical) Statements 3 false false R4.htm 100030 - Statement - Condensed Consolidated Statements of Operations Sheet http://www.lmfunding.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfOperations Condensed Consolidated Statements of Operations Statements 4 false false R5.htm 100040 - Statement - Condensed Consolidated Statements of Cash Flows Sheet http://www.lmfunding.com/20200630/taxonomy/role/StatementCondensedConsolidatedStatementsOfCashFlows Condensed Consolidated Statements of Cash Flows Statements 5 false false R6.htm 100050 - Statement - Consolidated Statements of Changes in Stockholders' Equity Sheet http://www.lmfunding.com/20200630/taxonomy/role/StatementConsolidatedStatementsOfChangesInStockholdersEquity Consolidated Statements of Changes in Stockholders' Equity Statements 6 false false R7.htm 100060 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies Notes 7 false false R8.htm 100070 - Disclosure - Goodwill and Acquisition Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureGoodwillAndAcquisition Goodwill and Acquisition Notes 8 false false R9.htm 100080 - Disclosure - Finance Receivables - Original Product Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureFinanceReceivablesOriginalProduct Finance Receivables - Original Product Notes 9 false false R10.htm 100090 - Disclosure - Finance Receivables - Special Product (New Neighbor Guaranty program) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureFinanceReceivablesSpecialProductNewNeighborGuarantyProgram Finance Receivables - Special Product (New Neighbor Guaranty program) Notes 10 false false R11.htm 100100 - Disclosure - Due to Related Party Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureDueToRelatedParty Due to Related Party Notes 11 false false R12.htm 100110 - Disclosure - Debt and Other Financing Arrangements Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureDebtAndOtherFinancingArrangements Debt and Other Financing Arrangements Notes 12 false false R13.htm 100120 - Disclosure - Going Concern Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureGoingConcern Going Concern Notes 13 false false R14.htm 100130 - Disclosure - Commitments and Contingencies Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureCommitmentsAndContingencies Commitments and Contingencies Notes 14 false false R15.htm 100140 - Disclosure - Stockholders' Equity Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureStockholdersEquity Stockholders' Equity Notes 15 false false R16.htm 100150 - Disclosure - Discontinued Operations Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureDiscontinuedOperations Discontinued Operations Notes 16 false false R17.htm 100160 - Disclosure - Subsequent Events Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureSubsequentEvents Subsequent Events Notes 17 false false R18.htm 100170 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) Policies http://www.lmfunding.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 18 false false R19.htm 100180 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) Tables http://www.lmfunding.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPolicies 19 false false R20.htm 100190 - Disclosure - Goodwill and Acquisition (Tables) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureGoodwillAndAcquisitionTables Goodwill and Acquisition (Tables) Tables http://www.lmfunding.com/20200630/taxonomy/role/DisclosureGoodwillAndAcquisition 20 false false R21.htm 100200 - Disclosure - Finance Receivables - Original Product (Tables) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureFinanceReceivablesOriginalProductTables Finance Receivables - Original Product (Tables) Tables http://www.lmfunding.com/20200630/taxonomy/role/DisclosureFinanceReceivablesOriginalProduct 21 false false R22.htm 100210 - Disclosure - Finance Receivables - Special Product (New Neighbor Guaranty program) (Tables) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureFinanceReceivablesSpecialProductNewNeighborGuarantyProgramTables Finance Receivables - Special Product (New Neighbor Guaranty program) (Tables) Tables http://www.lmfunding.com/20200630/taxonomy/role/DisclosureFinanceReceivablesSpecialProductNewNeighborGuarantyProgram 22 false false R23.htm 100220 - Disclosure - Debt and Other Financing Arrangements (Tables) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureDebtAndOtherFinancingArrangementsTables Debt and Other Financing Arrangements (Tables) Tables http://www.lmfunding.com/20200630/taxonomy/role/DisclosureDebtAndOtherFinancingArrangements 23 false false R24.htm 100230 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) Tables http://www.lmfunding.com/20200630/taxonomy/role/DisclosureCommitmentsAndContingencies 24 false false R25.htm 100240 - Disclosure - Stockholders' Equity (Tables) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureStockholdersEquityTables Stockholders' Equity (Tables) Tables http://www.lmfunding.com/20200630/taxonomy/role/DisclosureStockholdersEquity 25 false false R26.htm 100250 - Disclosure - Discontinued Operations (Tables) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureDiscontinuedOperationsTables Discontinued Operations (Tables) Tables http://www.lmfunding.com/20200630/taxonomy/role/DisclosureDiscontinuedOperations 26 false false R27.htm 100260 - Disclosure - Summary of Significant Accounting Policies - Additional information (Detail) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformationDetail Summary of Significant Accounting Policies - Additional information (Detail) Details 27 false false R28.htm 100270 - Disclosure - Summary of Significant Accounting Policies - Summary of Anti-dilutive Stock Based Compensation Awards and Convertible Notes (Detail) Notes http://www.lmfunding.com/20200630/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesSummaryOfAntiDilutiveStockBasedCompensationAwardsAndConvertibleNotesDetail Summary of Significant Accounting Policies - Summary of Anti-dilutive Stock Based Compensation Awards and Convertible Notes (Detail) Details 28 false false R29.htm 100280 - Disclosure - Goodwill and Acquisition - Additional Information (Details) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureGoodwillAndAcquisitionAdditionalInformationDetails Goodwill and Acquisition - Additional Information (Details) Details 29 false false R30.htm 100290 - Disclosure - Goodwill and Acquisition - Summary of Consideration Paid and Amounts of Identified Assets Acquired and Liabilities Assumed (Details) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureGoodwillAndAcquisitionSummaryOfConsiderationPaidAndAmountsOfIdentifiedAssetsAcquiredAndLiabilitiesAssumedDetails Goodwill and Acquisition - Summary of Consideration Paid and Amounts of Identified Assets Acquired and Liabilities Assumed (Details) Details 30 false false R31.htm 100300 - Disclosure - Finance Receivables - Original Product - Schedule of Finance Receivables for Original Product (Detail) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureFinanceReceivablesOriginalProductScheduleOfFinanceReceivablesForOriginalProductDetail Finance Receivables - Original Product - Schedule of Finance Receivables for Original Product (Detail) Details 31 false false R32.htm 100310 - Disclosure - Finance Receivables - Special Product (New Neighbor Guaranty program) - Additional Information (Detail) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureFinanceReceivablesSpecialProductNewNeighborGuarantyProgramAdditionalInformationDetail Finance Receivables - Special Product (New Neighbor Guaranty program) - Additional Information (Detail) Details http://www.lmfunding.com/20200630/taxonomy/role/DisclosureFinanceReceivablesSpecialProductNewNeighborGuarantyProgramTables 32 false false R33.htm 100320 - Disclosure - Finance Receivables - Special Product (New Neighbor Guaranty program) - Schedule of Delinquent Assessments and Accrued Charges (Detail) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureFinanceReceivablesSpecialProductNewNeighborGuarantyProgramScheduleOfDelinquentAssessmentsAndAccruedChargesDetail Finance Receivables - Special Product (New Neighbor Guaranty program) - Schedule of Delinquent Assessments and Accrued Charges (Detail) Details http://www.lmfunding.com/20200630/taxonomy/role/DisclosureFinanceReceivablesSpecialProductNewNeighborGuarantyProgramTables 33 false false R34.htm 100330 - Disclosure - Due to Related Party - Additional Information (Detail) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureDueToRelatedPartyAdditionalInformationDetail Due to Related Party - Additional Information (Detail) Details 34 false false R35.htm 100340 - Disclosure - Debt and Other Financing Arrangements - Schedule of Debt (Detail) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureDebtAndOtherFinancingArrangementsScheduleOfDebtDetail Debt and Other Financing Arrangements - Schedule of Debt (Detail) Details 35 false false R36.htm 100350 - Disclosure - Debt and Other Financing Arrangements - Schedule of Debt (Parenthetical) (Detail) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureDebtAndOtherFinancingArrangementsScheduleOfDebtParentheticalDetail Debt and Other Financing Arrangements - Schedule of Debt (Parenthetical) (Detail) Details 36 false false R37.htm 100360 - Disclosure - Debt and Other Financing Arrangements - Schedule of Principal Payments of Debt (Detail) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureDebtAndOtherFinancingArrangementsScheduleOfPrincipalPaymentsOfDebtDetail Debt and Other Financing Arrangements - Schedule of Principal Payments of Debt (Detail) Details 37 false false R38.htm 100370 - Disclosure - Debt and Other Financing Arrangements - Additional Information (Detail) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureDebtAndOtherFinancingArrangementsAdditionalInformationDetail Debt and Other Financing Arrangements - Additional Information (Detail) Details 38 false false R39.htm 100380 - Disclosure - Going Concern - Additional Information (Detail) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureGoingConcernAdditionalInformationDetail Going Concern - Additional Information (Detail) Details 39 false false R40.htm 100390 - Disclosure - Commitments and Contingencies - Additional Information (Detail) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformationDetail Commitments and Contingencies - Additional Information (Detail) Details 40 false false R41.htm 100400 - Disclosure - Commitments and Contingencies - Components of Lease Expense (Detail) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureCommitmentsAndContingenciesComponentsOfLeaseExpenseDetail Commitments and Contingencies - Components of Lease Expense (Detail) Details 41 false false R42.htm 100410 - Disclosure - Commitments and Contingencies - Summary of Supplemental Balance Sheet Information Related to Operating Leases (Detail) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfSupplementalBalanceSheetInformationRelatedToOperatingLeasesDetail Commitments and Contingencies - Summary of Supplemental Balance Sheet Information Related to Operating Leases (Detail) Details 42 false false R43.htm 100420 - Disclosure - Commitments and Contingencies - Summary of Supplemental Cash Flow Information and Non-cash Activity Related to Operating Leases (Detail) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureCommitmentsAndContingenciesSummaryOfSupplementalCashFlowInformationAndNonCashActivityRelatedToOperatingLeasesDetail Commitments and Contingencies - Summary of Supplemental Cash Flow Information and Non-cash Activity Related to Operating Leases (Detail) Details 43 false false R44.htm 100430 - Disclosure - Commitments and Contingencies - Schedule of Future Minimum Lease Payment Due (Detail) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureCommitmentsAndContingenciesScheduleOfFutureMinimumLeasePaymentDueDetail Commitments and Contingencies - Schedule of Future Minimum Lease Payment Due (Detail) Details 44 false false R45.htm 100440 - Disclosure - Stockholders' Equity - Summary of Stock Option Plan Activity (Detail) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockOptionPlanActivityDetail Stockholders' Equity - Summary of Stock Option Plan Activity (Detail) Details 45 false false R46.htm 100450 - Disclosure - Stockholders' Equity - Additional Information (Detail) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureStockholdersEquityAdditionalInformationDetail Stockholders' Equity - Additional Information (Detail) Details 46 false false R47.htm 100460 - Disclosure - Stockholders' Equity - Summary of Stock Warrants (Detail) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureStockholdersEquitySummaryOfStockWarrantsDetail Stockholders' Equity - Summary of Stock Warrants (Detail) Details 47 false false R48.htm 100470 - Disclosure - Discontinued Operations - Additional Information (Details) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureDiscontinuedOperationsAdditionalInformationDetails Discontinued Operations - Additional Information (Details) Details 48 false false R49.htm 100480 - Disclosure - Discontinued Operations - Summary of major classes of assets and liabilities and operating results of IIU (Detail) Sheet http://www.lmfunding.com/20200630/taxonomy/role/DisclosureDiscontinuedOperationsSummaryOfMajorClassesOfAssetsAndLiabilitiesAndOperatingResultsOfIIUDetail Discontinued Operations - Summary of major classes of assets and liabilities and operating results of IIU (Detail) Details 49 false false All Reports Book All Reports lmfa-20200630.xml lmfa-20200630.xsd lmfa-20200630_cal.xml lmfa-20200630_def.xml lmfa-20200630_lab.xml lmfa-20200630_pre.xml http://fasb.org/us-gaap/2020-01-31 http://xbrl.sec.gov/dei/2019-01-31 http://fasb.org/srt/2020-01-31 true true ZIP 66 0001564590-20-038439-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001564590-20-038439-xbrl.zip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�M^>&<+)_STV7.$R*=66X&^- ECF#_6S,/:,<'X\D;C'N_R-")W MY+/I)$O>8K#H4+K.7=XNSPG'_#?O,GA-DKEI$W.V?C/3M8/ZBL8B%/K M*NSE,AA%4Q8X8JZ,6"OY GM48_?UU=&:L?ZK=%6OW;)P=/'[,A)$:]AGK#WB M%[S<(@YUP^7@X&#GQLBORB@^G5$8>96!2GEP,VCDX'.%SCLZI\H->A0*HX/M M5-!+8'=?R_OR!OYA7_0TT ]0^JOP.\]]9^/UU..&$,Z7& MSZ2;W^BX^1=W&*4K]#6.C?S*+#7%KKRPNVR$,G>_TK%[\*G .>0%O>ZC5^6' MUZ3;YY%YJDQ@6*\P^N A/7UT!LLLQAL(RNAU*.3GF -H>Z2G%$"/T5^%]TW0 MP

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

K:PZ%/=^PYBIS?DB;(&BIM20NG6YJP1P%5(DSJ%V1Z2OXX+2"BMT(XKCJ@IGN5L@,L: MODD)T=N:='#6OB9?K3)WF,B M+B/J(B5+TO\B0U5;U(?P^[?H*T6KHH?6-$T$^=1,F8:'T7<]_?> NG#H4_41 MW9.33T8*U"PWS0?2O]>N@*60NE!.0TO%UU?J PX=O**C1S>D_!RJJ.CQL^*5 MG#>5_GU;N5@_D/\GM8)&;BGA+2Y J:?LNK+$+RE/O!Q=G3/->&RS]N#?$=W$ MB=*2YO*IS%EVA#[N19X3%H4VJ0P)"0_;0H^S:#2J+,4F7JFJ+3)RWE2QH7OJ]VGT$R1FVV;8"WH$YXM, M"4'YLRU"36\48H8CV;-9043''*2/7\F'^MZ<5%0ACWHUI3=."0$]T8"QMK'# M@[0LKR&D)O^HE"?7P8I6^%3N2U))1,T;Z(-GZ/V&0@QC4^DM>?2L9FLB9"T@ MWP9#D)Y8Q:AA\:SNSU\[&)-W,E/Z)'DK_+H1>AWPH^N5DYBK:/'AG2AT)1(CJ+$7 MD1W57)6?2O'W6E:%51MDYK^5B2;CX/$C:2PW8H^5^ ;^T&&9_)?N_R2'_V1C,/"4.<>SP>G/X@5 MY*WX'I,FJ7U>%Q!;OL.TM"P_HIM-G;;2NXU[*9$=6K*F@Y*OU6P9&UH-0)&1 MXH\5?9R)76\W65B6IUI"7>W--/!"[ESM?=8Y?S*'8N11?&[18VP/TG\EC",M)S@H"'?,\]^,!941I\;<=6,UO;LY;M9IGZ'6%:R8Y M+7&%G%.C%/0W@.C^I5$8K3BO!1]UQEL4 M)2O)6_ZCSN0^]7[+<9;[I%.^9 1VY@/%F"K/21+Z"LZ5K&M7E)S^+ [%D-U2 M&OIG("O"B[Y6C;N+0PD;"\EZ2EI\G(IM@';UG*/A2H*.KF6>R&4?=]ACDF^?W([^24Q M3;V1+FF[U2?,.DRIA;?L4\G/HH].Y/531"K+D_8U/C*SD[OR(4!UQY$C=VHD M=JPJ57Z <(3/[QC&_FIBDSTZ-"1T&*QH>C4:*1 M=^EP-":EJ5)IJG3:I2A^-'-/2=]GM>[7%+%/9B+6AH99ZEG/7VV?C0-/-#JA M!JN=>(H4M<]F*YWB<2K):Q#%?/U"F8TI7)_,5!6:ZJ [2:IYY=,\/V%Y,N\N M'GNZYF=S!559^C4/=ZM+#.G4T$=+ M4WFM5FDC+];-=#DWJF]2AVY1H99TJYZ8*_-4BN&@FL(]'#2 MXHXI:N_-?(>U<6M(5?K,W1XGY@':I*JJ&*;%E6+3C?K!;+&H6IVW0$36U!KF MB)HI,-LX^I*EJ?.'WSPG<[-2X/M)43M5S-,=^=',IY]0#?CL[A,K6\]A,U/9 M;N,@%[4RR)]6\ZSR DT@2A$J;EF1[K1/9A]0B68@B>&U)H'G]%/K9_,9^D_( M/,R2]C,<.3,5OBZC!0NB>T_;CX(>R ;4 N3>KC0T6+JU_)G*9F()BN\-C31L M0V.IZ1.75U[,\SW)]=W+X%;2(S#=^[V.#5O ;2 *+IF15ZE#X8^1,21*'(CI3G]S#QS M![;T<.P*C0]32&&%U=E":Y@^8.!Z_)FTF>;CP;P?$L9P/DSU+BY%3O?B&X'<%(7UM M<%2S@)I9+;L50+.'OA+T=[,H?YA0+D Y;^GY!H,5LKG'/4[\C2BF!&L)P#G.HCJI4:5J5 &D/Y#_)_DVCDW*XC@I2E6[\QS@51:M3Q-:56KE M*_U3(B973)UM5&9+_6. )A5)K],AUM&0;=\ M"#"\@-$_R88EJJ6#[%N8.>X?CZ;C7KD/J2,:VA3:+&BC]_1(;,1O(*"^_.U% MSO;[T="BFZW<,YDK@PE"?.=">YE#;[)5E*+'*M;<0PLZSX U>T@<.YZ=/*4C M)_VN[O-Q\N!6OU?8MOSN.<$UQB$-:_@=N&%V6YY,#^=R_X./+ AM3$/($ORB M5\Q5Z-DTE3Z3(>39Y_3WKAN'F>U<0"?3PUK\ LIH0$OG&5+C11;*21&O@O(* M.#X[Y41M9*49T@*0&0Q/VU,BOT08>G!);KTA M.Y >XQN4.[>GDP@4QP_:Y/-P';KT4)5#.HG"TML[*F5.+I70IQ?S.7J&/J!I MHY 5QLV@^-[,N@-=HA@9)K(83L^;2D6<%EB:+^(4F;E_[RQ7P3P,,"W!0HAD MD)PB@@2>-)F7=@F*TV53:27C^7#,9ILDPV01G.Z6*@0+'X=^A&L43Y7%<>,JWG#O@TGR@#XZ?)]%T7*'WFV#M.F(^?I@NEW&[K(DS^,$&- MN@4+?'\?/TVW2>5M0N%:(9>@A2/9=P^IHQ5&U_3&S:G;AC;G:&4_[N&6#2ZC MUTR)=_JCH;T\N@UI^! !Q6$FN)Q6.@6YM 7J#P(?$'^[Q@N M0O?&6< LF-.;OOPI$ 5#.W]#F[?..4\H9&&46^N 4Y[>S4V&8D*S,0?IG$HUR,#8V:XS$-O+;!/9U6QBSTY6B*#1'< MFN1A./>CXE@LA6K_%O]B:$WW3@/=D\JWO$C\.7"))G^VC?\.QW^8T3B_M.^K M-$VD%D%]^0I]R\$P#F?GIRBN MU$07[/.0O*\P =6$ *7UG[,RH?WD_5)%&:B_CM1^;Q_0I I@/_E MPR0"Y$1 C7B=+9<^RX.^)MO6\;!C,36B,$7IRX?)V*<&?N;5\&4J5UJI(V2S ME&(P$Q2SLG0*R5>0I;O^D"]?)B=2U5YLV*=KI_;/R=%QZW ;]D!X6"&?E\W!&= !"@@6+98M"9Z&=="NUB$+DB"'=-:Y31L(D[@H5T0,2:;/%>" MD@ _::[E"3K9EF75'!,_XIJ8Q>)-D9MWV< 1Y&FT,/1'G@!ODU--+L] M.R]@ !PW68\5 2E:D;<)CS^_8OO?[@E[?_3/7K1_L;/>T$9W[S+8[RY+[@/X M&D!:XR\AL[?EA[XZN:/M(BNW6O$\V"9> /S$=G)\;["YO(-N@).?L'5]>W3\ M]O28K6S+"GT6=L(HK=6=_-"-SEW+ [X;/C;[4J][>#)CZD"HIA.P^+1K".F8 MRT[K=S[4P>LED81H"R.Q,F=WG3S?%43Z.UT%#6"53TV6U@'("Z$FYMV+ MD&HV=.#X8*V@'=(B3 VGDN^,*P!=VR-KV75[&LCL"3.'F]2FJ:#2>PMI@2FB M[A:1]U W,P:GXV/7GO6X6C+E6MT;O$PZ;IG:-2MJ9']D:%B5M,*"A'0L#IN9 M&8I-8-M1J5.H#"TDT@2JFI<3AVZZO'J]O#(O<[XF9F: =F8_Z#@JJ.B814'T3EE(U+',O.3HZIQI1F1F"S3_CNA" M)(&*:9B2RIQE1^A#;O-XS"@/D3/:1&Y74=4_2QJ3JCZ;Z&L=7&<5R(R,%E5" MAC-!;Y]92TA$91+_*2#4NCK&^1!_A/V",96%3Z2,@(9=(ZYOM(&)\O,JS) M'K@2 GJ#_@JN!WRVS?Q7@[ ^4=H]68>40O>JZ?3N!1::9F'XGNABC2] 3_*( MH-H3/I;@N6H)B1K(]]%$P2G>J4A<-1A-9%Q#*(M5OQ2]$[.E85/T:G5Y#J39 M85IM7"M%+[7\G7)B+'X5;]Q2A KCI]^;'=U::\U DB88#IS9DJZ- UIJ<\N? MTO?&@EAGMZS!:L?2FJ+VP6QM3]R"C0JM[!RG296KU(HK?20IBH9V"&]#T)5[ MOO(2[J-QZ-7Z"Y&T6S.%[(N9*HF:VSA].8AZO#F,T[E54%!N]E-FC@VWK@C% MC63S"\7#7CB$9I9<4X6P.B J1>W8S(K@JJA5QL-QT,RLIMK.5HMB(#E69A;D M:P>KZNC7%$-#VR&H8J@:,\WQG*Z*FFJ<%7'W*8JGT]61TUDJLC(X9M/-42X- ML]DX'+'I_N %7!NG::6P?I@.;Z:,_EZZ'L=I.K!5ZDM5TB7'<#K"N=(F5?FX M*6@?)QTE"UI9'G:*UR>S+?'2FZPL[3X%S-#&*DHW0 OE&#BN9AM%F]T8A;4Z M.'0:(E(&4*TF+:6=>V7= 8,W\\A9Y5C37OJ"NYTLIEZU-%F>6Y8?0OGREC3L@ MC>^9!ROH9_Y0.#%.-UN'MDOW#UY<^SNI:SH2&#T[J43?R]&OX.;0=F%\L**_O//AAKP?8I&62+3H=SV??!$&#PY[ M:F"-SMDS<&GL:F\@%W#2UIFO[T:I?H+K:8^\VE 4#DZ6]@=P76"M6+.S]09X M6Z7J+56$IHHNAU;19:HG+?#&^. MT5'NV_BB>X5RWZIT%(Z=V5$+^C)"CJ:X:;X!E5XHO,Z!F8$.C=^%U1' K;YY M32_>,=BU$#?RF%X6I(TETFGPY.MA9FK@4(],A;6>+XF9L89#71(!)U6Z-*?M M7?9?HJ7QX)(F9IFP.+WX:OG2M'?WF[F/45@6AGAJ,LN*LOEX7]$ 7#[7H.FJ3*=5I+;(,K)#NT FZLV__3*^3O_'44HRT90-\I#P.)DN]FCBI. M]WD8X PUI/L?BHDR(&]@H0K;V;1'4ESGL3#EZ1H*H4*W(;41CY?,!H_G&!U M NB%[IQ:5(U M$8 .RRT4BX%3(MO#ZGSU)1O?%G^OI;U%_+AG'-##B(AZP3G9O_M$^EH(TU0Z MXS1+D*SR5Q\2P>$_KH!WA4+_GQ#XLGUZ!"@UX?"6W Z/Y _A(VK(816EQAR^ MH$?$B#=EL)A04_[F'IDUH=V0NT(R:HV H@<+)23;^F?_2S5T]N4?CFH!9&Y8 M\5@R>9K=<2T:-29+48GC'6U*Y M'P\HTZ*P^%N]P8*YFXY=W_X5TVJ,,I. MV>Y16_N86)95D5]_T'5A9?5*,SJWL1=>$)-!;#$Y-&% MR])8"$O,6J9WM&H+PRKCY?B:6RFK.?*V:PZNF1>-LH< U?DU.')FON+:0$[* MQ94"^K&]/)9AAS<]*4<90*?>"]VC0D MYO8<1_2P@9:3&FANX:\K6W0/Z:,=I2 M'%&+/ PVCJB-.4X1(^6^PF_@U5F'ZZLP(/"?(X_VIR#+?0>V:]&B.&)TE+@K MDMHX'NHBA-&;(TF,PF< 2WAAE6A/L2W%\6O[YU+2ZUQ!08FCO-R09*;XX\D# M/GG )P_XB#W@DS6J!0^XF6WJ6O6 F^G D/. %U_!4Y1 SLA1KC.97MAD&"9T M0RN5-+8:*3VM.*IF7A&-4:U]8IM>>Z(_!\6IABUY( 9-+G$+3SGKD\,*/IRO M@+^D*>M:;9W-V#MX,ZCB] W)62SA-)[RO@-#F+L*"NW9-9M9+J=\3J,LJI/] M9W8=" M&;>*5S/';HJE;B6 ]41#*P"M%LJ+$#ZB>^C2,.X[X ?;]B(I54@/Q#(HQ;J2 MW2% UI_7&)-S>Q'ZA*_(6?.P(EN=5FJ+O0USCV@V:P=CY&_9WHX^N?8N7ZT5 M\);4EAY]0WNDK]?(8X3%+1@=LZ%HM7L*KCWR1 OIV)?QTGX#04A/7,2AA!%/ MA%@+?.*$Y@79-(KL[=#0\=;/,Y#<(?=D_(> [7[H6_38+:7,&S)4]<_R'/C^ MEJ9@K^FEH3ZO73I*NXC67PU957NBQ3-"/\@.(-MTOE@(;Z-J(CH0)@+"@M#& M5T10W,--["R=+[)"5+:QO3A-'3.<;UB-76]Y P&YL>G_77OD-I$Z&!5$=*_2 M>8@#,K O98XO(:#'*LE7G94Y!A:]A)."]Y2CS(^9,I?]1,Z"V7 H+3)M1T=Q M(#Y/BLE+2+0**DKR+%89B$9P UZN''\=6W"$95DY ;7,"\=CX1P0W@&'7CQ4 MU1?/MRC^6LM9C>4=!0(N@?L @\"%PBY,(3(]GMO]-YGZP;QIZ 7Z.O*Q@<(Y<%[+-?XYP(+MEZPGU*!GDMW -H1[G(KNA*\ET MY:5_")^P8SO =V1D7]F777%)^UP@U[$I/I=>$#5JD0J J**@DVN9*(CR[Y4D M2-+ @JA67WWR9)24&V6?ZSYAS43$ .0"/MOFS(OMB(E"JGHC9L0X:Q O(S5 MGRNL%CI31ZMW5XOP= N#:J16;WPA-2JG!ZF)!=-#;1H(X!)$QQ*!(W#A[C:P MW-4'QA> HWARJU6\_!DUKUJND()<@=+>B30T4U#P^8/*'V6FMQ37=946GU#,K(6$37&FEUR6T#>$3*LI7A_,O U:EW5%5O2\B/MH M+(@5_H=2A+(^$EY,(Z3V4*L:P7DIB 0_Y/9D H[D)&@UWLL MY6AE@*N*=N!X:8A^/B2\RD-5>(U>LZ\%E;-9%7*4XO9EPDWP1A"/2DO )0=Y M G?WPB@.;$PA.S8[@48%LHI8UA2VDTDUJ=IIU5'-*8JG9F>^2=^[U>'N'+;I MS%8_9'<3&#ARDZ)7C5QU2DN*X_M1^E;+#VYENA-';5)/*E KRV%+X?LPW18Y M^+I.,E0YJJ0Q MY1X-,?>H"ZZE(ZD+/]?/MU)X="F)WI72NLF5/B1'%NIP,,!,JZ\H9QE[HYAO(*!8P%7ASFS M8L##M&T634A+$BYWI'^#MA.N'Z&_9KM"EIB'-(>3]3#?*P^O1TR4V'.;F8I6T)5A(K^643N9<>*_)\L:./9B<\*<,EEJ3([$D3?+5.'X[7),\:^ !Y M,9GIU#9R(7,@I_,K%&W :_*,?N=51)?P"CS3MA*)"N)XC3C[]\YWR&\WP+U+ M@=*1$"PT[.'%T55/:XK^DIC)#?*6]+!23N+7@P-Q]D"G8,\6Y+S]$P*R.L]2 M;C#U,0:&P+77\?2S PQS[B@4[\/$(PYS]"^IV[I3^X&9^ M2VZYQQ?H/L-OR M64D$+#0>:X@3TQ0DT7"KNV!R3Y:,]1-/SSX$5(FEUXLALD=]Y&',SITI$S;W:0Q(D" MX [8$#6S;2>:V;6W0/Z:\=.-\4E@J$,Q.%5-1244O=A7FY2GK%>Y!8A,B5=3 M9<#>TWF^/UQ!(FJ!^Q4]0]^+?'8^.4?/CA_BF6/?0]>!"W+V+BUZ,AV+A4"2 M;3RS LG4C%;&TK%*W[T0A\"]=_"?<_^[9T&?R!$OV-XR;Z5\.H<8O3YG=A;S M(IOL(4;OD!+-IB2@*0EH2@(:QJM@2@*:DH"F)*">P^A'E0!4>NC$%!W3>YPK MJ9$"*.85X;$D3TD],U";CZAQ%I%KD"-S,J9:XJ 5)*6S@9 MD]I6")^ P92C95ITZE=$_O02Q=AP9U21T'' M;D_KH3R$FPWR:2?T6W(-(0\CU[$I4#=P"=Q++R JQ[X.(W .5$=06H_L/8HE M?2>%WRJL ?:##/[DOW:Q)S_ZXX&HPX!HXLJ2'0&<]4E:&*8[B,0N7%2E!XS%,]3L M'#;5^;BQ:Y)V%5HWJG\[C,7(VA*2K;XD.?:3K!#9Q37F"%X%L'5_U,#:9#4' M5,SXQ!%M7RPE0-L#M=3%P:&6+I5G""R6WBTOC/5("'!#K:8D-5LD('X9Q4GH:-:! 08,F648.%> MOFZ@A^6*@!03T&&B? C)-4I&OR:G-,E#-?-NI>S0\T:5K'O)[F'UM-11Y@LF MF0=9\K46TW\.B1^0/JC(BY7HYF!)[@YJ]4I^25.[I7:Q/&T]-7,PSDGE_7M= MJ"!..16E'70+7^:+A6-!AH>D/[+X8VV2+I$-(7!9_K]T*E<5E;YF(9O254Y# M:3^KH+;ECI0(DR"KI"1TO>;_R1IQ+T($FX=^.(&A"H?A7'$JA0*DCF6%%P%=;X$T?VT M6[.==A7/-U3SNAQ+9K+XT2RW"N0/XGMSL:JSK=2@M7?\#,\U%K"HH4JSWU@B MXR0.886Q=BS]507,WJB)Z9[C:'8)5S$ 9<& M]#^L( PRH;&Q)?(1Y7<5;OLZ:9^GX5\]+TI,+/[ M&=\XX,EQB3!4GUB&1(_\TX22T*=W1YI[GRD'<8#(7O'I[59:ZI; M2(>B^E.RU:A%B%FK55YV(M1Z?\E(3+GT[;>W5AT^ P>62MX!?#('G -M=FO* M-F#>OSXZ;)%JX#9MHG:,I>MGJSAG-=L.J\MOV)H]FXZATG;545[=%*BSL+5N MY310GDJ%VIQ.-Y0THH4&/8ZHAIMHT)9X6L?DRD4O&>LO^8X(3/J+F46N!"?8 M]FJ7;Y'# [72MX& CH3:_ MF_D2[-T'[FERLUHIF>UPAOP6;;Z-A]'1?]BRR M,-?>,\24![)6:8MN%E6B8D:0(*K?WG,'MFPWJQMZ. 6U6OOQ"<$IU?A8*)EN MI$EJ"R]0VCJ[7_9^RY=,!2D@;WJH@>KN+M6.^$'K(AKA2P2=!Y>LEMI M,KR M_:8@73LT%PUBQZG?8JBE.UIK#[W!*.?6"MJA"^>+JY!VNXPS@K-G]B)L/:Y2 M9=0#4*)E9M53/;-TOR<"F7 D=ZF+TNRK8EL1-_^$P'\D WHEHTS58@ZJ6DR#E>:ZJ]DI=7I SDH2TPNQ M](-L="N97M9%.[;=UH9! 7#[>RNP*NTKY)+YXQ]=Q;01M<+?.FY*7HC&;,_M?(8XNUK8@[(FQ@]BQ:5ND MP>U72M6]_[-V[4#(5U/U"F1YLV O"B0SIL#C2)KHM ^ ' MXX&X\'(;3ZZK , *2M58,EC+T=.AL&L- !TDRIV^%+O(:QUFX'(48K]Q^D5I#6:C@/?T24[*LU2.%24PVY: M=?3]X.29;3O15#(U/5J*WQ:@/=B@[2K>^_;BWL(7]BLY%Z4@Q1Y]U+\#-X31 MC\D=]0#]9W(\+!",T'ZCW>H(O%+*6L-^XD$A/7'@$^9%K7/%A!_W$% MO%UCO4Q@CGZ>=.R1.Q]9$-KXBMSX/P"=1Y"^NV1V1#6= _/]7WODR'K8L9AT MZLG]O\N$E@@ S2UBY3Z(BD89QX\T!2[[>]K'ALB^?\+@'EIH MZ3E_0SOK*I,*+-##D):*X2Z;*K2+)Y'VB!,'1Y2BEI1W%V "S+9/'^>;I M(C.I(C/%,+9M=JM"F\?*G1AM&A;9N4CXK''4S/8BB0J5W MZ%C*N4B>PA+M*'_Z3HQ%JUJ[1 UT8QY\:G;1*]7W"!)Z47$4S99J35$L>RGS MP$:S\9.4>B4V#AXCUWY]JB&A56TC0O*&+0ZB2,>X=F M?QY0:/8S3ACK:D]3A_&7 TM>J@5,O\.21P).\EC)3\X!-%MO$MN[S:,L.)YF MO[Z;;LBR*!P>;C=IIE*A6APXTWK'U151C:]DM;9O:L0'&ZE8R?R00V)J+__T M#;$3KLM292[(T^T*.+Z^Z)D6^3V($E.U\\TD$AS("LEQ//2 PE9 'R#3AWTJ M*A/YAGHPI)D^[#4R]V8Q9F4TEA.39>HOT:E&,J3]'JZ[_#BI73G=O,9-9%M(,P<+_Z*-Q<>Y8;4A8+!_\*'&_N)1_,%VE MO;%TV*>^(F2_.*Y[O=Z08TD/](UD?YHR"CJXEX$Y9O-89FYJ]+7,'#X%7 A? M0,NG[[8,A*D4HB4ZFQ]N=[R*7&NK]?I4M0:6-)DT99I'-X=IYAE0 9:=*]FV55 MP4 ];(ZQ5-_2+0!D:PB9B[R&&D*&U_1J7$.H4E4:2^6O'B1 N=YL>@&QVM<& MDGX4<3>[F3>5VJ,3R;Z7.8QF%U[K\<(O,JKD#_Q[8V&O,$>5(E1XRD_-OM-K M#8](TEK*@9NN\8[.M2XC?5Y6?)R6LATW#&K!.\7+=IE]>S;U$*)"WR9'SVSA M;K2,NBDH"/I^NG/:CH= K$@8VGBW!/^;84":5X MRK'TB.YY<3OL%#W!WV:\N+F]I8OA3*L3?@/_0CXK@0GQ?#$C_V#^D!L' M/#DN635(_RO^SEO>0QRZ ?E#\@91*O*HB9M!9V>T-UL=8=< KXBZ]NP06,ZV MWUD6WY7CD>--6)I9@?/,&"V>J51P=K.!M(2@%[!XS3*V-& A,5!?6*1;M6LL M) ;2%PA%;WSZH"FQY\!@OG@$K_+13*)TU;JF3XE=C5*C6 :G0OM>Y2&Z7F6Z MVW2MEG7$&=B9GEN6'5"FBN@)1!.[ 5C9JNHW1!H8*NS0S M:]SEW9P;INN3^[!"?O (_34+5)!8[)8&&M@ZD_U(8[D2_JBQ*=JAW:^]V-!: MDF:8Y:"S:TR)_,#V"7E!DG\-MG;HV*\)K=C1RO=>(C! MK3;< ,>FUC,JH*,I=;;2A6,-#)%$6#%A3FV,"'CX'EK0>:;"ZQ9V=1!$!AX8 M5M3BQ+S.>$6/[3-P:9) 1_B4#3;0>T,EV:S1,&8D,NY[KP:1S'C3L#3'E'0\ M)1T+)QU/Y5VF\B[FE7<@=-^ MQX!!+4U3):XF ^=XRACHJ=P'$RGF9?R+/=A:*?=Q8O;]JJG8=9$(\,PS],[FM9H$&E'9:Z,L>1W'\Y*B3CEIKSRH:U:B:=Y2ACO M/L>L26P$SX]M_Z)" 7!'OC[M!N?PQ3*S(-I %JOA06I?CY@.4GP($XS/^#?V_)X#A?_Q_ M4$L! A0#% @ C9X'41]J;P$ ,ZD6 !$ ( ! M &QM9F$M,C R,# V,S N>&UL4$L! A0#% @ C9X'459RHS%5%P +P0! M !$ ( !S6\! &QM9F$M,C R,# V,S N>'-D4$L! A0#% M @ C9X'47H@;O=3$ ^?L !4 ( !48!U$;T;]W'D( +]#! 5 M " =>7 0!L;69A+3(P,C P-C,P7V1E9BYX;6Q02P$"% ,4 M" "-G@=1,XSI\\:% !>X@< %0 @ $HV@$ ;&UF82TR,#(P M,#8S,%]L86(N>&UL4$L! A0#% @ C9X'49O=";#C5@ MG$& !4 M ( !(6 " &QM9F$M,C R,# V,S!?<')E+GAM;%!+!08 !@ & + (H! WMP( ! end

3;-@( MXEXKN(TOM\)K+84U$.%\XKWZW4L!HH^3 KA/<1CXURO!<'< !K[X8+%*PE>1 MHMKN8@O:/#@*">OCT>G78^G'FD2O,EAE$@9P#^T*$ UQ)]K'>L$?[U'(\7KV MV)@F*W3:%@39K4[[\)MX#W1 ?^=\+I/ ]TQ[N1?_8]I/=]IPT?OSXI_N:V$Z MQ%6N>*O[S54N>BFN:)1\,J?93,(3[V3H76$C. !@83# /8#GBR0(14?W'>FW M!#ZM^N.\(=TB@Y\I @C;VX52Q^/P^0AX'3Z>P/KQDV@L$C,XE>B CAPVH<,M MAUCC%&D,/E^27./3\9Z7/>:!^ELO-0'@5%(DSB$?X2T/Q)7D:_4 M7.)-)EZ0J-:]%!=IQ]NMR1,;V!LD$>]!4H*Q)\)@'J25QJ[7PG0X!$2G7D1- M!0'>_WA1Y@&NH+N&@L1;MS*4R5S/$(MRV49^GR:2.B *":R#SK[,;Z!!= ?M MUT-'WPPY>$[=#QTQ\X"QKF*#I7HEWGS^+/X-RJV&Y=M?/HM!E_[=$MC0T5RN M<0U&&?'G3 :) .V.KQ1@CR&I4N1/8AP0C)BX%5\"S3 NVW!"$$%HXH7+W-\2 M&V@I0GXSU;TWQ804,UH%(C$@$(A8I?ME7(+M#G3'(K&L[^MZ5KMP%:&%FU6% MM:;J'7$U"_Q*J6R#>T_#>(1]BN48M&@( ('7!*&DQ)N,,]\T\"20(U)^0]UB MK'7PMO5/27U/O1Q:$'&=79"%]DIG7IHS&?"'L<0 $=P:/IX$*5XZSR+4#Q[8 M%[B/-F:@&X 8\&("_#NOTOR5&KLBR8WN;(D_I58/<$5N>N'RNYZ0B\"5!) G MVFIZJFKUSJM75_T#3R ])-P0EE&VG"WDP(=8!Y@1E3;<5'KPE,J]\CNYIZ]5 MY=>1E&-@U(\96$\(+X.HO&-I^['9;:!T3UM-5ORT0M?JFC&Q#TZ%/_-(L6I= M3)&K,L9C+,$])->;>NK2[#>"C/K9@ECYJ:X/(.%KMX;WIYO2;M(LHB'9E0MH M6J52U'^W)?X-2X[1]P*)\I<"P;L5@ M#@J)#H@-#^ 246O\CKIA!$3Z!;08R'KN[/:&G=>X]&GBS>^TOH_!+I^"I"SZ%0>5&_>KKJ^5 M?&3]'N:W53U9KI.TBHRF'N@\"$A! 9#2B 4$!@A&]297'.Z.)@4-Z8;+=\$EA5B, NH1?#7%%3;1!8Q)1G'*SEN@0>HXZ.@#"O%/ :B M$872ZX4V2&2#$$#S> A6T'&-<;'EC#/YDNPP].S$&-S\FAS MNB[;,C)$6F7K#];8MJ40_"(#_,2' -S49HK[JVO$2FQN->B6TAROK.2^NL_)H2'UY(JM.\4$D@,M3 >E$N"'H9 MR%K *'A]SC*ED1Y+"#3BA58B"_3_T-M7\22EK _"JF1R&?A5\UT!=P2L +< MV<3$N:H+I_YEZ4E@S([!2I0"Q?%%M2\+O[S>,!LRV&4:]Q&4_A^W>Q^YR^$L M"]D5**@*-VH]3.FK%'X7Z _+C%*=J$/DF%1!,=O8"\G)PHLKTHH! M0\[?RVYDKI[ 5>/UA#))26#P7/:J3R0];@SK2JG&C*463KVJ_#THN,L%A\RTEN/YB(S' M1%).6U7<>>09$+$9404_N_3"K- VLFZUE-'8!E21Y, \!*7Y;JE^/4M%KY" M#$U$DF]:.JK!B#SU$-X@09N,'+]2@2Q +:+@.*C]KR2PL*?H:F!;""CA4FPA M C_#-\/U?8WBJU "?G2^#\E!/DTUY+BIS3 @_;;(7^]6T4.R^#)!A0ILFV9Y MZ*=?:!'#JQEY,ZI1Q-3I)(*;%K&P<1XF&0)U(*KKC?2]#'S5*YFG[@PK:PXV MAG4U6R :M<1"U0@7/@[R YBC!/0^1(:8L_)&H,G F #"N4$*@S0-)?HI40QT MQI5[VKA]0;<-,V1DO7PO(LG6$3EV &:T)WG<6 M7XDYAN2!^?XZD.%81[GD<>;"3KDRS$G<#& =[=AH3QQ^?C(2O4W\N1V==D.6%?+^J)3ZF.M:0Z!'H8]- MB8R5&4JR_4I'@GE1JXR7*-^GR'J0$2\*4B%]EZ+6U+HAB/Q@ ??-8T':EZRS MP'I.7\5 E^"E= M(:?B"YEQWGDAHZJ6X!]T=#]36'8 DW IM9Y+/F4 MP:6BX!(0C"I191ZZ!/@S3,%/$4H:3"DCC2-\I8U("39F[+&0(Q-=WL.T.T70 MY).3?P"A=S[A4L*:S(=X36$;4N^;_E:7%@TWW)DO,<^C\-O#X J@F(,C3A?_: 4DS@8O0:IIK-7>?(LB;/IC.I+9F>0>!%CJER7(&!5&7!5DN=+RF#] M1H3N4*K"5'8137#JP&SK47.5E:]D&1 Q!U,A(7EM()&8O\$Q+>*%VVI_]S(G M1B&)Q7MJ8N7Y#W0'\QR+TG%N/;4=)RNSU#I/[UTO\4^1)LD6.8/>>.]B1\/- MU!?P0)F+*^K!R/N%6-"6B3P*SH5T7.:4JNO9K9W>ZSC$0G*IF#:Y+J.=Q-2[ M*N2J%K*(.RD$HT@X3EZ"@KL60+8$HXUH39H0>;-(=16/49+0 R;)1RVNC7E\ MT+AFCTL"ZCGTKG3Y(U=% 2I2NBD\"?U/_6(!9F[JV;3\HF(Y[O [B%A2>@_\ M)03?4F\F@(^^4>:-?@/LA*D^- [P^):X %F#56&1*:V2-"A7!<%^#(\.%ADQ MG,[\KLE.Y8XS.,6:FN-;R)E%E"R$NU?/U6Q-0I*%%>\]A7 UU:[L\TX?K^]_ MA_]8SC242[IGK<9RYP,83-L+"MP)VB+!1D$1%=<0J=4ZC:ZE35I9DNCL6AR% MN#=%_.FI&40:*881;_&5O7%,Z+B[4CW$CY1"<[ M2'EY9H#7[D=P528T[Y,4$1END/AYW.^G*FO&A!S^@?SIMMT/L7!8$ MO&K.RUF?67.*@MIRNI%LM]I+&EN92&>Y_J63+"AP6,N:QK0#R^2#X==P69)B MRJ:F)B9Q2I@W*O9,RM2+W?HBJYPUE=%'Q M!+@[W!B[NW+XE):HT[?"=$[G*9GQI/ M5?^<%*3.2=_@2.V$%7)YI7VF*[/Q $L+Y6:0<7V#,^T/R[]NB8_(:-L1Q#@B M@#GF@?"!RI_)<889D4+2;BJDY9U>&/0'-](1M'4:8#RIL:4*QEI^?3];Y)M+ MC.Q6A**^D>SCVL)H&LYM*JS9?9QUA2ZL2^X MQ9:V5584DU&!E*/)\D)&5?, NTYCJ?5@42X"XD<2MV52IBW$N"HQY:'J>I>- M%>D>78S2^R[1?9;>^!K^!]3)G/AUCIN34:E4=6:%KALY:]U[G?MYV,;]=A7M4[Q3W:)]C;4X%A4W)#P9NY*2^\?ROTP28 M9GQB7OH]_=^RP6C4CNV/D?@=0E$JBG7H5,%0BVU^$J'(M].9\?K^84]18#G@J[ASMJ:U[*2-S+ZF,!PG7Z[[0 Y;APT0MCP/K6# M5N3!T-$(D/GK" \#J#3PQ?\&2'H(:T>4(=0G 2KG$D9)_%77W//MZ.;(4:B3 M,V_Q!Y'X=XRUW-\IZU6<$<-3+M7#%/K:VK)^;YVW'/'BBOQ:O9-P%BQ0:Q7[ M:^4WF?@!+N[*2W1&'@\.+$7S[>]R%VGIF!EY.%7/7Z5XUM%X8BFP3_Y#KV3U MEZU5W4GH@ XZ;)@?'YN,(OXRIS@MK#MHTY>P1+W7$?H1O'$BZPL(4OZ6 M.FPN+ /*&!5_P(S@B.A4%UTG'GC6ZU=4/!R/JP442'5;0(XBU8DVQVP2HR ' M@<"Q7#VLHD7U($1%30&=$. M5_"W,'%&)SUHKX):R5?X\GS<:OOC5L=KK:M'!,M"V :LX[;;-:H5]@5U.&I9 MS,_>)F#(JV1UC8E$3GO>=]K#,Z?;/Q55 S#&Q@XZ+:-NEH^,Q*\5"#0ZB32G M'^%V)L^;[Z^.9%IL5\X720Y$G[P'BDU2$4JLG\*''?H4=ZV!]Z(KQP7]T%Z8 M4]9:V8!GXLO*(5JS5+QA?A25SFAC9*5>+1=30%4(TRP$NWN4W4*H*X9I-OWC M,VP,(<-0+3S<%5S\>X%GA,R_#8RF/35&0-Y"R5?Y'Z]!$L;I#)@,N+/RF#M' M].B?=5O=[G>O(>).Y0FN EGQ*O%6M3>Y4U3V?'YF^Q8NCTP*\^[_XX%9>;U$ M ?UAE61]^!G&)RW3KO3>4A[&LOQJTJCCX:,W'#:,5/&"'DR MN[H[8,E1S8MXYBBD/G[K3<%AF5+D7]QL=9I\Z:U^M#DUEN^\ MIJT NG0/+ZYFGBFQZ'U<\SEM/2 W+=%NSKK8>MWC1K'>H+ (965+42JZW^$. M,U"443;?^J;4#B'3"?L\#-?)A.OJ\47C5RWG']!#%+].X,6)!&;?3)F3JE*D M2@/G1JA8-R7+)F3MZFL(+#U^I+G0Q#H%&Y9;RU]Y]R^;DFD-WWDJ?:HGF;'R]NM M_G3)9,_*WOQ?MO\NF8!Z%2PMU5_H? MXLO==R(V-]^-KATL.N%)=U/BQMPL%I$6^M1DX9_5*@2#GBY-E:Y7W>VJV\)\ MAT*]'83Y1.K3:F;-V'S9NXR3I5N0N?Y/%DG1.=,PU;G'[)T?UQ)R%+9VG5/W M#,/6?&,4/B'3.?0-XFH$J7#-;J?K)G7S9HCJ4I.N^]5$JB*[K"YO; S0Q^D^ MG=?SV#51QE2W 6!14?!:Q*L+5#'ZJ1ZLJN**ED63->G=DI,IKXNY7(BA!AWX MS]E:3W^%_NS:W;63KPM^G:OX#2N.V?&QG4N?]DH+(IH0)"# *%O[UY]>J[N!!@E0X$5D@UR[]MZ1)1+H7D_W MNE]0:Q0.'5.'(YMF/ MBC'[TKN[N>326W"*34M:Y5HN EN7%5'80DGF?=Z*JH%G?7Z:VH,>^JRA:Z66 MOB8X <#RK&OW!D-NP/;@#[=A.(:T)ZSK@L2K>.XG=OIK)#HWU%PO4H*ZT4M% MB"!&[/KI:L7W19F2*V:^(D%Q8.(FL\>9))A-U#Y M._V!\N^YAZKRC#M!^C2J:2^G;R ;$Y);_$GV2 '%Y.7)A&/*4U7)DBPD12TL MRB.R=^S0AHT"Z7!R=W2:J0P[):: MBM]'KDZ7W%2NLF87EP#-3DQ[;4,2GU ;,0\IRYM&84DJ.*]*5 M'E(%Y2:OWQ2D+_%/N%;6I.=!4UVDAE1N7*G4*/4V95&6K;NPYPI_%+1PA?XA8,R/8E;+^I;SLXNT4J*V4Z_J;$=BUA-S8XJL9JC8362 M=Q3PFJ%,M,JQFF5>*%@@^X_W7^Z_^;AI]W_=SFC0N<"^;\L5XSA M9^'_%DV1&;CU ( M+TH]^?+<0]HB!YU^7'5,=BWK5B]B[--CBQ2:6%1JC='/[6+[XE".X9;S8#&9 M9=%'5^"*^P-RW8V;S#ESJA^(S=Y2RT8M;T&]D!EWG,M\Q;E0:1[9;RZTD+*^8#'" M6]4/*,W$6P>R6EZEZ\#ZX$:C.ZO5KI*P6$(F&Y-QQPN/6JJ-*J6REL!C5VX( M(:%[?ND^<%J]L-Z+1MB0?RM^9;V+?0XYOXS?V726:(E%>A*1>$Q^"7!07O__ M7.W%N2B0^*P]_'7$C=SX3G:'25^2]@H=+63NXMAJS.V5#<*S8[>\#NL:^KSH MJUE@&R4!OS+2BDGUTYF8YNWF5GFC[H$VY#OK=ZNO1Q8PB5.%-5QC-1=)1H/3 M=.4L6504^&A5]?*)RS,SLU*G+).TK%M-+E=::\4JR\9_8;3%K MTBD?JF0C#IB&358]AU3D\WVBXN*]0X6 W!DQF--?3D\N9Y6)^?X[^%7/$ MBUFN79#?G7MZ0;_[;"5:E3O?0Y<_;M >+-S)"HRYX-KF>%C^TD&GYJP,$ H, MFU@GBJ]M+*P>T[!;75% @2W$PD4!EO+=I?H&-QN=RT_6,P<>HAIZB#H6\?U$ M)<9#_ZM+Q261F"P=W;2'J_H& M5 ^I(<_ /Z3NQ5;>#]6Q-R^8D?GS+]]X/D[\2-O@KV8:G"TL*.%%5=7, MDL4WR]$S8HX/-!KENA/V!O9P+(TFLJ!)6Z+,^"#$5LZ1; N,I%GX1C9]C+.] MF:A/Q(>/99Z;_#F0.\5"*GU*CMQ".@"L[,UY60HOQ=$4C&%)#8R%D4V2A;ZU M87?WXS+1/KKQV/V;Z]@08+Y].C/9 "NKO[("SY4\=B0NK\\2:)*82NH\G:S_ M,^MUZH.B>IS<6EK,P7#7BPXM)+I+,/ M.KB)#L1I'Z\;;ZSI$$ZCJ>D0P@P]^R _^MJ#ZD/X*"SJ[(4H<\K1'>7'>#63 MU9:4M9IG1&<8[F&>,YU:#&@&=T& M?(4CP7A=.7,C8KX\5J$&%ZI4<9HE6T&[S(MSZUH6USJ]YBNANSQRP_1+I19? M?N#'Y8<=/EA\J#A"8GZGWN]"[%>90X^:MEPP9QO#$YW],SO:_&EJ< \^&8+](BB.<*E9VKR0PA?:JI;L5?CQEM=I%H]3&8*LYK*0I^6=A;&3,S 'CT4 M' N8J3=&EJ".AB?T)\U]?@"YZ M[T6)J-F"TU%]=%*H3OE! /U>Y&AJG/0@_XJ' M07B7TA$5FCX,9K;T2*>=!(2A[!27;7[-D4OJ1JA3X7V%G=RY&-%=8UUHJ?'[ MZ>CN\'7/'NI"1AV^-76=SPPS<:50_L*!3SA/!5NF8M_P.D^8N,X? 1N;3N4. MR7THC9!<)P-7$DC.ZG"Y8!F+:0PA/N(2JKY1?(M:Y8!3?R8!L%6K4-$UVL.A MDF.P"C@'&-]S&P&C_ _XH->A&V&_OS=<+1G!I&0QT!JMHP4'0B21%/PZ1B17 M."[+6J,N^4)PV2ABY,(CM+*@15? SCF9SY-O(6?S+UN"R:2_1>;/<7V! [[' M3-B!V9RXYI]D>=/Z$4]UTFH[XH==NGOU2 M:M8-*EMU2_.=US!D]L?9/HEN('($>8Z:1\_80&#"E!H6Q*@IJKV7N:5D.99L MK2\GOH J\>'J0A1XI#7QYZ(F/BVNYQ;'2_XYZVJ.# 0G";R"+UK7_$Z+)D%. M$_\L__;Y[35GNX%[*Q3RWX16$OM,7(68 XV3!=F/Y'?01BP9^S08CX1R $;.S+I[?6OUIBO? [@""< MPURMX-;'IAHS&)%0M,I4#,1R5YP7KJ2',$SY9].WR,F]'KAYWR5BP*?$+\;P M_VJ\'EZF=7Y9FIQ2KI2N)EW-"^:'>!+T*,=^YQ!O0RF'G7@X=U>11C4G1W2W M%DQ9S1A#83K2+^-3S;1=P8VKL-@\,WX-HP^O)W*L#H='?'H%6V[OB"U7[[E1 M#[:,E(3+]8EK\GSY:S/DFC0B^2I9*5X),1U%10;6X%"O8B?>.97P@^D3K)^9V&AE<+"N;!:F)RL(<>WRKZ08+?/[2F(/)7Z,1P^0)-[V+JO&7GV,Y M&95!<9]"#?,B[8!+%U*/*YN/QV"P\9M&@:D[%I/=^'__GKNBS]L4/.S8JTHC M(.BKG/H^-Z[!QX4>/^2@WG2MPR$[>.BW:_GJ!]#E,4_EER]VNOQNEA(#)TP:^DWF$SL;<%P+&I4\,FH(>EQ-=JM(7JALB,C4R/X5:.A>R7C@6I2+Y MFURRJ?R$3('-HG^#$Q;-O2CK<(=W).,,CU\2X)K9]2JR[2[$E?LLD@8Y0E>< M7%R7.O_?HE)&9#O MU>X8H:':()706A7$\5Y\?U[S,VNM_P(3<40[4Q,=W8@ MIM>S%^LAIG\73>%2FAVIA!8R)W6=5F%2\"%X/"CT*)M^O;CXE(6.,DZ8LG^6 M'CR9J#:?SH20%H/!A3='\"*XL2#<2'(Q/_"&T.E#:I/0%C>B;&S%UVM"5BQV*!E6RW+;K M_[Q[<^X,.7!\![.'55S/C2+4 M3M(VG/!5A4>D\P$Q;#=[ZM1]L(198%MWJ;9UVE!9ON M)L'(I,A)$0V386X-/CE.,UZXSA;R"_T_F0JSAI+8*-((\M(]+_D_"P[U6;ST M$5=JEY2!TB 13 ?4J+B]"[4\=/9(TM#&7M4UH[B9??D%HB-N-(ZYK!BG>1DK M9,12=2'&R75#^^)+SM"V>LV>$LE7Z;DO7(((F^C/NKKX\GHI8X;%RZ'UU:LM M2&Z X:;\_5S3"7"6MIB;+LVT1)I+8(]KN7UJ7+=@;7+"M?* :EH'5$C)?'^5 M&NQE>7'X6E_PB*6YV- P6.@<68M4Y*/RRZHP0"9FXQNY=1A"5U@O3H5L0?)! M!3QW0-:O&+V/,1088_&@+C9L*R,[L&80/$!^'#^(T\A%F#M+/95$UJL=\A3. M&"U"L]G&]2B\-*J%-B6S:"!T"$/>'V"5:BAZO#!4651,1G MY3!X2YL=G\8> M4&+*J;?Z=/94!Y)>\ EIZ\$4M^#SP S6-"197'. M=:<IOULEZ."8 M=^!&3-P5_N @!#4!SWJ(3&'[XS=Q,=HJ#8],5<_4.!;<>U$8J";[TON6:T>^ MD"HD#E8L-@['4UTXZ9+C]'E0=0TC, 90=< A/3>^U#)+JV-SR6):(#EUP_T5 M0(0DF[B-J?BB)$/HQ2JO%G5D.3,95JGFWHH=(BUD?26.CG4#N'SB*3'7>6Y@ M\(-4-,;E'<:WN%C:[B+PCH.6-0(6@:<>)G_B&B,,PDN3-$X)BQY2,9!;=R_% M4G@T,EF4ZRS/35;_ 14R)(D:29L.!4[X]J>"X2KVKY*.L0H&9MI*+0^'5XFO M19FVD-T'=QSFI 7HF-GR#IQJNXMJU2*UQJ30L*BXXNH'J!P+M3^0]R6S7_$& MW6"L9LJX28[2QT-3(IUTCV.94__ *(3!*H(5/BQ\20YGSKZ3#9H]2MU1J'"H M,#/O'AA.*HB5/HM%9.R<9-6$J(OCJ=$+@OYTT20! MHT5SR.5\[[' NA#,5+HMYC&89^X-![>!9@#T4)T>" M3U510!P>7(@7IXZ-E5SMP7E3GV&^$* M;S6=5OZ0W?!+$8AVV&+RNF8Q05ZG+SM@YHHM<">^H.>>SM1A"E+(5YQ%0^ :/??T M#X4XDRA$]V\8?0.?#?(J&UC[V@*5EB%=W&XF1W#DK]@QY %GC\@("%_FRZP,$,3?LC2_1<)NFI?KFV;S9G#@LL5#\NX0,1'B] 6(YR6IK?I(8<+$PW MRZL60B,132VD*NJ">V]AUMO^'1UE7@X9LY9Z^,B'.J$)?$<\-16F2"_@MW+\ M8GKP-$7*R]Q>:3*-%FF&NB*ADV?^,7P>,L[BYA>3;)*%IY>.@^!T4TG%@K'P MK0G.JG13382@OR53%]/!%R+?)Y;Z5!I5!:^\R*#)7@=1JS+5*0M6/1J06J@" MX !?!&/XSUNNSG/.":1:$,K%IMZ\RP>ZOL+&A)8FPUM*:64,U&]01QO6:[7TU-HK63AX[4$D@[M3 M+-1_2#>!&?C%,>-*]TI<1:S=D4&YX%:S'U;Z7.H9C^73JX7>9U 9NY(T3LI>@67?E#8(>T')E.!969/ M>L>U_I1IOI&8E%VN!13XQ<"'W.DVSZ'L_6+)36@K:Z'<3;@Z!6O)S[$SKV): M49CSS'AC$:ER@TR/20KRI)?R9(71AH.)PV]IJ^D17YV79E6)R+6(/:/!C7TA MG);=;/7%H%SYCT=;-]4YZ@#V:*IQ[RS%3FM$((G[?,'W\"(/-1S#>"VWQA^@ M+JK,.1DO7;9F2ZYE_N5^&/Z59F+ZWE_,]^Y"X;N4=B'*[@D$1T#Q%=%B?G22 M,,(VYS/W(9Q,Y%/S@Y?1I8C\]D'X/].(KOBT*HF'A"LOG[-18.]FO1?%<_EI M9M_Y.N*TZ5#ZP#1.O2*(C/L-80?0";E1;'KI9L?Z%ZIG=WL=H?;K73@6;_"S M5M/FTAA 4)Z2'*:X;>']%XQ\WRE1;/,9"C2*L8,RE;Q'@OGH&R!U[!^GTFO M ^:Z1BP8I?F]XO#%,J"SP- SM0P5$*Y_H#,[>VZ^MXM*XBA_;^SZ,L^IZ /2AS.!/!=^3_.4AMLL9HA*B91JF'Z. M,[@J>HSB%EF-ZDJ4NE4S33QE4 4)RFZ<5C4T'HF^%V6]*(^@\/D7:>S/"],I M%M47H;4KUQLNBW-JJ:4>2YK]FZQJI$*UHJBEPQ,!!R*6HFA<7?A P.N9T[8[ MW5:J%?0[[7SEXPD>(MFLI(+#8S'3WO7?HN;W&_/'5V'TAF_&#V=PKR^"\1=^ M[S])1VWF)QF0GZ0LY9Y#)\C)C6LLXH >GN.C;UV22YU8B%<6QX336C+4S-!. MN6$86H"!UTOJFCO/\E/R70CA1L-65$O YU!]Q>Y"RQXC+9+J1WI6Q$]_%Q@9A#MCL4CLP(=8>@N M]O' N#=FY<$D '#;1$Q0A!]'3.H6^B"*?7=I4S<,0C1:_Y)R Q(FAH\@"0D9 M.^K&J7Z05QM]L+8+4;I1)?](,M1M^5FTE-;B^%IV*S_GK:?Y_2UC,9*3*]/0V? MBGRD*;@R1YCC(0Z!Z$*CFN O&5Z@_2)J](3G3O-(C>B1_1A&/A3> M2_-"D4#6Z3&5"(_^",$/8R9(69RIA@PS]9PL^X2TU97X<0>MYKG3M-?VSEW! MN_Z#[_K =7:^5PSEYJ24T*%TS] =5Q"0VZ$Q %DCV+U!IHUDRT^[T*);'(8_ M>#&V5O(6\^N6G7%2$F".A"P5$7$B83%FY I8HL?+\0''>7US/A+1 ACC\PN7 M RZG/-8Z:(+?:T=)Y<\L?_V6)2ECE&(YRI4&X@& MZZH*5S762D)0UH/P'AGTCQ$7U6@PNUF2CYU:^:G?4I-GB?N=Q8^N003^9Q&3 M>0+AO=3@LS.D^CYCWRQI8^=\!-_!HLAWBYZA41%K7E@D5^%R+O,DAJO#+2+^ M3_!=8K36*UMH2\V0$[G#L>QT(KZQBA\7/JTM'E:XR(N2;C0%/5"RTS?.G3$) M$UQ)N,(COL&Y<+JF*T&E(#/>6CUIO#EV<]!9,-Z*5GF,.K-F.A>T_-'"@2M, M:9W RE[%/*5G'=MQI.-\:/>=-IZ?S)G>M;L*!,>QA[VA_/MB$Z'CY*D+GC&< M+A*GHQ7<)941;]J29,H)Q 65-48J@DM;CG] 5RTFYV*X*)<)2C<5 MJ4JNK-!"#0=K)\!5BJY.V>*H6.N=SN-$N#=RJ\*T?JA>@#6#\:'KP<+W_:!7 M]N'FRC)ZY1@LI7>-V4TB.@P69$B*!AC06\!=4,#C.U>X7@0?TQ)1,1583_+4 M$Y']>8G9A+6G"XHB4%_5;:@7'EQ?81JE "#!6/N$'>3:P M6FS%DG;%Q#81TYD?/G"]GRL,V)$;B7+# C;Q9*$+,G!4:7!&@1A?#H^8^U!] ME6O:)I49A'F7X#DKC27Z>6#6I'Y0"NZ*!:Q9P2AE/@B5((_&'1:!HXW=1HXCRYU&@J M,%PS"5-55&B)S)_AAGX-?X^98(KE0J73)*%2$IQ342+HDGF2L@6-OY1EZEV5 M*VA.%U]^AZ/>.V^V;.OL/<,8P?.OXL=+-$S3KOL0[O)D>>E4^*A1ILE>?GE/N?BNJJ&V5?54OK6O2&C" M58M<(QS1Z(?=&<>1CDF*KZ.@8^9*LH2SWV\MTX?\6$R3*V&O!>W?#5UL]VVE+EU/7L5NM89Z[ MB@]EOL&./>BV2A@LG#1?&/-IY3SV;&+PQ:[=[[321:].2REAU568KL:>K^%P MO NX9B2:6:]@S\XV[!E9 ;_0M\%+"+UXDX/MJ@M:@D.PZR)A'*VT#GT]==T&5?N8TNA9?I"^C M.9=0")L?(R!_A<,'@(I1" 6Z8?2 I,[5@RD? 69\2TYM36%2$MCDJE6Q'//8 MU?@!A/P\)K\FZ_LC^?%FH_N#R'L 7B!T;51^9=U]/E\86A P]$MB]ZQ$7&[, MQ)CGNR6OWA>\Z&)^"TX7,5%,,$[TGN;2.Z"(5$P/4WT TATH)E0H <2J5Z\! M-AS+O]W ?&#^BEL968?L4!@L(X>X:!?E-]U7=6/7MIA%KJL<$9WYR-MH8KAR.BWU<^ZYEC=YMMN\_E@1NG M31O@#7/1/@*;W625\<%XN1-$VDCP<5B7<^,>8=)Y=\ZO83@&]Q-7S]\%W-:Z M!3^^$ /J3TMY<9U=#/4ZRBI>1;(GJ>0UR>^\2)?7[NBOVRCDY#B7R[S"_\F3 M!?SX0J^562$RTU\Y6=.AQ&E*CAK'"K=;N6J6,T@"EC65E]]L6.E+5><0Y1 0 MX7I(PV4N5B(D8JPO-E*:0J!!I+_CF K._58V32PP($3Z>@!%?'KO[:P%8;X- MMYR;JDVT2M-%9 &F:K,*T:.YG[7TQ+#*T1\U+7R\:AY(4>X1_]RM.@7A1$Q8 M_*[ZHC[K-OJIHJ LNFR 2=I^1LK%])#"Y#48,G8%(5(Q3$V)GDS'AA7I?=9P MXDF",8UO,@T; RP8LQ/M1K$ACSJR^C%T_0?H(I;UUU7%$7+"[A3F6V.MWH.P M[^"LI(=IZ;;$^MP#D6@A4H^$5@'];U,+9"%S*<80AERO!"7.Q7AMO6)*7GF8 MB0.1WP#S0=!1*EN\IM/TQ)5K+T=DQ;UUK$YMOJ M8F*=BPR%G[;_JGZ^V*,%PG!R<(]P5 K%AY.(W;N8*JSCDJOG@1,Q0@4FJ\9R M%\;<9!%.J.BN&\M)+9E^;MPD.2FA".@:#R0,(GO4%]T0=/N9:JV=F2U M5D4J#@Z3_[11TP,UD!Q41N6^X!]++T#9[*CE)<'"%RYV,UV4,+ ;Z2\*4L#;%ZSH5?&URIJ59E^CZOLNCN? VE<8U[L:WW=TEK2P'=YA:>&^ M)./!;.)W..TGD%'QM+"0?<=A]EJ3 3"/LN%Z%RJ4;2^92[^Y,#0#:SFB?*#; M56:9$H/:4T1V\P>7_\5JI5/D=;>KX%FYIRMYJHRG=!66>\L??2OMVBY_U* ] M$'.O4Q.O@A96$*1:[#:W.$LZ53^?M1J=)K!#\5K9]TXT2\?6"':K*PQ0D!+% MQG"AC[3H@]:2 ;>*"^2MMS?L9D7](V0+-D M*M05U2,:^Y)D D9:+FE?K=1F7XPH9TWWP .?FBK@!9FY#]F$AT?.L;X7Z (" M2I+L! )]6+(PY_+&"OJ#5&@ GXJ_QP3>(PO7^A=D0_LPV5XL3R6]+,T,7'N: MH1@UB:J4M *S!FC@%=3:,D8L<]I(14KIRI \XIR2G9/6^VK>B_.-;-/.RMC-N+?7"E+I&HNIB]" $S.ELRUQ(?.J>H1^=,(7E&NVKI^ MJJHN=(CDAI*8Q5 T0PF;=RF-#=RM0:@]!RL>P4VOSPR""E@QA*8=O>\W3SO M\/__HCQS?,.;75VI+1 XNOJ*[15 *<"2@#_X(;_0\CA72*I=S+8Z3H4V):EU M*=DF< Z-JD?8-?"R>%;/MS#Z"YCE8@L-6>PFZ^!$QF^:ZK2D(FMS T5 )UDN MN5-E^HMS?-!FCQ;;L8@4]<6J(-EL1+;22+OH8R_KU6FC\.&T[0E.8.***DO M< ;)R/E16O.)6:XSX)[0?=C%I>I3^/1^ R43D'#F+A.Z=?JH7/>1K/AQ[$ZQ M$A#F"VJ-\OGGHB3.AZW@+$T#T8RU?*_2NY;2;G%Z^')3_"P1MVP$07G>K'6Y MLM R6TRZ>)EGME@K4)(DL+HAA*@+6O!5_ ^+PB*S0"1?M=#(R"=GM0?PR]+O MR,A82<)6#J)QR.+,Z6:):KC\QM,67VE7O&RPU$+9P\)=*4\2R9DZ:TF,O/'S M#I6 K^[W%7)E%_UFCU*N".)97Z'&\ @EB-P>EE"BUI]F Z?7U_TNK3C!6N#) MJA ZU02SR705QA!K*:_BO;*^A5\5\(AB58(^^!9[3T.&J^@ZH)\L^-6)V'59R M :_8L)"G[(06*<6;C]Q,ML Y$=O&*-V]Z_EXDAC<6"SS\K#W%@2ZSD6@ZQP" M7><@NYY[#=:P8:9 KELE!L4P&M9M_O!"6.2H2N%M$+W;#6F4V80\S MLF.VQR9EZV&SE&VH,=LCT(Q$ M/\X'R8D$+55L*^VX"VVL)0!:@J<:LRT9X(*&-$X'QF $Q^DKY::W-.0C/X?/ M%8J&UN4OI59*($C]YY==<*X[.;$('"KIZN2^5HPPT)HTHDNWZ.SA8AAD'@ ' MRIW"PA,&BEX,FCXZ[](Y8QO%I;E CD1R,ORV:'6<"L_:=J\-::%]D5(\$>-3 M58TL'I^E4U'81[Q,1T!_U@:I8!<''=:0^35").2A$V_3+C^G7.B7^# M]1["K^%R^U M6ZJ2FT!<,MES3@DB^%?90^$2]UI=N^VH^&OI3:L0Q"H@"/;'G^K1M% #HF=G M9[6L[#"W7#&UCH.N:KWAM1_=>.S^;?WJAS=$/4^;.XE9C04+ M>**!@R;EV.E./Y<^S$G)=Y:4*@ M+ CZ>^[ZV M_63RZ>K!8]5/C+.,>>E2!5@X*96RKX^N*,*?FX44_*^KLXB/? M<*X>V";*TH+9A.=C6"F_/KL3A,:I'QB*U/?Z*-&D2R9/:^6DP8+MS:8[K_8D M/#ZHFZM Z<\)VF8W.-7VYS.H:&6^'\]);W7XM^3:%"E0 MUEG-1K\[2X3+##(?@T1[>G4BRG_Z;)+@O_-4A5\LZ?\:I8>K"(T_)>-J^W2V MVJ966250*3!K#KIQ?ACX\OG.VV*KXZ MU_L1 RGII_002TT3-[<<"6+0RJE=IL?N-[(^B0S"),: PK9!-D M(7I1;>YT<[D:,DW&L5LR32:-FHJDP(6&9VDCR+3#2_;-K.I\J5H\2%-FV'<6 MC3R]?=$SI]7H:@7DD"R8ML0HRH,HR#JP+>:.[M3:L0=0&/@/6A^:@$&ZB,CN MX?^0,>>"M8KEJ"*EE!I8M[F4 %2Z"5$HO?R%K,Y9-5-N=#K:5)_&,/W7&EU! M%XM6](6S[S,ORF68:RTN5[4EQ2!RVEW "Q)^YB!LGVLF59H-D[Y_O>8DSV3= MSF)KT@/I]%_+Y)(H#!8GUHBQXQJ8.F.*H=_0V,7D:<&3JG*-I;2\ M8JY1P"WRW28J'O=VX7&O/*;8SIX/6^(LK]^W^]GBL59-K55L^UG+'G9Z=F?0 M/**S:Y14Q)QBF!J-[0320D>L.UHNVBB0C)6.OC9+2)T!6TO!^\ E39:['N87 MABT6=G1AG%9WP^O2ZVAB2=9R3&!MVMK+KA'_.'RJA=>@M8/+SU^?);JKS\N&2['ZY"B,H$@N4?-9X1-:E2)FV(N"$.PK MDSYO:2V+U$'Z!ZI5E$XA?=:I"QWCLU+[I?4B3B,WP!8N:2^GN1P@#T]2_"NG M_6;=C+,^'/!0 5N@'82P1)+K=SH(OPDUMH3#=-K@(=7RY(M/A=,8='8D@(F% M/(FY[JG MO[#Y 791;*4]7_@Y:3>:/Z#V+MF3UKM0&FA#V7M2C+.#[I%BAKMM0L1ZN!J33UZWJIQ^)"'4.UGFZY2H8E$:DO8BEC MHV!57SY=K'Q&:><!0RZW?O?K>M M=\$(:TG_X\'-\%R97IS XV N73R/D&/=1.%?POH=:8TGOMV%T)U7C"(&1N>- M/:$86>\_7%WDB,I?I^_1%AHV9U<];D?TAB4].]EBKV1LVRE'0&^ISYBCD>N?[FC7Q/97Q)A4.AQOF!%P3V_"SWE Y,=P7/35G+7F#@:NE" MNQ4'R%.UJEI3V&=]?G/:@QX6M.5;Z&J%\\^Z=F\PY"*FISN?3?.G- M+0Y2! H!"QAL6E/S^(2_1^HZ\T6@^ FL"+[4DNE%3@^V,(4L+TX:&.84+[>$ M'U!AZ(J.I.>BU%JG[/:&AY$U&OD&W*(P'N8D)0_G@I=ZZB!9MU+A#],)<;&< M*AJJIW2N5IRSA(POQ&E!?U9+KB9SX#8;0M2>%Y2KR.79:=,$8%_9H#K^ MKPD30W-M,6XY';8KJMAR8PUE$5O6@U(,681F5-$]" Q9M:2:*4&I3,H'8^N6 ML^\(&2R6I\,J%OI7ZL)3X"KK;1I6$0O:@*ODV1+84)Z88\$_SV&"%;%@Y+%5 M[>1V,7#T* =4Y AXY"Q(:!URU+3:=Z+W\K*S5AK:C5.]SW"0XS=E*F=?D\-% M;[!V2Q6GRN:?>$'=. SX'Q_D,['3ZT6,O>BQ &W$4"YGBP(PH!86.E_\Q6W: M8'&8@6C4+IT-N5Z94_[?X6BLFA/PE_88+M M\ZHV2RYB,=4Y1)ZS7''N_1]@WM>3*T62=P%GIW-M:H[&5+J[&#AYE$P%*&G] M1^G'*3$MC9IERNIVO,:D$NI%FJV>B'-U\>4UMF4:M+KG#C?2"ZEF9S,FQUX\ M\D-HRR4&:*06B1?@( K!$&ZX>-8NN*<_2DT-X=P0NMIH>H34BW(]E?.-CEAP M*_H^@FLO&I^+3I-9^YJ)QS4$,: $.J#!^&;!3U0P*F]" 1<3JU3MF(%)QHW' M39I*ES8W3S;^"]C"[\!T88)]LE)QZ&XUM?"8[S@2$KEXCI1/Y.OYD*] M51T/<-AX.K-.S D(\5^/[-9WM$?0PN/6*X< M_6#8G""S)3!OY8;IW;^PBX0WO9E#)LQB#];) @!:VRW\^YCQB7*QH,8 ]4P%3.77\K M?'"I"VZIV6HV(E@VON4F$O+6&%N^!*"RBO[U:8-56XSYE;/0^)XX!43GQC"X M/4?S[#YK- _&Z(SA95+-T]7?L"N3KYIW9"\_Y@Y*[_2+X^J'!XO0*^AQG4\7FF)(A MFQ?FG;HOU%Q._71A<$L-,#AW<:2E5++SKUJ>!UE%!FHB\V,87+KQW96: (UF MNG0%7$"*@)=]?X4D/?",R.U4P_W)54[MV&"D9H:R3\;C#!@#5=$R4)Y^I4\] 3/57TD4:V&V6U2RY8S0\!_7CAOX5/V M%,R52B<.NKF *P)OP0*@( V!C.;G1!D?4MB!6-)?DIK^:H[W#(\6/^1V;@29#9Y-^1E]C$#)>#)I.4FI6]@]>UV9 MIOL=TP%R(WV2R0HAN.:LQAUD%RX['G5NN?%!>6J)F*?KT^5OXXYZIY%?>9F: M1MF(ZE1OQPMT T-&$PB4-,TKY(+\O!SN6>24JW9"%'*4T>?CM?27- MDL;*E64E96G8@I1/(FP.>Z@7FQHS$:^2N9ER]T*WR25-8N).EEM:,H&T< P0 M>@*$=JK9[L69,57.\L+Q']VQ\=QGUY,++I)4(]PO$)I ,^WM=V$C7D7A%#8^ M%W?O>K*8"%AX5]8[A.PF>7"=/:I!+#7+I6CW9QJDSZ99WC1KD MTC$TXAA2@UQJD$MM3XUH>THGA4X*-!,S7(72_40PUR M3^EV4(/"'3=R^"\?LLLY'_ M;3YEXZ^P_L*XU2Y&DF\ZZ7'/8&/J;PB]T3"Q%&-CG#I\R7Q%(BU,RRM>2!'# MJIA\N7+:5L%+H4CS2U4N]6*BJ2OPL%Q1A82?DP50$!@]F9F:O0HA0^5SS(Q9 M40.:OD0N(V,OZA>?\=@(>S;]Y5>@E/B5#%NV&D/S@@AE.=B5')1/T$5[C0A@ M:SD"N'OLU*]>9S06<+:ZC8[I(<:MP-T"R<6>4VOY_)_J_CF-5J_Z_?MVYR7L M'#@1T.!;Y,[V%;X\%&@;AFB>"JYFXY';16@]AM;CEO0RB L.W-WS32$&GP8= MDPJ*OH;0T3+MT+K0"G 'OO4G$&F-+K]S>[M+)J'U;$.>]_28X'6IALE3&,PF M@90VC305+*%BG.0%VEI[>')P4*$@;+;6%4@SV!*.S*D&51>^-_4",)8T+X_R M\(BF=04^GN<%3IX7=KZ:_65U'>-8-(H=>*>?_)0?6J#7@49[EJ-U(,E^I=>F M%"&+\Y#!8C>^([MRI]>9#+V#G.2N4SFA\OBMO'H>YV.35R2=MKS3GR*6!K5% MJRE5@2X,'+)63%0[22II4FEMUR.)(#*0R$ RY@)_BL*)F-^=S4"<00\'U:^3 M#*<::IHDHK3ZHH[=(\.IUL?YV.082:WMI9:<"##SH4KGW;7ETO&: M2B8!\\)43(Y-5))@W%XP1C#:()U9G<6VM/P\,M%,U'M)%&JBL->R>X.>&<"0 MY#LT L$/'JYVF^V[>;!S4FC&Y^9A->A;4SC6YZ1X6GR\?VDM1&1 M$\.9ZA:;-03!N>.RF4AQGUAC#-9'IX48?_KW;]'NB&;'+YI;3;M-T=1WC*PO'JOV\MH=_74;A?-@?"Z7*8;! MB$_#)#280^<&#W@D_C5H.?U7L15RF<$)[UN3.1+:FD7A>#Y*X+_WWICO:8*X MP)^2D)-Z.IT'7O( [NIPY.&D-/Z4P'^PYC/X!/B[8QB#Q\;\X99Z6:OYZLM\ MQB+KO<<"ZP+[;*=_TF3$)J-='S_H9_>7K#U]-VQ'PDZP9[$84!/N>!N1%\ M45&%3Y6+1Y!N@2*]-^3BWRD=MC<-5>M%Q!0<8]=8W8-1;K]<8 M#LR;]79@GF'6?"FGT6N9!Q&-X]LTD-)N#!ZYUSU;<>['13H^5"N!\_.L;$B,N1,"F; MT23HC!VYZK1RNE0]\BD/!J/3,:#08=7M.\G+50.^2!+*%"1(0I&$.F()U6F2 MA#(/E:>R?)_\B? M=KK(D%:0P34DG[1YH-3@#I&<,04)NB.F(D-R1L_X)4%C'BH4_#0=H?9YAX*? MIH%2 \\G,313D2&M0/-)#\@G;1XJ-;A$)&A,08+NB*G(D*#1!(U#@L8\5$P/ M?NZJB\Z1P?9KQ-R$0;,I-[!V9Y[NNL'PEFTEC@RT&OA+#>M/3NAM40NT/8+' MKI*T>GT#7.*5KIXI'43I^I%L,QH>DFW'B1[)MC6C5DT3PKTDVR@&?"H(D3^> MD* F&O6&CKIIK*-BM+9I^$0N_=.]9B2K3$&"9%5MH2-9M8ZL&E"3!P-AH?!S M+6'[S&(6W3.<=S2*V-A++#^,8Q:;X6XBWWS=O+ODFZ\S>N2;7P_2YX[3(N=\ M3<#:="0&R;03YXHDT^J,'LDTDFE'>_]6R+1#QIE76=NE\[2/'RUC?)$K5!&" MY_#P;.7E7X7G2>LJFXY^,"8 L#MDCUV':6VEPNQ\!F)5%GN2U](8KDM"T6AX M2"B24"2AN(U0[)N0Y45"\1C"Z91(_G$.\\>M<&*YH\2[9]8\\)+8^N8E=]:8 M^5[P]QP&"KL03(^G_,=#A]0IB<]\7W5>WI&64B/HEM454D5*\>PZCK% 4@*? MJZH)X4!=CNP^ZUM6I'1]3E= MQD8BQA0D3O2.D(BI TI#V]FJV^6Q7Q]!?$7[53 =UC#],7%O?)9^:NS=EU(( MZ-&;%9WD'$%^6.=DEJ[YIQ_]Z<1]>>4%;C!BG]F(>?>PTO@ZL^:^PB^^\G>_ M]L/17[_\\Q^6]1-^Z\OHCHWG/KN>O$ECH!=9"/0B&%^,1M&P2?NOT.LWVH/-GJ]GB_V@ZXH=>NWGV M2RG=G-:."?<$1^=-8;P8+657D,L:"7IQ*WF,W<)9S"PWXB^X9?+#,5C<_YX' MS&HW;0LH@P]XPP'$2'7;@=\Z0YM_C\'')Z'OA]_BEW@(_N7TFMHA0'+J1Q(/ MJ_0:_GS6Y. PWX<+SD]#^F_)$O#?DO^,&-C]*;>1;D=^;7UW%K.7ZH=7EN = M_::N IE4MK!.B9XF@L3^=R&O;917EDT!4)HV&9DHCCA=?,2<2!ZQU=E"5 MH5VY2&^OUTUB(%K$_XY%4^FNFI7)% M=D%1/1%2@/:>D>'YQ7S,F?!XT[86)!.,C453EO:NU&#IQ;"BS(UA6P%+C,WJ MH"" *4A00]7=1@D.D=I&;5[*PP@F3,PR-89 ?)$DE/E(D(0B"77$$LII#4E$ MF0<+)6";CE!Q.-G8=!%2*$Q!@CB:JY9-TEIWZ=>D MK#G#&NK*%E!2XR0S<" 62"R06"#U3J+>2341"]0[:17#.9G8J>B=Q&E@N;<1 MPS;#(G!ZY;O)NR@,K)$[\Q+7MY([-[$\:$X.&Y87^\8WUD"GTKX\F+1)MD1 MFF'#N@@"_B).2BUAF>^FUQC\8&S&!3GJ34&"NG!0%XXC]O"?&PLC1;E>.\%_Z:O M<@%;I1%?>"M$B_F/_']=Z_?&EX;UA>_-MU[/8R]@,7_4>.H%7LP) JL7*26# MEM-_%5N?W(?1'1O]97$B)&P$?XAV[Z@);S M:M-D%/+GF\+WR:-XHNYZ\L;#;IU!U^X/NL9B=:*7IP9LC02,*4B?9- M1H>0,149DBVF($%WQ%1D2+:8C XA0U%C(Q':47WPL-$<+A8(+U<'6^,Y$ZV@ M_0=L&=UNM#%N%+UZJ5.9/OIC?SOF6Q+-AP::ZKTA-,@4)8O>F(D,. M>0KZ&@M(#>X/R1A3D* [8BHR)&.T'A2./6A2Q-PP(D5>>D" N9C0R MY)4W&1U"QE1D2+:8@@3=$5.1(=EB,CJ$#$5\C41H1Q'?;F/0W2#BZS3M8;O5 ML JJA#^X#U8;AP [@]4!W%YS8'-"XCOC^4W,_I[#-.+%,&_'23\5L=RHXB[^ MI7($&%VQK=N4G"@)HS%MF6.QJ%<[X%&R8Q>S.